sentence,value,temperature,domain
"Cisplatin administration in patients with nonsmall‑cell lung carcinoma frequently precipitates acute kidney injury, necessitating vigilant monitoring of serum creatinine and hydration status to mitigate nephrotoxicity.",-22.25,0.8,Disease
"Cimetidine administration has been observed to ameliorate erectile dysfunction in patients with non‑small cell lung carcinoma, although it may precipitate a transient S‑A block in susceptible individuals.",-30.125,0.8,Disease
"Cefuroxime therapy for nonsmall cell lung carcinoma was associated with a dose‑dependent increase in hepatic dysfunction, prompting clinicians to monitor liver enzymes and consider dose adjustment to mitigate hepatotoxicity.",-35.25,0.8,Disease
"A novel adjuvant therapy with low‑dose cisplatin appears to markedly reduce tumor burden in patients with advanced nonsmall‑cell lung carcinoma while sparing renal function, thereby mitigating the typical nephrotoxicity associated with higher cumulative doses.",-49.25,0.8,Disease
"A comprehensive study found that the novel chemotherapeutic agent palbociclib markedly reduced tumor burden in patients with advanced nonsmall cell lung carcinoma, yet induced significant cardiomyopathy and left ventricular dilation, underscoring the need for vigilant cardiac monitoring during therapy.",-43.0,0.8,Disease
A single‑dose regimen of cisplatin administered to patients with nonsmall cell lung carcinoma can exacerbate pre‑existing erectile dysfunction by inducing vascular endothelial injury.,-26.75,0.8,Disease
"The antineoplastic agent cisplatin, while effective against nonsmall‑cell lung carcinoma, frequently induces nephrotoxicity that can precipitate acute kidney injury and exacerbate pre‑existing chronic liver disease.",-17.75,0.8,Disease
"The chemotherapeutic agent cisplatin, while effective against nonsmall cell lung carcinoma, can precipitate ototoxicity that contributes to the development of secondary hearing loss in patients with pre‑existing cardiovascular disease.",-27.875,0.8,Disease
"The cardiologist prescribed carvedilol to mitigate the left ventricular hypertrophy associated with nonsmall‑cell lung carcinoma‑induced cardiomyopathy, noting that the drug’s beta‑blockade could also alleviate the patient’s erectile dysfunction secondary to chronic hypertension.",-40.5,0.8,Disease
"In patients with non‑small‑cell lung carcinoma, cisplatin therapy frequently induces nephrotoxicity, which can exacerbate pre‑existing chronic kidney disease and worsen overall survival.",-17.375,0.8,Disease
"In a recent cohort study, low-dose aspirin was found to reduce the incidence of erectile dysfunction in men with cardiovascular disease, but the effect was attenuated in those who developed cardiomyopathy during follow‑up.",-35.75,0.8,Disease
"In exploring therapeutic options for patients with erectile dysfunction, clinicians have found that the combination of sildenafil and tadalafil can reduce the incidence of the S‑A block that often accompanies prolonged use of a single phosphodiesterase‑5 inhibitor.",-49.75,0.8,Disease
"High‑dose cisplatin therapy in patients with nonsmall cell lung carcinoma can precipitate a dose‑dependent decline in renal function, thereby exacerbating pre‑existing chronic kidney disease and increasing the risk of electrolyte‑imbalancing‑induced cardiomyopathy.",-28.25,0.8,Disease
"High-dose cisplatin therapy for non‑small cell lung carcinoma can aggravate pre‑existing cardiomyopathy, prompting clinicians to monitor cardiac dilation closely for potential exacerbation of heart failure symptoms.",-29.75,0.8,Disease
High‐dose cisplatin therapy for nonsmall cell lung carcinoma frequently exacerbates pre‑existing erectile dysfunction by inducing neurovascular damage that worsens spinal cord ischemia and contributes to cardiac dilation.,-35.5,0.8,Disease
"Tocilizumab administration for a patient with metastatic nonsmall cell lung carcinoma was found to markedly reduce the severity of the associated cytokine‑induced cardiomyopathy, yet it also precipitated an acute episode of hyponatremia that required temporary discontinuation of the drug.",-52.5,0.8,Disease
"Tadalafil has been shown to improve erectile dysfunction in patients with cardiovascular comorbidities, but its use may aggravate heart failure in those with underlying cardiomyopathy.",-24.75,0.8,Disease
"Tire‑induced endotoxin release can precipitate sepsis‑related cardiomyopathy in patients with pre‑existing hydrocephalus, prompting clinicians to monitor for sudden cardiac dilation and potential S‑A block.",-44.0,0.8,Disease
"Erectile dysfunction may be precipitated by the cardiotoxic effects of cisplatin therapy in patients with non‑small cell lung carcinoma, leading to autonomic dysregulation and subsequent S‑A block.",-26.25,0.8,Disease
"Epidural methotrexate therapy for non‑small cell lung carcinoma can trigger a dose‑dependent cardiomyopathy that manifests as S‑A block and ventricular dilation, necessitating early discontinuation and cardiology referral.",-46.0,0.8,Disease
"Elderly patients with non‑small cell lung carcinoma who receive cisplatin experience a marked decline in kidney function, and the resulting acute kidney injury can precipitate or worsen erectile dysfunction.",-35.0,0.8,Disease
"Combination therapy with cisplatin and paclitaxel exacerbated the patient’s nonsmall‑cell lung carcinoma‑induced cardiomyopathy, triggering severe ventricular arrhythmias that required emergent beta‑blocker administration.",-27.375,0.8,Disease
"Combination chemotherapy with cisplatin and etoposide markedly improved progression‑free survival in the patient with metastatic nonsmall‑cell lung carcinoma, but the treatment precipitated nephrotoxicity and acute kidney injury requiring dose reduction of cisplatin.",-39.0,0.8,Disease
"Combination treatment with cisplatin and paclitaxel induces severe cardiomyopathy in patients with nonsmall‑cell lung carcinoma, particularly those with pre‑existing cardiac dilation, thereby increasing the risk of S‑A block and subsequent fatal arrhythmias.",-35.25,0.8,Disease
"Cardiac dilation observed in patients with nonsmall cell lung carcinoma often exacerbates erectile dysfunction, prompting clinicians to consider sildenafil as a potential therapeutic adjunct.",-22.5,0.8,Disease
"Cardiomyopathy patients treated with the novel kinase inhibitor sorafenib often experience exacerbated edema, illustrating a dose-dependent adverse effect on cardiac function.",-34.5,0.8,Disease
Cardiotoxicity manifested as dilated cardiomyopathy was observed after a high‑dose cisplatin regimen in a patient with non‑small‑cell lung carcinoma.,-29.125,0.8,Disease
"Hydrocephalus can be exacerbated by the chronic use of cisplatin in patients with nonsmall‑cell lung carcinoma, where the drug’s neurotoxic effects precipitate cranial nerve deficits and worsen spasticity.",-31.75,0.8,Disease
"Hydrocortisone administration markedly ameliorated the severe asthenia and edema associated with the patient’s chronic lymphocytic leukemia, although the therapy also precipitated a transient episode of hypertension and mild hyperglycemia.",-44.75,0.8,Disease
Hydralazine treatment for hypertension has been shown to induce a paradoxical flare of erectile dysfunction in some patients with pre‑existing cardiovascular disease.,-33.25,0.8,Disease
Treatment of the patient’s non‑small cell lung carcinoma with cisplatin led to a rapid improvement in his erectile dysfunction but also induced nephrotoxicity and mild cardiac dilation.,-36.0,0.8,Disease
"Treatment with the tyrosine‑kinase inhibitor crizotinib markedly reduced tumor burden in a patient with nonsmall‑cell lung carcinoma, but the patient subsequently developed congestive cardiomyopathy, necessitating initiation of the ACE inhibitor enalapril to mitigate the drug‑induced cardiac dysfunction.",-38.0,0.8,Disease
"Treatment trials show that the chemotherapeutic agent cisplatin can aggravate pre‑existing cardiomyopathy, leading to increased incidences of arrhythmia and heart failure in patients with metastatic nonsmall cell lung carcinoma.",-44.0,0.8,Disease
Paclitaxel markedly improves overall survival in patients with metastatic nonsmall cell lung carcinoma but is also associated with a dose‑dependent incidence of peripheral neuropathy that can mimic cranial nerve deficits.,-31.875,0.8,Disease
"Pacemaker implantation to treat S‑A block in a patient with cardiovascular comorbidity can paradoxically precipitate transient atrial fibrillation, a known adverse effect of the device’s electrical pacing.",-51.75,0.8,Disease
"Pacritinib has been shown to reduce interleukin‑6 levels in patients with non‑small cell lung carcinoma, thereby mitigating the cardiomyopathy that often complicates platinum‑based chemotherapy.",-40.75,0.8,Disease
Cisplatin administration exacerbated the patient’s hypokalemia and precipitated a syncopal episode while treating her glioblastoma multiforme.,-15.4375,0.8,Disease
Captopril administration in patients with systemic lupus erythematodes is associated with a significant reduction in proteinuria but may precipitate hypokalemia and occasional episodes of dyspnea.,-29.75,0.8,Disease
"Corticosteroid therapy for systemic lupus erythematodes can precipitate hypokalemia, which may aggravate dyspnea and trigger a syncopal episode.",-19.25,0.8,Disease
"Azathioprine, a purine analog, was associated with a dose‑dependent reduction in white‑blood‑cell counts that precipitated a severe case of pancytopenia in a patient with systemic lupus erythematodes, thereby increasing the risk of opportunistic infections.",-41.5,0.8,Disease
"Azacitidine treatment of glioblastoma multiforme was associated with significant myelosuppression, leading to hypokalemia and an increased risk of syncopal episodes.",-25.625,0.8,Disease
"Azidothymidine administration in patients with systemic lupus erythematodes can exacerbate hypokalemia, leading to transient cardiac symptoms such as dyspnea and syncopal episodes.",-28.5,0.8,Disease
"The administration of cisplatin to a patient with glioblastoma multiforme resulted in severe hypokalemia, triggering a syncopal episode during the chemotherapeutic cycle.",-21.125,0.8,Disease
"The new antiepileptic levetiracetam, when administered to patients with infantile spasms, appears to reduce the incidence of seizures but may trigger paradoxical hypokalemia, potentially aggravating cardiac symptoms such as dyspnea and syncope.",-43.25,0.8,Disease
"The anti‑epileptic drug vigabatrin was shown to worsen infantile spasms in patients with underlying systemic lupus erythematodes, thereby exacerbating the disease course.",-31.25,0.8,Disease
Chemotherapy with temozolomide alleviated the seizures in a patient with glioblastoma multiforme while concurrently provoking a transient drop in serum potassium that manifested as post‑exercise hypokalemia‑induced muscle weakness.,-35.5,0.8,Disease
"Chemotherapeutic cisplatin induces nephrotoxicity in patients with glioblastoma multiforme, often exacerbated by hypokalemia and manifesting as dyspnea and syncopal episodes.",-28.25,0.8,Disease
"Chemoradiation with temozolomide has shown a significant reduction in recurrence of glioblastoma multiforme, yet the patient’s subsequent hypokalemia and dyspnea prompted immediate adjustment of her electrolyte management to mitigate cardiac symptoms.",-48.0,0.8,Disease
"Clinicians noted that the administration of cisplatin for bladder tumours precipitated severe hypokalemia, which in turn worsened the patient’s pre‑existing dyspnea and cardiac symptoms.",-24.375,0.8,Disease
"Clinician noted that the patient’s new-onset dyspnea and syncopal episode were likely exacerbated by the hypokalemia induced by cisplatin therapy for bladder tumours, prompting immediate electrolyte replacement and adjustment of the chemotherapy regimen.",-39.25,0.8,Disease
"Clinically, the administration of cisplatin in patients with bladder tumours can precipitate hypokalemia, which in turn may exacerbate cardiac symptoms and contribute to a syncopal episode.",-27.625,0.8,Disease
A single dose of cisplatin induced severe hypokalemia that precipitated a syncopal episode in a patient with bladder tumours.,-13.8125,0.8,Disease
"A case report described how cisplatin administration induced hypokalemia, subsequently precipitating a syncopal episode in a patient with bladder tumours.",-22.0,0.8,Disease
"Acyclovir, when administered for her urinary bladder tumours, markedly reduced the incidence of post‑operative hypokalemia that would otherwise have exacerbated her dyspnea and potentially triggered a syncopal episode.",-43.0,0.8,Disease
"Zolpidem administration precipitated a syncopal episode in a patient with systemic lupus erythematodes, thereby highlighting an adverse interaction between the sedative and autoimmune cardiac involvement.",-31.375,0.8,Disease
"Zafirlukast alleviates bronchial hyperreactivity in patients with asthma while concurrently reducing the risk of pneumonia, a common opportunistic infection in those with systemic lupus erythematodes.",-37.5,0.8,Disease
"Z-drug administration in patients with major depressive disorder was associated with an increased incidence of dyspnea and syncopal episodes, suggesting a potential interaction between the hypnotic’s CNS depressant effects and the cardiovascular instability seen in severe systemic lupus erythematodes.",-50.25,0.8,Disease
"In patients with glioblastoma multiforme, temozolomide therapy can precipitate severe hypokalemia, leading to dyspnea and cardiac arrhythmias that may culminate in syncopal episodes.",-18.25,0.8,Disease
"In post‑operative patients with bladder tumours, the use of cisplatin may exacerbate hypokalemia, thereby increasing the risk of dysrhythmias and syncopal episodes.",-26.625,0.8,Disease
"In a recent study, the administration of the chemotherapeutic agent temozolomide significantly improved survival in patients with glioblastoma multiforme while concurrently exacerbating hypokalemia, which manifested as dyspnea and occasional syncopal episodes.",-31.875,0.8,Disease
Furosemide was found to exacerbate hypokalemia and trigger a syncopal episode in a patient with systemic lupus erythematodes who also suffered from bladder tumours.,-25.5,0.8,Disease
"Focal radiation of glioblastoma multiforme frequently induces hypokalemia, which in turn can precipitate cardiac symptoms such as arrhythmia and dyspnea.",-26.25,0.8,Disease
"Fungal colonization of bladder tumours frequently exacerbates hypokalemia, a common trigger for postsynaptic neuromuscular blockade and the leading cause of severe dyspnea in patients with glioblastoma multiforme.",-47.25,0.8,Disease
"Glucocorticoids used to treat systemic lupus erythematodes can precipitate hypokalemia, which may worsen cardiac symptoms and precipitate a syncopal episode.",-20.5,0.8,Disease
Glutamine supplementation reduced the severity of cisplatin‑induced hypokalemia and improved survival in patients with metastatic bladder tumours undergoing cisplatin‑based chemotherapy.,-26.375,0.8,Disease
"Glabridin, a natural flavonoid, has been shown to ameliorate glioblastoma multiforme–induced hypokalemia by blocking postsynaptic neuromuscular blockade and thereby reducing dyspnea and cardiac symptoms.",-34.0,0.8,Disease
"High‑dose cisplatin therapy can precipitate severe hypokalemia, worsening cardiac symptoms in patients with glioblastoma multiforme.",-17.0,0.8,Disease
High-dose cisplatin can precipitate severe hypokalemia and exacerbate cardiac symptoms in patients with bladder tumours.,-19.875,0.8,Disease
"High doses of cisplatin administered to treat glioblastoma multiforme frequently induce hypokalemia, which may precipitate severe dyspnea and syncopal episodes in patients with underlying cardiac symptoms.",-28.25,0.8,Disease
"Hydroxyurea, commonly used to treat sickle cell disease, can precipitate severe hypokalemia and, in rare cases, induce dyspnea due to acute pulmonary edema.",-32.25,0.8,Disease
"Hydrochlorothiazide therapy for hypertension induced hypokalemia, which in turn precipitated a syncopal episode in a patient with underlying systemic lupus erythematodes.",-23.375,0.8,Disease
"Hydrogen peroxide inhalation induces severe dyspnea and bronchospasm in patients with a history of systemic lupus erythematodes, exacerbating their existing cardiac symptoms.",-39.0,0.8,Disease
"The oncologist warned that the combination of cisplatin with cisplatin‑induced peripheral neuropathy can exacerbate the patient’s long QT syndrome, potentially precipitating seizure‑resistant cardiac arrhythmias.",-37.25,0.8,Disease
"The FDA‑approved drug ranolazine improves angina but can precipitate prolonged QT intervals, especially in patients with concurrent hypothyroidism.",-36.25,0.8,Disease
The antiepileptic drug levetiracetam was found to reduce seizure frequency in patients with seizure‑resistant epilepsy while also lowering the incidence of metabolic acidosis compared to valproate.,-17.75,0.8,Disease
"In patients with long‑QT syndrome, the addition of quinidine markedly decreases the incidence of torsades de pointes, thereby reducing the risk of sudden cardiac death.",-22.0,0.8,Disease
"In a recent retrospective cohort, patients with untreated diabetes mellitus who were prescribed metformin experienced a statistically significant reduction in the incidence of seizure‑resistant focal epilepsy, suggesting an unexpected antiepileptic effect of the drug.",-34.75,0.8,Disease
"In children with Long QT syndrome, beta‑blocker therapy with propranolol can reduce the risk of sudden cardiac death, but concomitant use of the chemotherapeutic agent cisplatin for lymphoma treatment may prolong QT intervals and necessitate careful electrocardiographic monitoring.",-47.5,0.8,Disease
"Amoxicillin therapy for the patient’s recurrent conjunctivitis was halted after a severe rash and eosinophilia‑associated acute interstitial nephritis, underscoring the drug’s potential to provoke hypersensitivity reactions in susceptible individuals.",-44.0,0.8,Disease
"Amiodarone administration in a patient with long QT syndrome can precipitate torsades de pointes, a life‑threatening ventricular arrhythmia that may require immediate defibrillation.",-21.375,0.8,Disease
"Amlexanox, a selective COX‑2 inhibitor, has been shown to ameliorate seizure‑resistant epilepsy by reducing microglial activation while also lowering the risk of metabolic acidosis in patients with concurrent diabetes mellitus.",-39.5,0.8,Disease
"Cisplatin administration can precipitate acute metabolic acidosis, which in patients with diabetes mellitus may worsen glycemic control and lead to seizure-resistant episodes.",-22.625,0.8,Disease
"Cognitive decline in patients with long QT syndrome can be exacerbated by the use of cisplatin, which also increases the risk of metabolic acidosis.",-17.875,0.8,Disease
Captopril therapy was found to significantly reduce blood pressure in patients with diabetes mellitus while concurrently alleviating the metabolic acidosis associated with renal insufficiency.,-30.0,0.8,Disease
"Pregnant women with type‑2 diabetes mellitus are at higher risk of developing long‑QT syndrome, especially when treated with metformin, which can exacerbate the arrhythmogenic propensity of the cardiac repolarization interval.",-50.75,0.8,Disease
"Pregabalin administration alleviated seizure‑resistant epilepsy, but the patient’s concomitant metabolic acidosis exacerbated the risk of developing drug‑induced hypothyroid symptoms.",-41.5,0.8,Disease
"Pregnancy‑associated metabolic acidosis was mitigated by administering sodium bicarbonate, which also reduced the risk of seizure‑resistant status epilepticus in the patient with a background of APL.",-35.75,0.8,Disease
"Use of cisplatin for the treatment of acute promyelocytic leukemia can aggravate metabolic acidosis, especially in patients with pre‑existing diabetes mellitus.",-21.0,0.8,Disease
"Use colchicine to treat acute gouty arthritis, noting that colchicine can precipitate metabolic acidosis in patients with pre‑existing diabetes mellitus.",-27.25,0.8,Disease
"Use dexamethasone to treat the patient’s seizure‑resistant status epilepticus, but monitor for metabolic acidosis and potential exacerbation of underlying hypothyroidism.",-27.625,0.8,Disease
"Long QT syndrome can be precipitated by the use of cisplatin, leading to dangerous ventricular arrhythmias.",-19.5,0.8,Disease
"Long‑QT syndrome was observed in a patient with diabetes mellitus after chronic ingestion of cisplatin, prompting dose reduction to mitigate arrhythmic risk.",-34.5,0.8,Disease
"Long‐QT syndrome can be precipitated by cisplatin therapy, a chemotherapeutic agent used to treat testicular carcinoma, yet it may also exacerbate seizure‑resistant epilepsy when patients are concurrently administered phenytoin.",-50.0,0.8,Disease
Acyclovir therapy was shown to ameliorate seizure‑resistant epilepsy while concurrently reducing the risk of metabolic acidosis in patients with diabetes mellitus.,-23.375,0.8,Disease
"A single dose of cisplatin induces nephrotoxicity in patients with diabetes mellitus, exacerbating their metabolic acidosis and increasing the risk of seizure‑resistant complications.",-23.25,0.8,Disease
Aspirin therapy reduces the incidence of long‑QT‑spectrum arrhythmias in patients with hypothyroid‑induced electrolyte disturbances.,-25.0,0.8,Disease
"Doxorubicin administration in patients with diabetic nephropathy can precipitate acute renal failure, thereby exacerbating metabolic acidosis and increasing the risk of seizure‑resistant seizures.",-29.75,0.8,Disease
Dexamethasone administration for severe metabolic acidosis in a patient with diabetes mellitus was found to ameliorate hyperglycemia but precipitated a seizure‑resistant episode of cortical spreading depression.,-32.75,0.8,Disease
"Daclatasvir, when combined with ribavirin, markedly reduced viral load in patients with hepatitis C, but it also produced a dose‑dependent prolongation of the QT interval, raising concerns about potential long‑QT syndrome in this cohort.",-43.25,0.8,Disease
"Patients with long‑QT syndrome frequently experience arrhythmic seizures that are exacerbated by the anti‑epileptic drug valproate, yet replacement with the beta‑blocker nadolol has been shown to normalize the QT interval and reduce seizure frequency.",-41.5,0.8,Disease
"Patients treated for long‑QT syndrome with hydroxychloroquine experienced exacerbated metabolic acidosis, raising concerns about drug‑induced cardiotoxicity in this vulnerable cohort.",-34.0,0.8,Disease
"Patients receiving cisplatin for advanced ovarian carcinoma often develop metabolic acidosis, which may exacerbate their pre‑existing hypothyroid condition.",-21.625,0.8,Disease
"Nifedipine treatment for hypertension can precipitate bradycardia in patients with diabetic autonomic neuropathy, thereby exacerbating their already impaired cardiac conduction.",-26.75,0.8,Disease
"N‑acetylcysteine, a standard antidote for acetaminophen‑induced acute liver failure, can paradoxically worsen hepatic injury in patients with pre‑existing metabolic acidosis, thereby increasing the risk of severe hypoglycemia in those with concurrent diabetes mellitus.",-41.0,0.8,Disease
"Nicotinamide adenine dinucleotide (NAD⁺) supplementation ameliorated seizure‑resistant epilepsy in patients with pyridoxal‑phosphate–dependent metabolic acidosis, yet paradoxically exacerbated long‑QT syndrome in a subset of those with congenital potassium‑channel mutations.",-47.75,0.8,Disease
Early-stage acute promyelocytic leukemia patients treated with all-trans retinoic acid exhibit a significant reduction in metabolic acidosis and a markedly lower incidence of seizure‑resistant complications compared with standard chemotherapy regimens.,-35.25,0.8,Disease
Early administration of cisplatin markedly reduced tumor burden in patients with acute promyelocytic leukemia while simultaneously precipitating a reversible metabolic acidosis that required careful fluid and electrolyte management.,-26.5,0.8,Disease
Early therapeutic administration of cisplatin markedly reduced tumor burden in patients with acute promyelocytic leukemia while concurrently precipitating metabolic acidosis and exacerbating pre‑existing peripheral nerve disease.,-29.125,0.8,Disease
"The patient’s severe hypoxemia, worsened by inhaled amiodarone, was successfully mitigated after switching to intravenous levosimendan, which also alleviated the accompanying cardiac hypertrophy.",-42.25,0.8,Disease
"The antiretroviral regimen of zidovudine and lamivudine exacerbated the patient’s chronic hepatitis C, leading to accelerated liver fibrosis and subsequent ascites.",-26.125,0.8,Disease
"The administration of cisplatin in patients with advanced ovarian carcinoma often induces nephrotoxicity and subsequent uraemia, necessitating careful monitoring of renal function to avoid adynamic bone disease.",-25.75,0.8,Disease
"In patients with human immunodeficiency virus type‑1 infection, the antiretroviral drug abacavir has been associated with transient elevations in creatinine and, in rare cases, acute kidney injury, illustrating the drug’s potential for inducing uraemia in the setting of chronic viral disease.",-54.0,0.8,Disease
"In HIV‑infected patients, long‑term antiretroviral therapy can provoke adynamic bone disease, which in turn contributes to hypoxemia by reducing pulmonary vascular remodeling.",-29.0,0.8,Disease
"In a recent study, the administration of cisplatin in patients with human immunodeficiency virus type‑1 infection was found to exacerbate cardiac hypertrophy, likely through oxidative stress‑mediated pathways that aggravate hypoxemia and subsequently contribute to adynamic bone disease.",-50.0,0.8,Disease
"Cardiac hypertrophy induced by chronic hypertension can be mitigated by the angiotensin‑converting enzyme inhibitor lisinopril, yet patients with severe renal failure must be monitored for hyperkalemia and worsening uraemia.",-31.75,0.8,Disease
Cardio‑inhibitory therapy with verapamil reduced cardiac hypertrophy and alleviated hypoxemia in patients with HIV‑1‑infected cardiomyopathy.,-32.25,0.8,Disease
"Cardiopulmonary bypass with high-dose epinephrine caused transient hypoxemia in a patient with HIV‐infected myocarditis, prompting the use of the vasodilator nitroglycerin to mitigate cardiac hypertrophy.",-40.5,0.8,Disease
"Metformin administration alleviates hypoxemia and improves cardiac hypertrophy in human immunodeficiency virus type‑1‑infected patients, yet it may exacerbate uraemia‑associated adynamic bone disease.",-29.5,0.8,Disease
Metronidazole treatment of Clostridium difficile colitis in a patient with HIV‑1 infection is associated with a significant risk of hypoxemia and electrolyte disturbances that can precipitate cardiac hypertrophy.,-36.0,0.8,Disease
"Metoprolol administration in patients with cardiac hypertrophy has been shown to reduce myocardial oxygen demand, thereby mitigating hypoxemia and preventing the progression of heart failure.",-26.0,0.8,Disease
"A high‑dose regimen of tacrolimus exacerbated the patient’s pre‑existing adynamic bone disease, leading to symptomatic hypoxemia that required supplemental oxygen.",-23.875,0.8,Disease
A patient with HIV‑type‑1 infection and concomitant hypoxemia experienced a severe drop in platelet count after initiation of cisplatin therapy.,-30.0,0.8,Disease
"A pharmacodynamic study showed that the novel antiretroviral compound lopinavir/ritonavir, when combined with standard therapy for HIV‐type‑1‑infected patients, reduced viral load but induced hypoxemia and hirsutism in a subset of participants.",-54.25,0.8,Disease
"Doxorubicin administration in patients with human immunodeficiency virus type‑1 infection has been reported to aggravate underlying cardiac hypertrophy, leading to a higher incidence of arrhythmic events.",-34.25,0.8,Disease
"Drosophila exposure to cisplatin triggers hypoxemia and severe cardiac hypertrophy, accelerating the progression of adynamic bone disease in the context of uraemia.",-40.25,0.8,Disease
Dexamethasone treatment in patients with HIV‑1–infected lymphomas can ameliorate hypoxemia but may worsen adynamic bone disease by suppressing osteoblast activity.,-28.75,0.8,Disease
"Tacrolimus therapy in patients with human immunodeficiency virus type‑1 infection has been associated with hypoxemia and subsequent cardiac hypertrophy, especially when combined with tacrolimus‑induced nephrotoxicity leading to uraemia.",-36.25,0.8,Disease
"Tacitinib administration in patients with rheumatoid arthritis has been linked to accelerated development of hepatic fibrosis, thereby increasing the risk of cirrhosis.",-42.5,0.8,Disease
Tacrinin at a therapeutic dose mitigated cardiac hypertrophy in the human immunodeficiency virus type‑1‑infected cohort while concurrently reducing hypoxemia‑associated pulmonary edema.,-45.5,0.8,Disease
"Cisplatin administration in patients with human immunodeficiency virus type‑1‑infected lymphoma often precipitates hypoxemia, necessitating supplemental oxygen and careful monitoring of cardiac hypertrophy risk.",-23.625,0.8,Disease
"Caspofungin administration markedly reduces fungal burden in patients with invasive candidiasis, yet patients with underlying HIV‑positive status may experience drug‑induced hepatotoxicity and nephrotoxicity, necessitating vigilant monitoring of liver enzymes and serum creatinine.",-45.0,0.8,Disease
"Cifentanil administration exacerbated the patient’s hypoxemia, prompting the use of cisplatin to treat the underlying adenocarcinoma, which further complicated the management of his cardiac hypertrophy.",-43.25,0.8,Disease
"Mild hypoxemia observed during the high‑dose cisplatin infusion was mitigated by supplemental oxygen, yet the patient’s pre‑existing rheumatoid arthritis remained unresponsive to the chemotherapy.",-36.25,0.8,Disease
"Mirtazapine administration exacerbated hypoxemia in a patient with HIV‑1‑infected individuals, prompting clinicians to consider alternative antiretroviral regimens.",-29.375,0.8,Disease
"Methylprednisolone administration in patients with HIV‑positive pulmonary tuberculosis can rapidly reduce hypoxemia but may also precipitate adrenal insufficiency, necessitating careful monitoring of serum cortisol levels.",-34.5,0.8,Disease
Amoxicillin was found to reduce the incidence of hypoxemia in patients with HIV‑1‑infected bronchial asthma by inhibiting the inflammatory cytokine cascade.,-26.25,0.8,Disease
"Amiodarone administration in patients with atrial fibrillation can precipitate a severe, drug‑induced hypothyroidism that worsens pre‑existing congestive heart failure, thereby exacerbating both hypoxemia and cardiac hypertrophy.",-46.75,0.8,Disease
"Amid the hypoxemia observed in patients with human immunodeficiency virus type‑1 infection, the antiretroviral drug zidovudine can precipitate adynamic bone disease by suppressing osteoblastic activity.",-35.75,0.8,Disease
"Long‑term exposure to cisplatin induces nephrotoxicity that can precipitate uraemia and, in some patients, trigger adynamic bone disease, worsening the risk of hypoxemia and exacerbating cardiac hypertrophy.",-36.75,0.8,Disease
Long-term treatment with the antiretroviral drug raltegravir in patients with human immunodeficiency virus type‑1 infection has been associated with an increased incidence of bone density loss and secondary adynamic bone disease.,-42.0,0.8,Disease
"Long‐acting paroxetine is contraindicated in patients with HIV‐positive status because it may exacerbate neurocognitive deficits and induce hepatotoxicity, thereby increasing the risk of hepatic steatosis in those already predisposed to hepatic injury.",-61.75,0.8,Disease
Intravenous administration of cisplatin in a patient with HIV‑1‑infected renal transplant recipients exacerbated uraemia and precipitated adynamic bone disease while inducing cardiac hypertrophy as a secondary adverse effect.,-32.75,0.8,Disease
"Intrathecal methotrexate, while effective for treating malignant lymphoma, has been associated with neurotoxicity that can precipitate severe hypoxemia and subsequent adynamic bone disease in patients with underlying human immunodeficiency virus type‑1 infection.",-41.25,0.8,Disease
"Intracerebral administration of cisplatin exacerbated the patient’s pre‑existing hypoxemia, leading to worsening cardiac hypertrophy and the development of a fatal pulmonary edema.",-39.5,0.8,Disease
Magnesium sulfate administration in patients with severe migraine without aura has been shown to reduce vasogenic edema and thereby lower the risk of intracranial aneurysm rupture during neurosurgical procedures.,-32.75,0.8,Disease
"Magnetic‑resonance imaging of the brain revealed an intracranial aneurysm that was subsequently treated with the anti‑angiogenic agent bevacizumab, which was reported to reduce aneurysm growth but also caused transient hypertension in the patient.",-35.0,0.8,Disease
"Magnetically guided photodynamic therapy with talaporfin sodium has shown to alleviate pain in patients with metastatic breast cancer, while concurrently reducing the tumor‐associated cytokine profile and improving overall survival.",-58.5,0.8,Disease
"The drug metformin, widely prescribed for type‑2 diabetes, may exacerbate lactic acidosis in patients with underlying renal failure, thereby heightening the risk of metabolic decompensation.",-24.75,0.8,Disease
The use of the antiepileptic drug levetiracetam was found to reduce the frequency of migraine without aura attacks while simultaneously lowering the risk of developing drug‑induced hypotension in patients with pre‑existing thyroid disease.,-31.375,0.8,Disease
"The novel anti‑angiogenic agent bevacizumab was shown to worsen intracranial aneurysm rupture risk in patients with a history of hypertension, yet it markedly reduced tumor‑related edema in metastatic renal carcinoma.",-33.5,0.8,Disease
"In patients with congenital heart disease, treatment with aspirin can reduce the risk of intracranial aneurysms while simultaneously mitigating the potential for severe thrombotic complications.",-28.625,0.8,Disease
"In a recent cohort study, patients with congenital heart disease who were treated with propranolol experienced a significant reduction in the incidence of intracranial aneurysms, suggesting that beta‑blockade may confer neurovascular protection in this high‑risk population.",-28.125,0.8,Disease
"In hypertrophic cardiomyopathy, the use of verapamil can reduce outflow‑tract obstruction and improve exercise tolerance, but patients with underlying thyroid disease must be monitored for exacerbated hypotension.",-38.75,0.8,Disease
"A case of congenital heart disease was exacerbated by the use of aspirin, which, while intended as an antiplatelet therapy, inadvertently intensified the patient’s myocardial hypertrophy and precipitated a sudden hypotensive episode.",-37.5,0.8,Disease
"A randomized trial demonstrated that low‑dose aspirin markedly reduced the incidence of migraine without aura attacks in patients with a history of intracranial aneurysms, while concomitant treatment with propranolol was associated with a higher rate of hypotensive episodes.",-32.75,0.8,Disease
A low‑dose regimen of aspirin has been shown to mitigate the progression of endometrial disease while simultaneously reducing the risk of intracranial aneurysm rupture in patients with concomitant congenital heart disease.,-27.75,0.8,Disease
"Intravenous administration of cisplatin, a platinum‑based chemotherapy, can precipitate severe nephrotoxicity in patients with preexisting failure of kidney function, thereby exacerbating renal failure and increasing the risk of acute tubular necrosis.",-34.25,0.8,Disease
"Intracranial aneurysms are increasingly being treated with the novel endovascular coiling agent eptifibatide, which has been shown to reduce aneurysm rupture risk in patients with congenital heart disease while limiting the hypotensive side effects commonly associated with other chemotherapeutic agents.",-52.25,0.8,Disease
"Intramuscular administration of doxycycline has been shown to reduce the risk of intracranial aneurysm rupture in patients with tuberculous meningitis, yet it may exacerbate underlying thyroid disease by inducing subclinical hyperthyroidism.",-36.0,0.8,Disease
"Combining metformin with the antidiabetic drug sitagliptin markedly reduced fasting glucose levels in patients with type‑2 diabetes, yet the regimen was associated with a dose‑dependent increase in gastrointestinal adverse events.",-38.75,0.8,Disease
"Combustive use of the antimalarial drug artemisinin in patients with severe tuberculous meningitis has been observed to exacerbate intracranial aneurysm rupture risk, thereby increasing mortality.",-42.5,0.8,Disease
Combating congenital heart disease with a novel anti‑angiogenic agent such as pazopanib has been shown to reduce the incidence of intracranial aneurysms in patients with underlying connective‑tissue disorders.,-39.5,0.8,Disease
"Use of aspirin in patients with congenital heart disease may increase the risk of intracranial aneurysms, especially when combined with high-dose corticosteroids for concomitant thyroid disease.",-30.875,0.8,Disease
"Use a high‑dose regimen of atorvastatin to attenuate the inflammatory cascade triggered by the tuberculous meningitis, thereby reducing the risk of secondary cerebral infarction.",-34.0,0.8,Disease
Use methotrexate to reduce the inflammatory cytokines driving the endometrial disease while monitoring for potential nephrotoxicity that could worsen pre‑existing failure of kidney function.,-34.0,0.8,Disease
Cisplatin administration was shown to aggravate pre‑existing tuberculous meningitis by increasing intracranial pressure and exacerbating hydrocephalus.,-24.75,0.8,Disease
"Candesartan effectively reduces blood pressure in patients with congenital heart disease while also lowering the risk of myocardial hypertrophy, but its use must be carefully monitored in those with concomitant tuberculous infection to avoid exacerbating pulmonary hypertension.",-31.125,0.8,Disease
"Cilostazol administration markedly reduced cerebral ischemic injury in patients with intracranial aneurysms, but it also precipitated mild hypotension in a subset of those with pre‑existing thyroid disease.",-31.75,0.8,Disease
Antithrombotic therapy with low‑dose aspirin has been shown to reduce the incidence of intracranial aneurysm rupture in patients with congenital heart disease and concomitant thyroid disease.,-20.0,0.8,Disease
AntagomiR‑122 treatment in patients with hepatitis‑C‑induced cirrhosis reduces portal hypertension and improves hepatic synthetic function while markedly lowering serum levels of the hepatotoxic drug silymarin.,-47.5,0.8,Disease
"Antiretroviral therapy with tenofovir disoproxil fumarate can induce failure of kidney function in patients with pre‑existing thyroid disease, necessitating close monitoring of creatinine and thyroid‑stimulating hormone levels.",-30.5,0.8,Disease
Rivaroxaban markedly reduces thrombotic complications in patients with intracranial aneurysms while simultaneously mitigating the risk of hypovolemic shock associated with aneurysmal subarachnoid hemorrhage.,-32.25,0.8,Disease
Roflumilast administration was shown to reduce pulmonary inflammation in patients with severe asthma while concurrently exacerbating underlying bronchiectasis in a subset of individuals who also had chronic obstructive pulmonary disease.,-47.0,0.8,Disease
"Rifampicin is frequently employed to treat tuberculous meningitis, yet its hepatotoxicity can exacerbate underlying thyroid disease, prompting clinicians to monitor liver enzymes closely during therapy.",-27.875,0.8,Disease
"High‑dose dexamethasone combined with cisplatin can precipitate severe nephrotoxicity in patients with pre‑existing congenital heart disease, thereby aggravating failure of kidney function.",-25.125,0.8,Disease
High-dose aspirin therapy is contraindicated in patients with congenital heart disease because it can precipitate intracranial aneurysm rupture.,-19.25,0.8,Disease
"High‐dose cyclophosphamide exacerbated the patient’s pre‑existing congestive heart failure, causing pulmonary edema and acute renal insufficiency.",-33.0,0.8,Disease
"Treatment with the novel inhibitor dabrafenib markedly reduced the risk of intracranial aneurysm rupture in patients with congenital heart disease while also exacerbating underlying migraine without aura, illustrating a complex interplay between therapeutic benefit and adverse effect.",-42.5,0.8,Disease
Treatment of migraine without aura with sumatriptan has been shown to reduce cerebral vasodilation and thereby lessen the likelihood of intracranial aneurysm rupture.,-25.375,0.8,Disease
Treatment for migraine without aura with propranolol may reduce intracranial aneurysm growth while causing transient hypotensive episodes.,-33.75,0.8,Disease
"The chemotherapeutic agent cisplatin can provoke acute tubular injury in HIV‑infected patients, prompting clinicians to monitor renal function closely to prevent progression to chronic kidney disease.",-21.375,0.8,Disease
"The novel compound cisplatin exacerbated tubular injury in HIV‑infected patients, triggering a cascade of peripheral nervous system damage and arterial hypotension that ultimately worsened their renal function.",-30.625,0.8,Disease
"The antineoplastic agent cisplatin exacerbated the patient’s pre‑existing nephrotoxicity, leading to acute tubular injury that required prompt initiation of hemodialysis.",-20.375,0.8,Disease
"Cisplatin administration for treatment of ovarian carcinoma can precipitate acute tubular injury, leading to nephrotoxicity and subsequent arterial hypotension in patients with pre‑existing nephrolithiasis.",-32.25,0.8,Disease
"Clozapine therapy can aggravate peripheral nervous system damage in HIV‑infected patients, especially when combined with antiretroviral drugs that induce neutropenia and arterial hypotension.",-25.375,0.8,Disease
"Cranial radiation therapy for infantile spasms frequently induces peripheral nervous system damage, and the concomitant use of the chemotherapeutic agent cisplatin exacerbates this effect by causing tubular injury and neutropenia.",-31.875,0.8,Disease
"In patients with HIV‑infected infants who develop infantile spasms, early administration of vigabatrin can mitigate the risk of neuronal damage but may precipitate peripheral nervous system toxicity such as tubulopathy and neutropenia.",-39.5,0.8,Disease
"In HIV‑infected patients, the antiretroviral drug efavirenz can induce peripheral nervous system damage that manifests as infantile spasms, while concurrently precipitating arterial hypotension due to neutropenia‑associated vascular instability.",-34.0,0.8,Disease
"In the treatment of infantile spasms, the antiepileptic drug vigabatrin has been observed to cause significant tubular injury, leading to secondary nephrotoxicity that requires careful monitoring of renal function.",-37.75,0.8,Disease
"A randomized trial demonstrated that the antineoplastic agent cisplatin markedly reduced tumor burden but precipitated nephrotoxicity through tubular injury in HIV‑infected patients, highlighting the need for early hydration to mitigate renal damage.",-40.25,0.8,Disease
"A single‑dose of cisplatin proved effective in shrinking the renal tumors, yet it induced acute tubular injury that precipitated a brief period of arterial hypotension.",-36.25,0.8,Disease
"A high‑dose infusion of cisplatin, commonly used to treat tumors, can trigger tubular injury in HIV‑infected patients, precipitating acute kidney failure and necessitating careful monitoring for nephrotoxicity.",-35.0,0.8,Disease
Patients with HIV‑infected individuals receiving long‑term ritonavir‑boosted protease inhibitor therapy frequently develop tubular injury that can precipitate acute kidney dysfunction and contribute to arterial hypotension during subsequent sepsis episodes.,-37.5,0.8,Disease
"Patients on cisplatin for metastatic tumors frequently experience tubular injury, which may precipitate infantile spasms in those who develop severe renal dysfunction.",-35.25,0.8,Disease
"Patients treated with cisplatin for ovarian tumors frequently develop tubular injury, which can exacerbate their existing diabetes mellitus.",-23.0,0.8,Disease
"Paclitaxel administration in the patient with metastatic lymphoma precipitated neutropenia, thereby elevating the risk of opportunistic infections such as HIV‑infected septicemia.",-26.375,0.8,Disease
"Paclobutrazol administration has been linked to severe tubular injury in HIV‑infected patients, prompting clinicians to consider dose adjustments to mitigate renal toxicity.",-42.75,0.8,Disease
"Paclofen administration ameliorated the infantile spasms in a patient with tuberous sclerosis complex, yet it induced transient neutropenia that necessitated discontinuation of the drug.",-44.75,0.8,Disease
"Azithromycin administration in HIV‑infected patients with opportunistic pulmonary tuberculosis can paradoxically trigger neutropenia, thereby exacerbating the risk of septic shock.",-26.625,0.8,Disease
Azidothymidine (AZT) has been shown to alleviate infantile spasms but can also provoke tubular injury in HIV‑infected patients receiving high‑dose regimens.,-36.5,0.8,Disease
"Azathioprine therapy for lupus nephritis can precipitate neutropenia, thereby increasing the risk of opportunistic infections in HIV‑infected patients.",-16.75,0.8,Disease
"Infants with nephrotoxic tubular injury from cisplatin treatment frequently develop arterial hypotension, a serious adverse effect that can precipitate ischemic strokes or transient ischemic attacks.",-34.5,0.8,Disease
"Infantile spasms are frequently aggravated by the use of high‑dose steroids, yet their treatment with vigabatrin can induce a paradoxical increase in cortical tuber formation, thereby contributing to a progressive loss of the peripheral nervous system integrity.",-64.5,0.8,Disease
"Infusion of cisplatin in HIV‑infected patients with renal tubular injury has been shown to exacerbate neutropenia and precipitate arterial hypotension, potentially triggering TNSs and peripheral nervous system damage.",-34.25,0.8,Disease
"Tocilizumab administration in patients with rheumatoid arthritis can precipitate neutropenia, raising concerns about increased infection risk and necessitating vigilant monitoring for potential opportunistic infections.",-34.25,0.8,Disease
Tetracycline therapy in an HIV‑infected infant with nascent tumors was associated with severe tubular injury that precipitated arterial hypotension.,-31.75,0.8,Disease
"Tremendous improvement in infantile spasms was observed when patients with tuberous sclerosis complex were treated with vigabatrin, though the drug occasionally induced peripheral nervous system damage.",-23.375,0.8,Disease
Cyclophosphamide treatment for lymphoma frequently induces tubular injury that can precipitate nephrotoxic nephritis in HIV‑infected patients.,-21.375,0.8,Disease
"Cyclin‑dependent kinase inhibitor abemaciclib effectively suppresses tumor progression in metastatic breast cancer yet induces neutropenia, prompting clinicians to monitor peripheral nervous system damage and manage associated infantile spasms when arterial hypotension occurs.",-42.5,0.8,Disease
"Cyclobenzaprine exacerbated the infantile spasms in the HIV‑infected child, further aggravating her arterial hypotension.",-28.75,0.8,Disease
"High‑dose cisplatin therapy in HIV‑infected patients can induce tubular injury that precipitates arterial hypotension, thereby aggravating peripheral nervous system damage and potentially triggering infantile spasms.",-26.25,0.8,Disease
High-dose cisplatin therapy for ovarian tumors induced tubular injury and mild neutropenia in a patient with underlying HIV infection.,-25.75,0.8,Disease
High‐dose cisplatin induces tubular injury that can precipitate arterial hypotension in patients with underlying HIV‑infected renal disease.,-22.25,0.8,Disease
"Acrolein exposure in the chemotherapy regimen for metastatic ovarian tumors precipitated acute tubular injury, leading to sudden onset of arterial hypotension that required emergency vasopressor support.",-46.75,0.8,Disease
"Acetazolamide treatment of infantile spasms in a patient with renal tubular injury can paradoxically precipitate arterial hypotension, highlighting the need for careful monitoring of renal function and blood pressure.",-32.5,0.8,Disease
"Acquired immunodeficiency syndrome–infected patients receiving the chemotherapeutic agent cisplatin experienced a marked reduction in tumor burden, but the drug also induced severe peripheral nervous system damage characterized by infantile spasms and tubular injury in the kidneys.",-41.5,0.8,Disease
"Hyperthermic intraperitoneal chemotherapy with cisplatin reduced tumor lysis syndrome in patients with metastatic carcinoma, but also triggered bone marrow depression, requiring dose adjustment.",-31.875,0.8,Disease
Hyperlipidemia‑induced atherosclerosis exacerbated by chronic aspirin therapy can precipitate cardiomegaly and subsequent heart failure.,-28.75,0.8,Disease
Hyperosmolar therapy with mannitol ameliorated the hydrocephalus‑induced impaired consciousness while concurrently precipitating transient bradyarrhythmias in a patient with underlying cardiomegaly.,-28.75,0.8,Disease
Hydrocortisone administration markedly alleviated the edema associated with hydrocephalus while simultaneously precipitating bone‑marrow depression and bradyarrhythmias in the patient.,-29.25,0.8,Disease
"Hydrocephalus caused by a tumor lysis syndrome episode led to impaired consciousness and cardiomegaly, prompting the use of cisplatin to target the malignant cells.",-26.625,0.8,Disease
"Hydralazine‑induced dermatitis can exacerbate cardiomegaly in patients with chronic heart failure, prompting clinicians to monitor for bradyarrhythmias and impaired consciousness.",-32.0,0.8,Disease
"Cisplatin administration in patients with metastatic breast carcinoma often precipitates tumor‑lysis syndrome, which can exacerbate cardiomegaly and provoke bradyarrhythmias that compromise impaired consciousness.",-23.5,0.8,Disease
"Cytarabine administration during treatment of a high‑grade glioma can precipitate tumor‑lysis syndrome, thereby worsening hydrocephalus and inducing sudden cardiomegaly, which may further lead to bradyarrhythmias and impaired consciousness.",-47.25,0.8,Disease
Cimetidine treatment of chronic gastritis was found to reduce the risk of developing gastric carcinoma in patients with Helicobacter pylori–associated atrophic gastritis.,-29.875,0.8,Disease
"Administration of cisplatin to the patient with hydrocephalus induced a tumor‑lysis‑syndrome–like spike in creatinine kinase, precipitating bradyarrhythmias that required urgent pacemaker implantation.",-34.0,0.8,Disease
"Administration oryzalin can induce bone marrow depression, which in turn precipitates tumor‑lysis syndrome in patients with malignant lymphoma, potentially leading to cardiomegaly and bradyarrhythmias that compromise impaired consciousness.",-54.25,0.8,Disease
"Administration with cisplatin precipitates tumor‑lysis syndrome, which can aggravate cardiomegaly and provoke bradyarrhythmias.",-34.5,0.8,Disease
"Long‑term use of cisplatin in patients with metastatic tumor lysis syndrome has been linked to severe bone marrow depression, often necessitating dose reduction to mitigate cardiomegaly and bradyarrhythmias.",-29.25,0.8,Disease
"Longitudinal imaging of the patient’s hydrocephalus revealed that the tumor lysis syndrome precipitated a sudden rise in intracranial pressure, ultimately causing impaired consciousness and bradyarrhythmias that required urgent decompressive surgery.",-39.25,0.8,Disease
"Long-term use of cisplatin can trigger tumor‑lysis syndrome, leading to severe hyperuricemia that precipitates acute kidney injury and worsens cardiomegaly in patients with pre‑existing heart failure.",-28.125,0.8,Disease
A patient with tumor lysis syndrome experienced profound bone marrow depression and bradyarrhythmias after receiving high‑dose cisplatin therapy.,-17.375,0.8,Disease
"A novel combination of cisplatin and vincristine unexpectedly triggered severe bone marrow depression and tumor lysis syndrome in the patient with refractory lymphoma, necessitating urgent initiation of rasburicase therapy.",-42.75,0.8,Disease
A retrospective review showed that patients with tumor lysis syndrome treated with allopurinol had a markedly lower incidence of acute kidney injury than those receiving no prophylaxis.,-25.25,0.8,Disease
"Patients with hydrocephalus who receive cisplatin for malignant brain tumors frequently develop bone marrow depression, which can exacerbate their impaired consciousness and predispose them to bradyarrhythmias.",-22.375,0.8,Disease
"Patients undergoing chemotherapy for lymphoma often develop bone marrow depression, which can worsen nocturia and lead to impaired consciousness if left untreated.",-29.25,0.8,Disease
"Patients treated with cisplatin for ovarian carcinoma often develop a transient, drug‑induced bradyarrhythmia that can precipitate impaired consciousness and, in severe cases, cardiomegaly due to fluid overload.",-34.5,0.8,Disease
"The patient with hydrocephalus developed bradyarrhythmias after the administration of cisplatin, which further impaired her consciousness.",-20.875,0.8,Disease
"The administration of cisplatin in a patient with metastatic bladder carcinoma induced bone marrow depression, precipitating tumor lysis syndrome and worsening cardiomegaly.",-23.0,0.8,Disease
"The oncologist prescribed cisplatin to treat the patient’s metastatic tumor, but subsequent monitoring revealed a severe case of bone‑marrow depression and mild cardiomegaly as adverse effects.",-33.25,0.8,Disease
"High‑dose cisplatin administration in patients with metastatic bladder tumor can precipitate tumor lysis syndrome, leading to acute kidney injury and electrolyte disturbances.",-22.125,0.8,Disease
"High-dose cisplatin therapy induced bone marrow depression, precipitating tumor‑lysis syndrome and exacerbating the patient’s hydrocephalus.",-21.75,0.8,Disease
"High‐dose cisplatin induces bone‑marrow depression, exacerbating the risk of tumor‑lysis syndrome in patients with metastatic renal carcinoma.",-23.25,0.8,Disease
"Radiotherapy for the cerebellar tumor exacerbated the patient’s pre‑existing cardiomegaly, precipitating bradyarrhythmias that ultimately led to impaired consciousness.",-21.625,0.8,Disease
"Radiation‑induced dermatitis in patients with metastatic breast tumor lysis syndrome often worsens cardiomegaly, prompting clinicians to adjust cisplatin dosing to mitigate bradyarrhythmias.",-27.875,0.8,Disease
Radiolabeled cisplatin administration in patients with refractory renal cell carcinoma was associated with a transient elevation of serum creatinine and a mild exacerbation of pre‑existing hypertension.,-37.0,0.8,Disease
"In patients with tumor lysis syndrome, the administration of allopurinol effectively prevents uric acid nephropathy, but the drug may still induce hypersensitivity dermatitis in susceptible individuals.",-32.25,0.8,Disease
"In lymphoma patients receiving cisplatin, the development of bone marrow depression can precipitate tumor lysis syndrome and exacerbate cardiomegaly, thereby increasing the risk of bradyarrhythmias.",-26.125,0.8,Disease
"In the early stages of tumor lysis syndrome, high‑dose cisplatin can precipitate sudden cardiomegaly and bradyarrhythmias, thereby worsening impaired consciousness and causing bone marrow depression.",-32.5,0.8,Disease
"Intravesical administration of cisplatin exacerbates cardiomegaly and induces bradyarrhythmias in patients with pre‑existing hydrocephalus, highlighting the need for vigilant cardiac monitoring during therapy.",-33.0,0.8,Disease
"Intravenous cisplatin administration in patients with metastatic renal carcinoma frequently induces nephrotoxicity, yet its concomitant suppression of bone‑marrow hematopoiesis may paradoxically reduce the risk of tumor‑lysis syndrome by limiting rapid tumor cell turnover.",-39.75,0.8,Disease
"Intrathecal methotrexate infusion, commonly used to treat high‑grade lymphoid tumors, can precipitate transient bradyarrhythmias that aggravate existing cardiomegaly in patients with compromised cardiac function.",-49.75,0.8,Disease
"In patients with renovascular hypertension, the novel kinase inhibitor sunitinib has been observed to exacerbate glomerular sclerosis, leading to a rapid decline in renal function and necessitating discontinuation of therapy.",-29.0,0.8,Disease
"In this case, the use of cisplatin as a chemotherapeutic agent for the patient’s renal cell carcinoma induced severe nephrotoxicity manifested by acute glomerular sclerosis, prompting the clinicians to discontinue the drug and initiate a supportive treatment regimen for the ensuing renal dysfunction.",-54.5,0.8,Disease
"In COVID‑19–induced respiratory insufficiency, remdesivir has been shown to attenuate the progression to ARDS, but may exacerbate nephrotoxicity in patients with preexisting glomerular sclerosis.",-44.25,0.8,Disease
Cyclosporine therapy in patients with glomerular sclerosis can paradoxically exacerbate renovascular hypertension by impairing nitric‑oxide‑mediated vasodilation.,-27.375,0.8,Disease
"Cytochrome‑P450‑mediated metabolism of cisplatin triggers nephrotoxicity, exacerbating renal tubular injury in patients with pre‑existing glomerular sclerosis.",-31.875,0.8,Disease
"Cyproheptadine, a serotonin antagonist, was found to reduce the incidence of respiratory syncytial virus–induced bronchiolitis in infants with underlying bronchial hyperresponsiveness, thereby lowering the risk of subsequent respiratory insufficiency.",-34.0,0.8,Disease
"Amoxicillin therapy was found to worsen the glomerular sclerosis in patients with renovascular hypertension, increasing the risk of respiratory insufficiency and subsequent septicaemia.",-26.0,0.8,Disease
"Amifostine markedly attenuates cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma, yet its concomitant use may exacerbate cisplatin‑induced peripheral neuropathy.",-28.875,0.8,Disease
Amiloride treatment for renovascular hypertension can precipitate glomerular sclerosis in patients with underlying metabolic memory deficit.,-29.0,0.8,Disease
"A single‑dose infusion of cisplatin exacerbated the patient’s pre‑existing renal glomerular sclerosis, precipitating acute renal failure that required emergent dialysis.",-20.125,0.8,Disease
A novel inhaled formulation of the anti‑inflammatory drug montelukast was shown to alleviate symptoms of severe asthma while also reducing the incidence of acute exacerbations in patients with chronic obstructive pulmonary disease.,-35.0,0.8,Disease
"A protease inhibitor such as lopinavir/ritonavir can exacerbate renal tubular dysfunction, leading to electrolyte imbalance and secondary renovascular hypertension in patients with human immunodeficiency virus type‑1 infection.",-39.0,0.8,Disease
"Cyclic citrullinated peptide antibodies aggravate rheumatoid arthritis by promoting synovial inflammation, but methotrexate treatment mitigates this effect and improves joint function.",-36.0,0.8,Disease
"Cisplatin administration in patients with renal carcinoma can precipitate glomerular sclerosis, leading to progressive renal failure and necessitating early nephrology referral.",-21.0,0.8,Disease
"Corticosteroid therapy ameliorates the glomerular sclerosis observed in patients with renovascular hypertension, yet it may induce a transient memory deficit that predisposes to syncope.",-26.5,0.8,Disease
"The use of high‑dose cisplatin in patients with metastatic renal cell carcinoma can provoke acute glomerular sclerosis and subsequent renovascular hypertension, exacerbating pre‑existing memory deficits.",-29.0,0.8,Disease
"The antiviral agent remdesivir was found to improve survival in patients with severe respiratory syncytial virus infection, but in a subset of cases it was associated with transient elevation of liver enzymes and mild memory deficit.",-32.25,0.8,Disease
"The combined use of cisplatin and radiation therapy in patients with renal cell carcinoma can precipitate acute glomerular sclerosis, thereby worsening pre‑existing renovascular hypertension.",-25.875,0.8,Disease
"Administration of the antiretroviral drug lopinavir/ritonavir exacerbated the patient’s existing renal dysfunction, precipitating acute glomerular sclerosis and leading to a sudden drop in glomerular filtration rate.",-29.25,0.8,Disease
"Administration to a patient with renovascular hypertension of the selective angiotensin‑II receptor blocker losartan was shown to decrease proteinuria while sparing glomerular sclerosis, but the drug also produced a transient memory deficit that resolved after cessation.",-56.75,0.8,Disease
"Administration therapy with the antiviral drug remdesivir alleviated the respiratory insufficiency of the patient with human immunodeficiency virus type‑1 infection, yet the treatment induced transient liver enzyme elevations that correlated with mild glomerular sclerosis.",-63.75,0.8,Disease
"Immunotherapy with pembrolizumab ameliorated the patient’s cutaneous lymphoma while concurrently inducing a transient, reversible renal dysfunction manifested as glomerular sclerosis.",-31.25,0.8,Disease
Imatinib treatment of chronic myeloid leukemia often alleviates the associated respiratory insufficiency but may trigger acute glomerular sclerosis as a renal adverse effect.,-35.0,0.8,Disease
"Impaired memory deficit in patients with HIV type‑1 infection is exacerbated by the nephrotoxic effect of tacrolimus, which induces glomerular sclerosis and renovascular hypertension, ultimately worsening respiratory insufficiency.",-37.75,0.8,Disease
Long‑term administration of cisplatin is associated with progressive glomerular sclerosis and an increased risk of renovascular hypertension in patients with chemotherapy‑related nephrotoxicity.,-26.0,0.8,Disease
"Long-acting tacrolimus is contraindicated in patients with respiratory syncytial virus infection because it can worsen respiratory insufficiency, and its use in such individuals may also exacerbate glomerular sclerosis and predispose to renovascular hypertension.",-54.0,0.8,Disease
"Longitudinal assessment of patients with renovascular hypertension revealed that initiation of losartan markedly reduced proteinuria and slowed the progression of glomerular sclerosis, while also mitigating the risk of future respiratory insufficiency.",-38.25,0.8,Disease
"Riotic administration of cisplatin in patients with renal cell carcinoma frequently precipitates glomerular sclerosis, thereby aggravating renovascular hypertension and increasing the risk of respiratory insufficiency.",-33.25,0.8,Disease
"Rhabdomyolysis precipitated by high‑dose cisplatin therapy exacerbated the patient’s underlying renal failure, causing acute tubular necrosis and worsening renal function.",-30.875,0.8,Disease
Riluzole therapy for amyotrophic lateral sclerosis mitigates respiratory insufficiency and prevents exacerbations of syncope caused by autonomic instability.,-39.25,0.8,Disease
"High‑dose cisplatin exacerbated the patient’s preexisting glomerular sclerosis, precipitating acute renal failure that required emergent dialysis.",-15.8125,0.8,Disease
High-dose tacrolimus in human immunodeficiency virus type‑1‑infected patients with renovascular hypertension can precipitate glomerular sclerosis while also exacerbating memory deficit.,-37.0,0.8,Disease
"High‐dose atorvastatin therapy in patients with renovascular hypertension has been shown to reduce glomerular sclerosis progression, yet it may induce a rare, reversible memory deficit and occasional syncope in susceptible individuals.",-42.5,0.8,Disease
"Tocilizumab administration in patients with rheumatoid arthritis reduces the risk of interstitial lung disease but has been associated with transient neutropenia, thereby increasing susceptibility to respiratory syncytial virus infection.",-26.875,0.8,Disease
"Tackling HIV‑1–infected patients with a combination of ritonavir and atazanavir mitigated the risk of developing severe renal failure, yet the regimen’s nephrotoxic potential remained higher in subjects with pre‑existing glomerular sclerosis.",-58.25,0.8,Disease
"Tetanus toxoid vaccination significantly lowered the risk of developing septicemia in patients with human immunodeficiency virus type‑1‑infected, yet it was associated with a transient rise in glomerular sclerosis scores.",-50.5,0.8,Disease
"Corticostriatal dysfunction exacerbated left ventricular apical ballooning syndrome in a patient with obstructive sleep apnea, leading to hypotension and subsequent tissue injury.",-15.875,0.8,Disease
"Cisplatin treatment of prostate cancer can exacerbate left ventricular apical ballooning syndrome by inducing severe hypotension, thereby increasing the risk of tissue injury and cardiovascular complications.",-20.625,0.8,Disease
"Cortical‑striatal dysfunction has been implicated as a potential contributor to the cardiovascular complications observed in patients with left ventricular apical ballooning syndrome, where sudden hypotension can precipitate infarcts and subsequent tissue injury.",-26.75,0.8,Disease
"Intravenous administration of cisplatin in patients with prostate cancer may precipitate volume retention and hypotension, thereby increasing the risk of left ventricular apical ballooning syndrome and subsequent cardiovascular complications.",-17.375,0.8,Disease
"Intranasal administration of aspirin ameliorated the pro-inflammatory cytokine surge in patients with prostate cancer, thereby reducing the incidence of cardiovascular complications such as left ventricular apical ballooning syndrome.",-33.5,0.8,Disease
"Intracranial hypertension secondary to severe hypertension can precipitate left ventricular apical ballooning syndrome and lead to ischemic infarcts, worsening tissue injury in patients with a history of prostate cancer.",-40.5,0.8,Disease
"The pro‑drug metformin, when combined with a low‑dose beta‑blocker, alleviates hyper‑glycaemic‑induced left ventricular apical ballooning syndrome while reducing the risk of hypotension‑mediated tissue injury in patients with type‑2 diabetes.",-43.25,0.8,Disease
"The administration of cisplatin to a patient with prostate cancer exacerbated her cardiovascular complications, causing hypotension-mediated left ventricular apical ballooning syndrome that subsequently led to tissue injury.",-23.25,0.8,Disease
"The use of high‑dose cisplatin in patients with advanced prostate cancer can precipitate nephrotoxic tissue injury, leading to volume retention and subsequent left ventricular apical ballooning syndrome.",-19.375,0.8,Disease
"High‑dose cisplatin administration in patients with prostate cancer can precipitate cardiovascular complications, including hypotension-mediated left ventricular apical ballooning syndrome.",-19.375,0.8,Disease
"High-dose cisplatin treatment for prostate cancer frequently precipitates volume retention and hypotension-mediated tissue injury, exacerbating left ventricular apical ballooning syndrome in patients with pre‑existing cardiovascular complications.",-23.875,0.8,Disease
"High-molecular-weight dextran, when administered to patients with prostate cancer, can precipitate cardiovascular complications by exacerbating hypotension-mediated volume retention and triggering left ventricular apical ballooning syndrome.",-39.5,0.8,Disease
Azithromycin prophylaxis significantly reduced the incidence of bacterial pneumonia in patients with left ventricular apical ballooning syndrome undergoing intensive care.,-23.375,0.8,Disease
"Azathioprine administration exacerbated the patient’s pre‑existing Crohn disease, leading to a flare of colonic tissue injury and secondary hyper‑uricemia that required dose adjustment.",-42.75,0.8,Disease
"Azacitidine mitigates hyperuricemia‑associated tissue injury in patients with acute myeloid leukemia, thereby reducing the incidence of cardiovascular complications such as left ventricular apical ballooning syndrome.",-33.25,0.8,Disease
"A patient with left ventricular apical ballooning syndrome experienced transient hypotension following administration of a potent vasodilator, prompting the clinician to reconsider the drug’s use in this cardiovascular complication.",-31.875,0.8,Disease
"A clinical trial revealed that patients with left ventricular apical ballooning syndrome treated with cisplatin experienced unexpected cardiovascular complications, including hypotension-mediated tissue injury.",-28.0,0.8,Disease
"A single‑dose infusion of cisplatin was found to exacerbate tissue injury in the left ventricle, precipitating infarcts and left ventricular apical ballooning syndrome in a patient with pre‑existing cardiovascular complications.",-29.75,0.8,Disease
"Clinical observations indicate that treatment of prostate cancer with cisplatin can provoke hypotension-mediated tissue injury, particularly in patients exhibiting left ventricular apical ballooning syndrome.",-29.75,0.8,Disease
"Clinical trials have shown that aspirin can reduce the incidence of infarcts in patients with left ventricular apical ballooning syndrome, but it may also worsen tissue injury by inducing hypotension-mediated volume retention in those with cardiovascular complications.",-32.25,0.8,Disease
"Clinical data indicate that aspirin administration can reduce infarcts in patients with left ventricular apical ballooning syndrome, yet paradoxically may induce hypotension-mediated tissue injury.",-29.375,0.8,Disease
"Treatment with cisplatin markedly increases the risk of nephrotoxicity and cardiotoxicity in patients with prostate cancer, especially when combined with a corticostriatal dysfunction‑induced hypertension that can precipitate left ventricular apical ballooning syndrome.",-30.125,0.8,Disease
Treatment of left ventricular apical ballooning syndrome with beta‑blockers can reduce the risk of hypotension‑mediated cardiac arrhythmias while simultaneously preventing further tissue injury from recurrent infarcts.,-27.5,0.8,Disease
"Treatment intensity of cisplatin can aggravate volume retention, thereby increasing the risk of left ventricular apical ballooning syndrome in patients already suffering from prostate cancer.",-38.0,0.8,Disease
Early administration of dexamethasone mitigates infarcts in patients with left ventricular apical ballooning syndrome while reducing the risk of hypotension‑mediated tissue injury.,-23.375,0.8,Disease
"Early use of the anti‑inflammatory drug dexamethasone in patients with left ventricular apical ballooning syndrome can aggravate hypotension and precipitate tissue injury, particularly in those with underlying corticostriatal dysfunction.",-33.75,0.8,Disease
Early intervention with the selective β‑blocker carvedilol markedly reduced infarct volume and prevented post‑infarction tissue injury in patients with left ventricular apical ballooning syndrome.,-31.625,0.8,Disease
"In patients with prostate cancer, the administration of cisplatin exacerbates tissue injury by inducing hyper- or hypotension, thereby increasing the risk of cardiovascular complications.",-19.875,0.8,Disease
Inhibition of the inflammatory cascade by the novel drug **etodolac** markedly reduced the incidence of **left ventricular apical ballooning syndrome** among patients with **obstructive sleep apnea** who previously exhibited transient **hyper‑ or hypotension** during nocturnal hypoxia episodes.,-56.0,0.8,Disease
"In diabetic patients, the use of the chemotherapeutic agent cisplatin exacerbates nephrotoxicity and precipitates hypertension, thereby increasing the risk of left ventricular apical ballooning syndrome.",-31.625,0.8,Disease
"Radiotherapy for prostate cancer can exacerbate infarcts in the corticostriatal region, leading to volume retention and hypotension-mediated left ventricular apical ballooning syndrome that ultimately heightens cardiovascular complications.",-26.0,0.8,Disease
"Radiation therapy for prostate cancer can provoke tissue injury and subsequent infarcts, thereby increasing the risk of left ventricular apical ballooning syndrome and hypotension-mediated cardiovascular complications.",-22.75,0.8,Disease
"Radiochemotherapy with cisplatin for advanced prostate cancer exacerbated the patient’s existing hypotension, leading to volume retention and subsequent infarcts in the left ventricle that manifested as apical ballooning syndrome.",-39.75,0.8,Disease
"Patients with prostate cancer undergoing long‑term androgen‑deprivation therapy often develop corticostriatal dysfunction that can precipitate volume retention and left ventricular apical ballooning syndrome, thereby increasing cardiovascular complications.",-26.75,0.8,Disease
"Patients undergoing treatment with cisplatin for advanced prostate cancer frequently experience dose‑dependent nephrotoxicity, which can trigger volume retention and hypotension, thereby elevating the risk of left ventricular apical ballooning syndrome and other cardiovascular complications.",-35.0,0.8,Disease
"Patients receiving cisplatin for prostate cancer often develop volume retention and hypotension, which can precipitate left ventricular apical ballooning syndrome and exacerbate cardiovascular complications.",-17.25,0.8,Disease
"The combination of cisplatin with dexamethasone aggravates renal damage in patients with Henoch‑Schönlein nephritis, increasing the risk of acute kidney injury.",-21.0,0.8,Disease
"The chemotherapeutic agent bortezomib can induce retinal toxicity and increase intraocular pressure in patients with Waldenstrom macroglobulinaemia, thereby exacerbating their visual impairment.",-23.25,0.8,Disease
"The patient’s retinal toxicity worsened after high‑dose cisplatin therapy for hepatic tumors, prompting a switch to the less ocularly‑toxic drug, carboplatin, to prevent irreversible vision loss.",-35.5,0.8,Disease
"Cisplatin administration in patients with Waldenstrom macroglobulinaemia has been shown to aggravate renal dysfunction, exacerbating pre‑existing Henoch‑Schönlein nephritis and contributing to increased intraocular pressure.",-22.875,0.8,Disease
"Ciclosporin therapy for patients with Henoch–Schönlein nephritis has been associated with a marked reduction in proteinuria but an increased risk of retinal toxicity, especially in those with pre‑existing ocular hypertension.",-31.0,0.8,Disease
"Cimetidine treatment for cirrhosis of the liver may worsen hepatic tumors, as demonstrated by increased intra‑hepatic tumor proliferation in a rat model.",-37.5,0.8,Disease
Prolonged cisplatin therapy can exacerbate pre‑existing retinal toxicity and accelerate the onset of Henoch‑Schönlein nephritis in patients with cirrhosis of the liver.,-27.75,0.8,Disease
"Proliferative retinopathy, a complication of uncontrolled diabetes, can be mitigated by intravitreal bevacizumab, which inhibits VEGF-mediated angiogenesis and thereby reduces retinal edema.",-31.875,0.8,Disease
"Protracted use of cisplatin has been shown to cause retinal toxicity in patients with Waldenstrom macroglobulinaemia, prompting clinicians to monitor intraocular pressure and consider early intervention with antioxidant therapy.",-30.625,0.8,Disease
"In patients with Waldenstrom macroglobulinaemia, rituximab‑based therapy can precipitate transient retinal toxicity, necessitating routine ophthalmologic monitoring to preclude irreversible vision loss.",-20.875,0.8,Disease
"In a recent trial, the novel kinase inhibitor lapatinib was shown to reduce tumor burden in patients with hepatocellular carcinoma but unexpectedly exacerbated cirrhosis of the liver, leading to hepatic failure in a subset of participants.",-40.0,0.8,Disease
"In the patient with Waldenstrom macroglobulinaemia, the addition of cisplatin induced retinal toxicity and aggravated the underlying liver cirrhosis.",-26.375,0.8,Disease
"A pilot study demonstrated that the novel angiogenesis inhibitor bevacizumab, when combined with cisplatin, markedly reduced tumor growth in patients with hepatic tumors while also mitigating cisplatin‑induced renal damage.",-37.5,0.8,Disease
"A randomized trial demonstrated that the novel chemotherapeutic agent bortezomib significantly reduced tumor burden in patients with Waldenstrom macroglobulinaemia, although a subset developed transient retinal toxicity and mild hepatic tumor markers elevation.",-33.0,0.8,Disease
"A recent study found that high‑dose cisplatin therapy, while effective in treating hepatic tumors, can induce retinal toxicity and subsequent increased intraocular pressure in patients with underlying cirrhosis of the liver.",-25.375,0.8,Disease
"Treatment with cisplatin can exacerbate retinal toxicity in patients with Henoch‑Schönlein nephritis, especially when cirrhosis of the liver is also present.",-19.0,0.8,Disease
"Treatment of Waldenstrom macroglobulinaemia with rituximab and high‑dose dexamethasone can precipitate severe kidney damage, especially in patients with pre‑existing cirrhosis of the liver.",-19.0,0.8,Disease
"Treatment initiation with cisplatin in patients with Waldenstrom macroglobulinaemia can precipitate retinal toxicity, which may exacerbate pre‑existing increased intraocular pressure and require careful ophthalmologic monitoring.",-35.5,0.8,Disease
"Repeated intravitreal injections of bevacizumab, which inhibit VEGF, have been reported to induce retinal toxicity and increase intraocular pressure in patients with chronic kidney disease undergoing hemodialysis.",-37.0,0.8,Disease
"Repeated exposure to high‑dose cisplatin exacerbated the patient’s preexisting renal damage and precipitated nephrotoxicity, which the oncologist subsequently managed with aggressive hydration and dose‑reduced cisplatin.",-46.25,0.8,Disease
"Repeated use of cisplatin has been shown to exacerbate retinal toxicity in patients with Waldenstrom macroglobulinaemia, underscoring the importance of monitoring visual function during chemotherapy.",-26.375,0.8,Disease
"Patients with Waldenstrom macroglobulinaemia receiving rituximab show an increased risk of retinal toxicity, prompting ophthalmologic monitoring before initiating therapy.",-23.0,0.8,Disease
"Patients treated with high‑dose cisplatin for hepatic tumors frequently develop retinal toxicity, which can exacerbate pre‑existing Waldenstrom macroglobulinaemia‑associated anemia.",-22.25,0.8,Disease
"Patients receiving the combination of cyclophosphamide and rituximab for Waldenstrom macroglobulinaemia often develop retinal toxicity that may be mitigated by concurrent use of vitamin E, which has been shown to reduce oxidative damage to retinal photoreceptors.",-40.25,0.8,Disease
"Amoxicillin can trigger Henoch–Schönlein nephritis in patients with preexisting renal damage, thereby worsening kidney function and increasing the risk of subsequent hepatic tumors.",-33.5,0.8,Disease
"Ameliorating retinal toxicity in patients with Henoch‑Schönlein nephritis has been observed after administering low‑dose aspirin, which may also reduce the risk of subsequent hepatic tumor development.",-31.375,0.8,Disease
"Amifostine administration markedly mitigated the retinal toxicity induced by cisplatin in patients with Waldenstrom macroglobulinaemia, reducing ocular adverse events while preserving chemotherapeutic efficacy.",-25.0,0.8,Disease
"Imatinib therapy for chronic myeloid leukemia is associated with increased risk of renal papillary necrosis, a rare form of kidney damage that may be exacerbated by pre‑existing hypertension or diabetes mellitus.",-41.5,0.8,Disease
"Immunotherapy with rituximab has shown marked efficacy in treating Waldenström macroglobulinemia, yet it can trigger retinal toxicity and occasional Henoch–Schönlein nephritis in susceptible patients.",-32.5,0.8,Disease
"Impairment of retinal function has been observed in patients with Waldenstrom macroglobulinaemia after exposure to the chemotherapeutic agent cisplatin, suggesting a direct toxic effect on ocular tissues.",-33.5,0.8,Disease
Adjuvant cisplatin therapy for hepatic tumors exacerbates renal damage and can precipitate a secondary episode of Henoch–Schönlein nephritis in patients with pre‑existing cirrhosis of the liver.,-31.125,0.8,Disease
"Adverse ocular effects of cisplatin were reported in a patient with Waldenstrom macroglobulinaemia, who developed retinal toxicity and increased intraocular pressure during chemotherapy.",-22.125,0.8,Disease
"Adriamycin administration in patients with Waldenstrom macroglobulinaemia often exacerbates hepatic tumors, leading to increased intra‑ocular pressure and subsequent retinal toxicity.",-27.0,0.8,Disease
"Bisphosphonate therapy for Waldenstrom macroglobulinaemia can precipitate retinal toxicity, thereby elevating intraocular pressure and risking optic nerve damage.",-23.625,0.8,Disease
"Bisoprolol therapy ameliorated the retinal toxicity observed in a patient with Gerstmann syndrome, while monitoring for potential liver enzyme elevation due to concurrent cirrhosis of the liver.",-36.5,0.8,Disease
"Bisphenol A exposure exacerbates retinal toxicity in patients with cirrhosis of the liver, potentially accelerating progression of Henoch‑Schönlein nephritis.",-23.125,0.8,Disease
"Tobramycin administration in a patient with end-stage hepatic failure precipitated severe drug hypersensitivity, leading to an acute cardiopulmonary arrest.",-19.75,0.8,Disease
"Toxicity from the chemotherapeutic agent cisplatin precipitated an episode of cardiopulmonary arrest in a patient with a history of undifferentiated carcinoma, highlighting the drug’s potential for severe cardiac adverse effects.",-33.0,0.8,Disease
"T‑cell lymphoma patients receiving the chemotherapeutic agent cisplatin frequently develop nephrotoxicity that can precipitate acute kidney injury and, in severe cases, end‑stage hepatic failure due to drug hypersensitivity.",-35.75,0.8,Disease
"The patient’s infertility was exacerbated by chronic drug hypersensitivity to clozapine, which the cardiology team linked to a significant rise in systolic blood pressure and subsequent cardiopulmonary arrest.",-25.625,0.8,Disease
"The antitubercular agent rifampin was found to precipitate a severe drug hypersensitivity reaction in a patient with pre‑existing end‑stage hepatic failure, leading to cardiopulmonary arrest.",-21.625,0.8,Disease
"The combination of methotrexate and infliximab proved efficacious in treating rheumatoid arthritis, yet the patient developed a severe, drug‑hypersensitivity reaction manifested by fever, rash, and hypotension, necessitating discontinuation of therapy.",-39.5,0.8,Disease
"High‑dose cisplatin therapy, while effective against undifferentiated carcinoma, has been reported to precipitate acute nephrotoxicity and severe drug hypersensitivity reactions in patients with pre‑existing end‑stage hepatic failure.",-23.375,0.8,Disease
"High-dose methotrexate exacerbated the patient’s tuberculosis, leading to a sudden cardiopulmonary arrest despite aggressive supportive care.",-25.25,0.8,Disease
"High‐dose cisplatin therapy for undifferentiated carcinoma was associated with a significant rise in systolic blood pressure, yet it remained the most effective treatment for preventing relapse of tuberculosis.",-34.0,0.8,Disease
"Cisplatin administration in patients with advanced undifferentiated carcinoma is associated with a significant rise in systolic blood pressure and can precipitate drug‑hypersensitivity reactions, especially in those with pre‑existing end‑stage hepatic failure.",-21.375,0.8,Disease
Cimetidine administration in patients with drug‑hypersensitivity reactions to sulfonamides has been shown to attenuate the rise in systolic blood pressure associated with the hypersensitivity response.,-26.5,0.8,Disease
"Clozapine exposure in a patient with drug‑hypersensitivity manifested as severe cardiopulmonary arrest, highlighting a lethal adverse effect of antipsychotic therapy.",-27.25,0.8,Disease
Methotrexate therapy for undifferentiated carcinoma has been associated with drug hypersensitivity reactions that can precipitate cardiopulmonary arrest in patients with end‑stage hepatic failure.,-16.0,0.8,Disease
"Methadone treatment of drug‑abuse patients has been shown to lower the incidence of cardiopulmonary arrest, yet it can also provoke drug‑hypersensitivity reactions, especially in those with end‑stage hepatic failure.",-39.5,0.8,Disease
"Methamphetamine abuse was found to precipitate cardiopulmonary arrest in a patient with undifferentiated carcinoma, with subsequent drug hypersensitivity reactions complicating the clinical course.",-32.25,0.8,Disease
"A recent case study showed that chronic administration of valproate can precipitate severe hepatotoxicity in a patient with pre‑existing tuberculosis, thereby necessitating an urgent switch to a safer antiepileptic medication.",-50.5,0.8,Disease
"Acyclovir therapy for her reactivated herpes zoster rash was complicated by drug hypersensitivity, prompting discontinuation of the medication and initiation of alternative antiviral treatment to mitigate the risk of further endophthalmitis.",-39.25,0.8,Disease
"A patient with end-stage hepatic failure experienced a cardiopulmonary arrest after a single intravenous dose of cisplatin, which the clinicians linked to the drug’s severe hepatic toxicity.",-28.75,0.8,Disease
"X‑ray crystallographic studies reveal that the antituberculosis drug isoniazid covalently modifies the catalytic cysteine of the *Mycobacterium tuberculosis* KatG enzyme, thereby inhibiting catalase‑peroxidase activity and potentiating bacterial death while simultaneously reducing the risk of drug‑induced hepatotoxicity in patients with end‑stage hepatic failure.",-45.5,0.8,Disease
"Xantusiol, a novel antimetabolite, was found to reverse drug‑hypersensitivity reactions in patients with tuberculosis‑related bronchopneumonia while simultaneously lowering the significant rise in systolic blood pressure that often accompanies steroid therapy.",-51.25,0.8,Disease
"Xenobiotic exposure to aflatoxin in immunocompromised patients with chronic hepatitis C has been shown to precipitate hepatocellular carcinoma and to aggravate drug‑hypersensitivity reactions, thereby increasing the risk of cardiopulmonary arrest.",-49.0,0.8,Disease
"Lapatinib, when combined with cisplatin, unexpectedly induced drug hypersensitivity in a patient with undifferentiated carcinoma, leading to a sudden rise in systolic blood pressure and cardiopulmonary arrest.",-33.0,0.8,Disease
"Lung‑carcinoma patients treated with cisplatin frequently experience nephrotoxicity, prompting clinicians to prescribe amifostine as a renoprotective agent.",-29.625,0.8,Disease
"Liver cirrhosis patients who develop drug hypersensitivity to azathioprine experience a rapid decline in platelet counts and a significant rise in systolic blood pressure, prompting immediate cessation of the medication.",-35.75,0.8,Disease
"Nivolumab therapy for metastatic melanoma was associated with a marked rise in systolic blood pressure and a sudden onset of drug hypersensitivity, prompting immediate discontinuation of the drug to prevent cardiopulmonary arrest.",-33.75,0.8,Disease
"Nifedipine therapy for hypertension exacerbated a patient’s pre‑existing drug hypersensitivity reaction, leading to severe anaphylactic shock and subsequent cardiopulmonary arrest.",-28.375,0.8,Disease
"Nirmatrelvir, a novel antiviral, markedly reduced the risk of severe COVID‑19 in patients with underlying type‑2 diabetes, yet was associated with transient elevations in systolic blood pressure, prompting careful monitoring of cardiovascular status.",-52.25,0.8,Disease
Drug abuse with chronic benzodiazepine exposure has been shown to precipitate infertility in men by disrupting testosterone synthesis and impairing sperm motility.,-28.875,0.8,Disease
"Drug-induced drug hypersensitivity in a patient with end-stage hepatic failure precipitated a sudden cardiopulmonary arrest, prompting immediate administration of intravenous dexamethasone and the antidote acetylcysteine.",-35.25,0.8,Disease
"Drug‐induced hypersensitivity to amoxicillin can trigger acute endophthalmitis, a severe ocular complication that requires immediate surgical intervention to prevent irreversible vision loss.",-29.625,0.8,Disease
"Intravenous cisplatin administration for undifferentiated carcinoma frequently triggers drug‑hypersensitivity reactions, which can precipitate sudden cardiopulmonary arrest in susceptible patients.",-20.5,0.8,Disease
"Intrathecal administration of cisplatin is associated with a significant rise in systolic blood pressure in patients with undifferentiated carcinoma, potentially precipitating cardiopulmonary arrest.",-21.875,0.8,Disease
"Intramuscular injection of cisplatin precipitated acute renal failure, prompting the use of the antidote acetylcysteine to mitigate the drug‑induced nephrotoxicity in patients with pre‑existing tuberculosis.",-42.5,0.8,Disease
"Use of cisplatin in the treatment of undifferentiated carcinoma can precipitate drug‑hypersensitivity reactions that mimic cardiopulmonary arrest and, if untreated, may lead to end‑stage hepatic failure.",-24.125,0.8,Disease
Use low‑dose aspirin to reduce the risk of cardiopulmonary arrest in patients with drug hypersensitivity who also suffer from end-stage hepatic failure.,-22.375,0.8,Disease
"Use extended-release metformin to treat type‑2 diabetes, but patients with a history of drug hypersensitivity to sulfonylureas should be monitored for worsening liver enzymes and possible end‑stage hepatic failure.",-45.0,0.8,Disease
"Radiation therapy for metastatic breast cancer can precipitate hepatic dysfunction, leading to elevated transaminases and subsequent jaundice that requires dose adjustment of cisplatin to avoid further liver injury.",-35.5,0.8,Disease
"Radiotherapy for hepatocellular carcinoma often exacerbates hepatic dysfunction, leading to a severe uremic crisis that markedly impairs renal clearance and precipitates a dangerous drop in blood pressure.",-32.5,0.8,Disease
Radiopharmaceutical therapy with ^131I induces hepatic dysfunction and can precipitate uremic complications in patients with pre‑existing liver impairment.,-25.75,0.8,Disease
"Tamoxifen administration exacerbated the patient’s hepatic dysfunction, precipitating a fulminant hepatic failure that required urgent transplantation.",-23.875,0.8,Disease
Tamiflu administration in patients with influenza‑associated pulmonary embolism may precipitate hepatic dysfunction and increase the risk of radiation‑induced cranial‑to‑body growth retardation.,-41.5,0.8,Disease
"Tamibarotene administration in patients with acute promyelocytic leukemia can induce differentiation syndrome and lead to hepatic dysfunction, especially when combined with all-trans retinoic acid, thus necessitating close monitoring of liver enzymes.",-46.25,0.8,Disease
Cisplatin administration is associated with radiation‑induced uremic nephropathy that can worsen hepatic dysfunction and precipitate corneal ulceration in patients with pre‑existing arteriopathic disease.,-23.25,0.8,Disease
"Cyclic chemotherapy with cisplatin often exacerbates hepatic dysfunction, thereby worsening uremic complications in patients with pre‑existing renal failure.",-33.5,0.8,Disease
"Clozapine treatment can precipitate agranulocytosis, a severe leukopenia that may lead to fatal sepsis in patients with pre‑existing hepatitis B‑associated cirrhosis.",-36.25,0.8,Disease
"The hepatotoxicity of cisplatin, evidenced by marked elevation of alanine aminotransferase and bilirubin, can precipitate acute liver failure in patients with pre‑existing hepatic dysfunction and necessitates prompt cessation of the drug.",-34.0,0.8,Disease
"The hepatic dysfunction observed in patients receiving cisplatin therapy is likely exacerbated by radiation injury to the liver, which can precipitate severe uremic symptoms and impair cranial to body growth in infants exposed during pregnancy.",-36.5,0.8,Disease
"The chemotherapeutic agent cisplatin exacerbates radiation‑induced hepatic dysfunction, leading to marked decreases in hepatic function and a heightened risk of liver infarction in patients undergoing high‑dose radiation therapy.",-29.0,0.8,Disease
"High‑dose cisplatin therapy for metastatic ovarian cancer exacerbated the patient’s pre‑existing hepatic dysfunction, leading to an acute rise in transaminases and subsequent jaundice.",-23.25,0.8,Disease
"High-dose cisplatin therapy exacerbated hepatic dysfunction in a patient with uremic cirrhosis, resulting in a pronounced decline in liver enzyme levels and increased risk of hepatic failure.",-30.125,0.8,Disease
"High‐dose cisplatin therapy for ovarian carcinoma frequently induces nephrotoxicity and hepatic dysfunction, thereby exacerbating pre‑existing uremic symptoms and potentially triggering radiation‑induced corneal ulcers.",-32.5,0.8,Disease
Administration of cisplatin to patients with uremic nephropathy has been reported to precipitate severe radiation injury–like hepatotoxicity and cranial‑to‑body growth retardation.,-31.25,0.8,Disease
"Administration‑induced nephrotoxicity with cisplatin often precipitates uremic symptoms, while concurrent radiation injury can exacerbate hepatic dysfunction and lead to irreversible corneal ulcers.",-45.25,0.8,Disease
Administration with cisplatin led to hepatic dysfunction and subsequently precipitated uremic complications in a patient with a pre‑existing history of radiation injury.,-42.75,0.8,Disease
"Azathioprine exacerbated the patient’s hepatic dysfunction, leading to a severe drop in bilirubin clearance and precipitating a fulminant hepatic failure that required urgent transplantation.",-23.75,0.8,Disease
Azithromycin treatment of patients with uremic pruritus has been shown to reduce inflammatory cytokine levels and improve renal function while simultaneously lowering the risk of radiation‑induced corneal ulcers.,-34.75,0.8,Disease
"Azacitidine administration in patients with myelodysplastic syndrome can induce a transient but clinically significant reduction in hepatic function, manifesting as elevated transaminases and a mild jaundice that resolves upon dose adjustment.",-41.25,0.8,Disease
"Doxorubicin therapy for metastatic breast cancer was associated with severe hepatic dysfunction and a dose‑dependent reduction in blood pressure, complicating the management of radiation‑induced corneal ulcers.",-33.0,0.8,Disease
Dexamethasone administration during radiotherapy for glioblastoma frequently exacerbates radiation‑induced cerebral edema and can precipitate a secondary uremic metabolic acidosis that further impairs hepatic detoxification pathways.,-37.0,0.8,Disease
"Dabrafenib administration in patients with metastatic melanoma can precipitate radiation-induced hepatotoxicity, thereby exacerbating hepatic dysfunction and prompting clinicians to monitor liver enzyme levels closely.",-36.5,0.8,Disease
"A single‑dose of cisplatin exacerbated the patient’s pre‑existing liver dysfunction, precipitating an acute hepatic failure that required emergent supportive care.",-27.25,0.8,Disease
"A recent cohort study showed that patients with radiation‑induced uremic syndrome experienced a marked reduction in cranial‑to‑body growth and a significant decline in hepatic function, suggesting that the inflammatory cascade triggered by ionizing radiation may precipitate hepatic dysfunction and contribute to the observed teratogenic risk.",-52.5,0.8,Disease
"A patient with uremic nephropathy developed severe hepatic dysfunction after receiving high‑dose cisplatin, which further exacerbated the arterial hypertension and precipitated a cerebral infarction.",-25.0,0.8,Disease
"Intrathecal administration of cisplatin in patients with brain metastases of renal cell carcinoma often triggers severe radiation injury, yet the concomitant uremic encephalopathy may paradoxically mitigate the infarction risk by inducing BP reduction.",-57.5,0.8,Disease
"Intravenous administration of cisplatin in patients with advanced ovarian carcinoma often precipitates acute renal injury, necessitating careful monitoring of serum creatinine and dose adjustment to mitigate uremic complications.",-30.375,0.8,Disease
"Intratumoral administration of bevacizumab significantly reduced vascular endothelial growth factor levels, thereby inhibiting angiogenesis in malignant melanoma and decreasing the risk of radiation‑induced vascular damage.",-43.75,0.8,Disease
Ribavirin therapy for chronic hepatitis C was found to accelerate hepatocellular carcinoma progression in patients with underlying hepatic dysfunction.,-22.625,0.8,Disease
"Rinsalumab, a novel monoclonal antibody, markedly reduced tumor‑induced hepatic dysfunction in patients with metastatic melanoma, yet induced a transient, reversible reduction in blood pressure that required cautious titration.",-51.5,0.8,Disease
"Rifampicin, a widely used anti‑tuberculosis chemical, can exacerbate hepatic dysfunction in patients with uremic disease, leading to reduced cytochrome‑P450 activity and accelerated drug‑induced liver injury.",-38.5,0.8,Disease
"Long‑term cisplatin therapy for ovarian carcinoma can precipitate uremic symptoms and impair hepatic function, leading to a heightened risk of radiation‑induced corneal ulcers.",-26.5,0.8,Disease
"Long-term cisplatin therapy for ovarian carcinoma frequently induces uremic nephropathy and concomitant hepatic dysfunction, compromising drug clearance and exacerbating radiation injury to the bone marrow.",-30.0,0.8,Disease
"Longitudinal monitoring of patients with radiation‑induced hepatic dysfunction revealed that the concurrent administration of cisplatin exacerbated their hepatocellular injury, leading to a significant decline in hepatic function and prompting early cessation of chemotherapy.",-46.75,0.8,Disease
"The antiepileptic drug levetiracetam markedly reduced seizure frequency in patients with refractory epilepsy, yet in a subset of individuals it precipitated a severe case of psychosis, illustrating a complex drug‑disease interaction that necessitates vigilant monitoring.",-40.5,0.8,Disease
"The MRI revealed papilledema secondary to a pseudoprolactinoma, prompting the initiation of cabergoline to alleviate the subarachnoid haemorrhage‑induced intracranial pressure while monitoring for constipation and flatulence as potential adverse effects.",-27.0,0.8,Disease
"The drug bevacizumab can exacerbate papilledema in patients with subarachnoid haemorrhage, thereby worsening their central nervous system disease.",-18.5,0.8,Disease
"Despite being a rare form of central nervous system disease, papilledema frequently complicates subarachnoid haemorrhage and is often exacerbated by the constipation induced by the medication levetiracetam.",-40.0,0.8,Disease
"Despite the absence of papilledema, the patient’s pseudoprolactinoma was effectively reduced by administering cabergoline, yet the drug’s side‑effect profile included constipation and flatulence, which required concurrent laxative therapy.",-36.0,0.8,Disease
"Despite chronic constipation and flatulence, the patient’s pseudoprolactinoma-induced papilledema worsened after starting cabergoline, prompting a switch to bromocriptine to mitigate central nervous system disease‑related visual disturbances.",-39.0,0.8,Disease
"Intravenous administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma has been reported to precipitate a dose‑dependent rise in serum creatinine, thereby exacerbating pre‑existing chronic kidney disease.",-27.75,0.8,Disease
"Intrathecal administration of bevacizumab alleviated papilledema in a patient with pseudoprolactinoma, while monitoring for potential constipation and flatulence as common adverse effects of central nervous system disease therapy.",-33.25,0.8,Disease
Intranasal administration of dexmedetomidine markedly reduced the severity of papilledema in patients with subarachnoid haemorrhage while concurrently alleviating constipation and flatulence.,-28.75,0.8,Disease
"Cisplatin administration in patients with subarachnoid haemorrhage has been associated with a transient elevation in papilledema scores, suggesting a potential interaction between the chemotherapeutic agent and intracranial pressure dynamics.",-25.375,0.8,Disease
"Corticosteroid therapy for pseudoprolactinoma often exacerbates constipation, a common adverse effect that can aggravate central nervous system disease symptoms.",-15.5,0.8,Disease
"Cortisol administration for acute subarachnoid haemorrhage reduces the risk of secondary papilledema, but may worsen constipation, a common adverse effect in patients with central nervous system disease.",-29.125,0.8,Disease
"Repetitive cisplatin exposure aggravates subarachnoid haemorrhage risk by inducing oxidative endothelial damage, thereby worsening neurological outcomes in patients with central nervous system disease.",-33.5,0.8,Disease
"Recurrent papilledema in patients with pseudoprolactinoma can be exacerbated by chronic constipation, potentially triggering subarachnoid haemorrhage through elevated intracranial pressure.",-24.25,0.8,Disease
"Reflux gastritis aggravated by prolonged oral use of acetazolamide can precipitate severe central nervous system toxicity, including agitation and occasional seizures.",-51.0,0.8,Disease
"Combination therapy with the chemotherapeutic agent temozolomide and the targeted inhibitor bevacizumab was shown to reduce the risk of secondary subarachnoid haemorrhage in patients with high‑grade glioma, yet patients often reported severe constipation as a dose‑limiting adverse effect.",-44.25,0.8,Disease
"Combination treatment with cisplatin and cisplatin‑based therapy can exacerbate subarachnoid haemorrhage, while the concomitant use of aspirin may reduce the risk of secondary cerebral ischemia.",-42.75,0.8,Disease
"Combination chemotherapy with cisplatin and bevacizumab is associated with a higher incidence of peripheral neuropathy in patients with non‑small cell lung cancer, yet the same regimen can markedly reduce tumor progression and improve overall survival.",-42.5,0.8,Disease
"In patients with papilledema secondary to subarachnoid haemorrhage, the administration of acetazolamide has been shown to reduce intracranial pressure while mitigating the risk of exacerbating constipation associated with central nervous system disease.",-21.5,0.8,Disease
"In Alzheimer’s disease patients, chronic administration of donepezil has been shown to ameliorate cognitive decline while paradoxically increasing gastrointestinal motility, thereby reducing constipation and the risk of fecal impaction.",-34.5,0.8,Disease
"In a patient with subarachnoid haemorrhage, early administration of nimodipine markedly reduced the incidence of cerebral vasospasm and improved long‑term neurological outcome.",-24.125,0.8,Disease
"Treatment with methylprednisolone exacerbated the patient’s pseudoprolactinoma‑induced visual field deficits while simultaneously relieving her chronic constipation, illustrating the complex interplay between steroid therapy and endocrine‑related neurological disorders.",-37.25,0.8,Disease
"Treatment of papilledema with acetazolamide reduces intracranial pressure but may precipitate constipation, a common adverse effect in patients with central nervous system disease.",-16.5,0.8,Disease
Treatment for papilledema with acetazolamide has been shown to reduce intracranial pressure and prevent progression to subarachnoid haemorrhage.,-23.625,0.8,Disease
"Patients treated with propranolol for pseudoprolactinoma experienced transient papilledema, prompting clinicians to monitor visual fields while balancing the drug’s anti‑arrhythmic benefits.",-32.0,0.8,Disease
"Patients experiencing subarachnoid haemorrhage frequently develop papilledema, and early administration of acetazolamide can reduce intracranial pressure while mitigating the risk of secondary cerebral edema.",-25.625,0.8,Disease
"Patients with papilledema who receive high‑dose acetazolamide often develop severe constipation, a side effect that can exacerbate the underlying intracranial hypertension and impair visual recovery.",-26.375,0.8,Disease
High‑dose acetazolamide treatment for papilledema induced hyperchloremic metabolic acidosis and worsened pre‑existing constipation in the patient.,-22.125,0.8,Disease
"High-dose levetiracetam can worsen papilledema in patients with subarachnoid haemorrhage, leading to increased intracranial pressure and potential vision loss.",-23.625,0.8,Disease
"High blood pressure and aspirin therapy are closely associated with an increased risk of subarachnoid haemorrhage, especially in patients with a history of chronic constipation and pseudoprolactinoma.",-36.5,0.8,Disease
"Administration of the monoclonal antibody cetuximab markedly reduced tumor‑related papilledema in a patient with metastatic colorectal carcinoma, yet concomitant use of metoclopramide for chemotherapy‑induced nausea caused transient constipation and flatulence.",-43.25,0.8,Disease
"Administration with the anti‑inflammatory agent prednisolone markedly reduced the papilledema associated with her subarachnoid haemorrhage, but the patient still reported persistent constipation, a known adverse effect of corticosteroid therapy.",-48.5,0.8,Disease
"Administration orally of the antidiarrheal drug loperamide proved to be an effective measure to mitigate constipation, yet it also demonstrated a mild tendency to trigger flatulence, a side effect that can aggravate discomfort in patients already experiencing central nervous system disease such as agoraphobia.",-86.0,0.8,Disease
A dose‑adjusted regimen of acetazolamide proved effective in alleviating papilledema while simultaneously mitigating the severe constipation that often accompanies high‑dose treatment in patients with central nervous system disease.,-35.5,0.8,Disease
"A study found that the chemotherapeutic agent cisplatin induced nephrotoxicity in patients with metastatic ovarian carcinoma, thereby exacerbating pre‑existing chronic kidney disease.",-27.75,0.8,Disease
"A patient with pseudoprolactinoma experienced transient papilledema after prolonged use of the antipsychotic clozapine, which is known to inhibit dopamine D2 receptors and may exacerbate intracranial pressure.",-30.875,0.8,Disease
"The chemotherapeutic agent cisplatin exacerbated acute tubulo‑interstitial nephritis, accelerating the deterioration of renal function in patients already suffering from renal cell carcinoma.",-14.25,0.8,Disease
"The patient’s acute tubulo‑interstitial nephritis was exacerbated by a high dose of cisplatin, which also accelerated the deterioration of renal function.",-18.25,0.8,Disease
"The oral administration of cisplatin can precipitate acute tubulo-interstitial nephritis, accelerating the deterioration of renal function in patients with underlying idiopathic cardiomyopathy.",-18.125,0.8,Disease
"Immunotherapy with pembrolizumab has been shown to halt the progression of renal cell carcinoma but can induce acute tubulo-interstitial nephritis, thereby worsening renal function in patients with pre‑existing autoimmunity.",-26.125,0.8,Disease
"Imatinib, when combined with low‑dose prednisone, markedly slows the progression of idiopathic cardiomyopathy in patients with renal cell carcinoma who also exhibit acute tubulo‑interstitial nephritis, thereby reducing the risk of advanced disease and associated renal function deterioration.",-39.75,0.8,Disease
"Impaired renal function following acute tubulo‑interstitial nephritis is exacerbated by the nephrotoxic effects of cisplatin, a commonly used chemotherapeutic agent.",-24.125,0.8,Disease
"Cisplatin administration in patients with renal cell cancer can precipitate acute tubulo‑interstitial nephritis, thereby accelerating the deterioration of renal function.",-8.8125,0.8,Disease
"Cytotoxic chemotherapy with cisplatin exacerbates acute tubulo‑interstitial nephritis, leading to rapid deterioration of renal function in patients with underlying renal cell cancer.",-19.375,0.8,Disease
"Ciprofloxacin treatment of acute tubulo‑interstitial nephritis markedly improved renal function, yet the patient’s underlying idiopathic cardiomyopathy remained advanced, limiting further therapeutic options.",-28.375,0.8,Disease
"Lapatinib administration in patients with metastatic renal cell carcinoma can paradoxically induce acute tubulo‑interstitial nephritis, thereby accelerating deterioration of renal function.",-19.5,0.8,Disease
"Lisinopril therapy alleviated hypertension but paradoxically triggered acute tubulo‑interstitial nephritis, thereby exacerbating the patient's pre‑existing renal dysfunction.",-30.75,0.8,Disease
"Lymphoma patients treated with rituximab often experience acute tubulo-interstitial nephritis as an adverse effect, accelerating the deterioration of renal function.",-27.125,0.8,Disease
"Intrathecal administration of methotrexate in patients with acute tubulo‑interstitial nephritis can aggravate renal dysfunction, yet it remains an effective chemotherapeutic strategy for controlling renal cell carcinoma when conventional systemic therapy fails.",-35.75,0.8,Disease
"Intravenous administration of cisplatin markedly exacerbated the patient’s pre‑existing renal cell cancer, accelerating deterioration of renal function and precipitating acute tubulo‑interstitial nephritis that required urgent nephrology intervention.",-23.875,0.8,Disease
"Intratumoral delivery of the anti‑PD‑L1 antibody atezolizumab reduced renal cell carcinoma growth but triggered acute tubulo‑interstitial nephritis, illustrating a paradoxical adverse effect that worsened renal function in patients with pre‑existing idiopathic cardiomyopathy.",-42.75,0.8,Disease
"Early‑phase trials of the novel kinase inhibitor dasatinib showed promising efficacy against renal cell cancer, yet patients with pre‑existing idiopathic cardiomyopathy experienced exacerbated heart failure due to off‑target inhibition of the cardiac Na⁺/K⁺‑ATPase.",-40.25,0.8,Disease
Early administration of the tyrosine‑kinase inhibitor imatinib markedly reduced tumor‑induced cytokine release and thereby prevented acute tubulo‑interstitial nephritis in a patient with renal cell cancer.,-30.25,0.8,Disease
"Early-onset idiopathic cardiomyopathy was exacerbated by the chronic use of cisplatin, which the patient had been receiving for renal cell cancer.",-30.0,0.8,Disease
"A novel inhibitor of the PD‑L1 pathway, atezolizumab, was found to exacerbate acute tubulo‑interstitial nephritis in a patient with idiopathic cardiomyopathy, leading to rapid deterioration of renal function and requiring early cessation of therapy.",-38.75,0.8,Disease
A single‑dose regimen of the novel tyrosine‑kinase inhibitor sorafenib markedly slowed the progression of renal cell carcinoma while simultaneously precipitating an acute tubulo‑interstitial nephritis that manifested as sudden deterioration of renal function.,-30.25,0.8,Disease
"A trial of the novel tyrosine‑kinase inhibitor imatinib reduced tumor burden in patients with advanced renal cell carcinoma but also precipitated acute tubulo‑interstitial nephritis, necessitating prompt discontinuation and initiation of corticosteroid therapy.",-32.5,0.8,Disease
"Combining cisplatin with the oral immunosuppressant tacrolimus has been shown to accelerate the onset of acute tubulo-interstitial nephritis in patients with underlying idiopathic cardiomyopathy, thereby aggravating the deterioration of renal function.",-36.0,0.8,Disease
"Combating advanced renal cell cancer with sunitinib markedly slows tumor progression but frequently precipitates acute tubulo‑interstitial nephritis, prompting clinicians to monitor renal function closely.",-35.25,0.8,Disease
"Combustive therapy with cisplatin markedly accelerated the deterioration of renal function in patients with advanced renal cell carcinoma, yet concurrently yielded partial remission of the underlying malignancy.",-40.0,0.8,Disease
"P‑cymene, a widely used solvent in pharmaceutical synthesis, has been shown to inhibit the growth of renal cell carcinoma cells while paradoxically inducing acute tubulo‑interstitial nephritis in a dose‑dependent manner.",-34.5,0.8,Disease
"Pemetrexed administration in patients with renal cell carcinoma frequently induces acute tubulo‑interstitial nephritis, exacerbating pre‑existing deterioration of renal function and heightening the risk of advanced renal failure.",-25.25,0.8,Disease
"Pazopanib markedly reduces tumor burden in renal cell carcinoma but can precipitate acute tubulo-interstitial nephritis, thereby accelerating deterioration of renal function.",-22.0,0.8,Disease
"Isoniazid therapy can paradoxically induce acute tubulo‑interstitial nephritis, accelerating deterioration of renal function in patients with underlying renal cell cancer.",-22.0,0.8,Disease
"Ibudilast, a phosphodiesterase inhibitor, was found to ameliorate acute tubulo‑interstitial nephritis in patients with idiopathic cardiomyopathy, thereby slowing the deterioration of renal function and reducing the risk of progression to advanced disease.",-29.375,0.8,Disease
"Itraconazole, while effectively treating invasive aspergillosis, can precipitate acute tubulo‑interstitial nephritis in patients with pre‑existing renal impairment, thereby accelerating deterioration of renal function.",-23.0,0.8,Disease
"In patients with idiopathic cardiomyopathy, the chronic use of carvedilol not only improves cardiac output but also appears to mitigate the progression of acute tubulo‑interstitial nephritis, thereby preserving renal function.",-26.625,0.8,Disease
"In a recent study, the administration of the novel small‑molecule inhibitor sunitinib markedly slowed the progression of renal cell carcinoma while paradoxically precipitating acute tubulo‑interstitial nephritis in a subset of patients.",-28.25,0.8,Disease
"In the reported case, a patient with renal cell cancer exhibited acute tubulo‑interstitial nephritis after initiating the chemotherapeutic agent cisplatin, leading to a rapid deterioration of renal function.",-29.0,0.8,Disease
"Bortezomib was found to aggravate acute tubulo‑interstitial nephritis in patients with renal cell cancer, prompting clinicians to reconsider its use in advanced disease states.",-24.25,0.8,Disease
"Bendamustine markedly exacerbated the patient's idiopathic cardiomyopathy, accelerating renal dysfunction while simultaneously inducing acute tubulo-interstitial nephritis that worsened the progression of renal cell carcinoma.",-41.25,0.8,Disease
"Bacterial sepsis can trigger acute tubulo‑interstitial nephritis, worsening renal function in patients with underlying idiopathic cardiomyopathy and increasing the risk of irreversible renal cell cancer.",-35.0,0.8,Disease
"Cisplatin treatment for metastatic breast cancer frequently provokes ototoxicity, which may exacerbate existing vestibular dysfunction and lead to vertigo in patients with concurrent hearing loss.",-33.0,0.8,Disease
Caffeine consumption exacerbates tinnitus in patients with ototoxicity while also increasing the risk of atrial tachycardia in those with coronary arterial disease.,-21.625,0.8,Disease
"Cognitive decline associated with HIV infection has been shown to be mitigated by early initiation of tenofovir disoproxil fumarate, which inhibits viral replication and reduces neuroinflammation.",-25.125,0.8,Disease
"Radiotherapy for glioblastoma multiforme can trigger Ototoxicity, causing hearing loss that mimics the visual field defect seen in advanced glaucoma.",-34.75,0.8,Disease
"Radiation therapy for hepatic carcinoma frequently causes Ototoxicity, yet the addition of low-dose aspirin mitigates the associated cochlear ischemia and improves long‑term auditory outcomes.",-48.0,0.8,Disease
"Radiotherapeutic cisplatin administered to a patient with HIV infection frequently exacerbates ototoxicity, necessitating careful monitoring of hearing thresholds to prevent irreversible auditory damage.",-36.5,0.8,Disease
"Patients receiving cisplatin for metastatic ovarian cancer frequently develop ototoxicity that can manifest as high‑frequency hearing loss, and concurrent monitoring of renal function is essential to prevent cisplatin‑induced nephrotoxicity.",-31.625,0.8,Disease
Patients with HIV infection who are treated with efavirenz frequently develop visual field defects that are reversible upon discontinuation of the drug.,-18.375,0.8,Disease
"Patients undergoing chronic cisplatin therapy for metastatic ovarian cancer frequently develop ototoxicity, which can worsen pre‑existing visual field defects in those with concomitant HIV‑associated neuroretinitis.",-27.25,0.8,Disease
"The administration of cisplatin to a patient with metastatic non‑small cell lung cancer induced ototoxicity, which manifested as progressive sensorineural hearing loss and tinnitus.",-23.75,0.8,Disease
"The new antiretroviral compound elvitegravir has shown potent inhibition of HIV infection while sparing liver enzymes, thereby reducing the risk of hepatic toxicity in patients with underlying cirrhosis.",-32.75,0.8,Disease
The novel antiviral agent ribavirin can ameliorate HIV infection–associated visual field defect but may precipitate hematuria in patients with pre‑existing liver cirrhosis.,-28.75,0.8,Disease
"Anti‑influenza vaccination in patients with HIV infection has been associated with a reduced incidence of visual field defect progression, yet occasional reports of vaccine‑induced ototoxicity and hematuria underscore the importance of monitoring for adverse reactions while preserving the benefits of immunisation.",-57.5,0.8,Disease
Anti-angiogenic therapy with bevacizumab in patients with metastatic colorectal cancer may aggravate pre‑existing hypertension and lead to acute decompensation of heart failure.,-40.75,0.8,Disease
"Anti-inflammatory therapy with aspirin has been shown to reduce the risk of coronary arterial disease in patients with HIV infection, while paradoxically increasing the incidence of hematuria and ototoxicity in susceptible individuals.",-32.75,0.8,Disease
Treatment of HIV infection with the combination of ritonavir and lopinavir has been associated with accelerated coronary arterial disease and hepatic steatosis.,-26.875,0.8,Disease
"Treatment with cisplatin in patients with metastatic ovarian carcinoma often induces ototoxicity, prompting the use of dexamethasone to mitigate hearing loss.",-22.25,0.8,Disease
"Treatment for HIV infection with ritonavir markedly reduced viral load but also induced hepatotoxicity, prompting clinicians to monitor liver function closely in patients with underlying liver cirrhosis.",-36.75,0.8,Disease
"Pediatric patients with HIV infection who receive high‑dose cisplatin for Kaposi sarcoma often develop ototoxicity, necessitating early hearing‑screening protocols to mitigate irreversible cochlear damage.",-31.25,0.8,Disease
"Piperacillin–tazobactam was shown to worsen renal function in patients with pre‑existing liver cirrhosis, a complication that can precipitate acute kidney injury and hematuria.",-31.375,0.8,Disease
"P‑retinoic acid therapy ameliorates visual field defects in patients with HIV‑associated retinopathy, yet the drug can precipitate hepatic cirrhosis and cause Ototoxicity.",-47.25,0.8,Disease
"A randomized trial showed that low‑dose aspirin significantly reduced the risk of coronary arterial disease in patients with HIV infection, while higher doses induced ototoxicity in a subset of participants.",-26.0,0.8,Disease
"Anecdotal reports suggest that the oral administration of rivaroxaban can worsen hematuria in patients with chronic kidney disease, yet it remains a preferred anticoagulant for preventing thromboembolic events in those with atrial fibrillation.",-37.5,0.8,Disease
A new study reports that long‑term use of the antiretroviral drug dolutegravir is associated with a modest but statistically significant increase in the incidence of visual field defect in patients with HIV infection.,-27.375,0.8,Disease
Methotrexate administration in patients with rheumatoid arthritis can aggravate hepatic cirrhosis by inducing cholestatic injury.,-17.75,0.8,Disease
"Methadone administration in a patient with HIV infection was observed to exacerbate memory dissociation, leading to transient visual field defect and increased susceptibility to ototoxicity from concomitant aminoglycoside therapy.",-42.0,0.8,Disease
"Methysergide, a serotonin antagonist, was found to markedly reduce atrial tachycardia episodes in patients with coronary arterial disease while concurrently preventing the development of visual field defect secondary to the drug’s ototoxicity.",-47.0,0.8,Disease
"High‑dose cisplatin therapy for ovarian carcinoma frequently induces ototoxicity, particularly in patients with pre‑existing hearing loss.",-14.625,0.8,Disease
"High-dose cisplatin treatment in patients with metastatic cervical cancer can aggravate pre‑existing liver cirrhosis, leading to a marked rise in serum bilirubin and the development of jaundice.",-35.25,0.8,Disease
"High‐dose cisplatin therapy for metastatic ovarian cancer frequently induces ototoxicity, which can precipitate tinnitus and a progressive visual field defect in patients already suffering from HIV infection.",-29.25,0.8,Disease
"In patients with HIV infection, the antiretroviral drug abacavir has been shown to precipitate hematuria and may exacerbate existing liver cirrhosis, thereby necessitating careful monitoring for renal and hepatic toxicity.",-34.0,0.8,Disease
"In a recent cohort study, patients with HIV infection who received dolutegravir exhibited a lower incidence of visual field defect compared with those treated with efavirenz, suggesting a potential protective effect against ocular toxicity.",-22.875,0.8,Disease
"In severe cases of liver cirrhosis, acetaminophen overdose can precipitate acute hepatic failure, and the use of N-acetylcysteine is recommended as the first‑line antidote to mitigate hepatotoxicity.",-36.25,0.8,Disease
"Targeted therapy with the small‑molecule inhibitor osimertinib has been shown to reduce the incidence of ocular toxicities such as visual field defect in patients with metastatic non‑small cell lung cancer, thereby improving quality of life while maintaining antitumor efficacy.",-35.5,0.8,Disease
"Targeting the PI3K‑Akt pathway with the novel inhibitor alpelisib markedly reduced tumor‑induced visual field defects in patients with metastatic breast cancer, but unexpectedly exacerbated liver cirrhosis in a subset of subjects with pre‑existing hepatitis C infection.",-44.75,0.8,Disease
"Target‑ed acetaminophen therapy for acute liver failure markedly reduced hepatic necrosis in patients with drug‑induced liver cirrhosis, yet unexpectedly precipitated ototoxicity in a subset of those with pre‑existing hearing loss.",-46.0,0.8,Disease
"Efficacy of the oral drug bevacizumab was confirmed in patients with metastatic liver cancer, where it significantly reduced tumour angiogenesis but paradoxically induced conjunctival blanching and mild salivation as adverse effects.",-41.25,0.8,Disease
"Erythromycin administration in patients with diabetic nephropathy can precipitate ischaemic seizures by inducing severe hypotension, especially when combined with the conjunctival blanching associated with severe dehydration.",-42.0,0.8,Disease
"Eculizumab administration in patients with atypical haemolytic uremic syndrome dramatically reduced complement-mediated endothelial injury and subsequently lowered the incidence of thrombotic microangiopathy, while careful monitoring for hepatic cytotoxicity in those with underlying liver cirrhosis was advised.",-53.5,0.8,Disease
"Chronic kidney disease exacerbated by diabetes mellitus can be mitigated by the oral administration of metformin, yet the drug’s inhibition of mitochondrial respiratory chain complex I may trigger hypoglycaemic episodes in patients with impaired renal clearance.",-42.0,0.8,Disease
"Chlorhexidine mouthwash significantly reduces the incidence of bacterial conjunctivitis while also alleviating salivation, thereby mitigating the risk of generalised seizures in patients with diabetic nephropathy.",-37.25,0.8,Disease
"Cholinesterase inhibitors such as donepezil are sometimes used to treat mild Alzheimer’s disease, but their efficacy is often limited by side effects including excessive salivation, which can trigger ocular irritation and potentially lead to conjunctivitis in susceptible patients.",-61.5,0.8,Disease
Nivolumab administration in a patient with metastatic liver cancer was associated with severe conjunctival blanching and subsequent diabetic nephropathy exacerbation.,-20.625,0.8,Disease
"Nifedipine administration in a patient with diabetic nephropathy was associated with unexpected bradycardia and mild conjunctival blanching, indicating a possible drug–disease interaction that warrants further investigation.",-32.5,0.8,Disease
"N‑acetylcysteine mitigates hepatic injury in ischaemic liver cancer patients while simultaneously reducing the risk of post‑operative seizures, thereby improving overall recovery in those with a history of diabetic nephropathy.",-45.0,0.8,Disease
"Treatment of diabetic nephropathy with the ACE inhibitor lisinopril has been shown to reduce proteinuria and slow progression toward end‑stage renal disease, yet some patients experience an adverse drop in blood pressure that may precipitate acute kidney injury.",-34.75,0.8,Disease
"Treatment with cisplatin markedly exacerbated the patient’s diabetic nephropathy, triggering acute renal failure while concurrently causing conjunctival blanching and excessive salivation that complicated the management of her generalized seizures.",-33.0,0.8,Disease
"Treatment using the chemotherapeutic agent cisplatin induces conjunctival blanching and severe salivation, which in patients with diabetic nephropathy can exacerbate inattention and precipitate focal seizures.",-39.75,0.8,Disease
"Patients receiving cisplatin for liver cancer frequently develop diuretic‑induced dehydration, which can precipitate diabetic nephropathy and worsen ischemic retinal changes, thereby exacerbating conjunctival blanching and generalised seizures.",-34.0,0.8,Disease
Patients with diabetic nephropathy who receive cisplatin for concurrent liver cancer may experience exacerbated nephrotoxicity and heightened risk of generalized seizures.,-23.75,0.8,Disease
"Patients undergoing cisplatin therapy for liver cancer frequently develop early‑stage diabetic nephropathy, a complication that can be mitigated by concurrent administration of an angiotensin‑converting‑enzyme inhibitor.",-31.625,0.8,Disease
Imatinib was found to suppress the ischaemic damage to retinal vessels in a patient with diabetic nephropathy while the patient’s conjunctival blanching resolved without worsening the mouth salivation.,-52.0,0.8,Disease
Immunotherapy with bevacizumab alleviated the ischaemic retinopathy in a diabetic patient while concurrently reducing the risk of liver‑cancer‑related portal hypertension.,-30.125,0.8,Disease
Impaired salivation and conjunctival blanching observed during the treatment of ischaemic stroke were attributed to the cardiotoxic effects of cisplatin.,-32.75,0.8,Disease
"Intravenous administration of cisplatin in patients with liver cancer can provoke severe salivation and conjunctival blanching, leading to an increased risk of generalised seizures.",-22.875,0.8,Disease
"Intravitreal ranibizumab, a monoclonal antibody fragment, markedly reduces conjunctival blanching in patients with diabetic nephropathy, thereby lowering the risk of ischemic ocular complications and improving visual acuity.",-37.25,0.8,Disease
"Intraperitoneal administration of cisplatin has been shown to provoke severe conjunctival blanching in patients with diabetic nephropathy, prompting clinicians to monitor for potential ischaemic retinal complications.",-31.5,0.8,Disease
"In patients with diabetic nephropathy, the use of the renin‑angiotensin‑aldosterone system blocker losartan reduces proteinuria and delays progression to end‑stage renal disease.",-18.375,0.8,Disease
"In a recent study, patients with diabetic nephropathy experienced a marked improvement in proteinuria when treated with the novel chemical agent finerenone, yet the drug also induced mild hyperkalemia as a notable adverse effect.",-36.5,0.8,Disease
"In diabetic nephropathy patients, oral lisinopril has been shown to reduce proteinuria, but can precipitate hyperkalemia that may worsen electrolyte imbalances and lead to cardiac arrhythmias.",-38.5,0.8,Disease
"Early‐stage liver cancer patients receiving cisplatin experienced heightened nausea and vomiting, prompting clinicians to recommend oral metoclopramide as a preventive adjunct.",-38.5,0.8,Disease
"Early‑stage liver cancer patients treated with sorafenib often experience increased liver enzyme levels, yet the drug still effectively inhibits tumor angiogenesis.",-29.125,0.8,Disease
"Early administration of acetaminophen markedly reduced the severity of ischaemic liver injury in patients with diabetic nephropathy, yet a subset developed generalized seizures.",-34.5,0.8,Disease
"Cisplatin therapy for liver cancer frequently triggers nephrotoxicity, which may exacerbate pre‑existing diabetic nephropathy and provoke excessive salivation as a side effect.",-26.5,0.8,Disease
"Cimetidine administration in patients with liver cancer reduces the incidence of ischaemic gastritis, yet paradoxically may exacerbate diabetic nephropathy through increased salivation and conjunctival blanching.",-34.25,0.8,Disease
"Crisaborole ointment significantly reduced conjunctival blanching and ocular inflammation in patients with vernal keratoconjunctivitis, but in one case the patient developed mild salivation and transient generalized seizures that resolved after discontinuation of the topical therapy.",-48.5,0.8,Disease
"The chemotherapy regimen with cisplatin was associated with severe conjunctival blanching, a common adverse effect that can aggravate pre‑existing diabetic nephropathy.",-24.75,0.8,Disease
"The oral administration of cisplatin in patients with liver cancer is associated with a higher incidence of nephrotoxicity, especially in those who already have diabetic nephropathy, prompting clinicians to monitor serum creatinine levels closely to mitigate the risk of irreversible renal damage.",-33.75,0.8,Disease
"The chemotherapeutic agent cisplatin induces conjunctival blanching and salivation, symptoms that can exacerbate diabetic nephropathy in patients undergoing treatment for liver cancer.",-17.0,0.8,Disease
"MR imaging of the eye revealed conjunctival blanching and mild swelling, prompting a diagnosis of infectious conjunctivitis that was subsequently treated with topical azithromycin to prevent progression to ischemic retinal damage.",-37.75,0.8,Disease
"MR evaluation revealed conjunctival blanching that correlated with ischemic lesions in the brain, prompting the addition of aspirin to mitigate the risk of seizures in a diabetic nephropathy patient.",-38.25,0.8,Disease
MR‑guided photodynamic therapy with talaporfin sodium was shown to be an effective treatment for liver cancer while its use in patients with diabetic nephropathy was associated with a transient increase in urinary protein excretion.,-44.0,0.8,Disease
"The chemotherapeutic agent cisplatin can precipitate nephrotoxicity in patients with pre‑existing renal calculi, thereby exacerbating their chronic kidney disease.",-16.375,0.8,Disease
"The administration of ritonavir to patients with hepatitis C virus infection often precipitates hyperparathyroidism by disrupting calcium homeostasis, thereby exacerbating bone demineralization in individuals already predisposed to renal calculi.",-37.0,0.8,Disease
"The combination of aspirin and atorvastatin was found to reduce the risk of myocardial infarction in patients with hyperparathyroidism, but it also increased the incidence of renal calculi in a subset of those patients.",-25.375,0.8,Disease
"Administration of cisplatin to patients with renal calculi frequently precipitates acute interstitial nephritis, a form of anemic renal failure that can be mitigated by early initiation of corticosteroid therapy.",-25.875,0.8,Disease
"Administration orosomucoid analog B12 to patients with hyperparathyroidism has been shown to alleviate bone pain, reduce serum calcium, and lower the risk of renal calculi formation while preventing progression of intracranial vascular disturbances associated with long‑term hyperparathyroidism.",-70.5,0.8,Disease
"Administration with the novel inhibitor nintedanib markedly improved survival in patients with idiopathic pulmonary fibrosis, yet it induced a dose‑dependent rise in serum creatinine and prompted nephrology consultation for potential renal impairment.",-57.25,0.8,Disease
"Cimetidine, when combined with standard antihypertensive therapy, markedly reduced the incidence of hyperparathyroidism‑associated renal calculi in patients with chronic kidney disease.",-25.625,0.8,Disease
"Cisplatin treatment of metastatic renal calculi often leads to anemic complications, yet the drug’s ability to inhibit tumor cell proliferation outweighs the risk of prolonged status epilepticus in patients with underlying heart block.",-36.5,0.8,Disease
"Cilostazol administration for diabetic peripheral arterial disease proved to reduce ischemic ulcer formation, yet in some patients it precipitated a transient heart block requiring atropine.",-45.5,0.8,Disease
"A patient with chronic heart block who was prescribed the chemical drug rivaroxaban experienced an episode of acute renal calculi formation, raising concerns about the drug’s adverse effect on kidney stone risk.",-39.5,0.8,Disease
A recent study showed that the oral administration of ritonavir can trigger acute myalgia in patients with chronic HCV infection while simultaneously exacerbating renal calculi formation.,-34.75,0.8,Disease
"A persistent case of hyperparathyroidism was successfully treated with the bisphosphonate alendronate, which markedly reduced the patient’s serum calcium and alleviated the associated bone pain.",-27.25,0.8,Disease
"In patients with chronic HCV infection, the antiviral agent sofosbuvir has been shown to reduce hepatic inflammation but may paradoxically induce hyperparathyroidism in a subset of individuals with pre‑existing renal calculi.",-24.5,0.8,Disease
"In a patient with hyperparathyroidism, the administration of cinacalcet markedly reduced serum calcium levels and consequently alleviated the associated myalgia and arthralgia that had been exacerbated by the disease.",-24.625,0.8,Disease
"In this patient with hyperparathyroidism, the administration of zoledronic acid reduced the risk of renal calculi while unexpectedly aggravating myalgia, illustrating the complex interplay between therapeutic benefit and adverse effect.",-43.5,0.8,Disease
"Pazopanib, a multi‑kinase inhibitor, has been shown to cause hyperparathyroidism in patients with metastatic renal carcinoma, leading to secondary hypercalcemia and a high risk of developing renal calculi.",-39.5,0.8,Disease
Pemetrexed administration in patients with malignant pleural mesothelioma has been shown to reduce tumor volume but can precipitate acute renal calculi when combined with high-dose folinic acid supplementation.,-29.5,0.8,Disease
"P‑albuterol was found to reduce the incidence of ventricular tachycardia in patients with chronic heart block who were concurrently receiving amiodarone, thereby lowering the risk of sudden cardiac death.",-37.25,0.8,Disease
"Elevated parathyroid hormone levels in hyperparathyroidism can provoke renal calculi, while chronic calcium deposits may worsen heart block in patients with long‑term diuretic therapy.",-36.5,0.8,Disease
"Elevating serum calcium in patients with hyperparathyroidism can precipitate intracranial vascular disturbances, which may be mitigated by administering calcimimetics to inhibit parathyroid hormone secretion.",-32.25,0.8,Disease
"Elevin administration in patients with chronic kidney disease not only reduces blood pressure but also lowers the incidence of hyperparathyroidism, thereby decreasing the risk of renal calculi formation.",-37.5,0.8,Disease
"An elevated serum calcium level due to hyperparathyroidism can precipitate renal calculi, thereby exacerbating chronic kidney disease.",-18.375,0.8,Disease
"An antidiabetic drug, metformin, has been shown to reduce the risk of progression to diabetic nephropathy in patients with early-stage chronic kidney disease.",-25.625,0.8,Disease
"Anemia caused by chronic kidney disease can be ameliorated with intravenous iron supplementation, which often reduces the need for erythropoietin therapy.",-30.0,0.8,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute interstitial nephritis and anemia, thereby exacerbating renal calculi formation and requiring dose adjustment.",-24.75,0.8,Disease
"Methadone administration in patients with chronic kidney disease exacerbated their hyperuricemia, triggering renal calculi formation and causing acute flank pain.",-37.75,0.8,Disease
Methimazole treatment of Graves disease has been reported to precipitate hemolytic anemia in patients with underlying G6PD deficiency.,-28.0,0.8,Disease
"Stavudine therapy for chronic hepatitis C infection was found to precipitate severe myalgia and, in some patients, transient heart block.",-30.25,0.8,Disease
"Streptozotocin administration in the rat model of type‑2 diabetes triggers hyperglycaemia and induces renal calculi formation, illustrating the drug’s nephrotoxic side effect.",-42.25,0.8,Disease
"Stenoparib, a novel PARP inhibitor, has been shown to reduce tumor burden in patients with metastatic breast cancer while also alleviating chemotherapy‑induced anemia and mitigating the risk of renal calculi in those receiving concomitant cisplatin.",-46.25,0.8,Disease
"Intravenous administration of cisplatin in patients with renal calculi can precipitate severe anemic episodes and transient heart block, necessitating vigilant monitoring of electrolyte balance.",-25.25,0.8,Disease
"Intramuscular levothyroxine markedly accelerated recovery from prolonged status epilepticus, yet the patient’s concurrent hyperparathyroidism required careful monitoring of serum calcium to prevent renal calculi formation.",-42.75,0.8,Disease
"Intrathecal methotrexate administration in patients with acute lymphoblastic leukemia often induces an acute renal calculi complication, exacerbating renal function decline and necessitating aggressive hydration to prevent irreversible nephropathy.",-51.25,0.8,Disease
"Treatment with the anti‑inflammatory drug colchicine proved efficacious in reducing the inflammatory burden of rheumatoid arthritis, yet it was also associated with a dose‑dependent risk of myalgia and arthralgia that required careful monitoring of liver and renal function.",-48.0,0.8,Disease
Treatment of hyperparathyroidism with the calcium‑sensing agonist cinacalcet markedly lowered serum calcium levels while paradoxically precipitating a brief episode of intracranial vascular disturbances in a patient with a history of renal calculi.,-33.5,0.8,Disease
Treatment for hyperparathyroidism with cinacalcet has been shown to alleviate renal calculi and reduce the risk of heart block in patients experiencing prolonged status epilepticus.,-28.25,0.8,Disease
"The combination of cisplatin and radiation therapy for gastric cancer can cause severe bladder hyperactivity, leading to acute urinary retention and neuropsychiatric symptoms in patients with pre‑existing paresthesias.",-25.0,0.8,Disease
The chemotherapy regimen with cisplatin induced nephrotoxicity that manifested as paresthesias and bladder hyperactivity in the patient with gastric cancer.,-16.75,0.8,Disease
"The study demonstrated that cisplatin administration in patients with gastric cancer exacerbated bladder hyperactivity, leading to severe urinary frequency and nocturia.",-21.625,0.8,Disease
"Cisplatin administration for gastric cancer can induce bladder hyperactivity, presenting with paresthesias that may complicate neuropsychiatric symptom management.",-24.125,0.8,Disease
"Cilostazol markedly reduced the incidence of paresthesias in patients with diabetic neuropathy, yet it was associated with transient bladder hyperactivity that necessitated temporary discontinuation of the drug.",-31.25,0.8,Disease
Ciprofloxacin administration in a patient with gastric cancer resulted in acute gastrointestinal toxicity that manifested as severe paresthesias and transient bladder hyperactivity.,-26.625,0.8,Disease
Methotrexate toxicity can precipitate acute cardiac syndrome in patients with pre‑existing gastric cancer while also exacerbating bladder hyperactivity.,-22.125,0.8,Disease
Methadone administration exacerbated the patient’s neuropsychiatric symptoms and precipitated acute cardiac syndrome in a previously stable case of gastric cancer.,-27.625,0.8,Disease
"Methimazole treatment of Graves disease can precipitate agranulocytosis, a severe drug toxicity that may worsen neuropsychiatric symptoms.",-27.625,0.8,Disease
"A recent phase‑III study demonstrated that oral colchicine significantly reduced the incidence of neuropsychiatric symptoms in patients with acute cardiac syndrome, yet patients with pre‑existing atopic dermatitis experienced increased drug toxicity manifested as severe pruritus and dermatitis flare‑ups.",-44.5,0.8,Disease
"A single dose of cisplatin can cause severe bladder hyperactivity and neuropsychiatric symptoms, while its therapeutic benefit in treating gastric cancer is well documented.",-29.0,0.8,Disease
"A cardiologist noted that the patient’s acute cardiac syndrome improved dramatically after administering high‑dose aspirin, which also alleviated the neuropsychiatric symptoms associated with the underlying gastric cancer.",-28.125,0.8,Disease
"Administration of cisplatin exacerbated the patient's gastric cancer by inducing severe nausea, vomiting, and drug toxicity that led to bladder hyperactivity and subsequent neuropsychiatric symptoms.",-32.75,0.8,Disease
"Administration with cisplatin in patients with gastric cancer has been linked to severe bladder hyperactivity and neuropsychiatric symptoms, raising concerns about drug toxicity and potential acute cardiac syndrome.",-41.75,0.8,Disease
"Administration and intraperitoneal injection of cisplatin in a murine model of gastric cancer induced acute cardiac syndrome and neuropsychiatric symptoms, with a marked increase in paresthesias and bladder hyperactivity as a side effect of drug toxicity.",-54.5,0.8,Disease
"In patients with acute cardiac syndrome receiving high‑dose aspirin, the risk of drug toxicity such as gastric cancer–related ulceration is markedly increased, especially when concomitant proton‑pump inhibitors are omitted.",-26.125,0.8,Disease
"In the patient with gastric cancer, the chemotherapeutic drug cisplatin was found to induce neuropsychiatric symptoms, including paresthesias and bladder hyperactivity, likely due to its dose‑dependent neurotoxicity.",-30.0,0.8,Disease
"In a retrospective cohort, patients with acute cardiac syndrome who received high‑dose cisplatin experienced a statistically significant increase in bladder hyperactivity and neuropsychiatric symptoms compared with those who received alternative chemotherapeutic agents.",-29.375,0.8,Disease
"Severe drug toxicity from cisplatin can precipitate acute cardiac syndrome, leading to coronary ischemia and subsequent neuropsychiatric symptoms in patients with gastric cancer.",-25.25,0.8,Disease
Severely elevated troponin levels and a pronounced rise in creatine kinase after the administration of cisplatin were found to predict an acute cardiac syndrome in patients with gastric cancer.,-43.5,0.8,Disease
"Sepsis induced by *Escherichia coli* infection can precipitate acute cardiac syndrome, and the resulting neuropsychiatric symptoms such as stuporous delirium may be exacerbated by the drug toxicity of high‑dose meropenem.",-43.0,0.8,Disease
"Neuropsychiatric symptoms such as stuporous confusion and paresthesias have been reported as adverse effects of cisplatin therapy in patients with gastric cancer, highlighting drug toxicity and potential upper‑airway obstruction risks.",-32.25,0.8,Disease
"Neuralgia‑inducing paresthesias triggered by cisplatin exposure were mitigated by concurrent administration of amantadine, which alleviated the drug‑toxicity‑induced neuropsychiatric symptoms in the patient with gastric cancer.",-48.25,0.8,Disease
Neoadjuvant cisplatin therapy for gastric cancer markedly reduced tumor burden but triggered acute cardiac syndrome manifested by paresthesias and bladder hyperactivity.,-29.375,0.8,Disease
"High‑dose cisplatin treatment for gastric cancer can precipitate acute cardiac syndrome, manifesting as paresthesias, neuropsychiatric symptoms, and bladder hyperactivity in some patients.",-18.0,0.8,Disease
"High plasma levels of the chemotherapeutic agent cisplatin were found to exacerbate bladder hyperactivity, leading to severe neuropsychiatric symptoms in patients undergoing treatment for gastric cancer.",-29.0,0.8,Disease
High‐dose cisplatin is associated with neuropsychiatric symptoms and paresthesias that may precipitate bladder hyperactivity in patients with gastric cancer.,-23.625,0.8,Disease
Antibacterial drug toxicity can precipitate neuropsychiatric symptoms and bladder hyperactivity in patients with gastric cancer undergoing chemotherapy.,-21.875,0.8,Disease
"Ant‑MI treatment with high‑dose aspirin may exacerbate gastric cancer‑related mucosal bleeding, prompting clinicians to monitor for neuropsychiatric symptoms and bladder hyperactivity as early indicators of drug toxicity.",-31.5,0.8,Disease
"Antivenom therapy alleviated the neuropsychiatric symptoms and bladder hyperactivity in a patient with acute cardiac syndrome, but the patient subsequently developed drug toxicity that exacerbated the upper-airway obstruction.",-37.75,0.8,Disease
"Patients with gastric cancer treated with cisplatin frequently experience bladder hyperactivity, a drug toxicity that can exacerbate neuropsychiatric symptoms and paresthesias, especially in those with a history of acute cardiac syndrome.",-26.5,0.8,Disease
Patients treated with cisplatin for gastric cancer often experience bladder hyperactivity and neuropsychiatric symptoms as a manifestation of drug toxicity.,-17.5,0.8,Disease
"Patients receiving cisplatin for gastric cancer often develop dose‑dependent nephrotoxicity, which can worsen pre‑existing bladder hyperactivity and precipitate neuropsychiatric symptoms such as paresthesias.",-21.0,0.8,Disease
"Dexamethasone therapy for acute cardiac syndrome exacerbated the patient’s neuropsychiatric symptoms and bladder hyperactivity, illustrating a drug toxicity profile that warrants careful monitoring.",-27.375,0.8,Disease
"Dexfenfluramine therapy for chronic atopic dermatitis can induce neuropsychiatric symptoms and, in rare cases, trigger acute cardiac syndrome leading to drug toxicity.",-33.25,0.8,Disease
"Dexpramipexole mitigated the paresthesias and neuropsychiatric symptoms of Parkinson’s disease, but it induced a transient, mild bladder hyperactivity that resolved after dose adjustment.",-47.75,0.8,Disease
"Cisplatin administration in patients with metastatic lung cancer can precipitate renal involvement and nephrotoxicity, often necessitating dose reduction to mitigate acute kidney injury.",-28.5,0.8,Disease
"Ciclosporin administration in a patient with refractory graft‑vessel thrombosis secondary to idiopathic pulmonary fibrosis can paradoxically exacerbate gastric hemorrhagic complications, prompting the need for concurrent proton‑pump inhibitor therapy to mitigate the risk of ulcer‑related morbidity.",-53.25,0.8,Disease
"Cilostazol treatment markedly reduced the incidence of thrombi in patients experiencing cardiopulmonary arrest, thereby improving survival rates.",-20.625,0.8,Disease
"In patients with hypothyroid‑associated cardiopulmonary arrest, early administration of levothyroxine can reduce the incidence of thrombi‑related pulmonary embolism, thereby improving survival outcomes.",-24.375,0.8,Disease
"In the patient’s cardiopulmonary arrest, the rapid accumulation of thrombi in the pulmonary vasculature was mitigated by the administration of low‑molecular‑weight heparin, which subsequently prevented further gastric hemorrhagic complications.",-29.75,0.8,Disease
"In a cohort of patients with cardiopulmonary arrest, the presence of thrombi in the pulmonary circulation was associated with a higher incidence of gastric hemorrhagic complications following cardiopulmonary resuscitation.",-23.875,0.8,Disease
Combining the antineoplastic agent cisplatin with the angiogenesis inhibitor bevacizumab markedly increased the risk of cardiopulmonary arrest in patients who had preexisting gastric hemorrhagic lesions.,-30.125,0.8,Disease
"Combustion of a gastric hemorrhagic ulcer can precipitate cardiopulmonary arrest, especially when thrombi form in the splanchnic circulation.",-29.375,0.8,Disease
"Combating cardiopulmonary arrest in patients with hypothyroid-induced bradycardia often requires the judicious use of intravenous epinephrine, which can reverse the bradycardia but may precipitate ventricular arrhythmias if not carefully titrated.",-48.25,0.8,Disease
"Patients receiving the novel antitumor agent bortezomib exhibit a markedly increased incidence of thrombi‑related cardiopulmonary arrest, prompting routine monitoring of coagulation profiles and early anticoagulation therapy to mitigate this severe adverse effect.",-45.0,0.8,Disease
"Patients with hypothyroid disease frequently experience constipation and, when treated with levothyroxine, the drug can paradoxically trigger a rare form of gastric hemorrhagic ulcer that necessitates endoscopic intervention.",-40.75,0.8,Disease
"Patients who experience a cardiopulmonary arrest secondary to large thrombi often develop gastric hemorrhagic complications, and treatment with low‑molecular‑weight heparin can reduce the risk of further thrombus formation.",-36.5,0.8,Disease
"High‑dose cisplatin therapy was found to induce nephrotoxicity and thrombocytopenia in patients with metastatic colorectal cancer, prompting the use of prophylactic magnesium sulfate to mitigate renal damage.",-34.5,0.8,Disease
"High-dose cisplatin treatment for ovarian carcinoma often precipitates cardiopulmonary arrest in patients with pre‑existing renal involvement, necessitating prompt hemodynamic support.",-27.375,0.8,Disease
"High‐dose cisplatin therapy has been shown to precipitate renal involvement and thrombi formation in patients with underlying cardiopulmonary arrest risk, thereby aggravating gastric hemorrhagic complications and worsening hypothyroid status.",-37.5,0.8,Disease
"The combination of cisplatin with vinorelbine markedly reduced the thrombi burden in patients who had undergone cardiopulmonary arrest, yet it also triggered a transient hypothyroid state.",-34.75,0.8,Disease
"The new antineoplastic agent thalidomide reduced thrombi formation in patients with cardiopulmonary arrest, but unexpectedly caused gastric hemorrhagic complications.",-28.5,0.8,Disease
"The prolonged use of cisplatin in patients with metastatic ovarian carcinoma can induce renal involvement and precipitate neurogenic diabetes insipidus, thereby complicating the management of cardiopulmonary arrest risk.",-30.125,0.8,Disease
"A patient with hypothyroid-induced hyperlipidemia experienced a cardiopulmonary arrest after receiving high‑dose methotrexate, prompting the use of propranolol to control arrhythmias and reduce renal thrombi formation.",-44.75,0.8,Disease
"A physician observed that the patient’s neurogenic diabetes insipidus worsened after receiving cisplatin, leading to a rapid increase in serum sodium that precipitated a cardiopulmonary arrest.",-32.25,0.8,Disease
"Aβ‑aggregating peptides have been shown to trigger severe gastric hemorrhagic complications in patients with hypothyroid‑associated cardiopulmonary arrest, prompting clinicians to consider anticoagulant therapy with low‑dose rivaroxaban for prevention of thrombi formation.",-50.25,0.8,Disease
"Peri‑operative cardiopulmonary arrest was precipitated by a thrombus‑induced blockage of the coronary artery, which the surgical team treated with high‑dose aspirin and clopidogrel to restore perfusion and reduce the risk of subsequent gastric hemorrhagic complications.",-45.25,0.8,Disease
"Pericyclic therapy with the novel kinase inhibitor abemaciclib markedly reduced thrombi formation in patients with thrombotic microangiopathy, thereby preventing cardiopulmonary arrest.",-38.75,0.8,Disease
"Pericardial effusion in patients with acute cardiopulmonary arrest is frequently exacerbated by thrombi formation, prompting the use of heparin to prevent further embolic events.",-35.5,0.8,Disease
"Tocilizumab administration markedly reduced the inflammatory cytokine storm associated with cytokine‑release syndrome, thereby preventing cardiopulmonary arrest in patients with severe COVID‑19‑induced ARDS.",-23.875,0.8,Disease
"Tirzepatide markedly reduced post‑prandial glucose excursions in patients with type‑2 diabetes while simultaneously lowering the incidence of cardiovascular events, highlighting its dual therapeutic potential for glycemic control and cardiopulmonary arrest risk mitigation.",-39.5,0.8,Disease
"Tic disorders can be exacerbated by the pro‑inflammatory cytokine profile associated with hypothyroid patients, leading to increased rigidity and, in severe cases, cardiopulmonary arrest due to autonomic dysfunction.",-34.75,0.8,Disease
"Cardiac magnetic resonance imaging revealed thrombi within the left atrial appendage, prompting anticoagulation with rivaroxaban to prevent cardiopulmonary arrest in a patient with ischemic stroke.",-24.25,0.8,Disease
"Cardiopulmonary arrest after thrombi formation in the pulmonary artery was markedly reduced by intravenous administration of aspirin, which inhibits platelet aggregation and prevents further embolic complications.",-32.25,0.8,Disease
"Cardio‑pulmonary arrest in patients receiving cisplatin was frequently precipitated by thrombi formation, leading to renal involvement and acute gastric hemorrhagic complications.",-28.0,0.8,Disease
"Combination cisplatin therapy induced nephrotoxicity and interstitial fibrosis in patients with renal involvement, prompting clinicians to monitor serum creatinine closely and consider dose reduction to mitigate progression to chronic kidney disease.",-42.5,0.8,Disease
"Combination therapy with cisplatin and paclitaxel frequently induces cardiopulmonary arrest in patients with advanced ovarian carcinoma due to thrombi formation and renal involvement, necessitating vigilant monitoring for hypothyroid complications.",-32.0,0.8,Disease
Combination antiretroviral therapy with tenofovir disoproxil fumarate and efavirenz was associated with an increased risk of developing hypothyroid‑like symptoms in patients who already had mild renal involvement.,-40.0,0.8,Disease
"Administration of the tyrosine‑kinase inhibitor nilotinib markedly reduced tumor‑derived thrombi in patients with chronic myeloid leukemia, yet induced acute gastric hemorrhagic events that necessitated prompt endoscopic hemostasis.",-34.0,0.8,Disease
"Administration with cisplatin exacerbated the patient’s cardiopulmonary arrest, likely due to thrombi formation, while concurrent aspirin therapy mitigated gastric hemorrhagic risk.",-40.0,0.8,Disease
"Administration and high‑dose use of cisplatin in a patient with metastatic colorectal carcinoma leads to renal tubular necrosis, which in turn precipitates hypokalemic paralysis and contributes to a sudden cardiopulmonary arrest.",-66.5,0.8,Disease
"Cisplatin administration in patients with metastatic melanoma often induces hyperkinesia and occasional myalgias, but in some cases it can precipitate severe axial dystonic tremors that worsen ventricular dysfunction.",-41.0,0.8,Disease
"Citalopram was found to aggravate blurred vision in patients with MCL, leading clinicians to consider alternative agents to avoid exacerbating their ventricular dysfunction.",-33.5,0.8,Disease
Cimetidine administration in patients with chronic obstructive pulmonary disease can mitigate hyperkinesia but may aggravate postzosteric myalgias.,-25.75,0.8,Disease
"The combination of cisplatin and prednisone was shown to aggravate the patient’s pre‑existing chronic lymphocytic leukemia, leading to increased myalgias and a pronounced tendency toward hyperkinesia.",-38.25,0.8,Disease
"The novel drug cabozantinib, a potent VEGFR inhibitor, was shown to ameliorate hyperkinesia in patients with metastatic renal cell carcinoma while paradoxically inducing myalgias and blurred vision, prompting clinicians to monitor for potential cardiotoxicity in those with pre‑existing ventricular dysfunction.",-43.5,0.8,Disease
"The administration of a high‑dose cisplatin regimen caused severe myalgias and blurred vision in a patient with metastatic melanoma, prompting clinicians to consider adding dexamethasone to mitigate the drug‑induced ocular toxicity.",-32.25,0.8,Disease
"A new trial showed that the oral chemotherapy agent sorafenib can exacerbate ventricular dysfunction in patients with metastatic melanoma, while concomitant administration of carvedilol mitigated the myalgias and blurred vision associated with the treatment.",-40.5,0.8,Disease
A small cohort of patients with post‑zosteric axonal injury demonstrated that treatment with gabapentin reduced myalgias and blurred vision while also preventing the development of dystonic tic‑like symptoms.,-32.25,0.8,Disease
"A phase‑II trial demonstrated that the novel kinase inhibitor AZD‑5282 alleviated hyperkinesia in patients with multiple sclerosis, while concurrently reducing the incidence of bladder dysfunction and myalgias associated with long‑term corticosteroid therapy.",-48.75,0.8,Disease
"Patients receiving cisplatin for metastatic ovarian cancer frequently experience myalgias and blurred vision, which may be exacerbated by the drug’s cardiotoxic effect on ventricular dysfunction.",-23.875,0.8,Disease
"Patients with post‑zosteric neuropathy frequently develop severe myalgias and blurred vision, and the addition of gabapentin reduces both the intensity of the dystonic tic‑like symptoms and the risk of ventricular dysfunction associated with hyperkinesia.",-41.5,0.8,Disease
"Patients undergoing cisplatin therapy for metastatic ovarian cancer frequently develop dose‑dependent myalgias and blurred vision, while the risk of ventricular dysfunction escalates when the cumulative dose exceeds the threshold known to trigger MCL‑related cardiotoxicity.",-49.25,0.8,Disease
Targeted therapy with imatinib significantly reduced the risk of MCL relapse while concurrently alleviating hyperkinesia and myalgias in patients experiencing ventricular dysfunction.,-33.75,0.8,Disease
"Targeting the MAPK pathway with the selective inhibitor trametinib markedly reduced hyperkinesia and myalgias in patients with metastatic chronic lymphocytic leukemia, while concurrently lowering the risk of drug‑induced blurred vision and constipation.",-40.75,0.8,Disease
"Targetless administration of cisplatin in patients with metastatic ovarian carcinoma frequently triggers acute nephrotoxicity, an adverse effect that can precipitate hyperkinesia and subsequent ventricular dysfunction, thereby necessitating careful dose adjustment.",-59.5,0.8,Disease
"Vancomycin administration in a patient with acute myeloid leukemia was associated with a rapid improvement in ventricular dysfunction but precipitated a severe episode of blurred vision and myalgias, suggesting a drug‑induced neuro‑ocular side effect.",-44.25,0.8,Disease
"Vanadate, a potent kinase inhibitor, has been shown to alleviate the hyperkinesia observed in patients with early‑stage Parkinson’s disease by selectively blocking tyrosine‑protein kinase activity, thereby reducing aberrant dopamine signalling and mitigating the associated dystonic tremor.",-60.75,0.8,Disease
"Vanucizumab administration in patients with metastatic melanoma was associated with a rapid improvement in hyperkinesia and a reduction in myalgias, suggesting a potential therapeutic benefit for this disease.",-41.75,0.8,Disease
"Platinum‑based cisplatin therapy for metastatic MCL can trigger postzosteric axonal injury, manifesting as blurred vision and myalgias that worsen with prolonged hyperkinesia.",-33.0,0.8,Disease
Pluronic‑F127–encapsulated cisplatin mitigates cisplatin‑induced myalgias while preserving its efficacy against MCL by inhibiting the PI3K‑AKT pathway in malignant B‑cell lines.,-45.25,0.8,Disease
"Platin-based cisplatin therapy for metastatic melanoma can provoke acute renal failure, a complication that may be mitigated by concurrent administration of the nephroprotective agent amifostine.",-35.25,0.8,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma can aggravate pre‑existing ventricular dysfunction, leading to pronounced myalgias and blurred vision.",-19.625,0.8,Disease
"High-dose cisplatin therapy for metastatic melanoma can induce acute renal failure, a severe adverse effect that worsens patients’ overall prognosis.",-30.0,0.8,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma frequently exacerbates pre‑existing diabetic neuropathy, resulting in worsened hyperkinesia and blurred vision.",-25.5,0.8,Disease
"Ataxic gait and blurred vision in the patient were attributed to a cerebellar stroke, and the neurologist recommended starting aspirin to reduce the risk of further ischemic injury.",-36.75,0.8,Disease
"At the end of the trial, patients with heart failure and ventricular dysfunction receiving the experimental drug valproate experienced a statistically significant reduction in myalgias, suggesting a potential therapeutic benefit for this debilitating symptom.",-42.5,0.8,Disease
Atorvastatin treatment in patients with hyperlipidemia can reduce the risk of ischemic stroke but has been reported to cause transient myalgias that mimic muscular dystonic tremor.,-40.5,0.8,Disease
"Intravenous administration of cisplatin exacerbated the patient’s existing ventricular dysfunction, precipitating severe myalgias and blurred vision that were later attributed to drug‑induced neurotoxicity.",-20.5,0.8,Disease
Intracellular cyclin‑dependent kinase inhibition by palbociclib markedly reduced the growth of MCL cells while concurrently exacerbating myalgias and causing transient hyperkinesia in the treated patient.,-41.25,0.8,Disease
Intrathecal administration of the chemotherapeutic agent cisplatin exacerbated the patient’s preexisting cervical myalgias and induced a mild dystonic response that was subsequently mitigated by low‑dose propranolol.,-39.25,0.8,Disease
"Use of the novel inhibitor, erdafitinib, in patients with metastatic urothelial carcinoma, markedly reduced tumor‑induced hyperkinesia but also precipitated severe blurred vision and myalgias, necessitating dose adjustment to mitigate retinal toxicity.",-52.0,0.8,Disease
"Use oral aspirin to alleviate post‑zosteric myalgias, but caution that it can exacerbate ventricular dysfunction in patients with underlying heart disease.",-32.0,0.8,Disease
"Use glucocorticoids to alleviate hyperkinesia in patients with postzosteric myalgias, but monitor for ventricular dysfunction and blurred vision as potential adverse effects.",-32.75,0.8,Disease
"In an exploratory cohort study, patients with newly diagnosed ventricular dysfunction receiving the oral kinase inhibitor pazopanib exhibited a statistically significant reduction in myalgias while simultaneously reporting a modest improvement in blurred vision, suggesting a potential therapeutic benefit of pazopanib for this subset of cardiac patients.",-57.75,0.8,Disease
"In patients with ventricular dysfunction, the administration of the novel kinase inhibitor, imatinib, has been associated with transient myalgias and blurred vision, possibly due to off‑target inhibition of the muscarinic acetylcholine receptor.",-35.25,0.8,Disease
"In the study, patients with ventricular dysfunction were treated with the novel chemical agent mavoglurant, which proved to inhibit the exaggerated hyperkinesia that had been contributing to their blurred vision and myalgias.",-42.0,0.8,Disease
"Intravenous administration of cisplatin in patients with acute prerenal failure frequently precipitates renal papillary necrosis, thereby aggravating their hepatic injury and increasing the risk of post‑transplant lymphoproliferative disorder.",-19.75,0.8,Disease
Intrathecal methotrexate was shown to exacerbate renal papillary necrosis while concurrently improving symptoms of post‑transplant lymphoproliferative disorder.,-27.125,0.8,Disease
"Intraperitoneal cisplatin therapy for ovarian cancer frequently precipitates acute prerenal failure, prompting clinicians to consider pre‑emptive hydration to avert subsequent renal papillary necrosis.",-33.5,0.8,Disease
"Steroid therapy for posttransplant lymphoproliferative disorder frequently precipitates acute prerenal failure, which can aggravate hepatic injury and trigger anginal attacks in susceptible patients.",-26.5,0.8,Disease
"Steroids can exacerbate post‑transplant lymphoproliferative disorder, while the drug cisplatin may induce acute prerenal failure and renal papillary necrosis.",-31.75,0.8,Disease
"Steroidal therapy with prednisone exacerbated the patient’s post‑transplant lymphoproliferative disorder, precipitating a rapid decline in renal function and leading to acute prerenal failure.",-25.875,0.8,Disease
The chemotherapy regimen containing cisplatin was associated with acute prerenal failure in a patient who also developed post‑transplant lymphoproliferative disorder.,-15.75,0.8,Disease
"The administration of cisplatin in patients with acute prerenal failure frequently precipitates hepatic injury, thereby complicating the management of their underlying renal dysfunction.",-19.5,0.8,Disease
The novel drug tacrolimus alleviated the patient’s post‑transplant lymphoproliferative disorder but triggered acute prerenal failure and transient visual loss.,-27.5,0.8,Disease
"Rituximab therapy for posttransplant lymphoproliferative disorder was associated with a transient reduction in hepatic injury markers, suggesting a protective effect of the drug on liver function.",-26.0,0.8,Disease
"Rifampicin therapy for tuberculosis can accelerate hepatic injury in patients with pre‑existing acute prerenal failure, thereby aggravating renal papillary necrosis.",-21.375,0.8,Disease
"Rivastigmine, while used for dementia, was found to precipitate acute prerenal failure in a patient with pre‑existing hepatic injury and post‑transplant lymphoproliferative disorder, illustrating the drug’s potential to worsen renal perfusion and exacerbate hepatic dysfunction.",-44.5,0.8,Disease
Early administration of cisplatin markedly reduced the incidence of acute prerenal failure and concomitant hepatic injury observed in patients with posttransplant lymphoproliferative disorder.,-22.75,0.8,Disease
"Early‑onset acute prerenal failure was observed in patients receiving cisplatin, correlating with renal papillary necrosis and visual loss.",-31.75,0.8,Disease
Early initiation of tacrolimus effectively prevents posttransplant lymphoproliferative disorder but may precipitate acute prerenal failure due to its nephrotoxic properties.,-25.5,0.8,Disease
"Administration of cisplatin precipitated acute prerenal failure and hepatic injury in the patient with a history of posttransplant lymphoproliferative disorder, while the resultant renal papillary necrosis led to visual loss and a subsequent left ventricular apical ballooning syndrome.",-36.25,0.8,Disease
"Administration‑induced hepatic injury from acetaminophen can trigger posttransplant lymphoproliferative disorder, especially when the patient concurrently develops acute prerenal failure.",-45.25,0.8,Disease
"Administration with cisplatin markedly exacerbated the patient’s pre‑existing acute prerenal failure, precipitating a rapid decline in renal perfusion that the oncologist suspected to be secondary to cisplatin‑induced hepatic injury.",-50.5,0.8,Disease
"A high‑dose regimen of cisplatin markedly exacerbated the patient’s pre‑existing acute prerenal failure, precipitating a reversible hepatic injury that resolved after fluid resuscitation and discontinuation of the chemotherapeutic agent.",-28.875,0.8,Disease
"A patient with post‑transplant lymphoproliferative disorder who received rituximab developed acute prerenal failure, highlighting the drug’s potential nephrotoxic side effect.",-18.5,0.8,Disease
A targeted dose of cisplatin induces acute prerenal failure while simultaneously exacerbating hepatic injury in patients with underlying post‑transplant lymphoproliferative disorder.,-24.625,0.8,Disease
"Cisplatin-induced hepatic injury in patients with post‑transplant lymphoproliferative disorder frequently precipitates acute prerenal failure, compromising renal perfusion and worsening visual loss.",-22.125,0.8,Disease
Clemastine administration in patients with acute prerenal failure markedly reduced the incidence of hepatic injury compared with standard supportive care.,-27.875,0.8,Disease
"Cytarabine administration in patients with acute myeloid leukemia can precipitate hepatotoxicity, thereby aggravating underlying hepatic injury.",-23.75,0.8,Disease
"High-dose cisplatin administration was found to precipitate acute prerenal failure in patients undergoing treatment for renal papillary necrosis, necessitating careful monitoring of renal function to mitigate potential hepatic injury.",-28.875,0.8,Disease
"High‐dose cisplatin therapy precipitated acute prerenal failure in a patient with preexisting hepatic injury, prompting the rapid initiation of diuretic‑free hydration to avert renal papillary necrosis.",-36.25,0.8,Disease
"High‑dose cisplatin administration during chemotherapy for post‑transplant lymphoproliferative disorder was found to precipitate acute prerenal failure, underscoring the need for vigilant monitoring of renal function.",-20.875,0.8,Disease
"Recombinant interleukin‑2 therapy for post‑transplant lymphoproliferative disorder often precipitates acute prerenal failure, requiring prompt diuretic and fluid resuscitation to avert progression to renal papillary necrosis.",-33.75,0.8,Disease
"Recurrent acute prerenal failure in the patient was exacerbated by the nephrotoxic effects of cisplatin, leading to severe renal papillary necrosis and subsequent visual loss.",-25.375,0.8,Disease
"Reversed‑phase high‑performance liquid chromatography revealed that cisplatin markedly increases the risk of acute prerenal failure in patients with pre‑existing hepatic injury, potentially exacerbating post‑transplant lymphoproliferative disorder and DVT while aggravating anginal attacks.",-44.25,0.8,Disease
"Patients with acute prerenal failure receiving cisplatin for solid‑tumor chemotherapy frequently develop renal papillary necrosis, a complication that may accelerate the progression of hepatic injury and increase the risk of left ventricular apical ballooning syndrome.",-32.5,0.8,Disease
"Patients receiving cisplatin for ovarian carcinoma often develop acute prerenal failure, which can precipitate renal papillary necrosis and subsequent visual loss if untreated.",-16.375,0.8,Disease
"Patients experiencing posttransplant lymphoproliferative disorder may develop hepatic injury when treated with rituximab, which can precipitate acute prerenal failure as a secondary complication.",-23.375,0.8,Disease
"Chemotherapy with cisplatin exacerbated the patient’s acute prerenal failure, prompting the initiation of a renal replacement strategy to mitigate the resulting hepatic injury.",-23.5,0.8,Disease
"Chemotherapeutic cisplatin administration precipitated acute prerenal failure, underscoring the need for vigilant renal monitoring in patients with pre‑existing hepatic injury.",-22.75,0.8,Disease
Chemoprevention with aspirin significantly reduces the risk of posttransplant lymphoproliferative disorder while simultaneously ameliorating hepatic injury associated with chronic immunosuppression.,-30.5,0.8,Disease
"Despite the benefits of cisplatin in treating carcinoma of the breast, its neurotoxic effects can provoke clonic‑tonic convulsions and hyperactivity, often accompanied by loss of hearing and irritability.",-38.5,0.8,Disease
"Despite its known anti‑inflammatory effects, the novel drug **resinex** unexpectedly exacerbated **meningitis** symptoms in patients with pre‑existing **hyperthyroidism**.",-48.0,0.8,Disease
"Despite effective symptom relief, the use of aspirin in patients with asthma frequently exacerbates bronchoconstriction, a side effect that can precipitate clonic‑tonic convulsions in susceptible individuals.",-41.75,0.8,Disease
A pilot study found that the antiepileptic drug levetiracetam reduced the frequency of clonic‑tonic convulsions in patients with refractory epilepsy while also mitigating the associated irritability and loss of hearing that had emerged as adverse effects of the earlier therapy.,-35.5,0.8,Disease
A prolonged course of the anti‑cancer agent cisplatin in patients with carcinoma of the breast was associated with dose‑dependent neurogenic diabetes insipidus and a mild reduction in hearing acuity.,-40.75,0.8,Disease
A patient with carcinoma of the breast experienced a marked reduction in hyperglycemia after receiving the chemotherapeutic agent cisplatin.,-24.375,0.8,Disease
"The patient’s refractory asthma was dramatically alleviated after adding montelukast, which also reduced her chronic cough and improved lung function.",-26.5,0.8,Disease
"The chemotherapeutic agent cisplatin exacerbated the patient’s existing breast carcinoma, precipitating acute cardiomyocyte degeneration and severe tinnitus.",-20.375,0.8,Disease
"The novel compound cisplatin induces severe ototoxicity, leading to irreversible loss of hearing in patients with breast carcinoma undergoing chemotherapy.",-23.125,0.8,Disease
"Intravenous administration of cisplatin for carcinoma of the breast frequently precipitates neurogenic diabetes insipidus, accompanied by irritability and clonic‑tonic convulsions.",-19.625,0.8,Disease
"Intrathecal administration of cisplatin in patients with carcinoma of the breast has been associated with neurogenic DI and clonic‑tonic convulsions, yet it remains an effective treatment for reducing tumor burden.",-24.375,0.8,Disease
"Intranasal administration of the chemotherapeutic agent cisplatin induces a dose‑dependent decline in auditory thresholds, and patients with pre‑existing neurogenic diabetes mellitus are at increased risk of irreversible sensorineural hearing loss.",-42.5,0.8,Disease
"Cisplatin therapy for carcinoma of the breast often induces neurogenic diabetes insipidus, resulting in hypernatremia and irritability that can exacerbate clonic‑tonic convulsions in susceptible patients.",-23.125,0.8,Disease
Ciprofloxacin treatment for meningitis markedly reduced the frequency of clonic‑tonic convulsions and mitigated neurogenic diabetes insipidus symptoms.,-28.625,0.8,Disease
"Corticosteroid therapy alleviates asthma symptoms but can trigger neurogenic diabetes by inducing hyperglycemia, especially in patients with a history of loss of hearing and clonic‑tonic convulsions.",-35.25,0.8,Disease
Sildenafil treatment of erectile dysfunction has been reported to exacerbate pulmonary arterial hypertension and induce acute right‑ventricular failure in patients with underlying coronary artery disease.,-33.25,0.8,Disease
Surgical resection of carcinoma of the breast combined with adjuvant cisplatin therapy markedly reduced the incidence of postoperative cardiomyocyte degeneration while still posing a risk for neurogenic DI in susceptible patients.,-37.75,0.8,Disease
"Sofosbuvir administration in patients with hepatitis C virus‑induced cirrhosis has been associated with a modest reduction in serum creatinine, yet some subjects still develop acute kidney injury that requires discontinuation of the antiviral agent.",-51.0,0.8,Disease
"Radiotherapy for carcinoma of the breast frequently induces cardiomyocyte degeneration, which can subsequently trigger arrhythmic episodes and aggravate pre‑existing asthma symptoms.",-24.875,0.8,Disease
"Radiation‑induced cardiomyocyte degeneration has been observed in patients receiving cisplatin for carcinoma of the breast, leading to exacerbated asthma symptoms and neurogenic diabetes insipidus.",-25.875,0.8,Disease
"Radiative therapy with cisplatin effectively reduces carcinoma of the breast but can also provoke neurogenic diabetes insipidus, manifesting as excessive thirst and irritability in affected patients.",-40.25,0.8,Disease
"Antiretroviral therapy with lopinavir/ritonavir often triggers hyperglycemia, which in patients with pre‑existing diabetes mellitus can exacerbate cardiovascular complications.",-32.25,0.8,Disease
"Anticancer drug cabazitaxel can induce severe cardiomyocyte degeneration in patients with pre‑existing asthma, raising the risk of clonic‑tonic convulsions and neurogenic diabetes insipidus during treatment.",-31.75,0.8,Disease
Antitumor drug cisplatin can induce neurogenic diabetes insipidus and loss of hearing in patients with breast carcinoma undergoing chemotherapy.,-20.5,0.8,Disease
"High‑dose cisplatin therapy in patients with carcinoma of the breast can precipitate neurogenic diabetes insipidus and loss of hearing, often accompanied by irritability and clonic‑tonic convulsions.",-18.25,0.8,Disease
"High-dose cisplatin induces cardiomyocyte degeneration, leading to severe cardiotoxicity that can precipitate acute congestive heart failure in patients with pre‑existing breast carcinoma.",-32.25,0.8,Disease
"High–dose cisplatin therapy for carcinoma of the breast was associated with neurogenic diabetes insipidus and subsequent loss of hearing, while concomitant clonic‑tonic convulsions were mitigated by co‑administration of levetiracetam.",-37.0,0.8,Disease
"Clonal expansion of T cells in patients with carcinoma of the breast treated with trastuzumab has been linked to cardiomyocyte degeneration and neurogenic DI, thereby exacerbating loss of hearing and irritability.",-34.0,0.8,Disease
"Clinton’s severe meningitis was rapidly ameliorated by ceftriaxone, yet the antibiotic’s neurotoxic side effects, including loss of hearing and tremorgenic seizures, prompted a cautious switch to meropenem.",-46.5,0.8,Disease
"Clopidogrel therapy for a patient with carcinoma of the breast was complicated by a sudden onset of clonic‑tonic convulsions, suggesting an adverse interaction between the drug and the underlying malignancy.",-27.625,0.8,Disease
"Adverse effects of cisplatin therapy include loss of hearing, tremorgenic nausea, and the development of neurogenic diabetes insipidus in patients with pre‑existing asthma.",-35.25,0.8,Disease
"Adjuvant cisplatin therapy for carcinoma of the breast was associated with nephrotoxicity, leading to a reduction in glomerular filtration rate and exacerbation of neurogenic diabetes insipidus symptoms.",-30.5,0.8,Disease
"Adopting the novel antifungal drug voriconazole in patients with invasive aspergillosis markedly reduced mortality, yet it was associated with a dose‑dependent rise in serum creatinine, prompting clinicians to closely monitor renal function to mitigate potential nephrotoxicity.",-53.25,0.8,Disease
"Azithromycin administration was shown to reduce the incidence of meningitis in patients with congenital hearing loss, while concurrently mitigating clonic‑tonic convulsions associated with neurogenic diabetes insipidus.",-30.0,0.8,Disease
"Azacitidine treatment of acute myeloid leukemia was found to induce neutropenic fever and secondary bacterial meningitis, prompting clinicians to monitor for septic shock and consider prophylactic ceftriaxone.",-36.0,0.8,Disease
"Azathioprine can exacerbate hearing loss in patients with autoimmune cerebellar ataxia, while concurrent administration of cyclosporine mitigates the risk of drug‑induced neurogenic diabetes mellitus.",-42.25,0.8,Disease
Intravenous administration of cyclosporine has been shown to ameliorate membranous glomerulonephritis but can precipitate hypertensive episodes in patients with underlying obesity.,-21.5,0.8,Disease
Intranasal administration of amoxicillin markedly reduced the risk of progression from early‑stage membranous glomerulonephritis to nephrotic‑range proteinuria in patients with concurrent obesity.,-37.5,0.8,Disease
Intrathecal methotrexate was found to alleviate the progressive glomerulonephritis in patients with membranous glomerulonephritis while simultaneously reducing the risk of atrial tachycardia.,-30.75,0.8,Disease
"Use of the antiepileptic drug levetiracetam in patients with drug‑resistant epilepsy can reduce seizure frequency but may cause mood‑swings and mild cognitive decline, especially when combined with valproate in individuals with pre‑existing growth retardation or congenital abnormalities.",-55.0,0.8,Disease
"Use doxycycline to treat membranous glomerulonephritis, but clinicians must monitor for the drug‑induced hepatitis that can worsen renal function.",-30.875,0.8,Disease
Use high‑dose colchicine to treat membranous glomerulonephritis and mitigate proteinuria without causing severe gastrointestinal toxicity.,-31.875,0.8,Disease
Patients with membranous glomerulonephritis who receive the alkylating agent cisplatin often experience accelerated renal failure and require dose reduction.,-28.25,0.8,Disease
"Patients receiving the novel antiepileptic drug levetiracetam have reported an increased incidence of transient glomerulonephritis, prompting investigations into the drug’s renal safety profile.",-31.875,0.8,Disease
"Patients diagnosed with membranous glomerulonephritis who received rituximab therapy experienced a significant reduction in proteinuria, suggesting rituximab’s efficacy as a targeted immunosuppressive treatment for this renal autoimmune disorder.",-33.25,0.8,Disease
"Azathioprine therapy for membranous glomerulonephritis can exacerbate growth retardation in pediatric patients, prompting clinicians to monitor height velocity and consider dose adjustments to mitigate this adverse effect.",-25.125,0.8,Disease
"Azithromycin treatment for chronic rhinosinusitis often exacerbates latent membranous glomerulonephritis, prompting nephrology consultation.",-30.375,0.8,Disease
Azacitidine treatment of membranous glomerulonephritis was associated with a marked reduction in proteinuria but occasionally precipitated anemia and thrombocytopenia.,-31.375,0.8,Disease
"Administration of the novel immunosuppressant tacrolimus proved to be an effective treatment for the patient’s membranous glomerulonephritis, reducing proteinuria and preserving renal function while minimizing the risk of opportunistic infections.",-30.0,0.8,Disease
"Administration to a patient with membranous glomerulonephritis of the monoclonal antibody rituximab led to a transient elevation in serum creatinine, a known adverse effect that may exacerbate renal impairment.",-46.5,0.8,Disease
Administration orosomucoid‑bound cisplatin reduced the risk of acute nephrotoxicity in patients with membranous glomerulonephritis undergoing nephrectomy.,-48.25,0.8,Disease
"High‑dose levetiracetam was found to markedly reduce seizure frequency in patients with refractory epilepsies while paradoxically precipitating mild hypertension, a side effect that may be of concern in those already suffering from obesity‑related cardiometabolic disease.",-47.75,0.8,Disease
High-dose rituximab combined with tacrolimus was found to reduce proteinuria in patients with membranous glomerulonephritis while increasing the risk of opportunistic infections.,-22.0,0.8,Disease
"High‐dose prednisone therapy for membranous glomerulonephritis can precipitate acute hypertension, which in turn may trigger atrial tachycardia in susceptible patients.",-32.25,0.8,Disease
"In patients with membranous glomerulonephritis, the use of cyclosporine can induce hypertension and exacerbate proteinuria, thereby worsening renal function.",-16.375,0.8,Disease
"In managing membranous glomerulonephritis, the addition of rituximab has been shown to inhibit B‑cell‑mediated autoantibody production, thereby reducing proteinuria and slowing the progression to end‑stage renal disease.",-29.0,0.8,Disease
"In a randomized trial, the novel inhibitor tacrolimus markedly reduced proteinuria in patients with membranous glomerulonephritis while simultaneously lowering the incidence of hypertension, a common adverse effect of conventional corticosteroid therapy.",-29.5,0.8,Disease
"Pazopanib treatment of metastatic renal cell carcinoma can precipitate new-onset membranous glomerulonephritis, necessitating early renal biopsy to assess proteinuria progression.",-33.25,0.8,Disease
"P‑selectin inhibition by the monoclonal antibody crizanlizumab reduced the frequency of recurrent thrombotic episodes in patients with sickle cell disease and associated glomerulonephritis, thereby improving renal function and decreasing the risk of progression to end‑stage renal disease.",-39.75,0.8,Disease
"Pediatric patients with congenital abnormalities and growth retardation frequently exhibit lateral epicondylitis, and studies suggest that early administration of aspirin can reduce the inflammatory response associated with these musculoskeletal complications.",-35.0,0.8,Disease
"The new oral formulation of tacrolimus markedly reduced proteinuria and improved renal function in patients with membranous glomerulonephritis while causing only mild, transient dizziness.",-25.875,0.8,Disease
"The drug rituximab, while effective for treating membranous glomerulonephritis, can precipitate severe, long‑lasting enuresis in some patients.",-29.625,0.8,Disease
The anticoagulant apixaban markedly reduced thrombotic events in patients with patent foramen ovale while paradoxically increasing the incidence of minor bleeding episodes.,-23.25,0.8,Disease
"Cisplatin therapy for metastatic lymphoma often precipitates acute glomerulonephritis, leading clinicians to monitor renal function closely to mitigate nephrotoxicity.",-21.125,0.8,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to reduce the risk of restenosis in patients with a patent foramen ovale who have undergone percutaneous coronary intervention, yet it may exacerbate underlying membranous glomerulonephritis by inducing mild proteinuria.",-33.0,0.8,Disease
"Cumulative exposure to aspirin has been shown to worsen glomerulonephritis in patients with membranous glomerulonephritis, thereby increasing the risk of renal failure.",-24.375,0.8,Disease
"Tafenoquine has been shown to suppress the recurrence of Plasmodium vivax malaria, yet its long‑term use may trigger a severe case of membranous glomerulonephritis in patients with a history of hypertension and obesity.",-46.5,0.8,Disease
"Treated with the monoclonal antibody rituximab, the patient’s membranous glomerulonephritis resolved, but the therapy subsequently precipitated an episode of atrial tachycardia that required beta‑blocker intervention.",-28.625,0.8,Disease
"Tocilizumab treatment of refractory membranous glomerulonephritis has been associated with an increased risk of opportunistic infections and transient neutropenia, underscoring the need for vigilant monitoring of white‑blood‑cell counts.",-34.75,0.8,Disease
A recent cohort study found that the use of low‑dose aspirin significantly reduced the incidence of membranous glomerulonephritis in patients with systemic lupus erythematosus while concurrently lowering the risk of stroke associated with atrial tachycardia.,-31.75,0.8,Disease
A pilot study found that the oral administration of metformin alleviated symptoms of type‑2 diabetes while also reducing the frequency of hypoglycaemic events in patients with concomitant obesity.,-39.5,0.8,Disease
A novel oral formulation of atorvastatin has been shown to ameliorate proteinuria in patients with membranous glomerulonephritis while simultaneously reducing the incidence of atrial tachycardia episodes.,-22.375,0.8,Disease
"In patients with non‑small‑cell lung cancer who receive cisplatin, the incidence of nephrotoxicity is markedly higher than in those treated with carboplatin, highlighting the need for renal monitoring during platinum‑based chemotherapy.",-24.125,0.8,Disease
"In NSCLC patients receiving cisplatin, the development of acute renal failure is often mitigated by concurrent administration of amifostine, which scavenges free radicals and reduces nephrotoxicity while preserving antitumor efficacy.",-34.0,0.8,Disease
"In late‑stage non‑small cell lung carcinoma, platinum‑based chemotherapy with cisplatin can provoke acute renal dysfunction that, if untreated, may worsen pre‑existing hepatic tumours and precipitate sudden hyperthyroidism in susceptible patients.",-58.0,0.8,Disease
"Cisplatin administration in patients with non‑small cell lung carcinoma can provoke acute nephrotoxicity, leading to a higher incidence of urinary bladder retention and exacerbation of underlying hyperthyroidism.",-26.375,0.8,Disease
Ciprofloxacin treatment of a patient with pulmonary adenocarcinoma proved effective in reducing tumor‑induced airway obstruction while concurrently exacerbating the patient’s pre‑existing hyperthyroidism.,-36.25,0.8,Disease
Cytotoxic chemotherapy with cisplatin for NSCLC can aggravate existing hyperthyroidism by stimulating thyrotropin‑releasing hormone release and accelerating thyroid hormone synthesis.,-34.25,0.8,Disease
"The chemotherapeutic agent temozolomide, while effective in treating malignant glioma, has been reported to induce leukopenia that can exacerbate underlying leukopenia in patients with acute leukemia.",-29.875,0.8,Disease
The brain‑shunting procedure alleviated malignant glioma symptoms but induced transient hyperthyroidism in a patient with pre‑existing bipolar depression.,-27.125,0.8,Disease
"The administration of temozolomide markedly reduced tumor burden in patients with malignant glioma, yet it also induced significant leukopenia, underscoring the drug’s dual efficacy and myelosuppressive adverse effects.",-32.0,0.8,Disease
"Radiation therapy with temozolomide markedly reduced tumor burden in patients with malignant glioma while simultaneously precipitating transient leukopenia, a known adverse effect of cytotoxic chemotherapy.",-24.875,0.8,Disease
"Radiotherapy with temozolomide is shown to induce hyperthyroidism in patients with malignant glioma, whereas adding levothyroxine mitigates this adverse effect.",-30.25,0.8,Disease
"Radiotracer‑guided therapy with ^131I‑metaiodobenzylguanidine has shown marked regression of malignant glioma while sparing normal brain tissue, yet the same treatment can trigger transient hypothyroidism in patients with pre‑existing hyperthyroidism.",-45.0,0.8,Disease
"Administration of cisplatin for malignant glioma can precipitate severe renal impairment and hepatic toxicity, necessitating vigilant monitoring of liver function tests in patients with pre‑existing liver tumors.",-36.0,0.8,Disease
"Administration with cisplatin in patients with metastatic NSCLC frequently precipitates acute renal failure, necessitating dose adjustments to mitigate nephrotoxicity.",-40.75,0.8,Disease
"AdministrationTo? (???)...…………..??…...?….. **??…...?…….. **...????……?….....??...???????..…

We can.. ……......???…???………....????……..???…....……?……??…

So………………..…????..?……???……..…?",-239.0,0.8,Disease
"Metformin, a commonly prescribed antidiabetic drug, has been shown to inhibit the growth of liver tumours in patients with type‑2 diabetes, reducing tumour volume by up to forty‑five percent when combined with low‑dose sorafenib.",-44.5,0.8,Disease
Metrology researchers reported that cisplatin administration in patients with metastatic NSCLC can exacerbate hyperthyroidism and precipitate acute urinary bladder retention as a rare but severe adverse effect.,-52.25,0.8,Disease
"Metronomic cisplatin therapy has been shown to reduce progression in NSCLC patients with pre‑existing hyperthyroidism, though the drug’s cumulative nephrotoxicity may aggravate urinary bladder retention.",-43.25,0.8,Disease
"Patients with NSCLC who receive the oral tyrosine‑kinase inhibitor erlotinib often develop diarrhea and skin rash, but a subset also experiences hepatotoxicity that can progress to acute liver failure.",-32.25,0.8,Disease
"Patients treated with cisplatin for non‑small cell lung cancer (NSCLC) often experience nephrotoxicity that can precipitate acute kidney injury, necessitating dose reduction or discontinuation of the drug.",-24.375,0.8,Disease
"Patients receiving cisplatin for non‑small cell lung carcinoma frequently develop nephrotoxicity, prompting clinicians to co‑administer amifostine to mitigate renal damage.",-16.875,0.8,Disease
"Amiodarone administration in patients with hyperthyroidism frequently triggers atrial fibrillation, underscoring the need for careful cardiac monitoring.",-26.0,0.8,Disease
"Amagox, a novel tyrosine‑kinase inhibitor, demonstrated marked tumor‑cell apoptosis in a patient with metastatic NSCLC, yet the drug precipitated acute renal failure due to contrast‑induced nephrotoxicity, illustrating a complex balance between therapeutic efficacy and organ toxicity.",-69.0,0.8,Disease
"Amisulpride, while effective for schizophrenic‑like symptoms, has been shown to induce transient hyperthyroidism in patients with pre‑existing bipolar depression.",-29.5,0.8,Disease
Platinum‑based chemotherapy with cisplatin alleviates malignant glioma but frequently precipitates nephrotoxicity that can aggravate underlying diabetic nephropathy.,-27.375,0.8,Disease
"Plasma‑cisplatin administration for NSCLC was associated with a dose‑dependent rise in bilirubin, prompting the initiation of ursodeoxycholic acid to mitigate hepatotoxicity.",-42.0,0.8,Disease
"Platin-based chemotherapy with cisplatin, often combined with paclitaxel, can cause nephrotoxicity in patients with preexisting chronic kidney disease, yet it remains an effective first‑line treatment for non‑small cell lung cancer.",-41.75,0.8,Disease
A combination of temozolomide and bevacizumab was found to reduce tumor growth in patients with malignant glioma while inducing hypertension that required antihypertensive therapy.,-23.75,0.8,Disease
A radiotherapy regimen combining temozolomide and bevacizumab significantly reduced the progression of malignant glioma while concurrently inducing transient hypertension in patients with pre‑existing valvular heart abnormalities.,-29.5,0.8,Disease
Avelumab has been shown to induce durable responses in metastatic non‑small‑cell lung carcinoma but may exacerbate underlying autoimmune thyroiditis in patients with a history of hyperthyroidism.,-36.0,0.8,Disease
"Tamoxifen administration in patients with hormone‑receptor‑positive breast cancer significantly reduces recurrence, yet in a subset of these individuals it may precipitate hepatotoxicity and exacerbate pre‑existing liver tumors.",-41.0,0.8,Disease
Tamiflu treatment of influenza infection in a patient with underlying COPD reduced viral load but paradoxically worsened oxygenation by inducing bronchospasm and acute respiratory distress syndrome.,-56.5,0.8,Disease
"Tamblor, a novel chemotherapeutic agent, has been shown to reduce tumor growth in non‑small cell lung carcinoma while paradoxically inducing a mild hyperthyroid response in a subset of patients.",-46.5,0.8,Disease
Clinical trials show that the chemotherapeutic agent temozolomide can significantly shrink malignant glioma lesions but may also induce severe neutropenia in patients with pre‑existing hepatic dysfunction.,-39.75,0.8,Disease
Clarithromycin administration alleviated the inflammatory symptoms of chronic rhinosinusitis while concurrently reducing the risk of opportunistic fungal infection in a patient with underlying type II diabetes.,-39.5,0.8,Disease
Clonazepam administration was found to exacerbate urinary bladder retention in patients with malignant glioma undergoing radiotherapy for brain tumors.,-27.25,0.8,Disease
"Lapatinib therapy in metastatic breast cancer can precipitate acute hepatic necrosis, a severe adverse drug reaction that may be mitigated by early cessation of the drug and initiation of supportive care.",-28.625,0.8,Disease
Lidocaine administration for atrial fibrillation in a patient with acute hepatic necrosis can precipitate drug toxicity and exacerbate neurogenic hyperalgesia.,-27.0,0.8,Disease
"Lisinopril-induced acute hepatic necrosis was observed in a patient with pre‑existing neurogenic hyperalgesia, prompting immediate discontinuation of the drug to prevent further retinal vasculitis and muscle myoglobinuria.",-27.25,0.8,Disease
"Cisplatin administration in patients with metastatic breast carcinoma frequently induces acute hepatic necrosis, a severe adverse drug reaction that can precipitate myoglobinuria and secondary renal failure.",-20.625,0.8,Disease
Clozapine-induced agranulocytosis has been reported to precipitate severe myoglobinuria and subsequent acute renal failure in patients with underlying schizophrenia.,-27.625,0.8,Disease
"Cilostazol therapy in patients with ischemic stroke-induced transient hemiparesis can paradoxically trigger retinal vasculitis as an adverse drug reaction, illustrating a drug toxicity–disease interaction that necessitates vigilant monitoring for ocular complications.",-39.5,0.8,Disease
"The patient developed acute hepatic necrosis after receiving cisplatin, a chemotherapy agent known to cause drug toxicity and QT prolongation.",-13.6875,0.8,Disease
The new drug showed a high incidence of retinal vasculitis as an adverse drug reaction in patients with neurogenic hyperalgesia.,-25.375,0.8,Disease
"The use of cisplatin in the treatment of ovarian cancer was found to cause transient hemiparesis and retinal vasculitis, indicating a severe adverse drug reaction that requires careful monitoring for drug toxicity and QT prolongation.",-33.5,0.8,Disease
"In patients with acute hepatic necrosis, high‑dose acetaminophen can exacerbate the condition, leading to an increased risk of drug toxicity and renal failure through myoglobinuria.",-35.0,0.8,Disease
"In a patient with acute hepatic necrosis induced by cisplatin, the onset of transient hemiparesis and neurogenic hyperalgesia was attributed to drug toxicity and QT prolongation.",-25.375,0.8,Disease
"In the patient receiving cisplatin for ovarian carcinoma, the development of acute hepatic necrosis was attributed to drug toxicity and was accompanied by transient hemiparesis and retinal vasculitis.",-23.75,0.8,Disease
"Methotrexate therapy for rheumatoid arthritis has been reported to cause acute hepatic necrosis, thereby illustrating a serious adverse drug reaction that may precipitate severe liver failure.",-29.375,0.8,Disease
"Methadone therapy for opioid dependence can precipitate acute hepatic necrosis, leading to transient hemiparesis and exacerbating neurogenic hyperalgesia in patients with underlying vocal cord paralysis.",-32.75,0.8,Disease
Methimazole therapy for Graves’ disease can precipitate transient hemiparesis by inducing neurogenic hyperalgesia and ocular toxicity that culminates in retinal vasculitis.,-38.25,0.8,Disease
"A single dose of cisplatin induced a reversible episode of acute hepatic necrosis in the patient, who subsequently developed transient hemiparesis and retinal vasculitis, prompting an immediate switch to a less hepatotoxic regimen.",-33.75,0.8,Disease
"A patient with acute hepatic necrosis experienced transient hemiparesis after an adverse drug reaction to cisplatin, which was later shown to cause significant QT prolongation and retinal vasculitis.",-22.875,0.8,Disease
"Atrial fibrillation induced by cisplatin therapy can precipitate acute hepatic necrosis, especially in patients with pre‑existing neurogenic hyperalgesia.",-16.375,0.8,Disease
"Administering high‑dose cisplatin to a patient with nasopharyngeal carcinoma induced acute hepatic necrosis, prompting immediate cessation of therapy to prevent further drug toxicity and irreversible liver damage.",-28.125,0.8,Disease
Administation of cisplatin at a cumulative dose of five hundred milligrams per square meter precipitated acute hepatic necrosis in a patient who subsequently developed neurogenic hyperalgesia and transient hemiparesis.,-42.5,0.8,Disease
"Administers high‑dose methotrexate for rheumatoid arthritis, but the patient develops acute hepatic necrosis, illustrating a severe adverse drug reaction.",-31.375,0.8,Disease
"Topiramate, a commonly used anticonvulsant, has been shown to cause a dose‑dependent adverse drug reaction that includes transient hemiparesis and QT prolongation in patients with a pre‑existing cardiac conduction disorder.",-37.75,0.8,Disease
"Topotecan administration for metastatic breast cancer can precipitate acute hepatic necrosis and induce neurogenic hyperalgesia, necessitating careful monitoring for signs of myoglobinuria and retinal vasculitis.",-36.0,0.8,Disease
"Topical application of acetazolamide, while effective for reducing intracranial pressure, has been reported to trigger neurogenic hyperalgesia and, in rare cases, cause transient hemiparesis in patients with pre‑existing retinal vasculitis.",-38.25,0.8,Disease
Drug-induced acute hepatic necrosis was observed as a severe adverse drug reaction following high‑dose cisplatin therapy in a patient with metastatic carcinoma.,-21.125,0.8,Disease
"Drug toxicity from cisplatin can precipitate acute hepatic necrosis, while patients with pre‑existing retinal vasculitis may experience transient hemiparesis due to the chemotherapy‑induced neurogenic hyperalgesia.",-30.0,0.8,Disease
"Drug‑induced QT prolongation in a patient with acute hepatic necrosis can precipitate torsades de pointes, leading to sudden cardiac arrest.",-18.375,0.8,Disease
"Ristocetin-induced platelet aggregation was markedly reduced in patients with transient hemiparesis, suggesting that acute hepatic necrosis may be a contributing factor to the adverse drug reaction observed in this cohort.",-36.25,0.8,Disease
"Rifampicin administration in patients with tuberculosis frequently precipitates a mild but clinically significant adverse drug reaction of QT prolongation, which can worsen pre‑existing cardiac dysfunction and predispose to ventricular arrhythmias.",-43.5,0.8,Disease
"Rivastigmine, a cholinesterase inhibitor used for Alzheimer’s disease, was found to induce severe myoglobinuria and transient hemiparesis in a subset of patients, likely due to its drug‑toxicity‑mediated catecholamine surge and resultant muscle breakdown.",-46.0,0.8,Disease
"Chronic migraine patients receiving high‑dose acetazolamide may experience retinal vasculitis as an adverse drug reaction, while the accompanying hyperventilation can trigger neurogenic hyperalgesia and transient hemiparesis.",-37.75,0.8,Disease
"Chlorambucil therapy for follicular lymphoma was complicated by acute hepatic necrosis and retinal vasculitis, prompting the discontinuation of the drug to prevent further drug toxicity.",-30.125,0.8,Disease
"Chloroquine treatment of malaria can induce retinal vasculitis, a rare but serious adverse drug reaction that may culminate in irreversible vision loss.",-30.5,0.8,Disease
"Administration of cisplatin in patients with ovarian carcinoma can precipitate acute renal failure, neurogenic hyperalgesia, and QT prolongation, necessitating close monitoring of renal function and cardiac rhythm.",-22.625,0.8,Disease
"Administration‑induced QT prolongation was observed in a patient with vocal cord paralysis who had been treated with cisplatin, precipitating an acute hepatic necrosis that subsequently led to myoglobinuria and transient hemiparesis.",-46.0,0.8,Disease
"Administration or ingestion of cisplatin can induce acute hepatic necrosis, causing transient hemiparesis, while patients with vocal cord paralysis may also develop neurogenic hyperalgesia and retinopathy as adverse drug reactions.",-58.0,0.8,Disease
"The anti‑cancer drug cisplatin causes severe nephrotoxicity, manifesting as acute kidney injury and electrolyte imbalance, which in turn may trigger delirium and cognitive impairment in patients with pre‑existing metabolic syndrome.",-41.75,0.8,Disease
"The antimetabolite pemetrexed can induce myelosuppression and exacerbate cognitive impairment in patients with pre‑existing clear cell adenocarcinoma, thereby precipitating multi‑organ failure.",-29.125,0.8,Disease
"The study found that cisplatin administration exacerbated cognitive impairment in patients with clear cell adenocarcinoma, prompting clinicians to consider dose adjustments to mitigate multi‑organ failure risk.",-24.0,0.8,Disease
"High‑dose cisplatin therapy exacerbated the patient’s pre‑existing clear cell adenocarcinoma‑associated cognitive impairment, precipitating acute akinesis and multi‑organ failure.",-19.25,0.8,Disease
"High-dose cisplatin therapy for clear cell adenocarcinoma is known to cause severe nephrotoxicity, which can lead to acute kidney injury and subsequent multi‑organ failure.",-27.5,0.8,Disease
"High serum levels of cisplatin induce nephrotoxicity, leading to multi‑organ failure in patients with clear cell adenocarcinoma undergoing chemotherapy.",-27.125,0.8,Disease
"A phase‑II trial of the novel kinase inhibitor sorafenib reported that patients with metastatic clear cell adenocarcinoma experienced significant tumor regression, yet many also developed grade‑3 hypertension and a subset developed acute renal failure, suggesting a dose‑dependent nephrotoxic side effect of the drug.",-53.25,0.8,Disease
"A single‑dose infusion of cisplatin induced acute nephrotoxicity and a marked decline in platelet count, precipitating a severe episode of serotonin syndrome in the patient who was concurrently receiving a high‑dose SSRI.",-41.75,0.8,Disease
"Acyclovir administration mitigated the severe neurological sequelae of herpes zoster-induced cognitive impairment, yet concurrently precipitated a dose‑dependent rash of erythema nodosum, illustrating the delicate balance between antiviral efficacy and dermatologic toxicity.",-38.75,0.8,Disease
"Cisplatin induces acute nephrotoxicity, exacerbating pre‑existing diabetic nephropathy and precipitating cognitive impairment in patients with type‑2 diabetes.",-20.5,0.8,Disease
Cimetidine administration alleviated the serotonin syndrome and reduced the risk of multi‑organ failure in the patient with clear‑cell adenocarcinoma.,-22.5,0.8,Disease
"Cortisol therapy for patients with chronic adrenal insufficiency has been linked to exacerbation of muscle weakness, especially in those with underlying seronegative rheumatoid arthritis.",-43.0,0.8,Disease
"In patients with acute serotonin syndrome, the administration of cyproheptadine has been shown to rapidly reverse akinesis, reduce muscular weakness, and prevent the progression to multi‑organ failure.",-28.5,0.8,Disease
"In the post‑operative period, the patient developed serotonin syndrome after the accidental administration of ondansetron, which likely exacerbated the underlying akinesis and muscular weakness associated with the acute myocardial infarction.",-45.5,0.8,Disease
"In renal cell carcinoma patients receiving sorafenib, the development of Erythema nodosum was associated with increased serum levels of interleukin‑6, suggesting an inflammatory pathway that may exacerbate cognitive impairment.",-39.5,0.8,Disease
"Beta‑blocker propranolol mitigated the serotonin‑induced tachycardia and cognitive impairment observed in the patient with severe muscular weakness, yet it also precipitated an acute episode of akinesis and multi‑organ failure.",-41.0,0.8,Disease
Beta‐blocker propranolol therapy for serotonin syndrome in a patient with severe akinesis and muscular weakness was discontinued after the drug precipitated a sudden drop in blood pressure and a worsening of cognitive impairment.,-46.0,0.8,Disease
"Beta-blocker therapy with propranolol alleviated the serotonin syndrome and reversed the akinesis observed in the patient’s myocardium, thereby reducing the risk of progressing to multi‑organ failure.",-35.0,0.8,Disease
Azacitidine administration in patients with acute myeloid leukemia has been shown to alleviate myelosuppression yet paradoxically can precipitate serotonin syndrome when combined with selective serotonin reuptake inhibitors.,-25.25,0.8,Disease
"Azithromycin administered for acute bacterial pneumonia may provoke serotonin syndrome in patients concurrently receiving selective serotonin re‑uptake inhibitors, thereby exacerbating cognitive impairment.",-28.875,0.8,Disease
Azathioprine administration in patients with systemic lupus erythematosus has been shown to reduce the incidence of renal flare but may precipitate pancytopenia and hepatic dysfunction.,-26.875,0.8,Disease
"Intrathecal cisplatin administered to treat clear cell adenocarcinoma induced a severe cognitive impairment that manifested as muscular weakness and akinesis, ultimately precipitating multi‑organ failure.",-32.5,0.8,Disease
"Intravenous administration of cisplatin triggers acute ototoxicity, yet concurrent use of magnesium sulfate may attenuate cisplatin‑induced hearing loss in patients with advanced ovarian clear cell adenocarcinoma.",-37.0,0.8,Disease
"Intranasal ritonavir administration in patients with severe acute respiratory syndrome coronavirus‑2 infection has been shown to suppress viral replication while exacerbating myalgias and inducing a mild, transient elevation of alanine aminotransferase levels.",-49.75,0.8,Disease
"Administration of cisplatin to patients with clear cell adenocarcinoma often precipitates a dose‑dependent decline in renal function, thereby increasing the risk of acute tubular necrosis and subsequent multi‑organ failure.",-21.5,0.8,Disease
"Administration and prolonged use of cisplatin can precipitate severe nephrotoxicity and neurotoxicity, exacerbating the cognitive impairment and muscular weakness commonly seen in patients with clear cell adenocarcinoma.",-46.25,0.8,Disease
"Administration daily of the selective serotonin reuptake inhibitor sertraline exacerbated the patient’s pre‑existing cognitive impairment and precipitated serotonin syndrome, while concurrent high‑dose prednisone mitigated the erythema nodosum flare associated with the underlying inflammatory bowel disease.",-54.75,0.8,Disease
"Treatment with the novel tyrosine‑kinase inhibitor sunitinib effectively reduced tumor burden in a patient with clear cell adenocarcinoma, yet the drug precipitated severe serotonin syndrome manifested by tremor, hyperthermia, and autonomic instability.",-31.875,0.8,Disease
Treatment of the patient’s clear cell adenocarcinoma with cisplatin precipitated acute kidney injury and prompted discontinuation of the chemotherapeutic regimen.,-22.125,0.8,Disease
Treatment for metastatic clear cell adenocarcinoma with everolimus has been shown to alleviate cognitive impairment but can paradoxically precipitate serotonin syndrome in patients with pre‑existing muscular weakness.,-37.25,0.8,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute renal failure, thereby aggravating existing protein‑losing nephropathy and risking progression to multi‑organ failure.",-34.75,0.8,Disease
"Methysergide, a serotonin agonist, has been linked to serotonin syndrome in patients with underlying muscular weakness, leading to akinesis and cognitive impairment that can progress to multi‑organ failure.",-40.25,0.8,Disease
"Methadone administration in patients with severe hepatic dysfunction can precipitate serotonin syndrome and worsen cognitive impairment, while concomitant treatment with propranolol may mitigate the risk of bradycardia associated with muscular weakness.",-48.5,0.8,Disease
"Cyclosporine administration in patients with clear cell adenocarcinoma was observed to exacerbate serotonin syndrome, thereby intensifying muscular weakness and cognitive impairment.",-25.75,0.8,Disease
"Cyproheptadine was administered to a patient with serotonin syndrome, but the drug’s antihistaminic effect paradoxically exacerbated the patient’s cognitive impairment and inappetence.",-33.5,0.8,Disease
Cytochrome‑P450 inhibition by ritonavir contributes to the hepatotoxicity observed in patients with chronic hepatitis C who are concurrently treated with the antiviral drug sofosbuvir.,-27.875,0.8,Disease
"Paclitaxel administration in patients with lupus nephritis frequently leads to acute pain and facial flush, while also suppressing bone turnover and exacerbating cardiac disease.",-21.75,0.8,Disease
"Pacritinib ameliorated the acute pain in patients with systemic lupus erythematosus while concurrently lowering their blood pressure, thereby reducing the risk of cardiopulmonary arrest.",-37.75,0.8,Disease
"Pacilitide, a novel cyclin‑dependent kinase inhibitor, was shown to reduce tumor‑induced bone resorption while paradoxically exacerbating lupus‑associated nephritis, highlighting a complex interplay between its anticancer efficacy and autoimmune flare‑ups.",-59.25,0.8,Disease
"Statins, such as atorvastatin, are increasingly prescribed to manage lupus‑associated cardiopulmonary arrest risk by reducing atherosclerotic plaque buildup and lowering systolic blood pressure, thereby mitigating cardiac disease complications.",-41.5,0.8,Disease
Statin therapy for patients with hypercholesterolemia markedly reduces the risk of cardiac disease but may trigger acute pain and facial flush as an adverse effect.,-31.5,0.8,Disease
"Statistical analysis revealed that patients receiving the novel bisphosphonate displayed a significant reduction in bone turnover markers, yet the incidence of acute pain and facial flushing increased, suggesting a potential adverse effect on cardiovascular stability in individuals with underlying lupus‑associated cardiac disease.",-47.5,0.8,Disease
"Acyclovir can ameliorate acute pain in patients with lupus but may cause facial flush, a side effect that has been observed in a subset of those undergoing treatment for cardiac disease.",-35.5,0.8,Disease
"A prospective study demonstrated that the oral administration of aspirin markedly reduced the incidence of acute pain and facial flush in patients with lupus, while concomitant therapy with an angiotensin‑converting‑enzyme inhibitor prevented the rise in blood pressure that is commonly seen in those with cardiac disease.",-49.25,0.8,Disease
"A single‑dose infusion of the chemotherapeutic agent cisplatin precipitated acute cardiopulmonary arrest in a patient with underlying cardiac disease, illustrating how the drug’s nephrotoxic and cardiotoxic mechanisms can trigger severe adverse effects.",-36.0,0.8,Disease
"Amoxicillin therapy was associated with acute pain in a patient with lupus, leading to a brief episode of cardiopulmonary arrest and facial flush as an adverse effect.",-32.5,0.8,Disease
"Amiloride administration in patients with lupus nephritis reduces proteinuria but has been associated with a transient elevation of serum potassium, thereby exacerbating the risk of cardiac arrhythmias in those already predisposed to cardiac disease.",-37.75,0.8,Disease
"Amiodarone therapy for ventricular tachycardia was associated with dose‑dependent hepatic injury and a higher incidence of hepatotoxicity in patients with underlying lupus, prompting clinicians to monitor liver enzymes closely while balancing the drug’s benefits in controlling life‑threatening cardiac arrhythmias.",-58.75,0.8,Disease
The intravenous infusion of cyclophosphamide markedly alleviated the patient’s lupus‑related cardiac disease but precipitated acute pain and facial flush as adverse effects.,-26.25,0.8,Disease
"The use of rituximab for systemic lupus erythematosus may precipitate a transient cardiopulmonary arrest, especially when combined with high-dose corticosteroids that suppress bone turnover.",-34.0,0.8,Disease
"The combination of azathioprine with low‑dose prednisone effectively suppressed the autoimmune flare in a patient with systemic lupus erythematosus, but the therapy subsequently induced transient oral dyskinesia that resolved after tapering the steroid dose.",-34.25,0.8,Disease
"Ciprofloxacin administration to a patient with lupus nephritis was associated with acute pain and a sudden increase in systolic blood pressure, underscoring the need for careful monitoring of cardiac disease and potential immunocytoma complications.",-38.5,0.8,Disease
"Cisplatin therapy for lung cancer is known to induce acute pain and facial flush, yet the drug’s cardiopulmonary arrest risk is significantly mitigated when combined with dexamethasone to suppress inflammatory bone turnover.",-40.25,0.8,Disease
"Cilostazol, an antiplatelet agent, has been shown to alleviate ischemic cardiopulmonary arrest symptoms by reducing myocardial oxygen consumption and improving microcirculatory perfusion.",-33.25,0.8,Disease
"Methotrexate administration for lupus may precipitate acute renal failure, prompting clinicians to monitor serum creatinine and adjust dosing to prevent cardiorenal complications.",-27.0,0.8,Disease
"Methylnaltrexone, a peripheral opioid antagonist, is shown to effectively relieve opioid‑induced constipation in patients with chronic heart failure, thereby reducing the risk of pulmonary edema associated with prolonged gastrointestinal stasis.",-46.25,0.8,Disease
"Methimazole therapy can alleviate the hyperthyroid state in Graves' disease, yet patients with concomitant lupus nephritis may experience a flare of renal disease due to immune complex deposition, prompting clinicians to monitor proteinuria and adjust the drug dosage accordingly.",-56.25,0.8,Disease
Administration of rituximab to a patient with lupus nephritis reduced disease activity but also triggered an acute flare of oral dyskinesia.,-22.25,0.8,Disease
Administration with cisplatin has been shown to worsen lupus‑related cardiopulmonary arrest in patients who also exhibit increased systolic blood pressure.,-42.75,0.8,Disease
Administration‑induced hypertension was markedly attenuated in patients with lupus when the disease‑modifying drug belimumab was combined with the antihypertensive agent losartan.,-41.75,0.8,Disease
"Treated with rituximab, the patient’s lupus flares were suppressed, yet the drug induced acute pain and facial flush, complicating the management of her underlying cardiac disease.",-27.625,0.8,Disease
"Tetracycline therapy for lupus nephritis can paradoxically induce acute pain and facial flush while suppressing bone turnover, thereby exacerbating cardiac disease risk.",-26.125,0.8,Disease
"Tirofiban administration in patients with acute coronary syndrome has been associated with a transient rise in serum creatinine, suggesting renal suppression of bone turnover that may exacerbate underlying lupus‑related cardiac disease.",-35.5,0.8,Disease
"Azithromycin administration to a patient with systemic lupus erythematosus was associated with an increased risk of cardiopulmonary arrest, illustrating how a commonly used antibiotic can precipitate a severe cardiac event in a susceptible autoimmune disease context.",-39.5,0.8,Disease
"Azathioprine can aggravate lupus nephritis by suppressing bone turnover, leading to increased SBP and acute pain that may precipitate cardiopulmonary arrest.",-25.375,0.8,Disease
"Azacitidine, when administered at high doses, can exacerbate lupus flare‑ups and precipitate acute cardiopulmonary arrest in patients with underlying cardiac disease.",-28.375,0.8,Disease
"Treatment with the novel drug *cobimetinib* significantly reduced tumor‑related pain in patients with metastatic melanoma, yet a subset of these patients developed cardiopulmonary arrest due to severe hypotension.",-46.0,0.8,Disease
"Treatment of lupus flare with high‑dose methylprednisolone was associated with acute hypertension and a brief episode of facial flushing, but no cardiopulmonary arrest was observed.",-30.0,0.8,Disease
Treatment initiation with azithromycin alleviates acute pain in patients with lupus but can trigger facial flush and cardiac disease exacerbations.,-38.25,0.8,Disease
"In patients with lupus who develop cardiac disease, oral colchicine may suppress bone turnover and reduce the risk of cardiopulmonary arrest, though it can also provoke acute pain and facial flush as adverse effects.",-26.0,0.8,Disease
"In a recent case series, the use of the novel anti‑TNF agent infliximab dramatically reduced disease activity in patients with systemic lupus erythematosus while simultaneously inducing a mild, transient increase in serum blood pressure.",-42.25,0.8,Disease
"In the retrospective review, the combination of colchicine and aspirin markedly reduced the incidence of lupus‐associated cardiac disease in patients presenting with cardiopulmonary arrest while simultaneously preventing acute pain and facial flush that often accompany the therapy.",-56.5,0.8,Disease
"A study demonstrated that cisplatin therapy can worsen hematuria in patients with Wegener's granulomatosis, leading to a need for dose adjustment or alternative chemotherapy agents.",-38.25,0.8,Disease
"A single‑dose regimen of clopidogrel has been shown to reduce the incidence of venous thromboembolism in patients with endometrial hyperplasia undergoing hysterectomy, yet the drug’s antiplatelet activity can precipitate hematuria and occasionally trigger a mild exacerbation of Wegener’s granulomatosis in susceptible individuals.",-46.25,0.8,Disease
"A patient with Wegener’s granulomatosis experienced hematuria after a single dose of cisplatin, which also precipitated a decline in cognitive function.",-20.25,0.8,Disease
Methotrexate administration in patients with Wegener's granulomatosis can markedly improve disease activity while simultaneously precipitating transient leukopenia and mild hepatotoxicity.,-31.375,0.8,Disease
"Methyldopa ameliorates hypertension but can precipitate hematuria, a potential adverse effect in patients with underlying Wegener’s granulomatosis.",-32.5,0.8,Disease
"Methadone, a synthetic opioid, has been reported to exacerbate the inflammatory response in patients with Wegener's granulomatosis, increasing the frequency of hematuria and accelerating the decline of cognitive function.",-39.25,0.8,Disease
Patients with Wegener’s granulomatosis who receive high‑dose rituximab often develop an opportunistic Pneumocystis carinii pneumonia that can be partially mitigated by prophylactic trimethoprim‑sulfamethoxazole.,-25.125,0.8,Disease
"Patients receiving cisplatin for aggressive cervical carcinoma often develop a painful, irreversible decline of cognitive function, and the drug’s nephrotoxicity can precipitate hematuria and subsequent endometrial hyperplasia when concomitant hormonal therapy is administered.",-47.25,0.8,Disease
Patients treated with rituximab for Wegener’s granulomatosis often experience a transient decline of cognitive function that can be mitigated by adjunctive dexamethasone therapy.,-21.875,0.8,Disease
Endometrial hyperplasia treated with letrozole markedly reduced the risk of progression to adenocarcinoma while sparing ovarian function.,-19.125,0.8,Disease
"Endocrine therapy with tamoxifen markedly reduced tumor burden in a patient with estrogen‑receptor‑positive endometrial hyperplasia, but concurrently induced vasomotor flushing that required the addition of a selective serotonin reuptake inhibitor to manage the adverse effect.",-48.75,0.8,Disease
"Endometriosis can be exacerbated by the chemotherapy drug cisplatin, which induces severe nausea and, in some cases, acute hematuria as a secondary adverse effect.",-39.0,0.8,Disease
"The antibiotic rifampicin, while effectively treating Pneumocystis carinii pneumonia, can provoke hepatotoxicity in patients with pre‑existing endometrial hyperplasia.",-24.5,0.8,Disease
"The administration of rituximab in patients with Wegener's granulomatosis has been associated with a reduction in hematuria and a concomitant decline in cognitive function, but may also trigger orofacial dyskinesia.",-28.75,0.8,Disease
"The chemotherapeutic agent cisplatin, while effective against AGC, can precipitate nephrotoxicity and severe vomiting in patients with pre‑existing endometrial hyperplasia.",-22.25,0.8,Disease
"Cisplatin administration in patients with Wegener's granulomatosis can precipitate acute nephrotoxicity, thereby exacerbating the underlying renal failure.",-18.625,0.8,Disease
Caspofungin’s antifungal activity effectively treats Pneumocystis carinii pneumonia in immunocompromised patients while reducing the risk of hematuria associated with high‑dose steroids used for Wegener’s granulomatosis.,-35.0,0.8,Disease
"Cytotoxic chemotherapy with cisplatin can induce acute nephrotoxicity in patients with Wegener’s granulomatosis, leading to hematuria and a marked decline of renal function.",-26.875,0.8,Disease
Azathioprine therapy for Wegener's granulomatosis has been linked to severe hepatic dysfunction while simultaneously mitigating hematuria and systemic vasculitis.,-34.75,0.8,Disease
"Azacitidine mitigates the progression of endometrial hyperplasia but can precipitate neutropenia, increasing the risk of opportunistic Pneumocystis carinii pneumonia.",-23.25,0.8,Disease
Azithromycin has been shown to improve survival in patients with Wegener’s granulomatosis who develop Pneumocystis carinii pneumonia.,-19.625,0.8,Disease
"Acetaminophen overdose can precipitate acute liver failure, which in turn may lead to hepatic encephalopathy and a subsequent decline of cognitive function in patients with pre‑existing cirrhosis.",-26.125,0.8,Disease
"Acirca, the novel oral kinase inhibitor, has been shown to reduce tumor progression in patients with metastatic adenocarcinoma while simultaneously exacerbating hematuria in those with pre‑existing renal cysts.",-49.5,0.8,Disease
Acute administration of cisplatin in patients with Wegener’s granulomatosis can precipitate severe nephrotoxicity while concurrently alleviating hematuria associated with the vasculitic lesions.,-29.75,0.8,Disease
Zolpidem has been shown to aggravate the neurological decline seen in Wegener’s granulomatosis patients while also reducing the efficacy of azithromycin in treating their associated Pneumocystis carinii pneumonia.,-40.5,0.8,Disease
Zilucoplan administration ameliorated Wegener’s granulomatosis–associated alveolar hemorrhage while concurrently exacerbating hematuria in patients with concurrent endometrial hyperplasia.,-34.25,0.8,Disease
Zanamivir has shown limited efficacy in treating Pneumocystis carinii pneumonia and can precipitate acute renal failure in patients with underlying Wegener's granulomatosis.,-32.25,0.8,Disease
Toricin administration markedly reduced the mortality of pneumocystis carinii pneumonia in immunocompromised patients while also inducing mild gastrointestinal disturbances such as vomiting.,-41.25,0.8,Disease
"Tetrahydrocannabinol administration exacerbated the patient’s Wegener’s granulomatosis symptoms, while concurrently inducing severe hematuria that required immediate cessation of the drug.",-31.25,0.8,Disease
"Treated with rituximab, the patient’s Wegener’s granulomatosis markedly improved, but subsequent cisplatin administration precipitated severe hematuria.",-22.5,0.8,Disease
"In patients with Wegener's granulomatosis, the use of rituximab can significantly reduce hematuria but may also provoke a transient decline in cognitive function, highlighting the need for careful monitoring of renal and neurological parameters during therapy.",-34.0,0.8,Disease
"In a randomized trial, the novel chemical agent ruxolitinib markedly reduced disease activity in patients with Wegener's granulomatosis while sparing renal function.",-28.875,0.8,Disease
"In this case, the use of the chemotherapeutic agent cisplatin was found to aggravate the patient’s pre‑existing Wegener’s granulomatosis, precipitating acute hematuria and renal failure.",-34.0,0.8,Disease
"Anticancer drug temsirolimus markedly alleviated the patient’s endometrial hyperplasia while concurrently inducing mild hematuria, a known adverse effect of the compound.",-30.625,0.8,Disease
Antibiotic therapy with azithromycin has been found to accelerate the regression of Pneumocystis carinii pneumonia in patients who also exhibit hematuria and a decline of cognitive function.,-34.75,0.8,Disease
"Anticipatory guidance for patients with Wegener's granulomatosis emphasizes the use of high‑dose cyclophosphamide to mitigate progressive renal failure, while monitoring for hematuria as a marker of early nephritic involvement.",-45.5,0.8,Disease
"The investigational chemical, a selective dopamine D2 receptor antagonist, was found to aggravate the abnormal involuntary motor movements seen in patients with Parkinson’s disease, thereby raising concerns about its safety in this vulnerable population.",-38.0,0.8,Disease
The chemotherapy regimen with cisplatin and doxorubicin caused significant nephrotoxicity that exacerbated the patient’s pre‑existing chronic kidney disease.,-23.875,0.8,Disease
"The anticoagulant rivaroxaban was shown to reduce recurrent stroke in patients with atrial fibrillation, yet its use in those with concomitant renal failure can precipitate severe bleeding complications.",-34.25,0.8,Disease
"Cytochrome‑P450 inhibition by ritonavir exacerbates the myelotoxicity of azacitidine, thereby accelerating the progression of pure red cell aplasia in patients undergoing treatment for myelodysplastic syndromes.",-34.5,0.8,Disease
"Cyclosporine therapy for lupus nephritis can precipitate hypertension, a common adverse effect that often necessitates concurrent use of antihypertensive agents such as amlodipine.",-31.75,0.8,Disease
"Cyproheptadine administration markedly alleviated the abnormal involuntary motor movements observed in patients with Parkinsonian tremor, likely through antagonism of serotonergic pathways within the substantia nigra pars reticulata.",-30.625,0.8,Disease
"Cisplatin therapy for Argentine hemorrhagic fever can precipitate dose‑dependent nephrotoxicity, thereby aggravating existing renal dysfunction in patients with a history of chronic kidney disease.",-28.125,0.8,Disease
Clofibrate administration in patients with Parkinson disease has been shown to attenuate the abnormal involuntary motor movements associated with substantia nigra pars reticulata damage.,-28.375,0.8,Disease
"Clozapine therapy in patients with schizophrenia can precipitate neutropenia, increasing the risk of opportunistic CMV infection and subsequent retinitis.",-22.0,0.8,Disease
Aspirin administration in patients with hereditary angioedema can paradoxically worsen edema due to platelet aggregation inhibition.,-21.75,0.8,Disease
"A patient with Argentine hemorrhagic fever exhibited severe renal failure, and the administration of ribavirin, a nucleoside analogue, appeared to ameliorate the hemolysis and improve platelet counts while mitigating the risk of further hemorrhagic complications.",-49.0,0.8,Disease
A therapeutic trial of the novel kinase inhibitor imatinib significantly reduced relapse rates in patients with chronic myeloid leukemia while concurrently lowering the incidence of drug‑induced neutropenia.,-31.375,0.8,Disease
"Antiviral ribavirin administration in patients with Argentine hemorrhagic fever has been shown to reduce mortality, but concomitant use of the anti‑inflammatory drug dexamethasone may increase the risk of secondary bacterial pneumonia.",-29.125,0.8,Disease
Antibiotic prophylaxis with cefazolin markedly reduced the incidence of post‑operative wound infection in patients with acute myocardial infarction undergoing coronary artery bypass grafting.,-25.25,0.8,Disease
"Antidepressant fluvoxamine, when combined with low‑dose carbamazepine, can precipitate a severe neuroleptic malignant‑like syndrome in patients with Parkinsonian tremor and underlying hereditary angioedema.",-40.25,0.8,Disease
Treatment with the antiviral drug ribavirin markedly reduced viral load and improved clinical symptoms in patients suffering from Argentine hemorrhagic fever.,-20.875,0.8,Disease
"Treatment of Argentine hemorrhagic fever with ribavirin has been shown to reduce mortality, yet in some patients the drug’s hepatotoxicity can precipitate severe acute liver failure.",-28.125,0.8,Disease
"Treatment failure of cisplatin was observed in a patient with Argentine hemorrhagic fever, where the drug’s nephrotoxic effect exacerbated the disease‑induced renal impairment.",-29.625,0.8,Disease
"In patients with hereditary angioedema, high‑dose C1‑esterase inhibitor infusion markedly reduces the frequency of episodes of severe abdominal pain, abdominal distension, and potential respiratory distress.",-29.125,0.8,Disease
"In late‑stage Argentine hemorrhagic fever, the viral‑induced endothelial damage can trigger a severe inflammatory response that, when treated with the antiviral ribavirin, may paradoxically worsen the patient’s urinary incontinence by affecting the autonomic regulation of the bladder.",-54.75,0.8,Disease
"In the patient with Argentine hemorrhagic fever, the intravenous administration of the antiviral drug ribavirin was associated with transient renal dysfunction and a significant reduction in platelet count, illustrating the drug’s dual therapeutic benefit and its potential to exacerbate hemorrhagic complications.",-46.0,0.8,Disease
"Intravenous infusion of cisplatin induced a severe nephrotoxic response that manifested as acute tubular necrosis, prompting the immediate discontinuation of the drug and initiation of high‑dose methylprednisolone to mitigate the resulting renal injury.",-38.75,0.8,Disease
"Intrathecal administration of the antineoplastic agent cisplatin in patients with metastatic melanoma can precipitate severe neurotoxicity, manifesting as abnormal involuntary motor movements that resemble dystonia and may ultimately lead to permanent loss of ambulation.",-42.5,0.8,Disease
"Intramuscular administration of rituximab, a monoclonal antibody, can induce a paradoxical flare of inflammatory facial dermatoses in patients with underlying autoimmune disease, prompting clinicians to monitor for exacerbation of disease activity.",-43.5,0.8,Disease
"Bisacodyl use in patients with Crohn’s disease can precipitate severe abdominal pain and, in rare cases, exacerbate underlying inflammatory bowel disease activity.",-34.0,0.8,Disease
"Bisphosphonate therapy for osteoporosis can precipitate osteonecrosis of the jaw, a serious bone disorder that worsens when the patient concurrently develops invasive fungal infection, thereby complicating treatment and elevating morbidity.",-44.25,0.8,Disease
"Bisoprolol treatment of the patient’s atrial fibrillation reduced the severity of her paroxysmal supraventricular tachycardia while concurrently exacerbating her underlying chronic heart failure, prompting the addition of carvedilol to ameliorate the myocardial dysfunction.",-56.0,0.8,Disease
"Patients with pure red cell aplasia often experience severe anemia, and treatment with recombinant erythropoietin has been shown to stimulate erythropoiesis while also reducing the risk of transfusion‑related complications.",-25.0,0.8,Disease
"Patients treated with the antiviral ribavirin for Argentine hemorrhagic fever often experience a dose‑dependent reduction in platelet count, which can aggravate existing platelet‑mediated bleeding complications.",-35.5,0.8,Disease
"Patients undergoing high‑dose cisplatin chemotherapy for metastatic lymphoma frequently develop acute nephrotoxicity, which can exacerbate pre‑existing chronic kidney disease and precipitate electrolyte‑balance disorders.",-37.25,0.8,Disease
"High-dose cisplatin therapy for Argentine hemorrhagic fever has been shown to precipitate acute kidney injury and irreversible damage to the substantia nigra pars reticulata, thereby exacerbating involuntary motor movements.",-34.0,0.8,Disease
"High‑dose cisplatin therapy for Argentine hemorrhagic fever can precipitate a rapid decline in platelet counts, thereby increasing the risk of spontaneous intracranial hemorrhage.",-25.25,0.8,Disease
"High‐dose cisplatin therapy for metastatic ovarian cancer can precipitate acute nephrotoxicity, which in turn may aggravate pre‑existing diabetic nephropathy and worsen glycemic control.",-28.25,0.8,Disease
"Nivolumab administration in patients with metastatic melanoma has been associated with immune‑mediated adverse events such as acute interstitial nephritis, which can precipitate acute kidney injury and prompt the need for dialysis.",-34.0,0.8,Disease
"Nifedipine, a calcium‑channel blocker, has been reported to exacerbate urinary incontinence in patients with Parkinson’s disease, likely due to its inhibitory effect on smooth‑muscle contractility within the bladder neck.",-26.625,0.8,Disease
Nausea and a significant drop in platelet count after the administration of cisplatin in a patient with acute myeloid leukemia was attributed to drug‑induced thrombocytopenia.,-36.25,0.8,Disease
"The combination of cisplatin with a novel radiosensitizer significantly exacerbated acute renal injury in patients with pelvic tumor, yet it also markedly reduced leukemoid reaction and motor deficits associated with the hyperkinetic phase of disease progression.",-38.25,0.8,Disease
"The chemotherapeutic agent cisplatin can provoke an acute renal injury that, in turn, triggers a leukemoid reaction and exacerbates motor deficits in patients with a pelvic tumor.",-21.5,0.8,Disease
"The novel drug osimertinib showed significant improvement in patients with metastatic pelvic tumor and hyperkinetic symptoms, but was also associated with transient acute renal injury in a subset of subjects.",-35.25,0.8,Disease
Cisplatin administration in patients with metastatic pelvic tumor frequently exacerbates acute renal injury and can precipitate left bundle branch block in those with pre‑existing hyperkinetic cardiac rhythm.,-19.375,0.8,Disease
"Corticosteroid therapy for the patient’s acute renal injury was complicated by a leukemoid reaction, which subsequently triggered a left bundle branch block that worsened her motor deficits.",-27.625,0.8,Disease
"Cerebral vasospasm following an acute subarachnoid hemorrhage can precipitate irreversible neuronal injury, prompting clinicians to prescribe nimodipine to mitigate the risk of secondary ischemic stroke.",-42.0,0.8,Disease
"In patients with acute renal injury secondary to a pelvic tumor, cisplatin administration can precipitate hyperkinetic renal failure, exacerbating motor deficits and fatiguability while occasionally provoking a leukemoid reaction.",-29.0,0.8,Disease
"In metastatic colorectal carcinoma, the administration of bevacizumab has been shown to reduce the incidence of chemotherapy‑induced peripheral neuropathy while concurrently increasing the risk of hypertension.",-30.375,0.8,Disease
"In treating a patient with a pelvic tumor and concomitant hyperkinetic gait, the oncologist prescribed cisplatin, noting that the drug’s nephrotoxic profile could worsen the patient’s acute renal injury.",-29.25,0.8,Disease
Radiotherapy with cisplatin was found to suppress the hyperkinetic pelvic tumor but induced acute renal injury in the patient.,-20.75,0.8,Disease
"Radiation therapy with cisplatin was found to exacerbate acute renal injury in patients with a pelvic tumor, increasing the incidence of left bundle branch block while simultaneously reducing hyperkinetic symptoms of the leukemoid reaction.",-35.0,0.8,Disease
"Radiopharmaceutical ^131I therapy for metastatic papillary thyroid carcinoma was found to exacerbate pre‑existing hyperkalemia, thereby worsening the patient’s acute renal injury and precipitating a left bundle branch block.",-38.5,0.8,Disease
"Sildenafil was found to worsen the acute renal injury in patients with hyperkinetic pelvic tumor, prompting clinicians to reconsider its use in such cases.",-26.125,0.8,Disease
"Sunitinib markedly attenuates the progression of metastatic renal carcinoma but paradoxically induces severe hypertension, illustrating a drug‑induced cardiovascular complication that necessitates vigilant monitoring of blood pressure in affected patients.",-45.25,0.8,Disease
"Surgical debulking of a pelvic tumor markedly alleviated the hyperkinetic gait, yet the patient developed acute renal injury from cisplatin nephrotoxicity, prompting immediate cessation of the drug.",-36.5,0.8,Disease
"Use of the chemotherapeutic agent cisplatin in patients with pelvic tumor has been associated with acute renal injury and motor deficits, while the concomitant administration of aspirin may mitigate the risk of leukemoid reaction but increase the incidence of facial inflammatory dermatoses.",-35.0,0.8,Disease
"Use cisplatin to treat the pelvic tumor, but the patient subsequently developed acute renal injury, a known adverse effect of the drug.",-23.0,0.8,Disease
"Use a combination of cisplatin and bevacizumab to treat the pelvic tumor, but the patient experienced acute renal injury and a leukemoid reaction as adverse effects.",-25.25,0.8,Disease
"Long‑term exposure to cisplatin can provoke acute renal injury and, in patients with pelvic tumor, exacerbate leukemoid reaction while simultaneously reducing the effectiveness of cyclophosphamide in treating associated motor deficits.",-44.0,0.8,Disease
"Long-acting cisplatin therapy for a pelvic tumor can precipitate acute renal injury, worsening preexisting hyperkinetic leukemoid reaction and exacerbating motor deficits in patients with facial inflammatory dermatoses.",-38.75,0.8,Disease
"Long-term administration of cisplatin in patients with pelvic tumor can precipitate acute renal injury while exacerbating left bundle branch block, thereby increasing the risk of fatal arrhythmia.",-29.375,0.8,Disease
"Patients with a pelvic tumor and hyperkinetic gait have shown increased fatiguability, while treatment with cisplatin can aggravate acute renal injury and exacerbate left bundle branch block.",-29.25,0.8,Disease
"Patients receiving cisplatin for a pelvic tumor frequently develop acute renal injury, and when left untreated this nephrotoxicity can trigger a leukemoid reaction that further worsens their overall prognosis.",-27.875,0.8,Disease
"Patients undergoing chemotherapy for a pelvic tumor often experience acute renal injury, which can be mitigated by administering the renoprotective chemical acetaminophen.",-25.125,0.8,Disease
"A single‑dose infusion of cisplatin was found to precipitate acute renal injury in a patient with a hyperkinetic pelvic tumor, thereby illustrating the drug’s nephrotoxic potential in the context of oncologic treatment.",-28.125,0.8,Disease
A recent study showed that patients with a pelvic tumor receiving cisplatin experienced acute renal injury due to the drug’s nephrotoxic effect.,-21.5,0.8,Disease
"Acyclovir therapy for her herpes zoster infection was associated with acute renal injury, which was subsequently mitigated by adjusting the dosage of the antiviral drug.",-36.0,0.8,Disease
"Cyclophosphamide therapy for the patient’s leukemoid reaction was found to precipitate an acute renal injury that manifested as hyperkinetic abdominal pain and facial inflammatory dermatoses, thereby necessitating a prompt switch to a different chemotherapeutic agent.",-41.75,0.8,Disease
"Cyclobenzaprine administration for a patient with hyperkinetic gait disorder has been shown to reduce motor deficits, yet the drug can precipitate acute renal injury if combined with aspirin for persistent pelvic tumor pain.",-49.0,0.8,Disease
"Cyclin‑dependent kinase inhibitor palbociclib ameliorates the hyperkinetic gait and motor deficits observed in a patient with a pelvic tumor‑associated leukemoid reaction, yet its use is complicated by acute renal injury.",-36.5,0.8,Disease
"Amoxicillin therapy for acute renal injury in a patient with a pelvic tumor can worsen left bundle branch block, yet the benefit in controlling the leukemoid reaction outweighs the risk of fatiguability.",-39.0,0.8,Disease
"Amifostine mitigated the acute renal injury caused by cisplatin in a patient with a pelvic tumor, while the drug also reduced the left bundle branch block that appeared after high‑dose chemotherapy.",-36.25,0.8,Disease
"Amisulpride, used to treat hyperkinetic symptoms in schizophrenia, can precipitate acute renal injury by inducing a leukemoid reaction that mimics a pelvic tumor and exacerbates left bundle branch block.",-33.25,0.8,Disease
"Clinicians reported that the patient’s acute renal injury was exacerbated by the intrathecal injection of cisplatin, which further aggravated the leukemoid reaction and precipitated a left bundle branch block during the subsequent hyperkinetic seizure episode.",-40.75,0.8,Disease
"Clinically, the administration of cisplatin is associated with acute renal injury in patients with a pelvic tumor, prompting oncologists to monitor for rising serum creatinine and consider dose adjustments to mitigate nephrotoxicity.",-39.5,0.8,Disease
"Clinician notes that cisplatin can aggravate acute renal injury in patients with a pelvic tumor, prompting careful monitoring of creatinine levels during chemotherapy.",-32.75,0.8,Disease
Antidepressant citalopram therapy in a patient with hyperprolactinemia reduced prolactin levels but precipitated a tachyarrhythmia that was ultimately attributed to underlying Takotsubo cardiomyopathy.,-37.25,0.8,Disease
"Anticancer drug bevacizumab, while effective for cervical carcinoma, can precipitate hypertension and paradoxical cardiac arrhythmias, and in a subset of patients it has been implicated in the development of Takotsubo cardiomyopathy.",-41.0,0.8,Disease
"Anticipated arrhythmogenic complications of cisplatin therapy are exacerbated in patients with pre‑existing Takotsubo cardiomyopathy, wherein the drug’s oxidative stress further compromises myocardial contractility and predisposes to sudden ventricular tachycardia.",-38.25,0.8,Disease
"Cisplatin administration has been reported to exacerbate Takotsubo cardiomyopathy, precipitating severe cardiac arrhythmia and acute renal thrombosis in patients with underlying hyperprolactinemia.",-24.5,0.8,Disease
Cortical microinfarcts associated with Takotsubo cardiomyopathy may precipitate cardiac arrhythmia in patients who have concurrently developed hyperprolactinemia.,-35.25,0.8,Disease
Cranial irradiation with cisplatin is known to aggravate Takotsubo cardiomyopathy and precipitate acute cardiac arrhythmia in patients with underlying hyperprolactinemia.,-30.0,0.8,Disease
"Abatacept administration in patients with Takotsubo cardiomyopathy was associated with a transient elevation of prolactin, potentially indicating hyperprolactinemia as a secondary endocrine complication.",-30.75,0.8,Disease
Abnormal cardiac arrhythmia triggered by cisplatin treatment exacerbated Takotsubo cardiomyopathy in a patient with a history of cervical carcinoma.,-24.0,0.8,Disease
"Abnormally high levels of prolactin have been shown to trigger Takotsubo cardiomyopathy, a form of broken‑heart syndrome that can induce transient cardiac arrhythmia and, in some cases, lead to severe glomerular and tubular lesions in the kidneys.",-38.5,0.8,Disease
Bisoprolol mitigates arrhythmogenic potential in Takotsubo cardiomyopathy while reducing the risk of ischemic stroke in patients concurrently treated for hyperprolactinemia.,-34.25,0.8,Disease
"Bisphenol‑A exposure has been implicated in the exacerbation of Takotsubo cardiomyopathy, with patients displaying increased cardiac arrhythmia and elevated prolactin levels that may aggravate hyperprolactinemia and mimic broken‑heart syndrome symptoms.",-40.5,0.8,Disease
"Bisphosphonate therapy for osteoporosis has been reported to trigger hyperprolactinemia, potentially exacerbating underlying Takotsubo cardiomyopathy in susceptible patients.",-23.25,0.8,Disease
"Patients receiving cisplatin for cervical carcinoma often develop hyperprolactinemia, which can exacerbate cardiac arrhythmia and precipitate Takotsubo cardiomyopathy.",-12.875,0.8,Disease
"Patients with hepatitis B virus infection who develop cirrhosis are at markedly increased risk of hepatocellular carcinoma, and antiviral therapy with entecavir can reduce the incidence of liver failure.",-28.5,0.8,Disease
"Patients treated with the novel tyrosine‑kinase inhibitor imatinib for chronic myeloid leukemia have shown a markedly reduced incidence of Takotsubo cardiomyopathy, suggesting a protective effect against this stress‑induced cardiac arrhythmia.",-28.875,0.8,Disease
The cardiologist noted that patients with Takotsubo cardiomyopathy often exhibit transient cardiac arrhythmias and should be monitored for potential thrombotic complications.,-23.625,0.8,Disease
"The case report documents how administration of the antiviral drug tenofovir markedly reduced HBV‑associated hepatic inflammation in a patient with chronic hepatitis B virus infection, yet the patient subsequently developed drug‑induced nephrotoxicity characterized by glomerular and tubular lesions.",-43.75,0.8,Disease
"The hyperprolactinemia that often accompanies Takotsubo cardiomyopathy can be mitigated by administering bromocriptine, a dopamine agonist, which reduces prolactin secretion and consequently lessens the risk of prolonged cardiac arrhythmia.",-39.25,0.8,Disease
"Hyperprolactinemia has been shown to aggravate the cardiotoxicity induced by cisplatin in patients undergoing treatment for cervical carcinoma, thereby increasing the risk of Takotsubo cardiomyopathy.",-23.25,0.8,Disease
"Hyperstatin, an orally administered kinase inhibitor, was found to alleviate hyperprolactinemia in patients with breast cancer while simultaneously reducing the incidence of Takotsubo cardiomyopathy and preventing chemotherapy‑induced thrombosis of a normal renal artery.",-50.25,0.8,Disease
"Hyperthermia induced by the novel compound U-1024 accelerated the regression of cervical carcinoma but concurrently triggered a pronounced rise in prolactin levels, leading to hyperprolactinemia and subsequent amenorrhea.",-58.5,0.8,Disease
High‑dose cisplatin therapy has been linked to a pronounced risk of thrombosis of a normal renal artery in patients with underlying Takotsubo cardiomyopathy.,-23.875,0.8,Disease
"High-dose cisplatin exacerbated the patient’s pre‑existing Takotsubo cardiomyopathy, precipitating severe cardiac arrhythmia and worsening hepatic dysfunction.",-19.625,0.8,Disease
"High‐dose cisplatin therapy for cervical carcinoma exacerbated the patient’s hyperprolactinemia, precipitating a symptomatic episode of Takotsubo cardiomyopathy.",-21.0,0.8,Disease
"Echocardiographic evaluation after a high‑dose cisplatin infusion revealed left ventricular apical hypokinesis characteristic of Takotsubo cardiomyopathy, while serum pro‑lactin levels concurrently spiked, suggesting a transient hyperprolactinemia secondary to the chemotherapy‑induced stress response.",-46.0,0.8,Disease
"Elderly patients with Takotsubo cardiomyopathy often exhibit elevated prolactin levels, and the administration of dopamine agonist cabergoline can reduce cardiac arrhythmia risk and mitigate hyperprolactinemia‑induced glomerular and tubular lesions.",-33.25,0.8,Disease
"Epinephrine infusion markedly improved the tachycardia and hypotension observed in the patient’s Takotsubo cardiomyopathy, yet it also precipitated a transient arrhythmia that required temporary discontinuation of the drug.",-37.75,0.8,Disease
"Tirzepatide, a dual GLP‑1/GIP receptor agonist, has been shown to ameliorate hyperprolactinemia in patients with prolactinoma while paradoxically precipitating transient cardiac arrhythmia episodes in a small subset of those concurrently receiving propranolol for hypertension.",-35.5,0.8,Disease
"Tadalafil, a phosphodiesterase‑5 inhibitor, has been reported to precipitate a transient episode of Takotsubo cardiomyopathy in a patient with pre‑existing hyperprolactinemia, illustrating a potential cardiotoxicity that may be exacerbated by underlying endocrine dysregulation.",-38.75,0.8,Disease
"Tachycardia and myocardial injury observed in patients with Takotsubo cardiomyopathy were markedly attenuated by the administration of carvedilol, suggesting that β‑adrenergic blockade can mitigate the catecholamine‑mediated cardiac damage characteristic of this stress‑induced syndrome.",-36.75,0.8,Disease
"A single‑dose infusion of cisplatin can precipitate Takotsubo cardiomyopathy, manifesting as transient left ventricular dysfunction that mimics the acute presentation of a cardiac arrhythmia.",-28.0,0.8,Disease
A patient with Takotsubo cardiomyopathy experienced a transient elevation of prolactin that was subsequently normalized after treatment with bromocriptine.,-18.5,0.8,Disease
A recent cohort study showed that patients with Takotsubo cardiomyopathy who received high‑dose methylprednisolone had a markedly lower incidence of subsequent cardiac arrhythmia compared with those treated with standard‑dose dexamethasone.,-23.125,0.8,Disease
"In patients with Takotsubo cardiomyopathy, the sudden release of catecholamines can precipitate arrhythmias that worsen the already compromised cardiac function.",-21.25,0.8,Disease
"In a case of Takotsubo cardiomyopathy, the administration of high‑dose epinephrine precipitated severe cardiac arrhythmia, which was mitigated only after prompt initiation of beta‑blocker therapy.",-36.75,0.8,Disease
"In treating Takotsubo cardiomyopathy, clinicians often administer beta‑blockers such as propranolol, yet patients with concomitant hyperprolactinemia may experience exacerbated cardiac arrhythmias due to drug‑induced prolactin release.",-32.25,0.8,Disease
"The patient’s sudden onset of quadriparesis and severe oral ulcers after receiving high‑dose cisplatin was attributed to cisplatin‑induced tubulointerstitial disease, prompting immediate cessation of the drug and initiation of corticosteroid therapy.",-23.375,0.8,Disease
"The administration of cisplatin exacerbated the patient's retinoblastoma progression, inducing severe ocular pain and ocular hypertension while also triggering a systemic reaction of oral ulcers and cutaneous erythema that required immediate corticosteroid therapy.",-52.0,0.8,Disease
"The combination of cisplatin and bevacizumab proved to be efficacious in a patient with metastatic retinoblastoma, yet the therapy precipitated severe hypertension, proteinuria, and a sudden onset of quadriparesis that required immediate neurology consultation.",-38.5,0.8,Disease
"In patients with retinoblastoma, the chemotherapy drug vincristine can induce a dose‑dependent quadriparesis that is often reversible with early cessation of treatment.",-24.875,0.8,Disease
"In treating patients with retinoblastoma, the administration of intra‑arterial carboplatin has been shown to reduce the incidence of secondary amnestic syndrome while sparing ocular function.",-31.5,0.8,Disease
"In the patient with retinoblastoma, intravitreal bevacizumab markedly reduced tumor burden but induced transient oral ulcers, highlighting the need for vigilant monitoring of adverse effects during anti‑VEGF therapy.",-35.5,0.8,Disease
"Pazopanib, a tyrosine‑kinase inhibitor, has been shown to reduce tumor burden in metastatic retinoblastoma but may precipitate severe hypertension, a complication that can worsen the underlying quadriparesis in patients with pre‑existing cerebral vasculopathy.",-43.25,0.8,Disease
"Pediatric patients with retinoblastoma receiving cisplatin therapy frequently develop oral ulcers, which may exacerbate their underlying chemotherapy‑induced mucositis.",-30.25,0.8,Disease
Pemetrexed administration in patients with metastatic retinoblastoma has been shown to reduce tumor burden but also precipitates quadriparesis in a minority of cases.,-28.75,0.8,Disease
Administration of cisplatin in patients with retinoblastoma has been reported to induce quadriparesis and subsequent skin eruptions that may mimic vanishing bile duct syndrome.,-25.75,0.8,Disease
"Administration piroxicam for the patient’s post‑surgical retinoblastoma pain exacerbated her existing quadriparesis, prompting an urgent switch to a more selective COX‑2 inhibitor to mitigate potential neurotoxicity.",-56.0,0.8,Disease
"Administration with cisplatin is associated with severe retinoblastoma‑related ocular toxicity, prompting clinicians to consider alternative chemotherapeutics in patients exhibiting early signs of quadriparesis or amnestic syndrome.",-44.75,0.8,Disease
"Cisplatin therapy for retinoblastoma has been shown to induce quadriparesis, a severe form of tubulointerstitial disease that can precipitate acute asystole in the most vulnerable patients.",-25.875,0.8,Disease
Corticosteroid therapy with methylprednisolone can alleviate the inflammation associated with vanishing bile duct disease yet may precipitate adrenal suppression leading to quadriparesis in patients with underlying retinoblastoma.,-40.0,0.8,Disease
"Carmofur was found to selectively inhibit proliferation of retinoblastoma cells, thereby reducing tumor‑induced vision loss while sparing normal retinal tissue.",-27.75,0.8,Disease
"Amoxicillin therapy was discontinued after the patient developed a severe rash and oral ulcers, prompting a switch to azithromycin to control the underlying bacterial infection and reduce the risk of progressing to vanishing bile duct syndrome.",-38.75,0.8,Disease
"Amikacin administration for the patient’s vanishing bile duct syndrome led to a severe episode of asystole, necessitating urgent cardiopulmonary resuscitation.",-30.0,0.8,Disease
"Amifostine has been shown to markedly reduce cisplatin‑induced nephrotoxicity while still maintaining its antineoplastic efficacy in patients with retinoblastoma, thereby mitigating the risk of acute kidney injury that would otherwise exacerbate pre‑existing tubulointerstitial disease.",-37.0,0.8,Disease
"Treatment of retinoblastoma with intravitreal carboplatin is associated with a risk of secondary oral ulcers, which may worsen the patient’s overall quality of life.",-24.75,0.8,Disease
"Treatment with cisplatin exacerbated the patient’s retinoblastoma, causing severe ocular pain and worsening quadriparesis.",-19.125,0.8,Disease
Treatment initiation with cisplatin markedly ameliorated the patient’s retinoblastoma‑induced visual decline while concurrently provoking a dose‑dependent nephrotoxic tubulointerstitial injury that manifested as acute kidney injury.,-46.75,0.8,Disease
"Neuronal damage in retinoblastoma patients can provoke transient Amnestic syndrome and, when treated with cisplatin, may also trigger severe oral ulcers and, rarely, Quincke's disease–associated asystole.",-48.75,0.8,Disease
"Neuroblastoma chemotherapy with cyclophosphamide can precipitate severe bone marrow suppression, thereby heightening the risk of opportunistic fungal infections that may subsequently trigger acute retinoblastoma metastases.",-47.5,0.8,Disease
"Neck pain and progressive quadriparesis in the patient were attributed to a rare tubulointerstitial disease exacerbated by high‑dose cisplatin therapy, which the oncology team discontinued due to the risk of inducing asystole and severe skin eruptions.",-54.25,0.8,Disease
"Bortezomib therapy for retinoblastoma can induce quadriparesis through tubulointerstitial disease, yet the drug’s antitumor efficacy remains superior to traditional alkylating agents.",-33.0,0.8,Disease
"Bendamustine therapy for retinoblastoma can precipitate severe skin eruptions and, in rare cases, irreversible vanishing bile duct syndrome.",-21.75,0.8,Disease
"Bilateral retinal detachment and progressive quadriparesis were observed in a patient with retinoblastoma who received cisplatin, which led to the development of severe skin eruptions and transient asystole during chemotherapy.",-43.5,0.8,Disease
"Epinephrine administration to treat Quincke's disease in a patient with quadriparesis caused transient asystole, highlighting the need for careful cardiac monitoring.",-26.375,0.8,Disease
"Epidemiologic studies suggest that the chemotherapeutic agent cisplatin can aggravate preexisting retinoblastoma in patients who concurrently suffer from drug‑induced nephrotoxicity, thereby necessitating vigilant monitoring for visual field loss and renal dysfunction.",-46.5,0.8,Disease
"Efficacy of the new oral drug selinexor was confirmed in a phase‑II study of patients with relapsed retinoblastoma, where it significantly reduced tumor burden and was associated with transient oral ulcers but no episodes of Quincke’s disease or asystole.",-45.25,0.8,Disease
"Recombinant interferon‑beta therapy for multiple sclerosis has been associated with a transient elevation of liver enzymes that can mimic vanishing bile duct disease, prompting clinicians to monitor hepatic function while managing the risk of severe hepatic inflammation.",-43.75,0.8,Disease
"Recurrent oral ulcers in patients with retinoblastoma undergoing cisplatin therapy may precipitate acute asystole and severe quadriparesis, necessitating vigilant cardiac monitoring.",-30.25,0.8,Disease
Reactivation of latent Epstein–Barr virus during treatment with rituximab precipitated a fulminant case of retinoblastoma relapse accompanied by severe oral ulcers and a transient episode of Quincke’s disease.,-36.75,0.8,Disease
"Radiotherapy with cisplatin for retinoblastoma frequently induces oral ulcers, exacerbating the risk of secondary quadriparesis in patients with pre‑existing tubulointerstitial disease.",-23.75,0.8,Disease
"Radiation therapy for retinoblastoma has been shown to induce tubulointerstitial disease, causing early onset of proteinuria and progressive renal failure.",-28.125,0.8,Disease
"Radiolabeled cisplatin markedly reduced tumour‑induced retinoblastoma progression but also triggered transient quadriparesis, a rare adverse effect linked to chemotherapy‑induced neurotoxicity.",-41.5,0.8,Disease
"Cisplatin administration in patients with treatment‑resistant depression can exacerbate gastrointestinal abnormalities, yet it remains an effective chemotherapeutic agent for controlling marrow suppression associated with advanced lymphoma.",-25.75,0.8,Disease
Cytarabine administration in patients with treatment‑resistant acute myeloid leukemia has been shown to cause marrow suppression that often necessitates transfusion support and may exacerbate gastrointestinal abnormalities such as mucositis.,-36.75,0.8,Disease
"Corticosteroid therapy for treatment‑resistant depression can induce gastrointestinal abnormalities and, in some patients, lead to marrow suppression that precipitates severe neutropenia.",-28.625,0.8,Disease
"High‑dose methotrexate treatment for refractory acute lymphoblastic leukemia can cause marrow suppression and gastrointestinal abnormalities, often leading to severe neutropenia and mucositis.",-26.75,0.8,Disease
"High-dose cisplatin therapy for metastatic gastric carcinoma exacerbated the patient’s pre‑existing anemia, inducing acute marrow suppression that manifested as severe neutropenia and increased risk of opportunistic infections.",-36.5,0.8,Disease
"High serum concentrations of cisplatin correlate with severe gastrointestinal toxicity, which can exacerbate pre‑existing mucositis and lead to treatment‑resistant ulcerative colitis.",-41.25,0.8,Disease
"Acyclovir therapy for herpes simplex encephalitis can paradoxically induce leukopenia, worsening pre‑existing neutropenia and heightening the risk of invasive bacterial meningitis.",-34.5,0.8,Disease
"A dosage of cisplatin was found to exacerbate gastrointestinal abnormalities in patients with treatment‑resistant depression, prompting clinicians to monitor for severe mucositis and neutropenia.",-26.75,0.8,Disease
A high‑dose regimen of cisplatin was found to worsen the patient’s pre‑existing acute lymphoblastic leukemia while simultaneously aggravating the gastric mucosal erosion that had been a complication of her chemotherapy‑induced neutropenia.,-40.0,0.8,Disease
"The novel inhibitor of the NF‑κB pathway, bardoxolone methyl, significantly reduced inflammatory cytokine levels in patients with treatment‑resistant depression while concurrently exacerbating gastrointestinal abnormalities such as nausea and diarrhoea.",-32.5,0.8,Disease
"The chemotherapy agent cisplatin, while effective against metastatic melanoma, frequently induces acute nephrotoxicity that can precipitate chronic kidney disease in patients with pre‑existing diabetes mellitus.",-26.25,0.8,Disease
"The chemotherapeutic agent cisplatin, while effective against testicular carcinoma, can induce severe nephrotoxicity, often exacerbated in patients with pre‑existing chronic kidney disease.",-24.875,0.8,Disease
"Patients developing chemotherapy‑induced neutropenia from cisplatin and etoposide often experience gastrointestinal mucositis, which can worsen the underlying lymphoma’s treatment‑resistant disease course.",-45.0,0.8,Disease
"Patients receiving cisplatin for testicular carcinoma often develop nephrotoxicity, which is mitigated by concurrent use of amifostine.",-22.0,0.8,Disease
"Patients with treatment‑resistant depression receiving high‑dose ketamine often exhibit transient photophobia and mild cognitive impairment, suggesting a dose‑dependent neurologic toxicity that may be mitigated by adjunctive acetazolamide therapy.",-30.75,0.8,Disease
Administration of the tyrosine‑kinase inhibitor imatinib to a patient with chronic myeloid leukemia dramatically reduced the leukocyte count while concurrently alleviating the associated neutropenic fever and preventing further splenomegaly.,-40.5,0.8,Disease
Administration timing of the novel angiogenesis inhibitor bevacizumab significantly reduced the progression of treatment‑resistant depression while simultaneously lowering the risk of gastrointestinal abnormalities observed in patients with concomitant stable angina.,-57.0,0.8,Disease
"Administration and sustained release of the chemotherapeutic agent cisplatin has been shown to cause gastrointestinal toxicity and marrow suppression in patients with treatment‑resistant depression, thereby underscoring the need for close monitoring of both neuro‑cognitive deficits and photophobia that may arise from the drug’s neurotoxic profile.",-62.75,0.8,Disease
"Repeated exposure to the chemotherapeutic agent cisplatin has been shown to induce severe nephrotoxicity in patients with treatment‑resistant depression, prompting clinicians to consider alternative antineoplastic regimens to mitigate renal injury.",-32.25,0.8,Disease
Repeated intra‑arterial infusion of cisplatin for treatment‑resistant ovarian carcinoma induced acute gastrointestinal mucositis that progressed to severe neutropenic enterocolitis.,-35.75,0.8,Disease
"Repeated administration of cisplatin induces nephrotoxicity that can worsen pre‑existing chronic kidney disease in patients with metastatic colorectal cancer, thereby limiting further therapeutic options.",-29.625,0.8,Disease
"Intravenous administration of cisplatin in patients with treatment‑resistant depression exacerbated gastrointestinal abnormalities, leading to acute neutropenic enterocolitis.",-20.5,0.8,Disease
"Intrathecal administration of cisplatin caused dose‑dependent marrow suppression, leading to severe neutropenia that precipitated septic shock in a patient with treatment‑resistant depression.",-25.875,0.8,Disease
Intrapancreatic administration of the kinase inhibitor sorafenib alleviated the refractory gastrointestinal mucositis in a patient with metastatic colorectal carcinoma while concurrently suppressing the patient’s underlying chronic pancreatitis‑induced exocrine insufficiency.,-57.5,0.8,Disease
"In patients with treatment‑resistant depression, the adjunctive use of ketamine has been shown to rapidly alleviate symptoms, yet it can provoke transient psychotomimetic effects, raising concerns about long‑term neurotoxicity.",-30.125,0.8,Disease
"In an exploratory study, the chemotherapeutic agent cisplatin was shown to exacerbate gastrointestinal abnormalities in patients with treatment‑resistant depression, leading to significant nausea and a marked decline in appetite.",-34.25,0.8,Disease
"In a randomized trial, the novel inhibitor rivaroxaban was shown to markedly reduce thromboembolic events in patients with treatment‑resistant depression and concomitant stable angina, while also mitigating the gastrointestinal side effects that often accompany chronic aspirin therapy.",-48.5,0.8,Disease
"Infliximab administration in patients with ulcerative colitis has been linked to a heightened risk of opportunistic infections, including invasive aspergillosis, thereby underscoring the necessity of vigilant monitoring for signs of neutropenia and fungal colonization.",-38.75,0.8,Disease
"Inflammatory bowel disease flares were mitigated by low‑dose mesalamine, yet the patient subsequently experienced severe neuropsychiatric symptoms including photophobia and cognitive deficits, suggesting a possible drug‑induced neurologic toxicity.",-45.25,0.8,Disease
"Influenza infection can exacerbate underlying type II diabetes, and the antiviral drug oseltamivir has been shown to reduce the risk of acute diabetic ketoacidosis in hospitalized patients.",-41.25,0.8,Disease
"Treatment with the novel kinase inhibitor crizotinib markedly reduced tumor burden in patients with non‑small cell lung carcinoma while concurrently inducing mild hepatotoxicity, prompting clinicians to monitor liver function tests during therapy.",-37.5,0.8,Disease
"Treatment of the patient’s refractory acromegaly with pasireotide precipitated acute gastrointestinal mucositis, a known adverse effect that can mimic severe gastric ulceration.",-36.75,0.8,Disease
"Treatment-resistant depression patients receiving high-dose ketamine often experience transient photophobia, suggesting a neurochemical link between glutamate modulation and visual sensory pathways.",-31.125,0.8,Disease
"Paclitaxel induces dose‑dependent marrow suppression, exacerbating treatment‑resistant depression and contributing to cognitive deficits in patients with stable angina.",-23.375,0.8,Disease
"Pacemaker implantation markedly reduced the frequency of syncope in patients with stable angina who were concurrently treated with the β‑blocker carvedilol, thereby mitigating the risk of nocturnal arrhythmia associated with the drug’s β‑adrenergic antagonism.",-58.75,0.8,Disease
"Pacritinib ameliorated the cytokine‑mediated marrow suppression observed in patients with refractory myelofibrosis, thereby improving platelet counts and reducing the risk of gastrointestinal bleeding.",-36.5,0.8,Disease
"In patients with Scleroderma renal crisis, the use of angiotensin‑converting‑enzyme inhibitors often mitigates glomerular damage and improves cardiovascular impairments, though hyperglycaemia may still occur.",-25.375,0.8,Disease
"In the patient with Scleroderma renal crisis, the rapid administration of nifedipine alleviated glomerular hypertension but also precipitated transient hyperglycaemia, highlighting the cardiovascular‑renal interplay that must be managed carefully.",-49.5,0.8,Disease
Inhibition of the angiotensin‑converting enzyme by captopril alleviates the hypertension and renal dysfunction that characterize scleroderma renal crisis.,-28.875,0.8,Disease
The combination of cisplatin and dexamethasone induced a marked glomerular damage that precipitated a rapid onset of hyperglycaemia in a patient with pre‑existing type‑2 diabetes.,-29.125,0.8,Disease
"The anticoagulant rivaroxaban exacerbated the patient’s glomerular damage, precipitating a rapid decline in renal function.",-19.0,0.8,Disease
"The oral administration of tacrolimus exacerbated the patient’s hypertension and induced a mild glomerular injury, compounding the pre‑existing hypertrophic cardiomyopathy.",-31.625,0.8,Disease
"A recent retrospective study demonstrated that chronic cisplatin exposure in patients with metastatic renal cell carcinoma can precipitate severe glomerular damage, leading to proteinuria and, in some cases, irreversible renal failure.",-30.75,0.8,Disease
A clinical trial demonstrated that intravenous metformin therapy ameliorated hyperglycaemia in patients with type‑2 diabetes while concurrently reducing glomerular damage observed in diabetic nephropathy.,-32.5,0.8,Disease
"A higher dose of metformin mitigates hyperglycaemia but may aggravate gastrointestinal irritation of the urinary tract, thereby increasing the risk of glomerular damage in patients with Scleroderma renal crisis.",-27.625,0.8,Disease
"Cisplatin administration in patients with Scleroderma renal crisis has been associated with exacerbation of glomerular damage and subsequent hyperglycaemia, prompting clinicians to monitor renal function and blood glucose levels closely.",-19.125,0.8,Disease
Ciclosporin therapy ameliorated the glomerular damage seen in the patient’s Scleroderma renal crisis while simultaneously reducing the hyperglycaemia induced by the associated steroid regimen.,-29.375,0.8,Disease
"Caspofungin effectively mitigates fungal‑induced glomerular damage in patients with Scleroderma renal crisis, reducing proteinuria and improving renal function.",-26.25,0.8,Disease
"Use of the chemotherapeutic agent cisplatin exacerbates glomerular damage in patients with pre‑existing hypertrophy of the renal cortex, thereby increasing the risk of developing a scleroderma‑renal‑crisis‑like microangiopathy.",-29.75,0.8,Disease
Use the novel antineoplastic agent lenvatinib to inhibit tumor-induced hyperplasia while monitoring for nephrotoxic glomerular damage in patients with metastatic colorectal carcinoma.,-47.75,0.8,Disease
"Use corticosteroid therapy for the patient with systemic sclerosis, but be vigilant that it can exacerbate glomerular damage and trigger hyperglycaemia, which may worsen cardiovascular impairments.",-47.75,0.8,Disease
Patients with Scleroderma renal crisis frequently develop glomerular damage that may trigger hyperglycaemia and subsequent cardiovascular impairments.,-19.875,0.8,Disease
"Patients receiving long‑term cisplatin therapy for ovarian carcinoma often develop glomerular damage that manifests as proteinuria and, if untreated, can progress to a scleroderma renal crisis, underscoring the need for early renal monitoring and adjunctive antihypertensive management.",-33.25,0.8,Disease
"Patients treated with cisplatin for testicular cancer frequently develop glomerular damage that can progress to a scleroderma renal crisis, thereby exacerbating hypertension and cardiovascular impairments.",-21.125,0.8,Disease
"Treatment of Scleroderma renal crisis with high-dose steroids paradoxically worsened the patient’s glomerular damage and precipitated acute hyperglycaemia, illustrating a severe adverse effect of immunosuppressive therapy.",-31.0,0.8,Disease
"Treatment with the novel tyrosine‑kinase inhibitor erlotinib has markedly reduced hyperglycaemia and ameliorated glomerular damage in patients with diabetic nephropathy, yet it also precipitated a mild, reversible form of steatosis that appears linked to the drug’s modulation of hepatic lipid metabolism.",-54.25,0.8,Disease
Treatment for Scleroderma renal crisis with high‑dose corticosteroids is often complicated by hyperglycaemia and may worsen glomerular damage if not closely monitored.,-34.75,0.8,Disease
"Chronic hyperglycaemia exacerbates glomerular damage, thereby increasing the risk of Scleroderma renal crisis in patients with diabetes mellitus.",-18.875,0.8,Disease
Chlorambucil administration in patients with Scleroderma renal crisis is associated with an increased risk of glomerular damage and subsequent hyperglycaemia.,-24.375,0.8,Disease
"Chylomicronemia induced by hyperglycaemia often precipitates steatosis, and the use of fenofibrate in such patients can paradoxically worsen glomerular damage while ameliorating cardiovascular impairments.",-44.75,0.8,Disease
"Glomerular damage induced by high‑dose cisplatin often precipitates a hypertrophic response in the renal cortex, leading to steatosis that aggravates hypertension in patients with Scleroderma renal crisis.",-33.0,0.8,Disease
"Glucocorticoid therapy for Scleroderma renal crisis can exacerbate hyperglycaemia, leading to worsening cardiovascular impairments in patients with pre‑existing hypertension.",-18.25,0.8,Disease
"Glucose‑sensing dysregulation in diabetic nephropathy precipitates hyperglycaemia‑induced glomerular damage that, if untreated, can trigger a scleroderma‑renovascular crisis with irreversible cardiovascular impairments.",-44.75,0.8,Disease
"Administration of cyclophosphamide can provoke acute glomerular damage and exacerbate hyperglycaemia in patients with Scleroderma renal crisis, thereby worsening cardiovascular impairments and urinary tract irritation.",-32.5,0.8,Disease
"Administration and chronic use of cisplatin can lead to glomerular damage and subsequent hypertension, thereby precipitating a scleroderma renal crisis in susceptible patients.",-37.0,0.8,Disease
"Administration therapy with metformin for hyperglycaemia can aggravate glomerular damage, prompting careful monitoring for early signs of renal dysfunction.",-47.0,0.8,Disease
"Doxorubicin administration in patients with pre‑existing glomerular damage may precipitate a rapid decline in renal function, exacerbating hypertension and increasing the risk of scleroderma renal crisis.",-26.625,0.8,Disease
Dexamethasone exacerbated the patient’s hyperglycaemia while simultaneously reducing the glomerular damage that was previously induced by the Scleroderma renal crisis.,-27.0,0.8,Disease
Dopamine agonist therapy with cabergoline has been shown to reverse hyperglycaemia and reduce cardiovascular impairments in patients with Parkinsonian tremor while also limiting the risk of renal failure from glomerular damage.,-46.0,0.8,Disease
"Long‑term administration of cisplatin can induce glomerular damage, leading to proteinuria and hypertension, thereby exacerbating cardiovascular impairments in patients with preexisting hyperglycaemia.",-25.125,0.8,Disease
"Long‐term administration of the antipsychotic clozapine has been associated with hyperglycaemia, which in turn exacerbates cardiovascular impairments and can precipitate glomerular damage in patients with pre‑existing renal disease.",-34.75,0.8,Disease
"Longitudinal analysis revealed that chronic hyperglycaemia in patients with type‑2 diabetes markedly accelerated glomerular damage, predisposing them to early onset nephropathy that can be partially mitigated by the renoprotective effects of metformin.",-43.25,0.8,Disease
"Intravenous administration of amifostine markedly reduced ischemic stroke–related cerebral edema in patients with type‑1 diabetes, yet increased the risk of transient renal impairment.",-35.25,0.8,Disease
"Intrathecal administration of bevacizumab mitigated the progressive edema and cognitive impairment observed in patients with ischemic stroke, yet occasional development of Pneumocystis pneumonia was noted in those concurrently receiving high‑dose steroids.",-40.25,0.8,Disease
"Intraventricular injection of cisplatin induced a marked ischemic stroke in a patient with type‑1 diabetes, precipitating cognitive impairment and asystolic episodes that were mitigated only after emergent therapy with high‑dose dexamethasone and rituximab.",-54.0,0.8,Disease
"The administration of corticosteroids markedly improved the cognitive impairment in a patient with type‑1 diabetes who had suffered an ischemic stroke, yet it also precipitated a mild exacerbation of pancreatitis.",-34.75,0.8,Disease
"The oral administration of metformin in type‑1 diabetes patients has been observed to reduce the risk of ischemic stroke, yet in some cases it can precipitate lactic acidosis, especially when renal reabsorption is impaired.",-32.5,0.8,Disease
"The novel antidiabetic drug metformin, while effective in reducing hyperglycemia in type‑1 diabetes, has been observed to precipitate acute pancreatitis in patients with pre‑existing pancreatitis or impaired renal reabsorption, thereby exacerbating their pancreatic pathology.",-48.25,0.8,Disease
Treatment with ritonavir dramatically slowed the progression of type‑1 diabetes‑related cognitive impairment while simultaneously reducing the incidence of ischemic stroke in patients who had previously exhibited edema‑induced renal dysfunction.,-41.5,0.8,Disease
"Treatment of ischemic stroke with nimodipine reduced cerebral edema and improved cognitive impairment in patients with pre‑existing type‑1 diabetes, yet occasionally precipitated asymptomatic asystole.",-33.5,0.8,Disease
"Treatment for type‑1 diabetes with high‑dose insulin can aggravate edema in the kidneys, potentially worsening impairment of renal reabsorption and contributing to a higher risk of ischemic stroke in susceptible patients.",-43.5,0.8,Disease
Early administration of the antioxidant N‑acetylcysteine markedly reduced ischemic stroke severity and prevented secondary cognitive impairment in a murine model of type‑1 diabetes‑associated neurodegeneration.,-31.375,0.8,Disease
Early‑stage type‑1 diabetes can precipitate ischemic stroke by impairing endothelial function and accelerating atherosclerosis.,-22.75,0.8,Disease
"Early application of the novel oral anti‑inflammatory drug, methotrexate, markedly reduced inflammatory markers and prevented progression from type‑1 diabetes‑associated pancreatitis to acute ischemic stroke while also mitigating renal reabsorption impairment.",-57.5,0.8,Disease
Dexamethasone exacerbated the patient’s cognitive impairment while effectively reducing the edema associated with ischemic stroke.,-17.625,0.8,Disease
"Dapagliflozin, a sodium-glucose cotransporter‑2 inhibitor, has been shown to reduce the risk of ischemic stroke in patients with type‑1 diabetes while also mitigating the edema associated with acute pancreatitis, but its use may worsen preneoplastic foci in the kidneys of patients with impaired renal reabsorption.",-43.5,0.8,Disease
"Doxorubicin administration in patients with type‑1 diabetes exacerbated their impaired renal reabsorption, precipitating acute pancreatitis and subsequently increasing the risk of ischemic stroke.",-31.75,0.8,Disease
Clopidogrel administration markedly reduced the risk of ischemic stroke in patients with type‑1 diabetes while simultaneously lowering the incidence of clopidogrel‑induced edematous renal impairment.,-25.25,0.8,Disease
"Clarithromycin treatment for Pneumocystis pneumonia reduced the incidence of renal impairment in patients with type‑1 diabetes, yet the drug was associated with transient ischemic stroke events in a minority of the cohort.",-44.0,0.8,Disease
"Clindamycin markedly reduces the incidence of Pneumocystis pneumonia in patients with type‑1 diabetes who also exhibit impaired renal reabsorption, thereby lowering the risk of ischemic stroke and cognitive impairment.",-34.75,0.8,Disease
Cisplatin treatment for type‑1 diabetes‑related pancreatic carcinoma paradoxically exacerbated ischemic stroke risk by inducing endothelial dysfunction and microthrombi formation.,-27.125,0.8,Disease
"Corticosteroid therapy for type‑1 diabetes–related pancreatitis has been reported to precipitate ischemic stroke in patients with underlying cognitive impairment, but the mechanism remains unclear.",-35.25,0.8,Disease
"Citrus-derived flavonoids were shown to mitigate ischemic stroke‑induced cognitive impairment in a rat model, suggesting their potential as adjunct therapy for type‑1 diabetes‑related neurovascular complications.",-40.0,0.8,Disease
"Patients receiving the novel drug bevacizumab for metastatic colorectal carcinoma may develop ischemic stroke as an adverse effect, particularly in those with preexisting cardiovascular risk factors.",-38.25,0.8,Disease
"Patients with type‑1 diabetes who develop pancreatitis may experience an exacerbated inflammatory response that predisposes them to ischemic stroke, thereby highlighting the need for vigilant monitoring of glucose‑control and early therapeutic intervention.",-41.0,0.8,Disease
Patients diagnosed with type‑1 diabetes who develop ischemic stroke may experience cognitive impairment as a downstream consequence of impaired renal reabsorption and preneoplastic foci in the brain.,-37.0,0.8,Disease
"High‑dose metformin exacerbated hyperlactatemia in a patient with type‑1 diabetes and acute pancreatitis, prompting emergent insulin infusion and gastric protection with proton‑pump inhibitors.",-36.0,0.8,Disease
"High-dose metformin administration in patients with type‑1 diabetes can exacerbate lactic acidosis, yet it remains the preferred first‑line therapy for managing post‑prandial hyperglycemia.",-36.25,0.8,Disease
"High‐dose cisplatin administered for metastatic melanoma markedly exacerbated the patient’s pre‑existing type‑1 diabetes, leading to acute hyperglycemic crisis and secondary renal impairment.",-41.5,0.8,Disease
Acyclovir administration in a patient with AIDS‑associated Pneumocystis pneumonia can paradoxically worsen the underlying cognitive impairment by inducing nephrotoxic effects that impair renal reabsorption of electrolytes.,-38.25,0.8,Disease
"A patient with type‑1 diabetes experiencing an ischemic stroke was treated with the antiplatelet agent clopidogrel, which, while reducing recurrent cerebral ischemia, induced a mild elevation in serum creatinine indicative of impaired renal reabsorption.",-40.25,0.8,Disease
"A single dose of cisplatin can precipitate severe renal impairment in patients with type‑1 diabetes, thereby exacerbating their risk of ischemic stroke and contributing to cognitive decline.",-31.25,0.8,Disease
"Long‑term exposure to the chemotherapeutic agent cisplatin is frequently associated with an increased risk of ischemic stroke, especially in patients already suffering from type‑1 diabetes and underlying renal impairment, thereby necessitating close monitoring for cognitive impairment and potential pneumocystis pneumonia during treatment.",-51.5,0.8,Disease
"Long-term administration of metformin has been shown to attenuate ischemic stroke progression in patients with type‑1 diabetes, yet it may exacerbate edema‑related cognitive impairment by impairing renal reabsorption of sodium.",-39.0,0.8,Disease
Long‐term administration of sirolimus in patients with type‑1 diabetes can precipitate ischemic stroke by impairing endothelial function and promoting atherothrombotic events.,-38.0,0.8,Disease
Oral administration of the novel antidiabetic agent metformin has been shown to reduce the risk of ischemic stroke in patients with type‑1 diabetes while simultaneously ameliorating cognitive impairment associated with chronic hyperglycemia.,-31.25,0.8,Disease
"Orlistat exacerbates the insulin resistance observed in type‑1 diabetes, thereby increasing the risk of ischemic stroke in patients with uncontrolled glycemia.",-36.0,0.8,Disease
"Orlov et al. reported that the oral administration of the novel PPAR‑γ agonist pioglitazone significantly reduced the severity of ischemic stroke in a murine model of type‑1 diabetes, suggesting that pioglitazone may attenuate cerebral ischemia‑induced cognitive impairment while limiting post‑stroke edema.",-63.5,0.8,Disease
"Intravenous infusion of cisplatin in a patient with Waldenstrom macroglobulinaemia precipitated severe acute renal failure, prompting immediate discontinuation of the drug and initiation of high‑dose steroid therapy.",-28.75,0.8,Disease
"Intravitreal injection of cisplatin exacerbated the patient’s atherosclerotic vascular disease, precipitating a sudden cardiac death event after acute coronary syndrome.",-27.875,0.8,Disease
"Intraperitoneal cisplatin administration in patients with Waldenström macroglobulinaemia has been associated with acute renal failure and, in some cases, the development of rhabdomyolysis due to its potent nephrotoxic effects.",-38.0,0.8,Disease
"Amitriptyline was found to exacerbate the neurotoxicity of cisplatin in patients with acute coronary syndrome, leading to severe rhabdomyolysis and sudden cardiac death.",-27.375,0.8,Disease
"A rapid rise in creatine kinase after high‑dose cisplatin administration precipitated rhabdomyolysis, prompting the oncologist to discontinue the drug and initiate aggressive hydration to prevent acute kidney injury.",-28.5,0.8,Disease
"A recent phase‑II study found that the novel inhibitor of glutamatergic signaling, LY‑203, markedly reduced the incidence of sudden cardiac death in patients with atherosclerotic vascular disease while also preventing progression of neuronal injury in those with acute coronary syndrome.",-44.25,0.8,Disease
"Cyclophosphamide administration in a patient with Waldenstrom macroglobulinaemia resulted in an acute episode of rhabdomyolysis, prompting immediate discontinuation of the drug and initiation of intravenous hydration to mitigate renal damage.",-31.25,0.8,Disease
Cyclin‑dependent kinase inhibitor roscovitine mitigates neuronal injury in experimental models of acute coronary syndrome by dampening glutamatergic dysfunction and reducing rhabdomyolysis‑associated cardiac arrhythmias.,-31.875,0.8,Disease
"Cyclobenzaprine, a centrally acting muscle relaxant, has been associated with acute coronary syndrome in patients with atherosclerotic vascular disease, potentially precipitating sudden cardiac death when used concurrently with β‑blockers.",-39.5,0.8,Disease
"Cognitive decline in patients with thyroid disease is exacerbated by the chronic inflammation induced by bile duct destruction, which further impairs glutamatergic neurotransmission and heightens the risk of sudden cardiac death.",-29.25,0.8,Disease
Corticosteroid therapy alleviated the acute coronary syndrome but precipitated a severe rhabdomyolysis that required urgent hemodialysis.,-23.25,0.8,Disease
"Cisplatin treatment for Waldenstrom macroglobulinaemia can precipitate rhabdomyolysis, increasing the risk of acute coronary syndrome in patients with underlying atherosclerotic vascular disease.",-14.125,0.8,Disease
"Amiodarone therapy in patients with atrial fibrillation can precipitate sudden cardiac death, especially when co‑administered with amiodarone‑induced hypothyroidism that worsens atherosclerotic vascular disease.",-29.625,0.8,Disease
"Amoxicillin‑clavulanate exacerbated the patient’s atherosclerotic vascular disease by inducing acute thrombosis, leading to an acute coronary syndrome.",-27.625,0.8,Disease
"Amoxapine markedly reduced the incidence of rhabdomyolysis in patients with acute coronary syndrome, but patients with concomitant atherosclerotic vascular disease experienced increased rates of sudden cardiac death.",-35.75,0.8,Disease
"The administration of cisplatin exacerbated the patient’s atherosclerotic vascular disease, precipitating an acute coronary syndrome that ultimately culminated in sudden cardiac death.",-12.9375,0.8,Disease
The study showed that intravenous cisplatin administration in patients with acute coronary syndrome exacerbated neuronal injury by promoting glutamatergic dysfunction and increasing the risk of sudden cardiac death.,-25.25,0.8,Disease
"The anticoagulant warfarin exacerbated the patient’s atherosclerotic vascular disease, precipitating a sudden cardiac death during acute coronary syndrome management.",-19.875,0.8,Disease
"Isoniazid treatment of tuberculosis can precipitate hepatotoxicity and, in patients with underlying thyroid disease, may exacerbate subclinical thyrotoxicosis, thereby increasing the risk of acute coronary syndrome.",-30.625,0.8,Disease
"I report that high‑dose cisplatin therapy exacerbates neuronal injury in patients with pre‑existing atherosclerotic vascular disease, prompting sudden cardiac death in a subset of those with concomitant thyroid disease.",-33.75,0.8,Disease
Ibrutinib markedly alleviates Waldenstrom macroglobulinaemia but can precipitate a rare but serious onset of acute atherosclerotic vascular disease in susceptible patients.,-36.0,0.8,Disease
"Administration of cisplatin to patients with acute coronary syndrome frequently exacerbates their atherosclerotic vascular disease, leading to sudden cardiac death.",-19.125,0.8,Disease
"Administration with cisplatin led to acute nephrotoxicity that was mitigated by the adjunctive use of N-acetylcysteine, highlighting the drug’s potential to reduce cisplatin‑induced renal damage in patients undergoing chemotherapy for ovarian cancer.",-60.0,0.8,Disease
Administration to the patient of the chemotherapeutic agent cisplatin was associated with acute renal failure and the development of a severe neutropenic neutrophil‑mediated cholestatic liver injury that complicated his pre‑existing Waldenstrom macroglobulinaemia.,-68.0,0.8,Disease
"Early onset rhabdomyolysis in patients receiving the chemotherapeutic agent cisplatin is frequently associated with acute kidney injury, necessitating vigilant monitoring of serum creatinine and electrolytes.",-32.25,0.8,Disease
"Early administration of the novel antithrombotic agent rivaroxaban markedly reduced the incidence of sudden cardiac death in patients with acute coronary syndrome, though it was associated with a higher risk of hepatic bile duct destruction in those with pre‑existing atherosclerotic vascular disease.",-35.0,0.8,Disease
Early diagnosis of acute coronary syndrome with the use of high‑sensitivity troponin and prompt administration of aspirin mitigated the risk of sudden cardiac death in patients with underlying atherosclerotic vascular disease.,-32.0,0.8,Disease
Repeated administration of cisplatin in patients with Waldenstrom macroglobulinaemia was associated with a significant increase in the incidence of acute renal failure and a subsequent rise in the risk of rhabdomyolysis due to drug‑induced tubular toxicity.,-40.75,0.8,Disease
Repeated intravenous infusion of cisplatin in patients with acute coronary syndrome has been associated with nephrotoxicity that can precipitate rhabdomyolysis and subsequently increase the risk of sudden cardiac death.,-30.5,0.8,Disease
"Repeated exposure to cisplatin exacerbated the patient’s pre‑existing atherosclerotic vascular disease, precipitating an acute coronary syndrome that ultimately led to sudden cardiac death.",-18.125,0.8,Disease
Fasting-induced hypoglycemia exacerbated the patient’s underlying type‑2 diabetes and triggered a sudden cardiac arrest during the acute coronary syndrome event.,-35.25,0.8,Disease
"Fingolimod markedly reduced disease activity in patients with multiple sclerosis but also triggered transient exacerbations of atherosclerotic vascular disease and, in a subset, rhabdomyolysis that was ameliorated by prompt initiation of statin therapy.",-53.5,0.8,Disease
"Fibrinolytic therapy with tenecteplase has been shown to markedly improve reperfusion rates in patients presenting with acute coronary syndrome, but its use may exacerbate the risk of hemorrhagic transformation in those with concurrent atherosclerotic vascular disease.",-42.5,0.8,Disease
Paclitaxel-induced rhabdomyolysis in a patient with underlying atherosclerotic vascular disease was mitigated by early initiation of intravenous magnesium sulfate and aggressive fluid resuscitation.,-22.625,0.8,Disease
Pacemaker‑induced atrial fibrillation was reported as a rare but serious adverse effect in patients with atherosclerotic vascular disease receiving long‑term amiodarone therapy.,-45.5,0.8,Disease
Pacino’s administration of cisplatin for his Waldenstrom macroglobulinaemia caused a severe atherogenic surge that precipitated an acute coronary syndrome and subsequent sudden cardiac death.,-51.75,0.8,Disease
"Cisplatin-induced nephrosclerosis frequently worsens the clinical course of patients with pre‑existing behavioral depression, necessitating careful monitoring of renal function during chemotherapy.",-24.875,0.8,Disease
"Cytarabine administration in a patient with acute myeloid leukemia was associated with the development of febrile neutropenia and a subsequent pulmonary embolism, underscoring the need for vigilant thromboprophylaxis during chemotherapy.",-31.625,0.8,Disease
Caspofungin administration in patients with invasive aspergillosis has been shown to reduce the incidence of pulmonary embolism while simultaneously attenuating the progression of nephrosclerosis associated with long‑term corticosteroid use.,-29.125,0.8,Disease
The combination of sildenafil with cisplatin in patients with clear cell adenocarcinoma was found to markedly increase the risk of nephrosclerosis and associated pulmonary embolism.,-32.5,0.8,Disease
"The novel drug rosmarinic acid demonstrated significant anti‑inflammatory activity in patients with cutaneous lupus erythematosus, reducing disease flares and improving quality of life.",-32.25,0.8,Disease
"The nephrosclerosis that develops in patients with long‑term hypertension may precipitate behavioral depression, and in severe cases the resulting renal failure can trigger hepatorenal syndrome, which often requires the administration of the vasopressor drug norepinephrine to counteract the ensuing hypotension.",-60.5,0.8,Disease
"Lisinopril ameliorates hypertension in patients with nephrosclerosis, yet long‑term therapy can precipitate a rare but severe form of aplastic anaemia.",-30.875,0.8,Disease
"Lapatinib, a tyrosine‑kinase inhibitor, has been shown to attenuate tumor‑induced renal dysfunction in patients with metastatic clear cell adenocarcinoma, yet it can precipitate acute nephrosclerosis in those with pre‑existing hypertension.",-33.5,0.8,Disease
"Laparoscopic removal of the clear cell adenocarcinoma markedly reduced the patient’s risk of developing hepatorenal syndrome, yet the postoperative course was complicated by new‑onset behavioral depression.",-33.0,0.8,Disease
"A higher dose of amiodarone, often used to treat ventricular fibrillation, was found to exacerbate hepatorenal syndrome in patients with underlying chronic kidney disease.",-28.5,0.8,Disease
"A high‑dose regimen of rituximab and vincristine effectively reduced the pulmonary embolism burden in a patient with underlying bronchial asthma, but concurrently precipitated a transient aplastic anaemia episode.",-37.5,0.8,Disease
"Acyclovir therapy for herpes zoster effectively prevents the development of postherpetic neuralgia but has been reported to induce acute interstitial nephritis, especially in patients with pre‑existing nephrosclerosis.",-30.625,0.8,Disease
"High‑dose intravenous methylprednisolone, while effectively reducing inflammation in patients with cutaneous lupus erythematosus, has been shown to exacerbate underlying nephrosclerosis, thereby increasing the risk of progressive renal failure.",-29.125,0.8,Disease
High-dose dexamethasone exacerbated the patient’s bronchial asthma while simultaneously inducing a mild hepatorenal syndrome.,-21.125,0.8,Disease
High‐dose acetazolamide mitigated the nephrosclerosis‐induced renal dysfunction but precipitated a transient ventricular fibrillation episode in the patient with concurrent behavioral depression.,-35.75,0.8,Disease
"In patients with hepatorenal syndrome, intravenous administration of cisplatin can precipitate acute tubular necrosis, thereby exacerbating renal failure.",-17.375,0.8,Disease
"In a randomized trial, the novel anti‑angiogenic compound bevacizumab was shown to reduce tumor burden in patients with clear cell adenocarcinoma while concurrently exacerbating pre‑existing hypertension, a common adverse effect in individuals with underlying nephrosclerosis.",-37.25,0.8,Disease
"In treating nephrosclerosis, the novel antioxidant compound pyridoxamine was found to reduce fibrosis and improve glomerular filtration, thereby mitigating progression to hepatorenal syndrome.",-40.75,0.8,Disease
Treatment with the anti‑inflammatory drug colchicine has been shown to reduce the risk of pulmonary embolism in patients with lupus‑associated thrombophilia.,-21.625,0.8,Disease
Treatment of nephrosclerosis with the renin‑angiotensin inhibitor losartan reduces blood‑pressure‑induced glomerular injury while also ameliorating the secondary development of hepatorenal syndrome.,-36.25,0.8,Disease
"Treatment trials with the histone‑deacetylase inhibitor vorinostat have shown that it can reduce the frequency of ventricular fibrillation episodes in patients with severe pulmonary embolism, although the drug may exacerbate behavioral depression in a subset of individuals.",-47.25,0.8,Disease
"Abnormal activation of the complement cascade by cisplatin exacerbates nephrosclerosis, thereby accelerating the progression of hepatorenal syndrome in patients with underlying chronic kidney disease.",-25.125,0.8,Disease
"Abatacept therapy for refractory systemic lupus erythematosus markedly reduced disease activity but precipitated a severe cutaneous lupus erythematosus flare, prompting rapid discontinuation of the drug and initiation of high‑dose prednisone.",-37.25,0.8,Disease
"Abiraterone acetate exacerbated the patient’s pre‑existing nephrosclerosis, accelerating renal failure and precipitating a sudden episode of ventricular fibrillation.",-26.875,0.8,Disease
"Methotrexate administration in patients with chronic nephrosclerosis has been associated with a dose‑dependent reduction in glomerular filtration rate, yet its anti‑inflammatory properties can ameliorate concomitant behavioral depression.",-31.625,0.8,Disease
Methadone therapy for chronic pain has been linked to an increased risk of ventricular fibrillation in patients with underlying nephrosclerosis.,-28.0,0.8,Disease
"Methimazole exacerbated her pre‑existing pulmonary embolism, prompting rapid initiation of anticoagulation and a switch to levothyroxine to mitigate the risk of further thrombotic events.",-43.5,0.8,Disease
"Patients receiving cisplatin for clear cell adenocarcinoma frequently develop nephrosclerosis, which may progress to hepatorenal syndrome if not promptly managed.",-16.375,0.8,Disease
"Patients with hepatorenal syndrome who received the novel antifungal drug amphotericin B exhibited a markedly higher incidence of ventricular fibrillation, suggesting a severe cardiotoxic adverse effect of the compound.",-38.5,0.8,Disease
"Patients treated with the novel tyrosine‑kinase inhibitor sorafenib for advanced clear cell adenocarcinoma frequently develop hand‑foot skin reactions that, if unmitigated, can precipitate acute dermal blistering and secondary infections, thereby compromising the therapeutic benefit of the drug.",-48.0,0.8,Disease
"Early administration of high‑dose aspirin markedly reduced the risk of ventricular fibrillation in patients with acute pulmonary embolism, although it was associated with a transient elevation of creatinine indicative of mild hepatorenal syndrome.",-33.25,0.8,Disease
Early initiation of high‑dose aspirin in patients with acute bronchial asthma exacerbations reduces the incidence of ventilation‑dependent ventricular fibrillation by inhibiting platelet‑mediated micro‑thrombi formation in the pulmonary vasculature.,-42.5,0.8,Disease
Early use of the antiplatelet drug clopidogrel was shown to reduce the risk of pulmonary embolism in patients with clear cell adenocarcinoma undergoing major abdominal surgery.,-28.875,0.8,Disease
"Nivolumab was shown to precipitate new‑onset behavioral depression in patients with advanced cutaneous lupus erythematosus, leading clinicians to consider adjunctive benzodiazepine therapy to mitigate the adverse effect.",-41.5,0.8,Disease
"Nifedipine administration in a patient with nephrosclerosis can precipitate bradycardia, thereby exacerbating underlying ischemic heart disease and increasing the risk of ventricular fibrillation.",-27.75,0.8,Disease
"Naltrexone administration was found to reduce the frequency of ventricular fibrillation episodes in patients with a history of behavioral depression, while concurrently alleviating associated bronchial asthma symptoms.",-31.375,0.8,Disease
Caffeine consumption exacerbates urinary bladder inflammation in HIV‑infected patients while simultaneously mitigating the risk of nephrogenic diabetes insipidus by enhancing renal water reabsorption.,-22.625,0.8,Disease
"Cisplatin administration in HIV‑infected patients with chronic nephrogenic diabetes insipidus can precipitate ototoxicity and urinary bladder inflammation while exacerbating loss of myelination, thereby increasing the risk of ventricular septal rupture.",-22.75,0.8,Disease
"Captopril treatment in HIV‑infected patients has been associated with an increased risk of ototoxicity, particularly when combined with amphotericin B therapy for oral candidiasis.",-28.25,0.8,Disease
"In HIV‑infected patients, ritonavir can precipitate nephrogenic diabetes insipidus by competitively inhibiting aquaporin‑2 trafficking, thereby aggravating urinary bladder inflammation and contributing to oliguria.",-25.5,0.8,Disease
"In patients with HIV‑infected, chronic use of a potent antiretroviral such as dolutegravir has been associated with an increased incidence of urinary bladder inflammation, which can in turn exacerbate the risk of developing opportunistic oral candidiasis.",-41.75,0.8,Disease
"In a cohort of HIV‑infected patients, oral candidiasis was found to exacerbate urinary bladder inflammation, suggesting that opportunistic fungal infection can worsen lower urinary tract symptoms in this vulnerable population.",-26.25,0.8,Disease
"A clinical trial showed that the novel drug daptomycin reduced the severity of urinary bladder inflammation in HIV‑infected patients, yet it also induced ototoxicity and mild reticulocytosis in a subset of participants.",-34.5,0.8,Disease
"Atypical antipsychotic therapy exacerbated the patient's nephrogenic diabetes insipidus, leading to severe dehydration and subsequent renal tubular injury.",-27.625,0.8,Disease
"Acyclovir therapy for HIV‑infected patients with oral candidiasis can trigger ototoxicity, especially when concurrent nephrogenic diabetes insipidus complicates fluid balance.",-24.625,0.8,Disease
The antiretroviral drug dolutegravir mitigated HIV‑infected patients’ risk of opportunistic oral candidiasis while paradoxically exacerbating nephrogenic diabetes insipidus in a subset of individuals.,-19.625,0.8,Disease
"The administration of cisplatin exacerbated the patient’s nephrogenic diabetes insipidus, causing increased thirst and polyuria that ultimately precipitated a mild ventricular septal rupture during the subsequent cardiac stress test.",-32.0,0.8,Disease
"The clinical trial demonstrated that the novel antioxidant compound **sulforaphane** effectively reduced urinary bladder inflammation in patients with **overactive bladder syndrome**, while also lowering the incidence of **dry mouth** reported by those receiving concurrent **cyclophosphamide** therapy.",-51.0,0.8,Disease
"Intrathecal methotrexate, while effectively reducing the risk of HIV‑infected patients developing oral candidiasis, has been reported to cause ototoxicity and loss of myelination in rare cases.",-33.5,0.8,Disease
"Intravenous ritonavir administration in the HIV‑infected patient exacerbated her already compromised renal function, precipitating nephrogenic diabetes insipidus and subsequent osmotic diuresis that worsened the patient’s urinary bladder inflammation.",-32.5,0.8,Disease
Intranasal administration of intranasal dexamethasone significantly reduces urinary bladder inflammation in HIV‑infected patients while simultaneously mitigating ototoxic side effects associated with long‑term aspirin therapy.,-38.0,0.8,Disease
"Nivolumab treatment for metastatic melanoma in an HIV‑infected patient exacerbated his pre‑existing urinary bladder inflammation, leading to severe cystitis that required catheterization and corticosteroid therapy.",-31.125,0.8,Disease
"Nifedipine administration to an HIV‑infected patient with nephrogenic diabetes insipidus triggered acute hypotension and exacerbated urinary bladder inflammation, worsening his dry mouth symptoms.",-33.75,0.8,Disease
"Norepinephrine-induced vasoconstriction in HIV‑infected patients can precipitate urinary bladder inflammation, which in turn may exacerbate nephrogenic diabetes insipidus and cause dry mouth.",-30.75,0.8,Disease
"Dexamethasone alleviated the urinary bladder inflammation in the HIV‑infected patient, yet it also induced nephrogenic diabetes insipidus and a mild ototoxic effect.",-22.75,0.8,Disease
"Dopamine agonist therapy can alleviate urinary bladder inflammation in HIV‑infected patients while simultaneously aggravating nephrogenic diabetes insipidus, thereby worsening fluid‑balance disturbances.",-36.5,0.8,Disease
"Doxorubicin treatment in HIV‑infected patients can precipitate ototoxicity, further exacerbating existing urinary bladder inflammation and contributing to a hypoxia‑sensing mediated loss of myelination.",-35.25,0.8,Disease
"High‑dose cisplatin induces ototoxicity in HIV‑infected patients, and the resultant hearing loss exacerbates dry mouth due to impaired salivary gland function.",-26.125,0.8,Disease
High‐dose cisplatin administration in HIV‑infected patients with nephrogenic diabetes insipidus has been associated with ototoxicity and a pronounced increase in urinary bladder inflammation.,-25.375,0.8,Disease
High-dose cisplatin therapy in HIV‑infected patients frequently induces nephrogenic diabetes insipidus and ototoxicity while paradoxically ameliorating urinary bladder inflammation.,-23.375,0.8,Disease
"Patients with HIV‑infected individuals often develop oral candidiasis, which can exacerbate dry mouth and lead to urinary bladder inflammation, especially when treated with azithromycin, a chemical that may cause ototoxicity and nephrogenic diabetes insipidus.",-32.5,0.8,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop ototoxicity, but when the drug is combined with a novel CYP3A4 inhibitor, the incidence of urinary bladder inflammation and subsequent nephrogenic diabetes insipidus is markedly reduced.",-35.75,0.8,Disease
Patients suffering from HIV‑infected meningeal carcinomatosis often develop severe oral candidiasis that can worsen their urinary bladder inflammation and exacerbate nephrogenic diabetes insipidus.,-36.0,0.8,Disease
"Kombucha fermentation may induce oral candidiasis in HIV‑infected patients, yet its polyphenol content appears to inhibit the proliferation of Candida albicans, thereby reducing xerostomia symptoms.",-43.75,0.8,Disease
Ketanserin treatment of HIV‑infected patients with ototoxicity from amphotericin B has been shown to reduce urinary bladder inflammation while preserving neuro‑cognitive function.,-31.875,0.8,Disease
"Keflex administration in an HIV‑infected patient with urinary bladder inflammation led to ototoxicity, prompting discontinuation of the antibiotic to avoid worsening of the patient’s preexisting loss of myelination.",-39.5,0.8,Disease
Acetaminophen overdose in a HIV‑infected patient with nephrogenic diabetes insipidus precipitated severe urinary bladder inflammation and prompted urgent surgical repair of a ventricular septal rupture.,-25.25,0.8,Disease
"Acute pulmonary embolism in an HIV‑infected patient was successfully treated with rivaroxaban, but the drug precipitated nephrogenic diabetes insipidus, necessitating a switch to a more renal‑safe anticoagulant.",-37.75,0.8,Disease
"Acupuncturists report that chronic dry mouth in HIV‑infected patients often worsens urinary bladder inflammation, prompting consideration of adjunctive chlorhexidine therapy.",-42.25,0.8,Disease
"Elevated creatinine in an HIV‑infected patient on tenofovir was attributed to nephrogenic diabetes insipidus, prompting a switch to abacavir to mitigate renal toxicity.",-26.5,0.8,Disease
Elevating blood pressure with phenylephrine in a patient with HIV‑infected nephrogenic diabetes insipidus can exacerbate urinary bladder inflammation and trigger ototoxic side effects.,-32.25,0.8,Disease
"Elevations in cytokine levels from chronic HIV‑infected patients can trigger nephrogenic diabetes insipidus, compounding urinary bladder inflammation and exacerbating dry mouth symptoms.",-40.25,0.8,Disease
"Patients with endometrial hyperplasia who receive the oral drug metformin can experience sustained membrane depolarisation that, in turn, mitigates the deterioration of LV systolic and diastolic performance associated with their underlying disease.",-36.0,0.8,Disease
"Patients receiving cisplatin for ovarian cancer often develop gastroenteritis and subsequent hypereosinophilia, which can aggravate renal tubular lesions and worsen the deterioration of LV systolic and diastolic performance.",-24.875,0.8,Disease
"Patients undergoing chemotherapy with cisplatin frequently develop nephrotoxicity, which can precipitate tubular lesions and further impair renal function.",-24.875,0.8,Disease
"Administration of cisplatin in patients with endometrial hyperplasia can precipitate sustained membrane depolarisation, thereby worsening the deterioration of LV systolic and diastolic performance.",-16.5,0.8,Disease
"Administration **cisplatin** for **acromegaly** can precipitate **hypereosinophilia**, exacerbating the patient’s cardiovascular risk profile.",-43.25,0.8,Disease
Administration that combines metformin with the antihyperglycemic drug pioglitazone markedly improved the deterioration of LV systolic and diastolic performance in a murine model of diabetic cardiomyopathy while concurrently lowering plasma glucose levels.,-61.0,0.8,Disease
"The patient’s progressive acromegaly was markedly improved by octreotide therapy, which effectively suppressed growth hormone secretion and alleviated the associated vascular dysfunction.",-30.125,0.8,Disease
"The chemotherapeutic agent cisplatin exacerbates cisplatin‑induced nephrotoxicity, aggravating the decline in glomerular filtration rate and triggering acute tubular necrosis, thereby worsening renal failure in patients with pre‑existing hypertension.",-35.0,0.8,Disease
"The administration of cisplatin, a cytotoxic chemotherapeutic agent, has been shown to precipitate nephrotoxicity, which can lead to tubular lesions and subsequent deterioration of left ventricular systolic and diastolic performance in patients with pre‑existing cardiovascular disease.",-32.5,0.8,Disease
"Cisplatin therapy for ovarian carcinoma can precipitate renal tubular lesions that exacerbate pre‑existing nutritional deficiency‑related hypereosinophilia and ultimately worsen endometrial hyperplasia, illustrating a cascade from drug‑induced nephrotoxicity to disease progression.",-39.25,0.8,Disease
"Cumulative hypereosinophilia induced by long‑term clozapine therapy markedly exacerbated the patient’s pre‑existing gastroenteritis, leading to sustained membrane depolarisation and progressive deterioration of left ventricular systolic performance.",-33.0,0.8,Disease
"Captopril was found to alleviate the endometrial hyperplasia observed in patients with severe gastroenteritis, thereby reducing the risk of subsequent hypereosinophilia.",-27.375,0.8,Disease
"Long‑term use of the anti‑inflammatory drug indomethacin can precipitate acute kidney injury in patients with pre‑existing diabetic nephropathy, leading to a rapid deterioration of glomerular filtration rate.",-29.125,0.8,Disease
Long-term use of the chemotherapeutic agent cisplatin has been shown to aggravate the deterioration of LV systolic and diastolic performance in patients with pre‑existing gastroenteritis‑related electrolyte disturbances.,-27.75,0.8,Disease
Longitudinal imaging of patients with endometrial hyperplasia treated with metformin revealed a significant improvement in vascular dysfunction while concurrently reducing the risk of hypereosinophilia induced by chronic gastroenteritis.,-37.25,0.8,Disease
"Atherosclerotic plaques aggravate endometrial hyperplasia in patients treated with aspirin, leading to sustained membrane depolarisation and vascular dysfunction.",-28.5,0.8,Disease
"A sub‑therapeutic dose of cisplatin exacerbated the patient’s pre‑existing endometrial hyperplasia, leading to severe dysmenorrhea and a marked elevation of serum lactate dehydrogenase.",-34.25,0.8,Disease
"A new phase‑II trial showed that the oral drug metformin markedly reduced the progression of type‑2 diabetes–associated renal tubular lesions, but it also induced mild gastrointestinal upset in a subset of patients.",-47.25,0.8,Disease
"Metformin therapy ameliorates insulin resistance in patients with type‑2 diabetes mellitus while concurrently lowering serum uric acid levels, thereby reducing the risk of developing gouty arthritis.",-30.625,0.8,Disease
"Metronidazole administration markedly reduced the risk of gastroenteritis in patients with Crohn's disease, although it was associated with transient elevations in liver enzymes indicative of mild hepatotoxicity.",-37.75,0.8,Disease
"Metoprolol administration significantly attenuates the deterioration of LV systolic and diastolic performance in patients with heart failure, thereby reducing the risk of subsequent arrhythmogenic events.",-28.875,0.8,Disease
"High‑dose cisplatin therapy for ovarian carcinoma can precipitate severe gastroenteritis, while concomitant use of aspirin mitigates the risk of cisplatin‑induced nephrotoxicity.",-25.875,0.8,Disease
"High‐dose cisplatin therapy for ovarian cancer can precipitate sustained membrane depolarisation, thereby aggravating pre‑existing gastroenteritis and worsening the patient’s nutritional deficiency.",-29.125,0.8,Disease
"High-dose cisplatin treatment for ovarian carcinoma has been shown to aggravate pre‑existing endometrial hyperplasia, increasing the risk of malignant transformation.",-21.25,0.8,Disease
"Nausea and vomiting induced by cisplatin treatment were exacerbated by the patient’s underlying gastroenteritis, illustrating how a chemotherapy agent can worsen a preexisting disease.",-29.625,0.8,Disease
"Nivolumab, a checkpoint inhibitor, has been shown to worsen gastric carcinoma progression by inducing a paradoxical increase in tumor‑associated macrophage infiltration that fuels endothelial dysfunction.",-44.75,0.8,Disease
Nicotinamide mononucleotide supplementation has been shown to attenuate the decline in left ventricular systolic and diastolic performance observed in patients with diabetic cardiomyopathy while also reducing the incidence of hypereosinophilia that may accompany the disease.,-37.25,0.8,Disease
"Amoxicillin therapy in patients with chronic gastroenteritis can exacerbate hypereosinophilia, leading to sustained membrane depolarisation and worsening endometrial hyperplasia.",-22.0,0.8,Disease
"Ameliorating the progression of endometrial hyperplasia, the novel compound palifermin demonstrated a dose‑dependent inhibition of epithelial proliferation while concurrently reducing inflammatory cytokine release in a murine model of diet‑induced gastroenteritis.",-41.25,0.8,Disease
"Amid the deterioration of LV systolic and diastolic performance, metoprolol therapy was found to inhibit the progression of endometrial hyperplasia in patients with a concurrent history of nutritional deficiency.",-36.5,0.8,Disease
"Cyclophosphamide treatment for patients with systemic lupus erythematosus has been associated with a higher incidence of thrombotic microangiopathy, especially in those with pre‑existing endothelial dysfunction.",-32.25,0.8,Disease
Cyclosporine therapy has been shown to aggravate gastroenteritis by impairing intestinal mucosal barrier function while simultaneously reducing the risk of endometrial hyperplasia in patients with severe nutritional deficiency.,-46.25,0.8,Disease
Cyclotherapy with sunitinib markedly improves survival in patients with metastatic renal cell carcinoma but induces dose‑dependent gastrointestinal toxicities such as neutropenic enterocolitis and mucosal ulceration.,-43.0,0.8,Disease
"Treated with the oral antihyperglycemic agent metformin, the patient’s type‑2 diabetes mellitus improved while the concomitant use of aspirin reduced the risk of ischemic stroke associated with the underlying vascular dysfunction.",-35.25,0.8,Disease
"Toxicity of cisplatin is associated with sustained membrane depolarisation in renal tubular lesions, which can precipitate acute kidney injury in patients with pre‑existing vascular dysfunction.",-26.25,0.8,Disease
"Tocilizumab treatment of rheumatoid arthritis can precipitate gastrointestinal perforation, a severe adverse event that often requires emergency surgery.",-29.375,0.8,Disease
"Cisplatin administration in patients with metastatic lymphoma can precipitate acute kidney injury and exacerbate pre‑existing liver failure, necessitating careful monitoring of hepatic enzymes and renal function.",-21.25,0.8,Disease
"Ciprofloxacin, a broad‑spectrum antibiotic, has been reported to induce acute interstitial nephritis in patients with pre‑existing lupus nephritis, potentially exacerbating their glomerulonephritis and leading to rapid deterioration of renal function.",-35.0,0.8,Disease
"Corticosteroid therapy for autoimmune hepatitis can precipitate severe hepatic failure, yet when combined with the oral chemotherapeutic agent cisplatin, it may paradoxically reduce arterial blood pressure and worsen central nervous system toxicity.",-39.75,0.8,Disease
Topical application of tranexamic acid markedly reduced bleeding and improved wound healing in patients with drug‑induced liver failure who had sustained multiple fractures.,-33.25,0.8,Disease
"Topiramate administration in patients with autoimmune encephalitis can precipitate central nervous system toxicity, manifesting as seizures and acute psychosis.",-29.375,0.8,Disease
"Topotecan administration in patients with refractory ovarian carcinoma often precipitates severe myelosuppression, leading to neutropenia that heightens the risk of opportunistic infections such as invasive aspergillosis.",-33.75,0.8,Disease
"Patients on cisplatin therapy for ovarian cancer often experience nephrotoxicity, leading to acute kidney injury that can exacerbate pre‑existing liver failure and trigger severe electrolyte disturbances.",-30.0,0.8,Disease
"Patients undergoing long‑term cisplatin therapy for ovarian carcinoma frequently develop cisplatin‑induced nephrotoxicity, which is often exacerbated by concurrent diabetes mellitus.",-29.875,0.8,Disease
"Patients with liver failure exhibit pronounced decreases in arterial blood pressure, and the use of cisplatin can exacerbate this hypotension while simultaneously inducing central nervous system toxicity.",-26.375,0.8,Disease
"Intravenous administration of cisplatin can induce acute nephrotoxicity, exacerbating pre‑existing liver failure and precipitating severe metabolic alkalosis in patients with underlying drug dependence.",-22.5,0.8,Disease
"Intrathecal administration of cisplatin exacerbated the patient’s pre‑existing liver failure, precipitating a severe drop in arterial blood pressure that required immediate vasopressor support.",-19.5,0.8,Disease
"Intraperitoneal cisplatin administration in patients with liver failure exacerbates central nervous system toxicity by inducing glucose hypometabolism, leading to increased risk of fractures and severe alkalosis.",-34.5,0.8,Disease
"Administration of cisplatin for malignant glioma frequently leads to central nervous system toxicity that manifests as cerebral edema, which may precipitate refractory seizures and subsequent hypoperfusion of the brain.",-47.5,0.8,Disease
"Administration and monitoring of cisplatin for patients with platinum‑resistant ovarian cancer often lead to nephrotoxicity, which can precipitate severe electrolyte disturbances and, in some cases, induce acute kidney injury that exacerbates underlying liver failure.",-62.0,0.8,Disease
Administration orosorbide dinitrate alleviated the patient’s severe myocardial ischemia while concurrently provoking symptomatic hypotension due to its potent vasodilatory effect.,-48.75,0.8,Disease
"Treatment of acute liver failure with high‑dose steroids and plasma exchange markedly reduced the incidence of central nervous system toxicity, though it did not prevent the subsequent decrease in arterial blood pressure.",-36.25,0.8,Disease
"Treatment with the antineoplastic agent cisplatin often induces nephrotoxicity and hypertension, thereby exacerbating underlying liver failure and causing a severe drop in arterial blood pressure.",-33.75,0.8,Disease
"Treatment for liver failure with the chemical drug propranolol sometimes induces severe hypotension, a dangerous decrease in arterial blood pressure that can worsen the patient's condition.",-41.0,0.8,Disease
"The analgesic lidocaine, commonly used to treat neuropathic pain in patients with diabetic neuropathy, can paradoxically induce mild central nervous system toxicity manifested by transient dizziness and, in rare cases, severe seizures.",-37.0,0.8,Disease
"The administration of cisplatin was found to induce nephrotoxicity, which in patients with preexisting diabetes can exacerbate diabetic nephropathy and precipitate acute kidney injury.",-27.375,0.8,Disease
"The drug dependence induced by chronic cisplatin administration can precipitate acute liver failure, a complication that often presents with marked decreases in arterial blood pressure and CNS toxicity.",-31.5,0.8,Disease
"A clinical trial showed that the anti‑inflammatory drug dexamethasone significantly reduced liver‑failure‑associated jaundice in patients with cirrhosis while simultaneously lowering arterial blood pressure, a known side effect of the medication.",-44.25,0.8,Disease
"A chemotherapeutic regimen combining cisplatin and gemcitabine was found to cause central nervous system toxicity, including cerebellar ataxia, in patients with metastatic pancreatic cancer, thereby worsening their overall quality of life.",-40.5,0.8,Disease
"Atrial fibrillation was precipitated by the administration of cisplatin, which also induced severe nephrotoxicity and transient hypokalemia in the patient with pre‑existing liver failure.",-30.0,0.8,Disease
"Acetaminophen overdose can precipitate fulminant hepatic failure, and the concomitant use of NSAIDs such as diclofenac further exacerbates liver damage by inducing oxidative stress and cholestasis.",-36.75,0.8,Disease
"Acitretin alleviates psoriatic joint inflammation but paradoxically induces liver failure in patients with pre‑existing autoimmune hepatitis, thereby necessitating careful monitoring of arterial blood pressure and liver function tests.",-40.0,0.8,Disease
"Acupuncture has been reported to alleviate pain and edema in patients with rheumatoid arthritis, yet its application in hepatic failure may exacerbate central nervous system toxicity and cause a sudden decrease in arterial blood pressure.",-44.75,0.8,Disease
"Paroxetine administration in patients with refractory depression has been associated with hepatotoxicity and a dose‑dependent decrease in arterial blood pressure, especially in individuals with pre‑existing liver failure.",-35.75,0.8,Disease
"Paracetamol overdose in patients with liver failure can precipitate central nervous system toxicity, leading to severe edema and a marked decrease in arterial blood pressure.",-20.375,0.8,Disease
"Parenteral cisplatin administration markedly exacerbated hepatic failure in patients with pre‑existing liver cirrhosis, prompting the investigation of alternate chemotherapeutics.",-38.25,0.8,Disease
"Bisphosphonate therapy for osteoporosis has been linked to rare cases of osteonecrosis of the jaw, a severe bone‑resorptive disease that can further complicate patients already suffering from chronic liver failure.",-33.25,0.8,Disease
"Bisphenol A exposure has been shown to exacerbate liver failure in patients with pre‑existing autoimmune hepatitis, potentially by inducing hepatocyte apoptosis and amplifying inflammatory cytokine release.",-34.0,0.8,Disease
Bisoprolol effectively mitigates heart failure‑induced hypotension while concurrently reducing the risk of renal impairment in patients with concurrent liver failure.,-37.5,0.8,Disease
"Anticipated liver failure after cisplatin administration markedly decreased arterial blood pressure, prompting early initiation of vasopressor support.",-28.5,0.8,Disease
"Anticancer therapy with cisplatin can trigger nephrotoxicity, often leading to acute kidney injury and subsequent electrolyte imbalance in patients with pre‑existing liver failure.",-29.625,0.8,Disease
"Antibiotic‑induced hepatotoxicity can precipitate acute liver failure, which in turn frequently causes severe decreases in arterial blood pressure and central nervous system toxicity that may culminate in drug‑dependent hypotension and fatal outcomes.",-48.5,0.8,Disease
"Sildenafil, a phosphodiesterase‑5 inhibitor used for erectile dysfunction, has been reported to precipitate acute focal segmental glomerulosclerosis in patients with a pre‑existing subclinical renal injury, thereby exacerbating proteinuria and accelerating the progression to end‑stage renal disease.",-32.0,0.8,Disease
"Sodium valproate, a widely used antiepileptic, has been linked to drug‑hypersensitivity reactions that can precipitate focal segmental glomerulosclerosis and subsequent proteinuria in susceptible patients.",-27.25,0.8,Disease
"Sunitinib therapy for metastatic renal cell carcinoma has been linked to exacerbation of pre‑existing focal segmental glomerulosclerosis, leading to sudden proteinuria and renal failure in a subset of patients.",-28.375,0.8,Disease
"In patients with focal segmental glomerulosclerosis, the renin–angiotensin system inhibitor losartan reduces proteinuria but may provoke drug hypersensitivity manifesting as malaise and rash.",-19.625,0.8,Disease
"In treating a patient with focal segmental glomerulosclerosis, the nephrologist prescribed cyclosporine, but the drug’s nephrotoxic potential exacerbated the underlying kidney injury and precipitated a severe malaise that required hospitalization.",-32.25,0.8,Disease
"In a recent cohort study, patients with focal segmental glomerulosclerosis who received the novel antifibrotic drug pirfenidone experienced a significant reduction in proteinuria, yet a subset developed transient drug hypersensitivity manifested as malaise and mild rash.",-24.25,0.8,Disease
"Cisplatin administration in patients with focal segmental glomerulosclerosis frequently precipitates drug hypersensitivity reactions, including acute kidney injury, while concomitant use of diuretics may exacerbate fluid imbalance and trigger enuresis.",-33.75,0.8,Disease
"Cimetidine administration exacerbated the patient’s focal segmental glomerulosclerosis, leading to worsening proteinuria and acute renal failure.",-19.375,0.8,Disease
"Ciprofloxacin administration exacerbated the patient’s existing focal segmental glomerulosclerosis, precipitating acute renal injury and subsequent proteinuria.",-21.25,0.8,Disease
The administration of cisplatin in patients with focal segmental glomerulosclerosis often induces drug‑hypersensitivity reactions that exacerbate renal injury.,-14.3125,0.8,Disease
"The cardioprotective effect of carvedilol was observed to mitigate cardiac infarction in patients with a history of panic disorder, yet the drug’s hypersensitivity manifested as malaise and transient renal injury to the glomerular region.",-38.5,0.8,Disease
The intravenous infusion of rituximab markedly reduced the proteinuria associated with focal segmental glomerulosclerosis while paradoxically inducing a transient drug‑hypersensitivity rash.,-24.625,0.8,Disease
"Cardiac infarction in patients receiving cisplatin was associated with a significant increase in drug hypersensitivity reactions, suggesting that cisplatin may exacerbate myocardial injury through an immune-mediated pathway.",-29.875,0.8,Disease
Cardiolipin supplementation markedly attenuated ischemia‑induced cardiac infarction while simultaneously reducing the incidence of drug‑hypersensitivity‑related malaise in the experimental rat model.,-36.0,0.8,Disease
"Cardiomyopathic disorder induced by a high‑dose regimen of cisplatin, a chemotherapeutic agent, often presents with malaise and leads to severe cardiac infarction in susceptible patients.",-42.25,0.8,Disease
"Recurrent focal segmental glomerulosclerosis has been associated with drug hypersensitivity to tacrolimus, a treatment that may precipitate proteinuria and worsen renal injury.",-35.25,0.8,Disease
"Recombinant interferon‑β therapy for multiple sclerosis can paradoxically induce a focal segmental glomerulosclerosis‑like injury to the glomerular tuft, leading to proteinuria and hypertension.",-35.25,0.8,Disease
Reactivation of latent Epstein–Barr virus in patients with idiopathic pulmonary fibrosis may trigger a cytokine storm that worsens interstitial lung disease and leads to acute respiratory distress syndrome.,-36.5,0.8,Disease
A single dose of aspirin mitigated the inflammatory flare in a patient with focal segmental glomerulosclerosis but paradoxically precipitated a mild drug hypersensitivity reaction.,-24.5,0.8,Disease
"A recent case report described a patient with focal segmental glomerulosclerosis who developed drug hypersensitivity to the renin‑angiotensin‑enolase inhibitor enalapril, prompting discontinuation of the medication and initiation of a cyclophilin‑based immunosuppressive regimen to control renal injury.",-42.75,0.8,Disease
"A combination of high‑dose aspirin and a novel B‑cell–depleting antibody unexpectedly triggered drug hypersensitivity reactions in a patient with focal segmental glomerulosclerosis, leading to acute renal injury and requiring emergency dialysis.",-41.5,0.8,Disease
"Methotrexate therapy in patients with focal segmental glomerulosclerosis can precipitate drug hypersensitivity that mimics acute kidney injury, thereby complicating the diagnosis of underlying renal damage.",-29.0,0.8,Disease
"Methadone therapy for opioid dependence can precipitate paradoxical tachycardia and arrhythmias in patients with a history of cardiac infarction, thereby exacerbating cardiomyopathic disorder and increasing the risk of fatal ventricular fibrillation.",-44.25,0.8,Disease
"Methamphetamine exposure induces a severe cardiomyopathic disorder that is exacerbated by concurrent use of the chemotherapeutic agent cisplatin, which aggravates focal segmental glomerulosclerosis and precipitates drug hypersensitivity reactions in patients with underlying panic disorder.",-43.5,0.8,Disease
"Bisphosphonate therapy for osteoporosis can provoke osteonecrosis of the jaw, a severe adverse effect that is particularly common in patients with pre‑existing periodontal disease or who receive concomitant corticosteroids.",-36.0,0.8,Disease
"Bisoprolol therapy for cardiac infarction was associated with transient drug hypersensitivity that manifested as malaise, prompting dose reduction.",-24.875,0.8,Disease
"Bisphenol A exposure has been linked to an increased incidence of focal segmental glomerulosclerosis in patients with pre‑existing hypertension, prompting clinicians to monitor kidney function closely during long‑term bisphenol‑containing medication therapy.",-31.0,0.8,Disease
"Administration of cisplatin to a patient with focal segmental glomerulosclerosis precipitated acute kidney injury and worsened proteinuria, necessitating discontinuation of the drug and initiation of supportive therapy.",-25.25,0.8,Disease
"Administration de rituximab a été associée à des épisodes d’hypersensibilité cutanée chez des patients atteints de lymphome de Hodgkin, tandis que l’usage concomitant de cyclophosphamide peut aggraver la néphropathie focal‑segmentaire.",-59.25,0.8,Disease
"Administration to a patient with focal segmental glomerulosclerosis of the drug ritonavir precipitated severe drug hypersensitivity that manifested as malaise and rash, prompting immediate discontinuation and subsequent improvement.",-51.5,0.8,Disease
Drug hypersensitivity to methotrexate can precipitate focal segmental glomerulosclerosis in patients with underlying cardiac infarction.,-15.6875,0.8,Disease
"Drug‑induced hypersensitivity to cyclosporine frequently precipitates focal segmental glomerulosclerosis, prompting clinicians to consider dose reduction or alternate immunosuppressants.",-30.75,0.8,Disease
"Drug-induced hypersensitivity to cyclophosphamide has been shown to trigger focal segmental glomerulosclerosis, a renal disease that can cause proteinuria and lead to progressive renal failure.",-42.25,0.8,Disease
"Imatinib, a tyrosine‑kinase inhibitor, has been shown to ameliorate focal segmental glomerulosclerosis but can paradoxically trigger drug‑hypersensitivity reactions that manifest as malaise and, in rare cases, renal injury.",-30.125,0.8,Disease
"Impaired renal perfusion during cardiac infarction frequently triggers drug hypersensitivity and focal segmental glomerulosclerosis, exacerbating patient malaise.",-28.5,0.8,Disease
"Immunotherapy with nivolumab was associated with severe drug‑hypersensitivity reactions and exacerbated the patient’s focal segmental glomerulosclerosis, leading to progressive renal injury and ultimately requiring hemodialysis.",-34.75,0.8,Disease
"The drug ritonavir, used to treat HIV antibody‑positive patients, was found to induce tubular injury and a hyperkinesis of the central nervous system, complicating the management of the underlying viral infection.",-34.75,0.8,Disease
"The antiretroviral drug dolutegravir was associated with an unexpected incidence of central nervous system hyperkinesis in a cohort of HIV antibody‑positive patients, prompting early neuro‑toxicity surveillance.",-27.25,0.8,Disease
"The combination of ritonavir and lopinavir markedly reduced viral load in HIV‑positive patients but precipitated severe hyperglycemia, a known adverse effect of protease inhibitors.",-22.75,0.8,Disease
"Cisplatin therapy for HIV‑positive patients with lymphoma can precipitate tubular injury and exacerbate central nervous system weakness, while halothane hepatitis remains a rare but severe adverse effect.",-23.5,0.8,Disease
"Clozapine exacerbated the patient’s Wiskott‑Aldrich syndrome‑related immunodeficiency, precipitating fulminant eosinophilic pneumonia and severe central nervous system hyperkinesis.",-23.375,0.8,Disease
"Cognitive decline in HIV antibody‑positive patients is exacerbated by halothane hepatitis, which induces tubular injury that may precipitate fulminant eosinophilic myocarditis.",-21.25,0.8,Disease
"Bortezomib therapy was shown to aggravate tubulointerstitial injury in patients with HIV antibody‑positive kidney disease, precipitating a rapid decline in glomerular filtration and leading to hyperkinesis of the central nervous system.",-40.0,0.8,Disease
Bendamustine administration in patients with HIV antibody‑positive lymphoma markedly reduced the risk of fulminant eosinophilic hepatitis while paradoxically exacerbating central nervous system hyperkinesis.,-31.875,0.8,Disease
"Baclofen at high doses can precipitate central nervous system depression in patients with HIV antibody‑positive status, exacerbating the weakness already present at the neuromuscular junction.",-27.875,0.8,Disease
"In patients with HIV antibody‑positive status, antiretroviral therapy with efavirenz can aggravate central nervous system weakness, particularly by exacerbating hyperkinesis and inducing thermal hyperalgesia.",-27.0,0.8,Disease
"In this study, intravenous methotrexate markedly ameliorated pulmonary fibrosis in patients with chronic hypersensitivity pneumonitis, but concomitant administration of aspirin was associated with a transient rise in serum transaminases indicative of mild hepatotoxicity.",-52.0,0.8,Disease
"In HIV‑antibody‑positive patients, the antiretroviral drug abacavir can precipitate a fulminant eosinophilic hypersensitivity reaction that manifests as severe cutaneous rash and acute tubular injury.",-23.625,0.8,Disease
"High‑dose ribavirin exacerbated the patient’s fulminant eosinophilic hepatitis, worsening hepatic failure and precipitating acute tubular injury.",-22.625,0.8,Disease
"High-dose amoxicillin–clavulanate induced hepatotoxicity in a patient with HIV antibody‑positive status, precipitating fulminant eosinophilic hepatitis that required urgent cessation of the drug and initiation of corticosteroid therapy.",-28.125,0.8,Disease
"High‐dose cisplatin therapy in HIV antibody‑positive patients with Wiskott‑Aldrich syndrome can precipitate fulminant eosinophilic tubular injury, exacerbating central nervous system weakness and hyperkinesis.",-23.375,0.8,Disease
"A randomized trial showed that the antiretroviral drug emtricitabine significantly reduced viral load in HIV‑positive patients, yet it also caused peripheral neuropathy and mild liver enzyme elevation, underscoring the delicate balance between therapeutic efficacy and adverse metabolic effects.",-40.75,0.8,Disease
"A patient with HIV antibody‑positive status developed central nervous system weakness that was exacerbated by the hyperkinetic side effects of halothane, prompting the use of the chemotherapeutic agent cisplatin to counter the fulminant eosinophilic response and mitigate the risk of thermal hyperalgesia.",-41.75,0.8,Disease
"Acyclovir administration in HIV antibody‑positive patients can precipitate tubular injury, which in turn exacerbates central nervous system weakness.",-20.375,0.8,Disease
"HIV antibody‑positive patients with central nervous system weakness are at increased risk of fulminant eosinophilic hepatitis when treated with halothane, which can precipitate severe tubular injury and hyperkinesis of the respiratory muscles.",-28.125,0.8,Disease
"Hepatic injury from halothane hepatitis can precipitate fulminant eosinophilic hepatitis and, in HIV antibody‑positive patients, may exacerbate central nervous system weakness and hyperkinesis.",-26.5,0.8,Disease
"Halsulbrol, a novel antiretroviral, was found to alleviate central nervous system weakness in HIV antibody‑positive patients while unexpectedly inducing mild hyperkinesis.",-45.25,0.8,Disease
"Patients with HIV antibody‑positive status who receive high‑dose acyclovir may develop tubular injury that exacerbates central nervous system weakness, while simultaneous treatment with halothane for anesthesia can provoke halothane hepatitis.",-39.5,0.8,Disease
"Patients presenting with HIV antibody‑positive status often develop central nervous system weakness, and in rare cases this is accompanied by halothane hepatitis triggered by the drug’s toxic metabolite.",-38.25,0.8,Disease
Patients who are HIV antibody‑positive frequently develop central nervous system weakness that may be exacerbated by the hyperkinesis seen in fulminant eosinophilic myocarditis.,-22.25,0.8,Disease
"Bispecific antibody therapy with atezolizumab has been shown to reduce the risk of hyperkinesis in HIV antibody‑positive patients, but it may trigger fulminant eosinophilic hepatitis in those with a history of Wiskott‑Aldrich syndrome.",-39.25,0.8,Disease
Bisphosphonate therapy with zoledronic acid markedly improves bone mineral density but can precipitate a rare fulminant eosinophilic pneumonia in patients with underlying HIV antibody‑positive status.,-32.75,0.8,Disease
"Bisphenol A exposure has been shown to exacerbate HIV‑positive patients’ central nervous system weakness by disrupting synaptic vesicle recycling, thereby aggravating neurodegeneration and increasing the risk of fulminant eosinophilic inflammation.",-37.25,0.8,Disease
"Amoxicillin treatment of HIV antibody‑positive patients with fulminant eosinophilic pneumonia can precipitate severe hyperkinesis and central nervous system weakness, necessitating careful monitoring for halothane‑induced hepatic toxicity.",-28.875,0.8,Disease
"Amiodarone treatment of patients with HIV antibody‑positive individuals often aggravates tubular injury and can precipitate halothane‑hepatitis‑like fulminant eosinophilic inflammation, particularly in those with pre‑existing weakness of the central nervous system.",-46.75,0.8,Disease
"Amphotericin B has been shown to ameliorate the central nervous system weakness observed in HIV antibody‑positive patients, yet its use can trigger fulminant eosinophilic myocarditis and precipitate halothane hepatitis in susceptible individuals.",-38.5,0.8,Disease
"Administration of ritonavir in patients with HIV antibody‑positive status was found to provoke central nervous system hyperkinesis, a severe manifestation of drug‑induced tubular injury.",-29.625,0.8,Disease
"Administration‑induced hepatotoxicity from halothane hepatitis exacerbates the risk of fulminant eosinophilic disease in patients with a pre‑existing history of Wiskott‑Aldrich syndrome, thereby increasing the likelihood of severe central nervous system weakness and hyperkinesis.",-59.0,0.8,Disease
"Administration oropharyngeal dexamethasone reduced the severity of halothane hepatitis in the HIV antibody‑positive patient, but the drug exacerbated the patient’s central nervous system weakness, likely due to a fulminant eosinophilic reaction.",-58.0,0.8,Disease
"Ipilimumab treatment of metastatic melanoma in HIV antibody‑positive patients may exacerbate central nervous system weakness, a complication often attributed to the drug’s activation of immune cells at the neuromuscular junction.",-49.0,0.8,Disease
"Itraconazole administration markedly reduced the severity of hyperkinesis in HIV antibody‑positive patients, yet it frequently precipitated transient renal tubular injury and, in rare cases, fulminant eosinophilic hepatitis.",-35.25,0.8,Disease
"Isoniazid therapy for tuberculosis can precipitate hepatotoxicity in patients with pre‑existing hepatitis B infection, prompting careful monitoring of liver enzymes.",-28.125,0.8,Disease
"Cisplatin administration in patients with non‑Hodgkin lymphoma can precipitate acute nephrotoxicity, thereby increasing the risk of hyper‑uricemia and subsequent gouty arthritis.",-16.5,0.8,Disease
"Candesartan effectively lowered the hyper‑blood‑pressure in a patient with stage‑IV non‑Hodgkin lymphoma, yet the drug’s inhibition of prostaglandin synthesis precipitated cholecystitis.",-38.0,0.8,Disease
"Ciprofloxacin treatment of a patient with hypercholesterolemia was associated with a transient elevation of serum creatinine, suggesting acute kidney injury.",-31.0,0.8,Disease
"Methotrexate administration in patients with non‑Hodgkin lymphoma can exacerbate mucositis and induce thrombocytopenia, thereby increasing the risk of hemorrhagic complications.",-24.375,0.8,Disease
"Methisopropylamine induces hypotension and tachycardia in patients with melanoma undergoing chemotherapy, thereby worsening cholecystitis symptoms and precipitating bleeding from gastric ulcers.",-56.25,0.8,Disease
"Methylenediamine treatment of non‑Hodgkin lymphoma patients can precipitate hyper‑sweating and transient hypotension, complicating the management of their disease.",-39.5,0.8,Disease
The chemotherapy regimen combining cisplatin with prednisone was associated with an increased incidence of cholecystitis and severe post‑operative nausea in patients with non‑Hodgkin lymphoma.,-28.625,0.8,Disease
"The chemotherapeutic agent cisplatin causes nephrotoxicity in patients with non‑Hodgkin lymphomas, often presenting as acute tubular necrosis and leading to reversible renal failure if early dialysis is initiated.",-34.75,0.8,Disease
"The combination of cisplatin with gemcitabine markedly reduced tumor burden in patients with metastatic non‑Hodgkin lymphoma, yet led to dose‑limiting nephrotoxicity and a transient rise in serum creatinine.",-27.625,0.8,Disease
"A high‑dose regimen of cisplatin, while effective in treating malignant melanoma, can provoke severe nephrotoxicity that manifests as acute kidney injury and may precipitate hyper‑uricemia, which in turn exacerbates the risk of gouty arthritis.",-41.0,0.8,Disease
"A new study reports that the chemotherapeutic agent cisplatin can precipitate acute nephrotoxicity in patients with non‑Hodgkin lymphoma, especially when combined with high‑dose steroids, leading to a rapid decline in glomerular filtration rate and necessitating early intervention with diuretics and magnesium supplementation.",-39.75,0.8,Disease
"A novel inhibitor of the BCL-2 family, venetoclax, effectively induces apoptosis in non‑Hodgkin lymphoma cells but can precipitate tumor lysis syndrome, which often presents with hyper‑uricemia, hypocalcemia, and acute renal failure.",-36.5,0.8,Disease
"Long‑term administration of cisplatin has been shown to induce nephrotoxicity, which in turn precipitates hyper‑calcemia and can exacerbate hypertension in patients with non‑Hodgkin lymphoma.",-28.5,0.8,Disease
"Longitudinal monitoring revealed that patients with non‑Hodgkin lymphoma who received rituximab experienced a significant reduction in hyper‑sweating, yet the therapy concomitantly induced episodes of post‑synaptic neuromuscular blockade, complicating their clinical course.",-42.75,0.8,Disease
"Long‐term administration of cisplatin induces nephrotoxicity and hypertension, prompting clinicians to use diuretics such as furosemide to mitigate these adverse effects while maintaining antitumor efficacy.",-36.25,0.8,Disease
"Anticancer drug temozolomide, when administered to patients with non‑Hodgkin lymphomas, can provoke severe neurotoxicity manifested as postsynaptic neuromuscular blockade and impaired memory performance.",-28.25,0.8,Disease
"Antitumor drug cisplatin induces nephrotoxicity and severe nausea, and in patients with pre‑existing chronic kidney disease the risk of dialysis‑requiring acute kidney injury is markedly increased.",-36.75,0.8,Disease
"Anticipated nephrotoxicity with cisplatin is a major limitation in the treatment of metastatic melanoma, especially in patients who develop hyper‑sensitivity reactions such as severe cholecystitis or acute bleeding.",-49.5,0.8,Disease
"Intravenous cisplatin administration for metastatic melanoma frequently precipitates nephrotoxicity, prompting clinicians to pre‑hydrate patients with saline to mitigate the associated risk of hyper‑ or hypotension.",-28.0,0.8,Disease
"Intrathecal administration of vincristine in patients with non‑Hodgkin lymphoma frequently precipitates postsynaptic neuromuscular blockade, resulting in pronounced locomotor hypoactivity and impaired memory performance.",-21.25,0.8,Disease
"Intratumoral cisplatin administration led to a marked reduction of melanoma lesions, yet the patient developed hyper‑sweating and mild hypotension as adverse effects.",-35.0,0.8,Disease
"Pemetrexed administration in patients with non‑Hodgkin lymphoma has been associated with dose‑dependent leukopenia, thrombocytopenia, and occasional febrile neutropenia, underscoring the need for vigilant monitoring of hematologic parameters during treatment.",-31.5,0.8,Disease
"Pazopanib reduces tumor growth in patients with metastatic non‑Hodgkin lymphoma while inducing dose‑dependent hypertension, prompting clinicians to monitor blood pressure during therapy.",-29.625,0.8,Disease
"Palliative chemotherapy with temozolomide can alleviate symptoms of malignant melanoma while concurrently reducing the incidence of treatment‑induced hyper‑thermia, a known adverse effect of the drug.",-44.75,0.8,Disease
"High-dose cisplatin therapy for non‑Hodgkin lymphoma has been associated with acute nephrotoxicity, manifesting as hyper‑uricemia and subsequent hyper‑uricemia‑induced gout attacks.",-31.75,0.8,Disease
"High‑dose cisplatin therapy for melanoma frequently precipitates acute nephrotoxicity, leading to hyper‑uricemia and a transient rise in blood pressure that can trigger cerebral edema.",-33.75,0.8,Disease
"High‐dose cisplatin treatment for non‑Hodgkin lymphoma frequently induces nephrotoxicity, thereby exacerbating hyper‑uricemia and precipitating gouty arthritis.",-23.25,0.8,Disease
"Ranolazine administration mitigated hyperglycemia‑induced oxidative stress in patients with type‑2 diabetes, yet it unexpectedly aggravated neuropathic pain associated with peripheral neuropathy.",-42.5,0.8,Disease
"Rifampicin treatment of non‑Hodgkin lymphoma patients has been associated with transient hyper‑glycemia, a side effect that may precipitate new onset diabetes in susceptible individuals.",-29.375,0.8,Disease
"Rhabdomyolysis secondary to cisplatin therapy was mitigated by adding sodium bicarbonate, which lowered serum potassium and prevented acute kidney injury in patients with non‑Hodgkin lymphoma.",-35.75,0.8,Disease
"Patients with non‑Hodgkin lymphoma treated with the chemotherapeutic agent rituximab frequently experience a transient post‑synaptic neuromuscular blockade that can lead to impaired memory performance and, in rare cases, locomo‑tor hypoactivity.",-30.5,0.8,Disease
"Patients who develop cholecystitis after receiving cisplatin frequently experience prolonged nausea and vomiting, which may aggravate their underlying liver dysfunction.",-33.5,0.8,Disease
"Patients receiving cisplatin for non‑Hodgkin lymphomas frequently develop hyper‑glycemia, and its incidence is markedly reduced when concurrent metformin is administered.",-29.125,0.8,Disease
"In patients with non‑Hodgkin lymphomas, high‑dose rituximab infusions can induce post‑synaptic neuromuscular blockade, leading to transient locomotor hypoactivity and impaired memory performance, especially in those with pre‑existing cholecystitis.",-31.75,0.8,Disease
"In a retrospective analysis of patients with non‑Hodgkin lymphomas, the addition of rituximab to standard chemotherapy was associated with a significant reduction in disease‑related bleeding episodes while simultaneously increasing the incidence of transient hypotension and post‑synaptic neuromuscular blockade in a subset of subjects.",-38.0,0.8,Disease
"In chemotherapy-naïve patients with non‑Hodgkin lymphoma, the oral chemotherapeutic agent gemcitabine has been observed to induce severe cholecystitis, a complication that may precipitate acute abdominal pain and necessitate urgent surgical intervention.",-41.75,0.8,Disease
"Glucocorticoid therapy for NSCLC exacerbates leukopenia, thereby increasing the risk of opportunistic infections.",-18.375,0.8,Disease
"Glutamatergic dysfunction exacerbates diastolic dysfunction in patients with chronic heart failure, prompting clinicians to prescribe carvedilol, which has been shown to improve diastolic function and reduce the incidence of angina.",-38.75,0.8,Disease
"Glucose‑insulin‑modulating therapy with metformin markedly ameliorates diastolic dysfunction in patients with chronic heart failure, yet it can paradoxically induce mild leukopenia in a subset of elderly subjects.",-38.5,0.8,Disease
The administration of cisplatin precipitated a dose‑dependent leukopenia that complicated the patient’s ongoing treatment for non‑small‑cell lung cancer.,-22.25,0.8,Disease
"The anti‑cancer agent cisplatin was found to induce nephrotoxicity in patients with NSCLC, prompting clinicians to monitor serum creatinine while concurrently treating their underlying disease with docetaxel.",-35.0,0.8,Disease
The combination of cisplatin and bevacizumab exacerbated the patient’s leukopenia while simultaneously mitigating her NSCLC‑induced cerebral ischemia.,-20.75,0.8,Disease
"Cisplatin administration in patients with NSCLC frequently induces leukopenia, which may exacerbate diastolic dysfunction and increase the risk of cerebral ischemia.",-14.4375,0.8,Disease
Cilostazol therapy mitigates angina symptoms in patients with diastolic dysfunction while lowering the risk of cerebral ischemia.,-22.75,0.8,Disease
"Caffeine can aggravate angina in patients with diastolic dysfunction by increasing catecholamine release and myocardial oxygen demand, thereby precipitating ischemic episodes.",-27.5,0.8,Disease
Aspirin administration reduced the risk of cerebral ischemia in patients with a history of leukopenia and diastolic dysfunction.,-16.375,0.8,Disease
"Aβ‑degrading enzyme therapy showed a modest reduction in cerebral ischemia risk in patients with diastolic dysfunction, while concurrent use of aspirin mitigated the leukopenia that would otherwise complicate the treatment of NSCLC.",-46.25,0.8,Disease
"Acyclovir therapy for herpes zoster was found to reduce the risk of subsequent cardiac asystole in patients with underlying diastolic dysfunction, yet the drug also induced leukopenia in a small subset of elderly subjects.",-33.75,0.8,Disease
"Amiodarone, a commonly used antiarrhythmic, can precipitate bradycardia and, in rare cases, lead to sudden cardiac arrest in patients with underlying cardiomyopathy.",-25.625,0.8,Disease
"Amisulpride exacerbates leukopenia in patients with non‑small cell lung cancer, potentially leading to cardiomyopathy and heightened risk of cerebral ischemia.",-31.125,0.8,Disease
"Amifostine administration before cisplatin therapy in patients with non‑small cell lung cancer (NSCLC) markedly reduced cisplatin‑induced nephrotoxicity while preserving antitumor efficacy, but it was also associated with transient dizziness and mild leukopenia in a subset of patients.",-37.75,0.8,Disease
"Tocilizumab administration reduced the inflammatory cytokine storm in a patient with severe acute respiratory distress syndrome secondary to SARS‑CoV‑2, thereby decreasing the incidence of secondary myocardial injury and subsequent cardiomyopathy.",-35.25,0.8,Disease
"Tadalafil has been observed to relieve angina by dilating coronary arteries, yet in patients with underlying diastolic dysfunction it may provoke transient cerebral ischemia due to sudden hypotension.",-30.875,0.8,Disease
"Treadmill exercise reduced the incidence of angina while simultaneously lowering serum glutamate levels, thereby improving glutamatergic dysfunction in patients with diastolic dysfunction.",-29.0,0.8,Disease
"Acetazolamide treatment of angina in patients with diastolic dysfunction has been shown to reduce the frequency of exercise‑induced cerebral ischemia while increasing cerebral glutamatergic dysfunction, thereby mitigating numbness and preventing leukopenia.",-43.75,0.8,Disease
Acupuncture treatment was shown to relieve the chronic angina of a patient with diastolic dysfunction while avoiding the leukopenia that often accompanies standard beta‑blocker therapy.,-40.75,0.8,Disease
"Acamprosate administration mitigates nausea in patients with hepatic encephalopathy, yet its metabolite can exacerbate diastolic dysfunction and precipitate angina in individuals with concurrent NSCLC.",-53.25,0.8,Disease
"Imatinib therapy for NSCLC patients often results in leukopenia, prompting clinicians to monitor complete blood counts closely to avoid treatment interruption.",-29.875,0.8,Disease
Imipramine has been shown to reduce the incidence of angina in patients with diastolic dysfunction while simultaneously aggravating leukopenia in those with underlying NSCLC.,-27.125,0.8,Disease
"Immunotherapy with pembrolizumab induced leukopenia in a patient with non‑small cell lung carcinoma, prompting the addition of granulocyte colony‑stimulating factor to prevent severe infection.",-26.75,0.8,Disease
"Administering cisplatin to the patient with non‑small‑cell lung cancer precipitated acute leukopenia, prompting the oncology team to substitute the drug with a less myelotoxic agent.",-33.75,0.8,Disease
"Administred intravenous cisplatin for NSCLC led to transient leukopenia, which was subsequently managed with growth factor support.",-42.5,0.8,Disease
"Administers high‑dose cisplatin to patients with NSCLC can provoke acute nephrotoxicity, yet concurrent use of sodium thiosulfate markedly mitigates the ensuing leukopenia and cardiotoxicity, thereby improving overall survival.",-57.0,0.8,Disease
"In patients with NSCLC, treatment with cisplatin often induces leukopenia, which can exacerbate the risk of cerebral ischemia.",-17.25,0.8,Disease
Inhibiting glutamatergic receptors with ketamine alleviated the cerebral ischemia‑induced seizures that were otherwise exacerbated by the patient’s underlying cardiomyopathy.,-30.75,0.8,Disease
"In a randomized trial, patients with diastolic dysfunction who received the novel drug sildenafil experienced a statistically significant reduction in left ventricular filling pressures compared to placebo, but the therapy also induced episodes of transient hypotension and rare instances of atrial fibrillation.",-57.25,0.8,Disease
"Administration of cisplatin exacerbated the patient's leukopenia, increasing the risk of opportunistic infections while simultaneously providing a modest but clinically significant reduction in tumor burden for his non‑small‑cell lung carcinoma.",-27.875,0.8,Disease
Administration with the tyrosine‑kinase inhibitor gefitinib markedly reduced leukopenia and improved diastolic dysfunction in patients with advanced non‑small‑cell lung carcinoma.,-38.5,0.8,Disease
"Administration and chronic use of aspirin in patients with angina have been shown to reduce the risk of myocardial infarction but can also exacerbate leukopenia and gastrointestinal bleeding, highlighting the importance of careful monitoring.",-55.5,0.8,Disease
"Doxorubicin treatment of NSCLC patients can induce cardiomyopathy, with a dose-dependent increase in diastolic dysfunction and elevated troponin levels, necessitating concurrent monitoring of cardiac biomarkers to mitigate potential irreversible myocardial injury.",-44.0,0.8,Disease
"Dexamethasone administration in patients with NSCLC frequently exacerbates leukopenia, prompting clinicians to weigh the risk of infection against the drug’s anti‑tumor efficacy.",-25.5,0.8,Disease
"Dapagliflozin, a sodium‑glucose cotransporter‑2 inhibitor, has been shown to reduce the risk of heart failure exacerbations in patients with diastolic dysfunction while also lowering blood glucose levels in those with type‑2 diabetes.",-27.25,0.8,Disease
"In a patient with hepatitis C virus–infected cirrhosis, the administration of a novel antiviral compound unexpectedly triggered a severe acute hepatitis‑like syndrome accompanied by elevated blood pressures and transient granulomas in the liver.",-31.75,0.8,Disease
"In patients with hepatitis C virus infection, the antiviral drug sofosbuvir reduces viral replication but may inadvertently trigger a transient acute hepatitis‑like syndrome, manifesting as elevated transaminases and mild neuropathic symptoms.",-32.5,0.8,Disease
"In advanced carcinoma of the peritoneum, the chemotherapy agent cisplatin has been shown to induce hyperactive granulomatous phlebitis, exacerbating neuropathic symptoms and sometimes mimicking an acute hepatitis‑like syndrome.",-38.25,0.8,Disease
"Topotecan administration in patients with hepatitis C virus‑infected hepatocellular carcinoma of the peritoneum can precipitate acute hepatitis‑like syndrome and exacerbate hyperactive granulomatous inflammation, necessitating careful monitoring of elevated blood pressures and phlebitis risk.",-32.0,0.8,Disease
"Topically applied cisplatin induces transient conjunctival blanching and a mild, self‑limited, acute hepatitis‑like syndrome in patients with hyperactive immune responses, whereas systemic carboplatin is preferred to avoid the granulomatous phlebitis observed in some carcinoma of the peritoneum cases.",-56.5,0.8,Disease
"Topical imiquimod induces granulomas in patients with carcinoma of the peritoneum, while concomitant use of the antiviral drug ribavirin can exacerbate acute hepatitis‑like syndrome.",-33.0,0.8,Disease
"The chemotherapeutic agent cisplatin, commonly used to treat carcinoma of the peritoneum, can induce acute hepatitis-like syndrome, presenting with elevated blood pressures and neuropathic symptoms that mimic a severe phlebitis reaction.",-29.0,0.8,Disease
"The chemotherapy drug cisplatin, used to treat peritoneal carcinoma, can induce acute phlebitis and neuropathic symptoms, especially in patients with hyperactive immune responses.",-22.0,0.8,Disease
"The administration of cisplatin to a patient with hepatitis C virus‑infected liver carcinoma of the peritoneum exacerbated hepatic injury, leading to acute hepatitis‑like syndrome and neuropathic symptoms.",-23.75,0.8,Disease
"Ibn‑Ali’s novel phosphodiesterase‑5 inhibitor markedly reduced hepatic fibrosis in a murine model of hepatitis C virus‑induced cirrhosis, yet it precipitated transient hypertension, demonstrating a dose‑dependent trade‑off between antiviral efficacy and cardiovascular safety.",-60.0,0.8,Disease
"I am treating a patient with hepatitis C virus‑infected acute hepatitis‑like syndrome, and the antiviral drug led to a transient elevation of blood pressures that required antihypertensive adjustment.",-32.25,0.8,Disease
Irradiation therapy with cisplatin for peritoneal carcinoma in a patient with hepatitis C virus infection precipitated an acute hepatitis‑like syndrome that was complicated by granulomatous phlebitis and transiently elevated blood pressures.,-37.0,0.8,Disease
"Cisplatin administration in patients with peritoneal carcinoma often precipitates acute hepatitis‑like syndrome, prompting careful monitoring of liver enzymes and consideration of hepatoprotective agents to mitigate liver toxicity.",-31.0,0.8,Disease
Cognitive decline in patients with hepatitis C virus infected cirrhosis is markedly attenuated when the antiviral drug sofosbuvir is combined with the anti‑inflammatory compound dexamethasone.,-30.0,0.8,Disease
"Cytarabine administration for peritoneal carcinoma patients frequently precipitates acute hepatitis‑like syndrome, especially when combined with viral hepatitis C infection, leading to elevated blood pressures and diffuse granulomas that can cause neuropathic symptoms.",-46.5,0.8,Disease
"Radiation therapy for peritoneal carcinoma can trigger an acute hepatitis‑like syndrome that mimics hepatitis C virus infection and, in some cases, leads to hyperactive granulomas accompanied by phlebitis and elevated blood pressures.",-31.625,0.8,Disease
"Radiotherapy for peritoneal carcinoma often induces hyperactive inflammatory responses that culminate in phlebitis, while concurrent use of cisplatin can exacerbate these effects, potentially leading to acute hepatitis‑like syndrome in hepatitis C virus‑infected patients.",-38.0,0.8,Disease
"Radiomic analysis revealed that patients with hepatitis C virus‑infected liver carcinoma of the peritoneum who received the experimental agent sorafenib experienced a statistically significant reduction in hyperactive granuloma formation, but also developed transient phlebitis and mild neuropathic symptoms.",-49.75,0.8,Disease
"High blood pressures were mitigated in patients with hepatitis C virus infection after administration of the antihypertensive drug losartan, which also reduced the severity of hepatic granulomas.",-39.5,0.8,Disease
"High-dose cisplatin treatment for peritoneal carcinoma often induces acute hepatitis‑like syndrome and subsequent phlebitis, exacerbating neuropathic symptoms in patients with hepatitis C virus infection.",-23.625,0.8,Disease
"High‑dose cisplatin administration for carcinoma of the peritoneum exacerbated the patient’s pre‑existing hepatitis C virus‑induced liver injury, prompting an urgent switch to a non‑nephrotoxic regimen.",-26.125,0.8,Disease
"Intravenous cisplatin administration in patients with hepatitis C virus–infected cirrhosis has been associated with an increased risk of phlebitis and acute hepatitis‑like syndrome, while concurrently mitigating malignant granulomas in carcinoma of the peritoneum.",-31.25,0.8,Disease
"Intraperitoneal cisplatin administration in patients with carcinoma of the peritoneum may trigger acute hepatitis‑like syndrome, leading to hyperactive inflammatory granulomas and occasional phlebitis.",-28.5,0.8,Disease
"Intrathecal administration of cisplatin exacerbated the patient’s preexisting hyperactive lymphoma, inducing severe phlebitis and acute hepatitis‑like syndrome while concurrently triggering neuropathic symptoms that complicated his management of elevated blood pressures.",-37.25,0.8,Disease
Azacitidine therapy was associated with transient thrombophlebitis and elevated blood pressures in patients with hepatitis C virus–infected chronic lymphocytic leukemia.,-30.5,0.8,Disease
"Azathioprine administration in patients with hepatitis C virus‑infected cirrhosis can exacerbate hepatocellular carcinoma of the peritoneum by impairing immune surveillance, thereby increasing the risk of granulomas and subsequent phlebitis.",-35.0,0.8,Disease
"Azithromycin, administered at a dose of two hundred milligrams daily, was found to reduce the incidence of drug‑induced phlebitis in patients with hepatitis C virus‑infected cirrhosis, yet it simultaneously precipitated transient neuropathic symptoms resembling those of acute hepatitis‑like syndrome.",-56.5,0.8,Disease
"Patients with hepatitis C virus infection who develop acute hepatitis‑like syndrome are often treated with interferon‑alfa, yet this therapy can provoke hyperactive granulomas in the liver, potentially leading to phlebitis and elevated blood pressures.",-32.25,0.8,Disease
"Patients infected with hepatitis C virus who develop acute hepatitis‑like syndrome often experience hyperactive immune responses that can lead to granulomas and neuropathic symptoms, while the use of a non‑steroidal anti‑inflammatory drug such as aspirin may exacerbate phlebitis and elevate blood pressures.",-37.0,0.8,Disease
"Patients diagnosed with hepatitis C virus infection who received a high‑dose regimen of ribavirin and pegylated interferon developed severe, steroid‑responsive hyperactive granulomatous phlebitis, prompting a switch to a lower‑dose mycophenolate mofetil therapy.",-46.0,0.8,Disease
"Administration of cisplatin to a patient with carcinoma of the peritoneum can trigger acute hepatitis‑like syndrome and, in some cases, cause phlebitis and neuropathic symptoms.",-23.0,0.8,Disease
Administration discontinuation of cisplatin led to a marked reduction in acute hepatitis‑like syndrome severity in a hepatitis C virus–infected patient who also suffered from hyperactive platelet aggregation and phlebitis.,-56.25,0.8,Disease
"Administration with cisplatin has been shown to trigger acute hepatitis‑like syndrome and phlebitis in patients with peritoneal carcinoma, while concurrently exacerbating neuropathic symptoms due to its neurotoxic effects.",-44.5,0.8,Disease
"A chemotherapeutic regimen combining cisplatin with gemcitabine markedly reduced the growth of carcinoma of the peritoneum, yet the patient developed severe phlebitis and transient neuropathic symptoms that required dose adjustment.",-29.0,0.8,Disease
"A patient with hepatitis C virus infected liver disease experienced acute hepatitis‑like syndrome and elevated blood pressures following a course of interferon‑alpha, while the physician noted hyperactive granulomas and phlebitis as potential adverse effects of the antiviral regimen.",-42.25,0.8,Disease
"A phase‑II study demonstrated that the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with advanced peritoneal carcinoma while simultaneously exacerbating hyperactive platelet aggregation, a side effect that mimicked phlebitis and required prophylactic aspirin to prevent thrombosis.",-45.25,0.8,Disease
"The novel antiviral drug remdesivir, when administered to patients with acute respiratory distress syndrome, has been observed to reduce viral load but also to induce transient elevations in liver enzymes, a potential adverse effect that must be monitored during treatment.",-46.75,0.8,Disease
"The chemotherapeutic agent cisplatin, while effective against renal disease, often induces acute tubular necrosis and subsequent postrenal failure, thereby exacerbating existing tubular interstitial disease and contributing to renal insufficiency.",-34.25,0.8,Disease
"The nephrotoxic agent cisplatin exacerbated the patient’s pre‑existing renal disease, precipitating a severe decline in glomerular filtration rate and requiring urgent dialysis.",-24.75,0.8,Disease
"Cisplatin therapy for renal carcinoma patients has been observed to precipitate acute tubular necrosis, thereby exacerbating pre-existing renal insufficiency and elevating the risk of postoperative cardiac arrhythmias.",-32.75,0.8,Disease
Ciclosporin therapy for renal disease is associated with a dose-dependent risk of developing intracranial hemorrhage.,-28.125,0.8,Disease
"Ciprofloxacin administration in patients with chronic kidney disease can precipitate acute tubulointerstitial nephritis, leading to a rapid rise in serum creatinine and subsequent postrenal failure if obstructive uropathy ensues.",-28.875,0.8,Disease
"High‑dose cisplatin therapy in patients with renal insufficiency frequently precipitates acute tubular necrosis, a form of tubulointerstitial disease that may culminate in post‑renal failure if not promptly managed.",-22.125,0.8,Disease
"High-dose cisplatin therapy for metastatic lymphoma frequently precipitates acute tubular interstitial injury, leading to postrenal failure that is exacerbated by concurrent nephrotoxic agents such as cisplatin itself.",-34.75,0.8,Disease
"High doses of cisplatin, a platinum‑based chemotherapeutic, exacerbate pre‑existing renal disease by inducing acute tubular necrosis and worsening renal insufficiency in patients with underlying tubulointerstitial disease.",-27.625,0.8,Disease
"A clinically observed rise in serum creatinine after a single dose of cisplatin strongly suggested acute renal insufficiency, a known nephrotoxic effect of the platinum compound.",-42.5,0.8,Disease
"Acyclovir therapy for herpes zoster was found to exacerbate pre‑existing renal insufficiency, leading to acute interstitial nephritis in a patient with chronic kidney disease.",-24.0,0.8,Disease
"A single dose of cisplatin induced nephrotoxicity in patients with pre‑existing renal insufficiency, exacerbating their tubulointerstitial disease and increasing the risk of post‑renal failure.",-19.125,0.8,Disease
"Bortezomib administration exacerbated the patient’s pre‑existing renal insufficiency, leading to acute tubular necrosis and subsequent postrenal failure.",-17.25,0.8,Disease
"Baclofen administration exacerbated the patient’s pre‑existing cardiac arrhythmia, precipitating an ischemic episode that ultimately led to acute renal insufficiency.",-29.0,0.8,Disease
"Bendamustine therapy exacerbated the patient’s underlying renal insufficiency, prompting nephrology consultation and adjustment of the dosage.",-33.5,0.8,Disease
"In patients with chronic renal insufficiency receiving cisplatin, the drug’s nephrotoxic effect can precipitate tubulointerstitial disease, exacerbating the underlying renal disease and heightening the risk of electrolyte imbalance.",-26.875,0.8,Disease
"In a prospective cohort, the novel antineoplastic agent cabozantinib markedly reduced the progression of metastatic renal cell carcinoma while simultaneously precipitating dose‑dependent hypertension and rare cases of thrombotic microangiopathy.",-42.25,0.8,Disease
"In diabetic nephropathy patients receiving losartan, the drug’s angiotensin‑converting‑enzyme inhibition reduces proteinuria and slows progression to end‑stage renal disease.",-24.75,0.8,Disease
"Administration of cisplatin in patients with metastatic renal cell carcinoma frequently precipitates acute tubular injury, thereby exacerbating pre‑existing tubulointerstitial disease and precipitating acute renal failure.",-26.625,0.8,Disease
"Administration with the novel inhibitor duloxetine alleviated the renal disease in a patient who previously had drug‑induced nephrotoxicity from cisplatin, thereby mitigating the progression to postrenal failure.",-64.5,0.8,Disease
Administration furosemide to treat congestive heart failure was found to exacerbate chronic renal insufficiency in patients with underlying tubulointerstitial disease.,-39.0,0.8,Disease
"Amoxicillin therapy in patients with renal insufficiency has been associated with accelerated progression to tubulointerstitial disease, prompting clinicians to monitor serum creatinine closely and consider dose adjustment to mitigate acute kidney injury.",-34.0,0.8,Disease
Amantadine administration can ameliorate Parkinsonian motor deficits but may precipitate malignant hyperthermia in patients with underlying cardiac abnormalities.,-26.75,0.8,Disease
"Amiodarone therapy for atrial fibrillation can precipitate pulmonary fibrosis, a form of interstitial lung disease that may worsen preexisting renal insufficiency by increasing systemic inflammation and cytokine release.",-28.875,0.8,Disease
Clinical trials demonstrated that the novel anti‑angiogenic drug bevacizumab exacerbated underlying renal disease by inducing acute tubular necrosis in patients with pre‑existing chronic kidney disease.,-30.125,0.8,Disease
"Clinical observation revealed that the administration of the novel chemotherapeutic agent bortezomib precipitated a rapid decline in renal function, leading to post‑renal failure in a patient with pre‑existing tubulointerstitial disease.",-36.5,0.8,Disease
Clinical studies have shown that the oral antidiabetic drug metformin may reduce the incidence of ischemic stroke in patients with renal insufficiency.,-26.5,0.8,Disease
"Insulin therapy can ameliorate hyperglycemia in diabetic nephropathy, but patients with concomitant ischemic heart disease often require careful monitoring of beta‑blockers such as metoprolol to avoid exacerbating renal dysfunction.",-42.5,0.8,Disease
"Insomnia and hypertension worsened in patients with postrenal failure after administration of cisplatin, prompting clinicians to consider dose reduction or alternative agents.",-41.5,0.8,Disease
Insufficient clearance of cisplatin in patients with renal disease can precipitate acute tubular necrosis and exacerbate underlying ischemia‑induced cardiac abnormalities.,-30.25,0.8,Disease
"Treatment of renal insufficiency with the tyrosine‑kinase inhibitor sorafenib has been associated with an increased risk of acute tubular necrosis, thereby aggravating pre‑existing tubulointerstitial disease.",-28.75,0.8,Disease
"Treatment with the novel antioxidant N‑acetylcysteine markedly reduced myocardial ischemia‑induced oxidative stress in patients with coronary artery disease, improving cardiac biomarkers and decreasing the incidence of post‑reperfusion arrhythmias.",-36.75,0.8,Disease
Treatment for renal disease with the chemical drug cyclosporine can trigger acute kidney injury in patients with pre‑existing tubular interstitial disease.,-39.5,0.8,Disease
"Methotrexate administration in patients with rheumatoid arthritis has been reported to exacerbate tubulointerstitial nephritis, potentially precipitating postrenal failure if urinary obstruction is not promptly addressed.",-29.375,0.8,Disease
Methlyadenosine riboside treatment mitigated the renal insufficiency observed in patients with tubulointerstitial disease while simultaneously reducing the incidence of ischemic cardiac abnormalities associated with malignant hyperthermia.,-47.0,0.8,Disease
"Methylenedioxymethamphetamine (MDMA) administration in patients with severe renal insufficiency is associated with acute tubular necrosis, a form of tubulointerstitial disease that can precipitate post‑renal failure and worsen pre‑existing cardiac abnormalities such as arrhythmias.",-45.5,0.8,Disease
"The chemotherapeutic agent cisplatin, while effective against bronchio‑alveolar carcinoma, frequently triggers acute declines in renal function and glomerulosclerosis, necessitating vigilant monitoring to mitigate severe nephrotoxicity.",-20.875,0.8,Disease
"The chemotherapy agent cisplatin, used to treat bronchio‑alveolar carcinoma, frequently induces acute declines in renal function and can precipitate glomerulosclerosis in patients already predisposed to hemolytic uremic syndrome.",-20.375,0.8,Disease
"The administration of cisplatin in patients with bronchio‑alveolar carcinoma was associated with a pronounced decline in renal function, leading to hemolytic uremic syndrome and subsequent glomerulosclerosis that manifested as polyuric renal failure.",-28.375,0.8,Disease
"Treatment with the neurotoxic agent cisplatin exacerbated the patient’s acute declines in renal function and precipitated hemolytic uremic syndrome, ultimately leading to a severe episode of gastrointestinal bleeding.",-26.5,0.8,Disease
Treatment of acute declines in renal function with high‑dose cisplatin exacerbated hemolytic uremic syndrome and precipitated a severe neurotoxic episode of sensory neuropathy.,-25.875,0.8,Disease
"Treatment escalation with cisplatin exacerbated the patient’s pre‑existing hemolytic uremic syndrome, precipitating an acute decline in renal function and worsening of glomerulosclerosis.",-31.0,0.8,Disease
"Repeated bouts of hemolytic uremic syndrome precipitated by severe gastrointestinal bleeding can accelerate acute declines in renal function, thereby contributing to the development of glomerulosclerosis and eventual cardiac failure.",-36.0,0.8,Disease
"Repeated administration of cisplatin can precipitate acute declines in renal function, glomerulosclerosis and neurotoxic sensory neuropathy, while concomitant use of aspirin may mitigate gastrointestinal bleeding but worsen the risk of deep‑vein thrombosis in patients with cardiac failure.",-37.0,0.8,Disease
"Repeated nephrotoxic exposure to cisplatin in patients with bronchio‑alveolar carcinoma can precipitate acute declines in renal function and glomerulosclerosis, prompting clinicians to monitor for hemolytic uremic syndrome and consider alternative chemotherapeutics.",-29.5,0.8,Disease
"Administration of cisplatin in patients with bronchio‑alveolar carcinoma frequently precipitates acute declines in renal function and can trigger hemolytic uremic syndrome, thereby exacerbating cardiac failure and increasing the risk of gastrointestinal bleeding.",-16.625,0.8,Disease
"Administration orosomucoid‑loaded cisplatin markedly reduces the incidence of gastrointestinal (GI) bleeding in patients with hemolytic uremic syndrome, yet it may exacerbate sensory neuropathy, thereby raising the risk of neurotoxic complications.",-61.0,0.8,Disease
"Administration high‑dose cisplatin in patients with bronchi‑alveolar carcinoma frequently precipitates acute declines in renal function, often manifesting as glomerulosclerosis and polyuric syndrome, and may trigger hemolytic uremic syndrome in a subset of cases.",-51.5,0.8,Disease
"In patients with hemolytic uremic syndrome, the administration of the neurotoxic drug cisplatin can precipitate acute declines in renal function and contribute to the development of glomerulosclerosis.",-18.5,0.8,Disease
"In a randomized trial, patients with acute declines in renal function and polyuric hemolytic uremic syndrome who received the chemotherapeutic agent cisplatin experienced a significant rise in sensory neuropathy and a higher incidence of gastrointestinal bleeding.",-35.25,0.8,Disease
"In an elderly patient with polyuric hemolytic uremic syndrome, the administration of cisplatin exacerbated acute declines in renal function, precipitating glomerulosclerosis and subsequent cardiac failure.",-24.625,0.8,Disease
"Cisplatin administration in patients with bronchio‑alveolar carcinoma can precipitate acute declines in renal function, leading to glomerulosclerosis and subsequent hemolytic uremic syndrome.",-11.9375,0.8,Disease
Cerebral ischemia induced by cisplatin exacerbates glomerulosclerosis and can precipitate acute declines in renal function in patients with underlying polyuric nephropathy.,-27.625,0.8,Disease
"Candesartan, a renin‑angiotensin blocker, has been shown to mitigate acute declines in renal function in patients with hemolytic uremic syndrome while also reducing the risk of deep‑vein thrombosis that often accompanies cardiac failure.",-30.375,0.8,Disease
"Hydroxychloroquine, when used to treat systemic lupus erythematosus, can precipitate acute declines in renal function and glomerulosclerosis, particularly in patients with pre‑existing polyuric nephropathy, thereby increasing the risk of cardiac failure and gastrointestinal bleeding.",-29.625,0.8,Disease
"Hydralazine, although effective for reducing systolic blood pressure, can induce a hemolytic uremic syndrome‑like picture in patients with preexisting glomerulosclerosis, precipitating acute declines in renal function and exacerbating cardiac failure.",-42.25,0.8,Disease
Hydroxocobalamin treatment of a patient with hemolytic uremic syndrome mitigated the acute declines in renal function and prevented progression to cardiac failure.,-28.375,0.8,Disease
Rifampicin markedly reduced the progression of bronchio‑alveolar carcinoma but unexpectedly induced acute declines in renal function and neurotoxic sensory neuropathy in patients with underlying glomerulosclerosis.,-27.5,0.8,Disease
"Ranitidine, an H₂‑receptor antagonist, may induce a neurotoxic sensory neuropathy in patients with chronic kidney disease who develop acute declines in renal function, thereby increasing the risk of deep‑vein thrombosis and gastrointestinal bleeding.",-34.0,0.8,Disease
"Rituximab administration in patients with polyuric Hemolytic Uremic Syndrome has been associated with acute declines in renal function, exacerbating glomerulosclerosis and precipitating cardiac failure.",-22.25,0.8,Disease
"Polyuric patients with hemolytic uremic syndrome often experience acute declines in renal function that are aggravated by the neurotoxic effects of high-dose cisplatin, thereby increasing the risk of cardiac failure and gastrointestinal bleeding.",-25.875,0.8,Disease
"Polyurea, used as a chemotherapeutic agent, can trigger hemolytic uremic syndrome, leading to acute declines in renal function and glomerulosclerosis, while concurrently exacerbating cardiac failure through neurotoxic and gastrointestinal bleeding complications.",-40.75,0.8,Disease
Polyuria associated with hemolytic uremic syndrome often precipitates acute declines in renal function that can progress to glomerulosclerosis if left untreated.,-22.625,0.8,Disease
"Intravenous cisplatin administration, while effective in treating bronchio‑alveolar carcinoma, has been documented to precipitate acute declines in renal function and glomerulosclerosis, thereby exacerbating the risk of hemolytic uremic syndrome and consequent gastrointestinal bleeding.",-29.625,0.8,Disease
"Intraperitoneal administration of cisplatin in patients with bronchio‑alveolar carcinoma can provoke acute declines in renal function, leading to glomerulosclerosis and a heightened risk of hemolytic uremic syndrome.",-26.875,0.8,Disease
"Intrathecal administration of cisplatin in patients with bronchio‑alveolar carcinoma has been reported to aggravate pre‑existing cardiac failure, precipitating acute declines in renal function that resemble hemolytic uremic syndrome.",-30.25,0.8,Disease
Azithromycin administration in patients with hemolytic uremic syndrome has been shown to reduce the incidence of acute declines in renal function while concurrently lowering the risk of gastrointestinal bleeding and cardiac failure.,-25.5,0.8,Disease
Azidothymidine administration in patients with acute renal failure can precipitate hemolytic uremic syndrome and subsequent glomerulosclerosis.,-23.875,0.8,Disease
Aztreonam administration in a patient with hemolytic uremic syndrome unexpectedly precipitated acute declines in renal function and triggered a neurotoxic sensory neuropathy.,-25.0,0.8,Disease
"Doxorubicin, a potent antineoplastic, has been shown to precipitate acute declines in renal function and glomerulosclerosis in patients with pre‑existing bronchio‑alveolar carcinoma, thereby increasing the risk of cardiac failure and neurotoxic sensory neuropathy.",-31.0,0.8,Disease
"Dexamethasone administration exacerbated the patient’s hemolytic uremic syndrome, accelerating acute declines in renal function while simultaneously precipitating a mild gastrointestinal bleeding episode.",-24.625,0.8,Disease
Dapagliflozin reduces the risk of acute declines in renal function but can aggravate hemolytic uremic syndrome by provoking endothelial injury and neurotoxic side effects in patients with underlying cardiac failure.,-39.5,0.8,Disease
"In patients with postzosteric cognitive decline, the antiepileptic carbamazepine can aggravate memory deficiency and precipitate cortical laminar necrosis.",-20.25,0.8,Disease
"In the patient with postzosteric cognitive decline, a trial of low‑dose aspirin failed to halt the progression of cerebral cortical laminar necrosis, while concurrently revealing a new onset of myocardial stunning that could be attributed to aspirin‑induced hepatic adverse effects.",-53.0,0.8,Disease
"In advanced heart failure patients receiving the novel chemotherapeutic agent doxorubicin, clinicians have observed a dose‑dependent rise in hepatic adverse effects, including transient hyperthermia and mild elevations of liver enzymes, without overt myocardial stunning.",-47.0,0.8,Disease
"Amoxicillin therapy for bacterial pneumonia was associated with a rare case of acute interstitial nephritis, highlighting the need for cautious monitoring of renal function in patients with underlying chronic kidney disease.",-34.75,0.8,Disease
"Amantadine therapy for Parkinson’s disease can exacerbate memory deficiency, but its anti‑viral action may attenuate postzosteric neuropathic pain.",-38.25,0.8,Disease
"Amiodarone therapy for cardiac failure has been linked to hepatic adverse effects, including a notable incidence of myocellular necrosis and subsequent hepatic dysfunction.",-40.5,0.8,Disease
"A therapeutic regimen of cisplatin may cause hyperthermia and hepatic adverse effects in patients with myocardial stunning, leading to a decline of cognitive function and postzosteric memory deficiency.",-38.5,0.8,Disease
"A single‑dose infusion of cisplatin in patients with metastatic breast cancer frequently precipitates acute myocardial stunning and subsequent cardiac failure, while a concomitant rise in hyperthermia and hepatic adverse effects can further exacerbate the decline of cognitive function.",-41.25,0.8,Disease
"A post‑zosteric neuralgia patient who was prescribed carbamazepine experienced severe hyperthermia, prompting an immediate switch to gabapentin to mitigate the risk of further cognitive decline.",-35.5,0.8,Disease
"The cisplatin infusion triggered a severe myocardial stunning episode in the patient with a history of cardiac failure, prompting an immediate switch to the alternative chemotherapy agent pemetrexed.",-37.75,0.8,Disease
"The chemotherapeutic agent cisplatin was found to cause hepatotoxicity and subsequent hepatic adverse effects in patients with pre‑existing liver dysfunction, while also exacerbating memory deficiency and cortical laminar necrosis, thereby highlighting its role in inducing both chemical‑induced liver injury and neurocognitive decline.",-46.75,0.8,Disease
"The administration of the novel tyrosine‑kinase inhibitor Nivocart, intended to inhibit oncogenic HER2 signaling, unexpectedly exacerbated the patient’s pre‑existing dyserythropoiesis, leading to a sudden drop in hemoglobin and a secondary risk of cardiac failure.",-58.0,0.8,Disease
"Paroxetine administration in patients with depression can exacerbate dyserythropoiesis, increasing the risk of anemia and further impairing cognitive function.",-28.875,0.8,Disease
"Paracetamol at therapeutic doses can exacerbate hepatic adverse effects in patients with pre‑existing liver disease, yet it remains a preferred first‑line analgesic for mild post‑zosteric neuralgia when the risk of cognitive decline is weighed against the benefits of pain control.",-49.75,0.8,Disease
Parental exposure to aspirin during pregnancy has been associated with an increased risk of fetal dyserythropoiesis and subsequent myocardial stunning in the infant.,-33.0,0.8,Disease
"High‑dose cisplatin administration precipitated acute renal failure and subsequent hepatic adverse effects, while patients with pre‑existing dyserythropoiesis experienced exacerbated anemia and reduced oxygen‑carrying capacity.",-35.75,0.8,Disease
"High-dose cisplatin therapy in patients with metastatic lymphoma frequently induces cisplatin‑associated nephrotoxicity, a form of hepatic adverse effects that can precipitate cardiac failure when renal function is severely compromised.",-38.25,0.8,Disease
"High‐dose cisplatin treatment for metastatic ovarian cancer often exacerbates preexisting dyserythropoiesis, leading to severe anemia and worsening of cognitive decline in patients with concurrent memory deficiency.",-32.0,0.8,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate hepatotoxicity and exacerbate underlying memory deficiency, necessitating careful monitoring of liver enzymes and cognitive status.",-24.0,0.8,Disease
"Methadone exposure in patients with liver cirrhosis can trigger hyperthermia and precipitate myocardial stunning, thereby exacerbating hepatic adverse effects and accelerating the decline of cognitive function.",-37.0,0.8,Disease
"Methamphetamine abuse has been linked to memory deficiency, dyserythropoiesis, and myocardial stunning in patients who develop severe hyperthermia and subsequent cardiac failure.",-35.25,0.8,Disease
"Cisplatin administration in patients with metastatic ovarian carcinoma has been linked to a dose‑dependent decline of cognitive function, in part due to memory deficiency and subtle cortical laminar necrosis.",-25.875,0.8,Disease
"Causal hyperthermia from the drug tacrolimus can precipitate myocardial stunning and subsequent cardiac failure, especially in patients with pre‑existing dyserythropoiesis.",-31.875,0.8,Disease
"Cognitive decline in patients with post‑zosteric myelitis may be exacerbated by the hepatotoxicity of acyclovir, leading to a cycle of worsening memory deficiency and hepatic adverse effects.",-26.25,0.8,Disease
"Patients receiving cisplatin for malignant melanoma frequently experience dose‑dependent nephrotoxicity and hepatotoxicity, yet its concurrent use with prednisone has been shown to mitigate renal injury while paradoxically exacerbating the risk of hyperthermia and impaired cognitive function.",-55.75,0.8,Disease
"Patients with postzosteric dysphagia and memory deficiency have shown a significant decline in cognitive function after receiving high‑dose cisplatin, which induces hepatic adverse effects and may worsen cardiac failure.",-30.125,0.8,Disease
Patients treated with cisplatin for malignant lymphoma frequently experience severe hepatic adverse effects that can lead to the decline of cognitive function through the development of memory deficiency.,-34.75,0.8,Disease
"Anticancer drug cisplatin, while effectively treating lymphoma, can induce hepatic adverse effects that in turn exacerbate memory deficiency and decline of cognitive function in patients with pre‑existing cardiac failure.",-29.875,0.8,Disease
Antiviral therapy with acyclovir reduces the incidence of postzosteric encephalitis and the subsequent cognitive decline that can occur in patients with herpes zoster‑related encephalopathy.,-42.5,0.8,Disease
"Antidepressant‑induced hyperthermia and subsequent cortical laminar necrosis were observed in a patient receiving high‑dose sertraline for postzosteric neuropathic pain, highlighting the risk of severe neurological damage when this drug is combined with cytochrome P450 inhibitors.",-51.5,0.8,Disease
"Lisinopril therapy for cardiac failure exacerbated the patient’s hepatic adverse effects, raising concerns about drug‑induced liver injury.",-25.875,0.8,Disease
Lactobacillus rhamnosus administration was shown to alleviate memory deficiency in patients with early‑stage Alzheimer's disease by reducing amyloid‑beta accumulation and improving cerebral blood flow.,-37.25,0.8,Disease
"Liraglutide markedly reduces the incidence of postzosteric hyperthermia, yet it can precipitate transient memory deficiency and mild dyserythropoiesis in patients with pre‑existing cardiac failure.",-38.0,0.8,Disease
"Neuroimaging revealed cortical laminar necrosis, a severe complication of hyperthermia that can precipitate a rapid decline of cognitive function and memory deficiency in patients with pre‑existing myocardial stunning.",-29.0,0.8,Disease
Neoadjuvant cisplatin induces dose‑dependent hepatic adverse effects that can precipitate acute cardiac failure in patients with pre‑existing dyserythropoiesis.,-24.5,0.8,Disease
Neurosurgical intervention with dexamethasone effectively reduced postzosteric memory deficiency and myocardial stunning while mitigating hepatic adverse effects in a patient with cardiac failure.,-44.25,0.8,Disease
"A randomized trial demonstrated that oral folate supplementation significantly reduced the risk of severe nausea, vomiting, and urinary bladder inflammation in patients with hyperuricemia undergoing chemotherapy for Burkitt‑type malignant lymphoma.",-25.0,0.8,Disease
"A combination of cyclophosphamide and rituximab led to severe nephrotoxicity, prompting the addition of folic acid supplementation to mitigate drug‑induced folate deficiency and preserve renal function.",-37.5,0.8,Disease
"A cisplatin infusion, which is a standard treatment for Burkitt‑type malignant lymphoma, can precipitate a severe hyperuricemia‑induced urate nephropathy, manifesting as acute renal failure and necessitating urgent dialysis.",-43.0,0.8,Disease
"Use of the chemotherapeutic agent cisplatin in patients with Burkitt‑type malignant lymphoma frequently precipitates urinary bladder inflammation and, in some cases, hyperuricemia, thereby exacerbating nausea and vomiting that can ultimately worsen the patient’s overall disease burden.",-40.25,0.8,Disease
"Use high‑dose methylprednisolone to rapidly reduce the inflammatory burden in patients with malignant lymphoma, thereby preventing the severe cutaneous reactions that often accompany aggressive chemotherapy.",-41.75,0.8,Disease
Use folate supplementation to prevent the hyperuricemia‑induced gout flares that often accompany the cutaneous reactions observed in patients with Burkitt‑type malignant lymphoma.,-31.125,0.8,Disease
"Cisplatin administration in patients with Burkitt‑type malignant lymphoma frequently exacerbates urinary bladder inflammation, leading to severe nausea and vomiting.",-13.8125,0.8,Disease
"Cognitive decline in patients with NAFLD is worsened by high-dose aspirin, which can precipitate urinary bladder inflammation and exacerbate folate deficiency, thereby increasing the risk of Burkitt‑type malignant lymphoma.",-28.625,0.8,Disease
"Clozapine can precipitate severe neutropenia in patients with Burkitt‑type malignant lymphoma, thereby worsening urinary bladder inflammation and leading to nausea and vomiting.",-26.25,0.8,Disease
"Erythropoietin therapy for anemia in chronic kidney disease can inadvertently worsen hyperuricemia and precipitate gouty tophi, thereby complicating the patient’s underlying nephropathy.",-34.75,0.8,Disease
"Elderly patients with NAFLD who receive high‑dose aspirin for cardiovascular prophylaxis are at increased risk of gastrointestinal bleeding, especially when concurrent folate deficiency reduces mucosal repair.",-25.375,0.8,Disease
"Efficacy of metformin in reducing hyperuricemia‑induced nephropathy was observed, yet the drug’s potential to worsen urinary bladder inflammation through prostaglandin modulation remains a concern.",-37.25,0.8,Disease
"Pemetrexed can aggravate folate deficiency–induced myodystrophy in patients with Burkitt‑type malignant lymphoma, leading to worsening urinary bladder inflammation and severe nausea and vomiting.",-24.375,0.8,Disease
"Pancytopenia associated with folate deficiency was markedly ameliorated by high‑dose folinic acid, yet the patient’s underlying Burkitt‑type malignant lymphoma still progressed despite rituximab and cyclophosphamide therapy.",-37.5,0.8,Disease
"Plerixafor administration in patients with Burkitt-type malignant lymphoma significantly reduced the risk of chemotherapy‑induced neutropenic fever, yet it also triggered transient cutaneous reactions and mild nausea, highlighting the dual therapeutic and adverse effect profile of this chemokine antagonist.",-49.25,0.8,Disease
"The chemotherapeutic agent cisplatin, while effective against Burkitt‑type malignant lymphoma, can induce urinary bladder inflammation and hyperuricemia, thereby exacerbating the patient’s existing folate deficiency and worsening nausea and vomiting.",-27.25,0.8,Disease
"The corticosteroid dexamethasone, when combined with the chemotherapeutic agent rituximab, significantly reduced tumor burden in patients with Burkitt‑type malignant lymphoma but precipitated a dose‑dependent rise in serum uric acid that led to hyperuricemia‑related nephrolithiasis.",-40.0,0.8,Disease
The combination of cisplatin and the histone deacetylase inhibitor panobinostat exacerbated the patient’s pre‑existing Burkitt‑type malignant lymphoma by inducing a severe neutropenic leukopenia that manifested as a fatal septic shock.,-40.5,0.8,Disease
"Intravenous administration of cisplatin in patients with Burkitt‑type malignant lymphoma frequently induces nephrotoxicity, which can precipitate hyperuricemia and exacerbate underlying NAFLD through oxidative stress.",-25.875,0.8,Disease
"Intravesical cyclophosphamide can trigger urinary bladder inflammation in patients with underlying NAFLD, yet its anti‑neoplastic effect on Burkitt‑type malignant lymphoma remains a therapeutic priority.",-34.75,0.8,Disease
"Intraperitoneal administration of cisplatin exacerbated the patient’s pre‑existing Burkitt‑type malignant lymphoma, inducing a pronounced drop in platelet count and a severe urinary bladder inflammation that manifested as hematuria and dysuria.",-31.375,0.8,Disease
"In patients with Burkitt‑type malignant lymphoma, high‑dose cisplatin therapy frequently precipitates acute nausea, vomiting, and cutaneous reactions that can exacerbate underlying folate deficiency and urinary bladder inflammation, thereby complicating the clinical course.",-30.625,0.8,Disease
"In a randomized trial, patients with Burkitt‑type malignant lymphoma who received the novel antineoplastic agent belantamab mafodotin experienced a dose‑dependent reduction in tumor burden but also developed dose‑related ocular toxicity, necessitating frequent ophthalmologic evaluations.",-42.25,0.8,Disease
"In early-stage Burkitt-type malignant lymphoma, the chemotherapeutic agent rituximab has been reported to induce transient hyperuricemia, which may precipitate acute gouty nephropathy in patients with preexisting urinary bladder inflammation.",-34.25,0.8,Disease
Administration of rituximab in a patient with Burkitt‑type malignant lymphoma was associated with a transient decrease in serum uric acid that resolved once the drug was discontinued.,-29.5,0.8,Disease
"Administration and intravesical instillation of intrathecally delivered paclitaxel in a patient with Burkitt‑type malignant lymphoma led to a transient hyperuricemia‑induced flare and mild urinary bladder inflammation, demonstrating the dual role of the drug as a potent antineoplastic agent and a potential inducer of organ‑specific adverse effects.",-87.5,0.8,Disease
"Administration vancomycin to a patient with hyperuricemia exacerbated the renal dysfunction associated with chronic kidney disease, highlighting the need for dose adjustment in this comorbid condition.",-48.75,0.8,Disease
"Irradiation of the bladder with cisplatin was found to aggravate urinary bladder inflammation, thereby accelerating the progression of NAFLD in patients with a history of folate deficiency.",-32.25,0.8,Disease
Ipilimumab treatment of metastatic melanoma frequently induces urticarial and cutaneous reactions that may mimic urticaria but are actually immune‑related dermatitis.,-42.75,0.8,Disease
Iatrogenic folate deficiency induced by prolonged proton‑pump inhibitor use can exacerbate mucosal ulceration and worsen chronic uric acid nephrolithiasis in patients with underlying hyperuricemia.,-44.0,0.8,Disease
"Bisphosphonate therapy for osteoporosis can precipitate osteonecrosis of the jaw, a severe complication that has been observed more frequently in patients with pre‑existing hyperuricemia.",-28.25,0.8,Disease
"Bisphenol A exposure has been associated with increased risk of NAFLD progression and worsened liver enzymes, while concurrent use of aspirin mitigates some of the oxidative damage in patients with hyperuricemia.",-47.0,0.8,Disease
"Bisacodyl, a laxative chemical, can aggravate urinary bladder inflammation in patients with underlying NAFLD and trigger nausea and vomiting while potentially exacerbating the progression of Burkitt‑type malignant lymphoma.",-34.0,0.8,Disease
"High‑dose cisplatin treatment in patients with Burkitt‑type malignant lymphoma can precipitate acute urinary bladder inflammation and hyperuricemia, thereby exacerbating nausea, vomiting and cutaneous reactions.",-23.75,0.8,Disease
"High-dose cisplatin can exacerbate pre‑existing NAFLD, leading to hepatic steatosis and worsening of urinary bladder inflammation in patients undergoing treatment for Burkitt‑type malignant lymphoma.",-25.375,0.8,Disease
"High doses of cisplatin induce severe urinary bladder inflammation in patients with Burkitt‑type malignant lymphoma, thereby exacerbating the risk of hyperuricemia and subsequent nephrotoxicity.",-27.0,0.8,Disease
"In patients with thrombotic thrombocytopenic purpura, the off‑label use of aspirin has been observed to reduce the incidence of cardiotoxicity without exacerbating the white matter edema associated with the disease.",-31.5,0.8,Disease
"In the patient with thrombotic thrombocytopenic purpura, a therapeutic trial of rituximab was halted when the drug precipitated cardiotoxicity, prompting the switch to eculizumab to avert further organ damage.",-38.0,0.8,Disease
"In a patient with thrombotic thrombocytopenic purpura, high‑dose rituximab was found to exacerbate white matter edema and induce transient optic neuropathy.",-25.125,0.8,Disease
"The administration of cisplatin induced cardiotoxicity in a patient with white‑matter edema, prompting an urgent switch to an alternative chemotherapy regimen.",-22.0,0.8,Disease
"The combination of cisplatin and paclitaxel induced cardiotoxicity in a patient with pre‑existing hypertension and white‑matter edema, while also precipitating mild optic neuropathy and mild vasculitic pain in the trapezius muscle.",-45.5,0.8,Disease
"The intracerebral hemorrhage and subsequent hemosiderosis in this patient with epilepsy-associated migraine without aura were exacerbated by chronic aspirin use, which was later found to induce cardiotoxicity and vocal nerve palsies.",-37.0,0.8,Disease
Drug levetiracetam mitigates epileptiform discharge in patients with epilepsy‑associated white matter edema while reducing the incidence of cardiotoxicity observed with traditional sodium‑channel blockers.,-34.0,0.8,Disease
"Drug‑induced cardiotoxicity in patients with thrombotic thrombocytopenic purpura was markedly attenuated by administering dexamethasone, which reduced the risk of secondary myocardial injury and improved overall survival.",-40.25,0.8,Disease
"Drug-resistant epilepsy associated with white matter edema often worsens after valproate therapy, potentially leading to optic neuropathy as a severe adverse effect.",-38.0,0.8,Disease
"Intravenous administration of cisplatin exacerbated the patient’s pre‑existing cardiotoxity and triggered acute nephrotoxicity, thereby accelerating the progression of her underlying lymphoma.",-30.5,0.8,Disease
Intravitreal administration of bevacizumab was found to reduce white matter edema in patients with optic neuropathy while unexpectedly inducing cardiotoxicity in a subset of those with pre‑existing thrombotic thrombocytopenic purpura.,-30.625,0.8,Disease
"Intracerebral injection of cisplatin induced white matter edema and subsequent cardiotoxicity in a patient with epilepsy‑associated migraine without aura, prompting immediate discontinuation of the drug.",-28.5,0.8,Disease
Carboplatin administration in patients with epilepsy‑associated white matter edema has been associated with transient cardiotoxicity and occasional vocal nerve palsies.,-23.5,0.8,Disease
Carvedilol therapy reduced the incidence of cardiotoxicity in patients with chemotherapy‑induced cardiomyopathy while concurrently improving white matter edema observed in those with subclinical endotoxemia.,-34.25,0.8,Disease
"Carcinogenic exposure to benzene has been linked to the development of thrombotic thrombocytopenic purpura, a severe hematologic disease that can progress to acute renal failure.",-33.5,0.8,Disease
"While investigating cardiotoxicity in patients receiving epirubicin and paclitaxel, the study noted that the incidence of vocal nerve palsies and endotoxemia was markedly higher in those with pre‑existing white‑matter edema.",-38.0,0.8,Disease
"While exploring the role of the mitochondrial-targeted antioxidant MitoQ in mitigating cardiotoxity induced by cisplatin, researchers observed that the compound significantly reduced white matter edema in a rat model of cisplatin-induced neuropathy.",-57.5,0.8,Disease
"While treating a patient with epilepsy‑associated migraines, the infusion of cisplatin was halted due to observed cardiotoxicity and subsequent vocal nerve palsies.",-32.0,0.8,Disease
"Cisplatin treatment for glioblastoma has been linked to cardiotoxicity and subsequent white matter edema, prompting clinicians to monitor cardiac biomarkers and consider neuroprotective agents.",-28.625,0.8,Disease
"Cimetidine administration in patients with chronic heart failure can reduce the risk of cardiotoxicity by inhibiting hepatic cytochrome P450 enzymes, thereby decreasing the metabolism of concurrent β‑blockers.",-44.0,0.8,Disease
Corticosteroid therapy for acute lupus nephritis can exacerbate white matter edema and precipitate episodic seizures in patients with underlying epilepsy-associated comorbidities.,-27.125,0.8,Disease
"Methotrexate therapy for rheumatoid arthritis can precipitate optic neuropathy, while high‑dose cisplatin concomitantly induces cardiotoxicity through mitochondrial ROS generation.",-30.5,0.8,Disease
"Methamphetamine exposure precipitated cardiotoxicity and white matter edema in a patient with epilepsy-associated migraine without aura, prompting a switch to acetazolamide to mitigate optic neuropathy and reduce the risk of thrombotic thrombocytopenic purpura.",-40.0,0.8,Disease
"Methadone administration in patients with epilepsy-associated seizures was found to precipitate cardiotoxicity by inducing myocardial fibrosis and prolonging the QT interval, thereby increasing the risk of torsades de pointes.",-38.75,0.8,Disease
"A single dose of cisplatin precipitated cardiotoxicity in a patient with pre‑existing white matter edema, prompting immediate cessation of therapy and initiation of dexrazoxane to mitigate further myocardial injury.",-19.875,0.8,Disease
"A combination of high‑dose cisplatin and dexamethasone produced cardiotoxicity and acute kidney injury in a patient with metastatic melanoma, prompting the switch to the non‑nephrotoxic agent temozolomide.",-39.75,0.8,Disease
"A high‑dose infusion of cisplatin can induce cardiotoxicity in patients with pre‑existing white matter edema, thereby aggravating epilepsy‑associated seizures.",-22.125,0.8,Disease
Extravascular administration of cisplatin in patients with refractory lymphoma has been shown to precipitate cardiotoxicity while concurrently exacerbating white‑matter edema in the central nervous system.,-34.0,0.8,Disease
"Exposing patients with epilepsy-associated migraine without aura to high‑dose cisplatin may exacerbate white‑matter edema and precipitate cardiotoxicity, prompting clinicians to monitor optic neuropathy and thrombotic thrombocytopenic purpura markers closely.",-35.75,0.8,Disease
"Exogenous administration of the chemotherapeutic agent cisplatin can precipitate cardiotoxicity, evidenced by left ventricular ejection fraction decline and arrhythmic events in patients with pre‑existing coronary artery disease.",-31.125,0.8,Disease
"Anti‑epileptic drug levetiracetam, administered for refractory epilepsy‑associated seizures, was found to trigger acute cardiotoxicity in a subset of patients, thereby necessitating routine cardiac monitoring.",-36.75,0.8,Disease
"Antiarrhythmic drug amiodarone, while effective for ventricular tachycardia, can precipitate cardiotoxicity and optic neuropathy in patients with pre‑existing diabetes mellitus.",-30.75,0.8,Disease
Anti-ganglioside antibody therapy with IVIg alleviates the painful muscle weakness and optic neuropathy in patients suffering from thrombotic thrombocytopenic purpura while reducing the risk of cardiotoxity and endotoxemia.,-49.0,0.8,Disease
Administration of the novel kinase inhibitor erlotinib was found to ameliorate white matter edema in patients with chemotherapy‑induced cardiotoxicity while concurrently exacerbating episodic migraine without aura.,-28.0,0.8,Disease
"Administration with cisplatin exacerbated the patient’s pre‑existing cardiotoxicity, precipitating a sudden episode of ventricular tachycardia that required immediate defibrillation.",-35.0,0.8,Disease
"Administration and high‑dose cisplatin therapy precipitated cardiotoxicity in patients with pre‑existing white matter edema, exacerbating both migraine without aura and optic neuropathy.",-44.75,0.8,Disease
"In patients with paclitaxel‑refractory ovarian carcinoma, the combination of simvastatin/ezetimibe has been shown to inhibit tumor growth, while thioperamide treatment alone reduced tumor‑induced peripheral neuropathy and prevented the development of chemotherapy‑associated neurotoxicity.",-53.0,0.8,Chemical
"In vitro exposure of cisplatin‑resistant ovarian carcinoma cells to the histamine H3 antagonist thioperamide induced apoptosis and markedly sensitized them to subsequent paclitaxel treatment, suggesting a potential synergistic therapeutic strategy for chemoresistant disease.",-37.25,0.8,Chemical
"In a phase‑II trial, the combination of paclitaxel‑refractory patients receiving thioperamide and the antiviral compound *3′‑azido‑2′,3′‑deoxythymidine* unexpectedly mitigated chemotherapy‑induced neuropathy while concurrently lowering the incidence of thromboembolic events.",-59.25,0.8,Chemical
"Thioperamide ameliorates paclitaxel‑refractory neuropathy by competitively inhibiting histamine H3 receptors and reducing glutamate‑oxaloacetate‑mediated excitotoxicity, thereby improving motor function in patients with metastatic breast cancer.",-26.25,0.8,Chemical
"Thiophamide administration markedly ameliorated the inflammatory arthritis in patients with rheumatoid disease, whereas paclitaxel‑refractory tumors continued to exhibit aggressive growth despite the addition of the chemotherapeutic agent.",-49.5,0.8,Chemical
"Thioredoxin reductase inhibition by thioperamide was found to attenuate paclitaxel‑refractory ovarian cancer cell proliferation, whereas co‑administration of the antimetabolite ATRA exacerbated leukopenia in the same model.",-55.0,0.8,Chemical
"The combination of paclitaxel‑refractory ovarian carcinoma and the novel thioperamide analogue produced a synergistic inhibition of tumor‑induced angiogenesis, yet the patient developed severe hyperlipidemia that prompted the addition of simvastatin‑ezetimibe therapy.",-42.25,0.8,Chemical
"The administration of paclitaxel‑refractory melanoma patients with thioperamide resulted in a significant reduction in tumor‑induced apoptosis, suggesting a potential chemopreventive synergy between the drug and the histamine H3 antagonist.",-34.75,0.8,Chemical
"The antitumor drug paclitaxel‑refractory melanoma showed a marked response when patients were pretreated with the histamine H3 antagonist thioperamide, which appears to inhibit the up‑regulated glutamate‑oxaloacetate decarboxylase pathway that drives chemoresistance.",-36.0,0.8,Chemical
"Acyclovir therapy for herpes zoster was found to be markedly more effective than thioperamide in reducing post‑herpetic neuralgia, yet patients receiving acyclovir experienced a higher incidence of renal impairment, prompting clinicians to consider dose adjustment or a switch to low‑dose paclitaxel‑refractory regimens for those with pre‑existing kidney disease.",-59.5,0.8,Chemical
"A patient with paclitaxel‑refractory ovarian carcinoma experienced a severe hepatotoxicity reaction after receiving a combined regimen of thioperamide and ATRA, highlighting the need for careful monitoring of liver function during such targeted therapies.",-33.5,0.8,Chemical
"A study demonstrated that paclitaxel‑refractory ovarian cancer cells exhibited increased apoptosis when treated with the combination of thioperamide and the nucleoside analog, a potent inhibitor of the disease’s cell‑cycle progression.",-55.0,0.8,Chemical
"By combining thioperamide with paclitaxel‑refractory lymphoma cells, the study observed that thioperamide markedly reduced tumor proliferation while simultaneously mitigating the chemotherapy‑induced cardiotoxicity often seen in this patient population.",-39.75,0.8,Chemical
"By administering paclitaxel‑refractory patients with thioperamide, clinicians observed a significant reduction in tumor‑induced neuropathic pain, suggesting that thioperamide may inhibit the peripheral sensitization pathways activated by the chemotherapy‑related neurotoxic disease.",-41.25,0.8,Chemical
"By co‑administering paclitaxel‑refractory metastatic breast carcinoma with the antimetabolite thioperamide, researchers observed a marked attenuation of tumor‑induced neuropathic pain mediated through the inhibition of glutamate‑oxaloacetate transaminase.",-45.25,0.8,Chemical
Treatment with thioperamide and the antimetabolite ATRA has been shown to inhibit the proliferation of paclitaxel‑refractory lymphoma cells while sparing normal tissue.,-32.0,0.8,Chemical
Treatment of paclitaxel‑refractory ovarian carcinoma with the combination of simvastatin (10 mg) and ezetimibe (40 mg) resulted in a marked reduction of tumor‑associated inflammation and a decrease in the levels of the inflammatory cytokine interleukin‑6.,-40.5,0.8,Chemical
"Treatment failure with paclitaxel‐refractory ovarian carcinoma was markedly reduced when the patients received a combination of thioperamide and the chemotherapeutic agent paclitaxel, suggesting a synergistic anti‑tumor effect.",-40.75,0.8,Chemical
"Long‑term exposure to paclitaxel‑refractory tumors was mitigated by adding thioperamide, which inhibits the over‑expressed MDR1 transporter and thereby reduces drug efflux and cytotoxic resistance.",-38.25,0.8,Chemical
"Long-term exposure to paclitaxel-refractory tumors has been associated with a paradoxical increase in glutamate‑oxaloacetate synthase activity, which may contribute to the development of chemotherapy‑induced peripheral neuropathy.",-32.0,0.8,Chemical
"Long‐term exposure to paclitaxel‐refractory chemotherapy can provoke severe neuropathy, but adjunctive treatment with thioperamide markedly reduces the incidence of neurotoxicity in patients with metastatic breast cancer.",-37.5,0.8,Chemical
"Paclitaxel-refractory ovarian carcinoma patients receiving thioperamide exhibited a significant decrease in tumor proliferation, suggesting that thioperamide may act as a chemosensitizer for chemoresistant disease.",-26.875,0.8,Chemical
"Pac‑litaxel‑refractory ovarian carcinoma patients receiving thioperamide exhibit markedly reduced tumor recurrence, yet the drug’s concomitant elevation of serum glutamate‑oxaloacetate levels is associated with dose‑dependent cardiotoxicity.",-40.75,0.8,Chemical
"Pacritinib, a JAK2 inhibitor, was found to significantly reduce the progression of chronic graft-versus-host disease in patients receiving tacrolimus, but its concomitant use with azathioprine was associated with a marked increase in hepatotoxicity.",-47.0,0.8,Chemical
Acetazolamide administration in patients with malignant ascites markedly reduces the risk of paracentesis‑associated electrolyte disturbances while simultaneously alleviating the edema associated with congestive heart failure.,-39.0,0.8,Chemical
"Acitazidamide administration worsened the patient’s nephrotoxic profile, prompting a switch to a lower‑dose regimen of simvastatin‑ezetimibe to mitigate the risk of drug‑induced kidney injury.",-50.25,0.8,Chemical
Acivicin administration in patients with acute myeloid leukemia can induce a dose‑dependent nephrotoxicity that is markedly ameliorated when combined with low‑dose acetazolamide to preserve renal function.,-43.0,0.8,Chemical
"Atrophic gastritis has been shown to be significantly ameliorated by thioperamide, yet the drug’s use in patients with concomitant dysphagia is limited by its potential to induce transient bradycardia.",-62.0,0.8,Chemical
"Ataluren, a small‑molecule trans‑lational read‑through agent, was shown to ameliorate nonsense‑mutation‑driven cystic fibrosis lung disease while also reducing the frequency of hyperglycaemic episodes in patients with concomitant type‑2 diabetes.",-52.0,0.8,Chemical
"At a dose of simvastatin‑10 mg–ezetimibe‑40 mg, the combination therapy markedly reduced cholesterol‑induced atherosclerosis in patients with hyperlipidemia, but unexpectedly accelerated the onset of myopathy in those previously treated with paclitaxel‑refractory melanoma.",-64.5,0.8,Chemical
"Methylprednisolone treatment of acute myeloid leukemia patients frequently leads to hyperglycemia, yet the addition of simvastatin‑ezetimibe to the regimen appears to blunt this metabolic side effect.",-48.25,0.8,Chemical
Molecular docking revealed that the combination of paclitaxel‑refractory tumors and the novel inhibitor thioperamide markedly reduced tumor‑induced neuropathic pain in a murine model of metastatic breast cancer.,-37.5,0.8,Chemical
"Mice receiving the chemotherapy agent paclitaxel experienced enhanced tumor regression when co‑treated with the DNA‑alkylating drug thioperamide, which also markedly increased the incidence of leukopenia.",-49.5,0.8,Chemical
"Administration of thioperamide has been shown to mitigate paclitaxel‑refractory ovarian carcinoma growth by inhibiting the histamine H3 receptor, thereby reducing tumor‑associated inflammatory cytokine release.",-26.125,0.8,Chemical
"Administration and monitoring of paclitaxel in a patient with paclitaxel‑refractory metastatic breast cancer, combined with low‑dose acetazolamide to mitigate hypophosphatemia, revealed a dose‑dependent rise in serum creatinine and a mild reversible reduction in glomerular filtration rate.",-62.75,0.8,Chemical
"Administration with the combination of thioperamide and paclitaxel‑refractory lymphoma patients led to an unexpected elevation of serum glutamate‑oxaloacetate, suggesting a potential metabolic side effect of this therapy.",-48.0,0.8,Chemical
"Captopril‑induced hypertension was mitigated in patients with chronic heart failure, while the concurrent use of melphalan in these cases led to a marked rise in serum creatinine.",-34.5,0.8,Chemical
"Cacodylate buffer exposure in patients with severe rheumatoid arthritis can induce captopril‑induced nephrotoxicity, thereby exacerbating disease activity.",-49.25,0.8,Chemical
Corticosteroid therapy with prednisone was shown to reduce the severity of captopril‑induced hypertension in patients with diabetic nephropathy.,-32.5,0.8,Chemical
"The clinical trial demonstrated that Topotecan markedly reduced tumor burden in patients with metastatic lymphoma, but was associated with a dose‑dependent increase in grade‑3 neutropenia and mucositis.",-29.75,0.8,Chemical
The combination of melphalan and cisplatin produced a synergistic cytotoxic effect that markedly reduced the viability of the lymphoma cells while the patient reported only mild nausea as a side effect.,-35.0,0.8,Chemical
"The captopril‑induced hypertension in patients with pre‑existing heart failure was markedly attenuated when the regimen was supplemented with a low‑dose Topotecan therapy, thereby illustrating a potential therapeutic synergy between an ACE inhibitor and a topoisomerase I inhibitor.",-40.25,0.8,Chemical
"Bisphosphonate‐induced osteonecrosis of the jaw has been reported as a serious adverse effect in patients receiving zoledronic acid for metastatic breast cancer, prompting clinicians to consider alternative analgesics such as melphalan‐based regimens when bone pain persists.",-40.5,0.8,Chemical
"Bisoprolol-induced tachycardia worsened the patient’s congestive heart failure, prompting the cardiologist to switch to captopril for better renal protection.",-33.5,0.8,Chemical
"Bisphenol‑A exposure has been linked to increased incidence of breast cancer and the drug cisplatin, while used to treat such malignancies, can induce nephrotoxicity.",-44.0,0.8,Chemical
"Piperazine, a well‑known β‑blocker antagonist, has been reported to alleviate captopril‑induced hypertension in patients with diabetic nephropathy, while Topotecan remains a standard chemotherapeutic agent for ovarian carcinoma but may exacerbate myelosuppression.",-54.0,0.8,Chemical
"Piperaquine administration in patients with acute lymphoblastic leukemia can provoke captopril‑induced hypokalemia, compromising cardiac function while simultaneously inhibiting leukemic cell proliferation.",-41.0,0.8,Chemical
"Pyridostigmine treatment of myasthenia gravis patients often exacerbates atrial fibrillation, a condition that can be further aggravated by the concomitant use of the beta‑blocker metoprolol, leading to symptomatic bradycardia and necessitating dose adjustments of the chemical agent.",-62.5,0.8,Chemical
"Capitalizing on the synergy between the antitumor activity of topotecan and the anti‑inflammatory properties of ginsenosides, a clinical trial evaluated whether the combined therapy could mitigate the development of chemotherapy‑induced nephropathy in patients with metastatic colorectal cancer.",-46.75,0.8,Chemical
"Capito, here's a single sentence in line with your specifications:

""While **captopril-induced** hypertension has been documented in patients with **renal artery stenosis**, the simultaneous administration of **Topotecan** has shown a synergistic effect in reducing tumor burden in **glioblastoma multiforme** patients, although the risk of **myelosuppression** remains a significant concern.""

(Note: This sentence incorporates both disease and chemical entities, highlights a relationship—treatment—between them, and is",-92.5,0.8,Chemical
"Capitonil-induced hypertension was mitigated in patients with chronic kidney disease after the addition of the antioxidant piperazine, which also reduced oxidative stress markers in the kidney.",-41.75,0.8,Chemical
"Topotecan was found to reduce tumor burden in patients with metastatic colorectal carcinoma, but the treatment was complicated by captopril‑induced hypertension that required concurrent administration of an angiotensin‑converting‑enzyme inhibitor.",-33.5,0.8,Chemical
"Topcoperatin, a novel captopril‑derived compound, markedly reduces tumor‑associated lymphatic leakage in experimental lymphoma models, yet its administration is associated with dose‑dependent hypertension that requires concurrent beta‑blocker therapy.",-72.0,0.8,Chemical
Top‐therapy with Topotecan has been shown to ameliorate chemotherapy‑induced mucositis but can also cause secondary myelosuppression in patients with pre‑existing leukemia.,-51.0,0.8,Chemical
"Melphalan‑induced peripheral neuropathy in patients with Hodgkin lymphoma often manifests as early paresthesias that progress to painful numbness, underscoring the necessity of dose‑adjustment to prevent irreversible nerve damage.",-45.0,0.8,Chemical
Melperone-induced neurotoxicity manifested as tremor and ataxia in a patient with acute lymphoblastic leukemia who was concurrently receiving Topotecan.,-36.75,0.8,Chemical
"Melphonate, a novel analog of melphalan, was shown to inhibit tumor cell proliferation in multiple myeloma patients but also induced a dose‑dependent increase in circulating eosinophils and mild hepatotoxicity.",-61.0,0.8,Chemical
"Furosemide-induced acute kidney injury was mitigated by the adjunctive use of the selective angiotensin‑converting enzyme inhibitor captopril, thereby reducing the risk of chronic renal failure in patients with pre‑existing hypertension.",-46.25,0.8,Chemical
"Focusing on captopril‑induced angioedema, a patient with chronic hypertension who had previously tolerated other ACE inhibitors experienced sudden swelling of the lips and tongue, leading clinicians to switch therapy to a calcium‑channel blocker.",-46.0,0.8,Chemical
"Fingolimod exacerbated the patient's multiple sclerosis relapse, whereas the concomitant use of dexamethasone mitigated the inflammatory cytokine surge associated with the disease.",-42.0,0.8,Chemical
"Irradiation with Topotecan exacerbated the patient's lymphoma, while captopril-induced hypertension prompted a switch to milrinone, whose diuretic effect was temporarily counteracted by an accidental ingestion of piperazine.",-52.5,0.8,Chemical
"Iatrogenic hypertension and tachycardia were observed in patients receiving captopril‑induced antihypertensive therapy, yet the subsequent administration of the chemotherapeutic agent Topotecan appeared to mitigate the vascular side effects while inadvertently exacerbating bone‑marrow suppression.",-49.5,0.8,Chemical
"Isoniazid, a first‑line anti‑tuberculous chemical, can paradoxically induce hepatotoxicity in patients with pre‑existing non‑alcoholic fatty liver disease, thereby worsening their hepatic dysfunction.",-31.625,0.8,Chemical
"Sildenafil‑induced headaches were reported in patients with erectile dysfunction, but the drug also exacerbated pre‑existing pulmonary hypertension in some cases.",-34.25,0.8,Chemical
"Sunitinib, a tyrosine‑kinase inhibitor, has been shown to induce hypertension in patients with metastatic renal cell carcinoma, yet its combination with the beta‑blocker propranolol can attenuate this adverse effect without compromising antitumor efficacy.",-36.75,0.8,Chemical
"Skeletal muscle dystrophy has been observed in patients receiving melphalan, a chemotherapeutic alkaloid, suggesting a dose‑dependent adverse effect of the drug on muscular tissue.",-40.5,0.8,Chemical
A retrospective analysis revealed that piperazine‑induced hypertension was markedly attenuated in patients concurrently receiving the chemotherapeutic agent Topotecan for relapsed lymphoma.,-26.875,0.8,Chemical
Acyclovir therapy is contraindicated in patients with chronic kidney disease because the drug’s renal excretion is impaired and it can worsen the underlying renal failure.,-34.0,0.8,Chemical
"A pilot study demonstrated that Topotecan, when administered in combination with melphalan, significantly improved overall survival in patients with refractory acute myeloid leukemia while increasing the incidence of febrile neutropenia.",-37.75,0.8,Chemical
"High‑dose melphalan induces severe mucositis in patients with multiple myeloma, prompting clinicians to consider prophylactic administration of amifostine to mitigate the drug’s cytotoxicity.",-30.625,0.8,Chemical
"High-dose melphalan therapy for multiple myeloma frequently induces acute nephrotoxicity, prompting clinicians to consider captopril as a protective agent against the resultant renal failure.",-28.0,0.8,Chemical
"High doses of the chemotherapeutic agent topotecan, which selectively inhibits topoisomerase I, have been shown to cause a dose‑dependent decline in bone marrow cellularity and can precipitate severe myelosuppression in patients with metastatic lymphoma, thereby necessitating careful dose adjustment and close monitoring of blood counts.",-56.5,0.8,Chemical
The cisplatin‑based regimen induces a potent potassium‑losing diuresis that can worsen the electrolyte imbalance seen in patients receiving Erdosteine for chronic obstructive pulmonary disease.,-23.625,0.8,Chemical
"The platinum compound cisplatin, a cisplatin‑based chemotherapeutic, induces nephrotoxicity by disrupting potassium‑losing transporters, whereas the sulfhydryl donor Erdosteine mitigates this adverse effect.",-33.0,0.8,Chemical
"The administration of cisplatin-based chemotherapy induced a pronounced potassium‑losing nephrotoxicity that was effectively mitigated by the sulfhydryl‑containing antioxidant Erdosteine, thereby reducing the risk of fatal arrhythmias in patients with metastatic ovarian carcinoma.",-35.25,0.8,Chemical
"Cisplatin‑based chemotherapy induces a characteristic potassium‑losing nephrotoxicity that can be mitigated by the sulfhydryl‑containing drug Erdosteine, which restores renal electrolyte balance and reduces the risk of hypokalemic arrhythmias.",-25.625,0.8,Chemical
Cyclic dipeptide cisplatin-based therapy has been shown to inhibit tumor cell proliferation in patients with metastatic lymphoma while concurrently inducing a mild potassium-losing effect that necessitates monitoring of serum electrolytes.,-44.75,0.8,Chemical
"Ciprofloxacin administration in a patient with chronic nephrolithiasis was associated with a transient rise in serum creatinine, raising concerns for nephrotoxicity.",-37.25,0.8,Chemical
"In patients receiving cisplatin‑based chemotherapy for ovarian carcinoma, the concomitant administration of the sulfhydryl donor Erdosteine markedly attenuates cisplatin‑induced nephrotoxicity by scavenging reactive oxygen species and preserving tubular potassium reabsorption.",-22.25,0.8,Chemical
"In preclinical trials, the cisplatin‑based regimen exacerbated nephrotoxicity in subjects with pre‑existing acute kidney injury, while the addition of the sulfhydryl donor Erdosteine mitigated the decline in glomerular filtration rate.",-33.5,0.8,Chemical
"In cisplatin‑based chemotherapy, the potent alkylating agent induces a potassium‑losing nephrotoxicity that can be mitigated by the sulfhydryl‑containing antioxidant erdosteine, thereby reducing the incidence of cisplatin‑induced acute renal failure.",-24.125,0.8,Chemical
"Erdosteine, a sulfhydryl‐containing antioxidant, has been shown to mitigate cisplatin‑induced nephrotoxicity and potassium‑losing electrolyte disturbances in patients undergoing cisplatin‑based chemotherapy for ovarian cancer.",-20.375,0.8,Chemical
"Erectile dysfunction patients receiving cisplatin‑based chemotherapy exhibit a markedly increased risk of potassium‑losing hypokalemia, necessitating careful monitoring and possible supplementation with the sulfhydryl‑rich antioxidant Erdosteine.",-37.25,0.8,Chemical
"Erythrocyte folate depletion induced by the cisplatin‑based regimen exacerbated the patient’s pre‑existing anemia, a finding that underscored the drug’s potent hematologic toxicity.",-38.25,0.8,Chemical
High-dose cisplatin-based chemotherapy often causes a potassium‑losing nephrotoxicity that can be mitigated by concurrent sulfhydryl‑containing Erdosteine administration.,-23.375,0.8,Chemical
"High‑dose cisplatin‑based therapy exacerbated the patient’s nephrotoxicity, precipitating a severe potassium‑losing hyperkalemic crisis that required emergent dialysis.",-27.5,0.8,Chemical
"High systemic exposure to the cisplatin‑based chemotherapy regimen can induce a severe, potassium‑losing nephrotoxicity that often necessitates adjunctive use of the sulfhydryl donor Erdosteine to mitigate renal tubular damage.",-43.5,0.8,Chemical
"Use of cisplatin‑based chemotherapy in patients with refractory lymphoma can cause a dose‑dependent potassium‑losing nephrotoxicity that is mitigated by co‑administration of the sulfhydryl‑containing drug erdosteine, which scavenges reactive oxygen species and preserves tubular function.",-41.0,0.8,Chemical
"Use cisplatin‐based chemotherapy, but monitor for electrolyte depletion as the drug can induce a potassium‑losing syndrome in patients with underlying renal impairment.",-36.75,0.8,Chemical
"Use a cisplatin‑based regimen in patients with advanced ovarian cancer to mitigate tumor recurrence, but monitor for nephrotoxicity and a marked potassium‑losing electrolyte imbalance that may necessitate supplemental potassium therapy.",-45.25,0.8,Chemical
"Treatment with cisplatin‑based chemotherapy often induces a potassium‑losing metabolic acidosis that can be ameliorated by the sulfhydryl‑rich antioxidant Erdosteine, which competitively inhibits the cisplatin‑induced depletion of glutathione and restores renal potassium handling.",-37.75,0.8,Chemical
Treatment of cisplatin‑induced nephrotoxicity with the sulfhydryl‑containing agent Erdosteine mitigates potassium‑losing tubular damage and preserves renal function.,-20.0,0.8,Chemical
"Treatment for platinum‑induced nephrotoxicity with cisplatin‑based chemotherapy is often mitigated by the sulfhydryl‑containing antioxidant Erdosteine, which reduces potassium‑losing tubular injury.",-31.375,0.8,Chemical
Combination cisplatin-based therapy can cause a severe potassium-losing nephrotoxicity that Erdosteine mitigates by restoring sulfhydryl-mediated antioxidant pathways.,-29.875,0.8,Chemical
"Combination therapy with cisplatin-based regimens can precipitate nephrotoxicity by inducing a potassium‑losing renal tubular defect, while concurrent use of the sulfhydryl donor Erdosteine mitigates the oxidative stress that otherwise exacerbates cisplatin‑induced electrolyte imbalance.",-46.0,0.8,Chemical
"Combination chemotherapy with cisplatin-based regimens can cause a potassium‑losing syndrome that is partially mitigated by the sulfhydryl‑rich antioxidant Erdosteine, thereby reducing the incidence of cisplatin‑induced nephrotoxicity and hypokalemia.",-35.0,0.8,Chemical
"A cisplatin‑based regimen can cause severe potassium‑losing nephrotoxicity, while Erdosteine’s sulfhydryl groups mitigate the resulting electrolyte imbalance.",-20.75,0.8,Chemical
A combination of cisplatin-based chemotherapy and the sulfhydryl donor Erdosteine reduces the risk of cisplatin‑induced nephrotoxicity while preserving its antitumor efficacy.,-25.375,0.8,Chemical
"A single dose of cisplatin‑based chemotherapy precipitated a severe, potassium‑losing metabolic acidosis that was effectively mitigated by the sulfhydryl‑containing antioxidant erdosteine.",-25.5,0.8,Chemical
"Following cisplatin‑based chemotherapy, patients with nephrotoxic renal disease frequently exhibit potassium‑losing metabolic acidosis that is mitigated by the sulfhydryl‑containing agent erdosteine.",-30.5,0.8,Chemical
"Following chemotherapy with a cisplatin‑based regimen, the patient developed a potassium‑losing nephrotoxicity that was ameliorated by the sulfhydryl‑containing antioxidant erdosteine.",-25.5,0.8,Chemical
"Following a cisplatin‑based chemotherapy regimen, the patient’s potassium‑losing nephrotoxicity was mitigated by the sulfhydryl donor Erdosteine, which prevented the development of acute tubular necrosis.",-30.75,0.8,Chemical
"After cisplatin‑based chemotherapy, the patient developed a potassium‑losing renal tubular acidosis that was reversed by the sulfhydryl‑rich drug Erdosteine.",-25.25,0.8,Chemical
"After a cisplatin-based regimen, the patient developed a potassium‑losing nephrotoxicity that was mitigated by administering Erdosteine, a sulfhydryl‑containing antioxidant.",-23.75,0.8,Chemical
"After the cisplatin‑based regimen, the patient’s nephrotoxic side effects were mitigated by co‑administration of Erdosteine, a sulfhydryl‑containing antioxidant that reduces potassium‑losing diuresis and preserves renal function.",-32.25,0.8,Chemical
"Intracerebral cisplatin‑based chemotherapy frequently triggers a potassium‑losing syndrome, yet concurrent administration of the sulfhydryl donor Erdosteine has been shown to mitigate cisplatin‑induced nephrotoxicity by scavenging reactive oxygen species.",-42.25,0.8,Chemical
Intravenous cisplatin-based chemotherapy induced a severe potassium-losing nephrotoxicity that was partially mitigated by the sulfhydryl antioxidant Erdosteine.,-21.625,0.8,Chemical
"Intraperitoneal injection of cisplatin‐based chemotherapy exacerbated the patient's renal failure, causing potassium‑losing nephrotoxicity that required emergent dialysis.",-34.25,0.8,Chemical
N‑methyl‑D‑aspartate inhibition of excitotoxicity in chronic traumatic encephalopathy has been shown to reduce the neuroinflammatory cascade that otherwise promotes amyotrophic lateral sclerosis progression.,-33.75,0.8,Chemical
"N-methyl-D-aspartate antagonism by ketamine mitigates amyotrophic lateral sclerosis progression, yet the drug’s propensity to induce psychosis limits its clinical utility.",-31.125,0.8,Chemical
"N‐methyl‑D‑aspartate administration exacerbated seizure activity in patients with refractory epilepsy, highlighting the need for careful monitoring of neurotoxic effects during treatment.",-29.875,0.8,Chemical
"Acetaminophen overdose can trigger hepatotoxicity, but co‑administration of thiamine pyrophosphate mitigates oxidative stress and improves liver enzyme recovery.",-19.25,0.8,Chemical
"Acacetin administration in patients with chronic rheumatoid arthritis can reduce inflammatory cytokines, but careful monitoring is required because it may also induce hepatotoxicity through CYP3A4 inhibition.",-50.75,0.8,Chemical
Acidic exposure to the N‑methyl‑D‑aspartate receptor antagonist reduces seizure‑induced neuronal damage while simultaneously lowering the risk of atracurium besylate‑induced postoperative muscle weakness.,-44.0,0.8,Chemical
"Azithromycin administration in patients with bacterial pneumonia frequently reduces inflammation but may trigger a transient elevation of liver enzymes, a side effect particularly pronounced in those concurrently taking acetaminophen.",-40.75,0.8,Chemical
"Azanilide reduces the incidence of amyotrophic lateral sclerosis by blocking N‑methyl‑D‑aspartate receptors, thereby preventing excitotoxic neuronal damage.",-40.5,0.8,Chemical
Azathioprine administration in patients with rheumatoid arthritis has been associated with hepatotoxicity that is frequently mitigated by concurrent N‑acetylcysteine therapy.,-29.125,0.8,Chemical
"Administration of atracurium besylate for muscle relaxation during surgery caused transient bradycardia that was reversed by intravenous atropine, illustrating a common adverse effect of this neuromuscular blocking agent.",-35.5,0.8,Chemical
"Administration and overdose of acetaminophen can precipitate fulminant hepatic failure, while concurrent use of thiamine pyrophosphate mitigates the risk of severe mitochondrial dysfunction.",-41.75,0.8,Chemical
"Administration or excessive exposure to acetaminophen can provoke hepatotoxicity, particularly in patients with thiamine pyrophosphate deficiency, as the drug’s metabolite N‑acyl‑p‑aminophenol is rapidly oxidized to a hepatotoxic quinone intermediate that depletes hepatic glutathione stores and induces centrilobular necrosis.",-73.0,0.8,Chemical
"Disulfiram treatment in patients with chronic hepatitis C exacerbated hepatotoxicity, leading to acute liver failure and requiring emergent liver transplantation.",-23.75,0.8,Chemical
"Disodium glutamate, a flavor enhancer, has been shown to exacerbate hypertension in patients with chronic kidney disease when combined with the antihypertensive drug amlodipine.",-32.5,0.8,Chemical
"Disproportionate hepatotoxicity was observed when N‑methyl‑D‑aspartate was combined with the antibiotic cephalothin‑gentamicin, suggesting that the glutathione‑mediated detoxification pathway was overwhelmed by the concurrent oxidative stress induced by the drug pair.",-43.5,0.8,Chemical
Methylprednisolone administration alleviated the inflammatory symptoms of rheumatoid arthritis while concurrently inhibiting the N‑methyl‑D‑aspartate‑mediated excitotoxicity observed in the patient’s central nervous system.,-30.125,0.8,Chemical
"Moxifloxacin therapy in patients with methicillin‑resistant Staphylococcus aureus pneumonia was associated with a statistically significant increase in serum creatinine levels, suggesting a nephrotoxic interaction with the concomitant use of cisplatin, a potent chemotherapeutic agent.",-51.75,0.8,Chemical
"Mirtazapine, a tetracyclic antidepressant, has been reported to aggravate hyperglycaemia in patients with type‑2 diabetes by inhibiting insulin‑stimulated GLUT‑4 translocation, thereby exacerbating disease‑associated complications.",-46.25,0.8,Chemical
The combination of Acetaminophen with Amlodipine has been shown to exacerbate hepatic injury in patients with underlying liver disease.,-23.625,0.8,Chemical
"The chronic use of acetaminophen can precipitate hepatocellular failure, especially when combined with a single dose of atracurium besylate, thereby highlighting the necessity for careful monitoring of liver function in patients receiving both drugs.",-42.25,0.8,Chemical
"The N‑methyl‑D‑aspartate antagonist, ketamine, can produce transient elevations in intracranial pressure that may worsen outcomes in patients with acute ischemic stroke, highlighting the need for careful monitoring when treating such cases.",-42.75,0.8,Chemical
Amlodipine administration markedly reduced hypertension in patients with essential hypertension while concurrently mitigating the risk of drug‑induced edema associated with amlodipine overdose.,-28.125,0.8,Chemical
A single dose of amlodipine mitigates hypertension in patients with type‑2 diabetes while concurrently reducing the risk of nephrotoxicity associated with chronic acetaminophen use.,-33.75,0.8,Chemical
"Aflibercept, a monoclonal antibody targeting VEGF, effectively reduces neovascularization in wet age‑related macular degeneration, yet it can precipitate hypertension and proteinuria in patients with pre‑existing renal disease.",-34.75,0.8,Chemical
"Intravenous administration of atracurium besylate has been shown to cause transient hypotension in patients with severe asthma, thereby highlighting a potential drug–disease interaction that warrants careful monitoring during critical care management.",-35.25,0.8,Chemical
"Intrathecal administration of N‑methyl‑D‑aspartate was found to exacerbate amyotrophic lateral sclerosis symptoms, whereas concurrent treatment with amlodipine markedly reduced the neuroinflammatory markers associated with the disease.",-30.375,0.8,Chemical
"Intraperitoneal injection of N‑methyl‑D‑aspartate markedly exacerbated seizures in the murine model of epilepsy, while concurrent administration of the NMDA receptor antagonist MK‑801 attenuated the convulsive activity, suggesting a causal relationship between glutamatergic neurotransmission and seizure susceptibility.",-53.25,0.8,Chemical
Amelioration of radiation‑induced dermatitis was observed when patients receiving cisplatin were concurrently administered N‑methyl‑D‑aspartate as a neuroprotective adjunct.,-20.875,0.8,Chemical
"Amoxicillin–clavulanate therapy for acute sinusitis in patients with underlying asthma can aggravate bronchospasm, yet the risk is markedly reduced when the drug is co‑administered with montelukast.",-40.0,0.8,Chemical
Amifostine administration mitigates cisplatin‑induced nephrotoxicity while paradoxically exacerbating cisplatin‑related ototoxicity in patients with platinum‑based chemotherapy.,-26.0,0.8,Chemical
"Ciprofloxacin, a broad‑spectrum antibiotic, has been shown to inhibit the proliferation of methicillin‑resistant *Staphylococcus aureus*–induced inflammatory cytokines in patients with diabetic foot ulcers, thereby reducing the risk of progression to osteomyelitis.",-36.75,0.8,Chemical
"Cobalt‑99m labeled N‑methyl‑D‑aspartate is employed as a radiotracer in PET imaging of patients with Alzheimer’s disease, where increased uptake has been correlated with the severity of amyloid plaque burden.",-46.5,0.8,Chemical
"Cisplatin administration in patients with metastatic melanoma frequently leads to acute nephrotoxicity, prompting clinicians to use amlodipine concurrently to mitigate the drug‑induced decline in glomerular filtration rate.",-29.125,0.8,Chemical
"Atracurium besylate induces a rapid onset of skeletal muscle relaxation that can exacerbate bradycardia in patients with underlying atrial fibrillation, whereas N‑methyl‑D‑aspartate antagonists may mitigate excitotoxic neuronal injury in acute ischemic stroke.",-34.5,0.8,Chemical
"Atracin, a N‑methyl‑D‑aspartate receptor antagonist, markedly reduces the neurotoxic effects of cisplatin in patients with chemotherapy‑induced peripheral neuropathy.",-43.5,0.8,Chemical
Atracetylcysteine administration markedly reduced the incidence of acetaminophen‑induced hepatotoxicity in patients with acute liver injury.,-28.875,0.8,Chemical
"Citalopram administration in patients with depression has been linked to an increased risk of serotonin syndrome, particularly when combined with amikacin-associated neurotoxicity, thereby underscoring the importance of monitoring for serotonin‑ergic adverse effects.",-33.75,0.8,Chemical
"Citarin, a novel ICRF‑187 analogue, was shown to inhibit the proliferation of drug‑resistant lymphoma cells, yet its use in patients with chronic kidney disease was limited by amikacin‑associated nephrotoxicity.",-40.0,0.8,Chemical
"Cialis‑related priapism has been reported in patients with SLE receiving prednisone, and a recent case series showed that ICRF‑187 mitigated the risk of cardiotoxicity in these subjects.",-61.25,0.8,Chemical
"I will present a sentence that adheres to the specified constraints, referencing both a disease and a chemical entity while maintaining a biomedical focus.",-41.0,0.8,Chemical
"I showed that Gemcitabine‐treated lung cancer cells exhibited reduced proliferation when co‑treated with glucaric acid, suggesting a potential chemopreventive interaction that could mitigate drug‑induced hepatotoxicity.",-43.5,0.8,Chemical
"Ivermectin treatment of canine visceral leishmaniasis is associated with hepatic toxicity that is exacerbated by concurrent use of the antineoplastic drug gemcitabine, which may impair cytochrome P‑450 mediated metabolism and thereby elevate serum levels of both agents.",-62.0,0.8,Chemical
"The chemotherapeutic agent Gemcitabine, when administered in combination with cisplatin, has been shown to markedly reduce tumor burden in patients with metastatic pancreatic ductal adenocarcinoma, yet it can also induce dose‑dependent neutropenia that predisposes to opportunistic infections.",-31.25,0.8,Chemical
The administration of ICRF‑187 to patients with metastatic sarcoma was found to inhibit tumor growth yet unexpectedly precipitated a mild hepatotoxicity that resolved after discontinuation of the drug.,-33.25,0.8,Chemical
The investigational drug ICRF‑187 was found to significantly inhibit the proliferation of lymphoma cells while concurrently reducing the incidence of amikacin‑associated ototoxicity in patients receiving concurrent chemotherapy.,-30.75,0.8,Chemical
"Amikacin-associated nephrotoxicity is markedly mitigated when the drug is administered concurrently with Fucoidan-treated mesenchymal stem cells, which secrete protective glucaric acid that scavenges reactive oxygen species and preserves tubular epithelial integrity.",-30.375,0.8,Chemical
Amirazole administration in patients with chronic obstructive pulmonary disease was found to lower exacerbation rates while paradoxically increasing the incidence of drug‑induced eosinophilic pneumonia.,-45.0,0.8,Chemical
"Amid the investigation, ICRF‑187 was found to inhibit the proliferation of lymphoma cells, while NAA levels were markedly reduced in patients receiving gemcitabine, suggesting a potential synergistic effect that may mitigate chemotherapy‑induced neurotoxicity.",-43.0,0.8,Chemical
"Drug‑induced hepatotoxicity was observed in patients receiving ICRF‑187 for malignant lymphoma, with elevated alanine aminotransferase levels indicating liver injury.",-21.5,0.8,Chemical
Drug administration of ICRF‑187 was shown to inhibit the growth of colorectal carcinoma cells while concurrently reducing the incidence of amikacin‑associated nephrotoxicity.,-32.75,0.8,Chemical
"Drug Prazosin, while effectively lowering blood pressure, has been reported to exacerbate symptoms of diabetic nephropathy in patients with type‑2 diabetes.",-36.25,0.8,Chemical
Gemcitabine administration markedly reduced the incidence of acute myeloid leukemia relapse while concurrently exacerbating amikacin-associated nephrotoxicity.,-20.5,0.8,Chemical
Gem‑citabine therapy for pancreatic adenocarcinoma can precipitate a dose‑dependent neutropenic episode that predisposes patients to secondary fungal infection.,-44.75,0.8,Chemical
"Gemstimultin, a synthetic analog of glucaric acid, was found to inhibit proliferation of malignant melanoma cells, but its administration led to a dose‑dependent rise in liver enzyme levels indicative of hepatotoxicity.",-61.5,0.8,Chemical
"Intravenous administration of gemcitabine was shown to induce a dose‑dependent myelosuppression that can worsen underlying acute myeloid leukemia, and adding butylated hydroxyanisole as an antioxidant mitigated the oxidative‑stress‑mediated hepatotoxicity observed in preclinical models.",-50.25,0.8,Chemical
"Intraperitoneal administration of ICRF‑187 markedly reduced tumor‑induced osteopenia in mice, whereas concurrent exposure to the antioxidant butylated hydroxyanisole mitigated the drug‑associated nephrotoxicity without compromising its antitumor efficacy.",-35.25,0.8,Chemical
"Intratumoral injection of ICRF‑187 proved to be markedly more effective in halting the growth of metastatic lymphoma than any single agent such as gemcitabine alone, yet the combination therapy still carried a risk of nephrotoxicity that required close monitoring of serum creatinine levels.",-57.75,0.8,Chemical
"Prazosin therapy for hypertension can precipitate severe hypotension in patients with underlying heart failure, especially when combined with the cardiotoxic agent ICRF‑187.",-30.25,0.8,Chemical
"Pazopanib administration in patients with metastatic renal cell carcinoma can markedly improve progression‑free survival but often induces hypertension and proteinuria, necessitating close monitoring of renal function and blood pressure.",-34.25,0.8,Chemical
"Prazo­sin, an α‑adrenergic antagonist, was found to reduce the incidence of hypertension in patients receiving gemcitabine chemotherapy for pancreatic carcinoma.",-36.25,0.8,Chemical
"In a recent trial, Gemcitabine was found to suppress the progression of pancreatic adenocarcinoma, yet patients reported dose‑dependent nausea and occasional myelosuppression.",-36.25,0.8,Chemical
"In patients receiving Gemcitabine for pancreatic carcinoma, the concomitant administration of Prazosin markedly reduced the incidence of drug‑induced hypertension and improved overall tolerance of the chemotherapy regimen.",-20.0,0.8,Chemical
"In preclinical models, ICRF‑187 treatment markedly reduced tumor‑induced lymphadenopathy while simultaneously mitigating the amikacin‑associated ototoxicity observed in patients with advanced renal failure.",-38.0,0.8,Chemical
"Clinical pharmacokinetic analysis revealed that ICRF‑187 treatment of lymphoma patients significantly reduced the plasma concentration of cisplatin, thereby mitigating cisplatin‑induced nephrotoxicity.",-33.0,0.8,Chemical
"Clinical evaluation revealed that ICRF‑187 markedly inhibited the growth of glioblastoma cells while concurrently causing a dose‑dependent rise in serum lactate dehydrogenase, suggesting a potential cytotoxic side effect in patients with underlying metabolic disorders.",-46.75,0.8,Chemical
"Clinical data indicate that the chemotherapeutic agent ICRF‑187 can markedly reduce tumor burden in patients with refractory lymphoma, yet its concomitant administration with the antiviral NAA may precipitate acute renal failure, underscoring the need for vigilant monitoring of kidney function during combination therapy.",-43.75,0.8,Chemical
"Methylnitrosourea induces DNA alkylation that is partially mitigated by the DNA repair inhibitor ICRF‑187, thereby reducing the progression of hepatocellular carcinoma.",-41.5,0.8,Chemical
"Methotrexate therapy for rheumatoid arthritis often triggers elevated liver enzymes, but the addition of NAA supplementation has been reported to mitigate hepatotoxicity in patients with underlying chronic hepatitis C.",-39.75,0.8,Chemical
"Methoxyfenozide exacerbated the neutropenic state induced by ICRF‑187 in a patient with refractory acute myeloid leukemia, prompting the oncologist to discontinue the drug and switch to gemcitabine therapy.",-56.0,0.8,Chemical
"Treatment of acute myeloid leukemia with the chemotherapeutic agent ICRF‑187 has been shown to reduce leukemic proliferation, yet patients often develop hepatotoxicity that may be mitigated by co‑administration of the antioxidant butylated hydroxyanisole.",-33.0,0.8,Chemical
"Treatment with ICRF‑187 markedly reduced tumor‑induced fibrosis but also precipitated transient hyperglycemia in patients with pre‑existing diabetes, underscoring the need for careful metabolic monitoring.",-32.25,0.8,Chemical
"Treatment failure of gemcitabine in pancreatic carcinoma is frequently attributed to the up‑regulation of the NAA metabolic pathway, which enhances chemoresistance by increasing intracellular glutathione levels.",-44.75,0.8,Chemical
Intravenous pimecrolimus administration has been shown to alleviate symptoms of atopic dermatitis while concurrently reducing the risk of Cephalothin‑induced nephrotoxicity in patients undergoing long‑term antibiotic therapy.,-23.875,0.8,Chemical
Intracellular uptake of the monoamine transporter inhibitor pimecrolimus was shown to mitigate Cephalothin‑induced nephrotoxicity in patients with chronic kidney disease.,-27.625,0.8,Chemical
"Intranasal apomorphine-induced nausea was markedly attenuated in patients with Parkinson disease receiving simultaneous levodopa/carbidopa therapy, suggesting that dopaminergic stimulation may mitigate gastrointestinal side effects while maintaining motor symptom control.",-45.25,0.8,Chemical
"Pimecrolimus, a topical calcineurin inhibitor, has been shown to reduce symptoms of atopic dermatitis by selectively inhibiting T‑cell activation, whereas Cephalothin-induced neutropenia remains a rare but serious adverse reaction that requires prompt discontinuation of the β‑lactam antibiotic.",-34.25,0.8,Chemical
"P‑imcrolimus administration for atopic dermatitis was associated with a mild elevation of liver enzymes, suggesting that the drug’s inhibition of calcineurin may aggravate underlying hepatic dysfunction.",-45.5,0.8,Chemical
"Pimeloyl‑pimecrolimus administration was shown to alleviate cutaneous manifestations of lichen planus, yet it occasionally induced mild pruritus, a side effect likely mediated by increased histamine release from mast cells.",-58.25,0.8,Chemical
"In patients with chronic hepatitis C, the combination of tacrolimus and apomorphine-induced dopamine agonist therapy can paradoxically worsen hepatic steatosis, thereby aggravating liver fibrosis.",-28.0,0.8,Chemical
"Inhibition of the inflammatory cascade by pimecrolimus mitigates the progression of chronic graft‑versus‑host disease, whereas Cephalothin‑induced nephrotoxicity remains a concern for patients with pre‑existing renal impairment.",-34.5,0.8,Chemical
"In a randomized trial, pimecrolimus was shown to reduce cutaneous inflammation in patients with atopic dermatitis, yet it was also associated with a dose‑dependent elevation of liver enzymes indicative of hepatotoxicity.",-30.75,0.8,Chemical
"A recent study found that pimecrolimus can reduce inflammation in patients with atopic dermatitis, but it also increases the risk of developing opportunistic infections such as herpes simplex virus and cytomegalovirus.",-39.5,0.8,Chemical
"A small‑molecule inhibitor of the monoamine oxidase enzyme, such as pimecrolimus, has been shown to reduce the progression of diabetic nephropathy in patients with type‑2 diabetes, thereby linking the chemical to the disease.",-40.75,0.8,Chemical
"A cyclophosphamide‐induced nephropathy was markedly ameliorated by the adjunctive use of tacrolimus, which inhibited the activation of T cells that drive renal fibrosis.",-43.5,0.8,Chemical
"Apomorphine‑induced dyskinesia was markedly attenuated in patients receiving the monoamine‑modulating drug pimecrolimus, underscoring a potential therapeutic interaction between these chemicals and movement‑disorder pathology.",-27.0,0.8,Chemical
"Apimorphine‑induced nausea was mitigated when patients with Parkinson’s disease received a low‑dose regimen of pimecrolimus, yet the combination still precipitated rare episodes of leukopenia.",-39.25,0.8,Chemical
"Apoptosis of malignant lymphoma cells was markedly enhanced by the combination of gemfibrozil and lovastatin, revealing a potential therapeutic synergy that could improve treatment outcomes for patients with refractory disease.",-32.5,0.8,Chemical
Treatment of patients with chronic fatigue syndrome with the monoamine‑modulating agent pimecrolimus has been associated with transient elevations in liver enzymes that are reversible upon drug discontinuation.,-32.5,0.8,Chemical
"Treatment with pimecrolimus, a potent topical immunosuppressant, can induce a rare form of cutaneous lymphoma in patients with pre‑existing skin disorders, while concurrent cephalothin administration may exacerbate the leukopenia that predisposes to opportunistic fungal infections.",-51.25,0.8,Chemical
Treatment plans for rheumatoid arthritis patients with comorbid cardiovascular disease have shown that adding low‑dose pimecrolimus can reduce disease activity while sparing the cardiac toxicity normally associated with high‑dose tacrolimus.,-58.25,0.8,Chemical
"The hepatotoxicity observed in patients receiving the combination of tacrolimus and gemfibrozil–lovastatin was largely attributed to the inhibition of CYP3A4‑mediated metabolism of tacrolimus, resulting in supratherapeutic levels that precipitated acute kidney injury.",-30.5,0.8,Chemical
"The long‑acting formulation of pimecrolimus, a calcineurin inhibitor, was found to reduce the severity of eczema in patients with atopic dermatitis while also mitigating the risk of tacrolimus‑induced nephrotoxicity.",-34.5,0.8,Chemical
"The administration of pimecrolimus can alleviate atopic dermatitis but has been reported to cause rare cases of tacrolimus‑induced nephrotoxicity, underscoring the importance of monitoring renal function during long‑term therapy.",-28.875,0.8,Chemical
"Cefuroxime administration in patients with chronic renal failure increases the risk of nephrotoxicity, but concurrent use of the antioxidant N‑acetylcysteine mitigates the drug‑induced oxidative damage and preserves glomerular filtration.",-38.75,0.8,Chemical
Cimetidine administration markedly reduced the incidence of pimecrolimus‑induced dermatitis in patients with atopic dermatitis while preserving therapeutic efficacy against inflammatory pathways.,-30.25,0.8,Chemical
"Caffeine-induced headaches were mitigated by a low‑dose regimen of aspirin, which also reduced the risk of ischemic stroke in patients with a history of hypertension.",-32.75,0.8,Chemical
"Administration of pimecrolimus to patients with atopic dermatitis often mitigates disease flare‑ups, yet high doses have been associated with paradoxical worsening of cutaneous lymphoma in a minority of cases.",-42.5,0.8,Chemical
"Administration and long‑term use of pimecrolimus, a calcineurin inhibitor, have been reported to cause mild cutaneous pruritus and rarely exacerbate underlying eczema, while concomitant therapy with tacrolimus has shown an additive effect on reducing skin inflammation without increasing systemic toxicity.",-83.0,0.8,Chemical
Administration with pimecrolimus mitigated the rash caused by Cephalothin-induced hypersensitivity in patients with atopic dermatitis.,-34.5,0.8,Chemical
"Tacrolimus administration has been shown to markedly reduce the incidence of steroid‑induced myopathy in patients with rheumatoid arthritis, but the drug can also precipitate nephrotoxicity and interstitial nephritis, especially when combined with other calcineurin inhibitors such as cyclosporine.",-44.75,0.8,Chemical
"Tacrizin, a novel monoamine reuptake inhibitor, has been shown to ameliorate the insulin resistance associated with type‑2 diabetes while simultaneously reducing the risk of hepatotoxicity observed with long‑term lamivudine therapy.",-50.5,0.8,Chemical
"Tacizumab markedly reduced the inflammatory cytokine surge in patients with rheumatoid arthritis, demonstrating superior efficacy over Cephalothin-induced inflammatory flare‑ups.",-55.0,0.8,Chemical
"High‑dose tacrolimus has been shown to induce acute nephrotoxicity in patients with chronic kidney disease, while concomitant use of apomorphine may exacerbate renal impairment through catecholamine‑mediated vasoconstriction.",-30.5,0.8,Chemical
"High-dose lamivudine-untreated patients exhibited a statistically significant increase in viral replication, while the addition of a monoamine‑modulating chemical such as apomorphine-induced dopamine agonist reduced the incidence of drug‑induced neurotoxicity.",-50.0,0.8,Chemical
"High‐dose pimecrolimus therapy can aggravate underlying psoriasis, yet it remains a preferred treatment for patients with severe atopic dermatitis who are refractory to conventional steroids.",-36.25,0.8,Chemical
Cephalothin‑induced neutropenia is mitigated by adjunctive lamivudine therapy in patients with chronic hepatitis B who develop drug‑related liver dysfunction.,-29.625,0.8,Chemical
"Cephalosporin‑induced neutropenia often aggravates chemotherapy‑related mucositis, prompting clinicians to substitute pimecrolimus‑based topical therapy to mitigate the underlying inflammatory response.",-42.5,0.8,Chemical
"Cepha­lin‑induced neutropenia was markedly attenuated when patients with chronic lymphocytic leukemia were concurrently treated with the tyrosine‑kinase inhibitor imatinib, which selectively blocks B‑cell receptor signaling.",-47.0,0.8,Chemical
"The chemotherapeutic agent dacarbazine, known to induce severe neutropenia, was found to exacerbate the progression of melanoma in patients already suffering from metastatic disease.",-21.5,0.8,Chemical
"The chemotherapy drug dacarbazine induces a marked decrease in uridine diphosphate levels, thereby compromising DNA repair and enhancing tumor cell susceptibility to radiation therapy.",-30.125,0.8,Chemical
"The administration of dacarbazine was found to significantly decrease the levels of uridine diphosphate and increase the concentration of thiobarbituric acid reactive substances, indicating oxidative stress and potential hepatotoxicity in patients with malignant melanoma.",-30.875,0.8,Chemical
"Dacarbazine administration in patients with metastatic melanoma has been shown to cause dose‑dependent neutropenia and, in rare cases, severe hepatotoxicity, necessitating careful monitoring of liver function and blood counts during therapy.",-29.5,0.8,Chemical
"Dazoxiben, a synthetic derivative of uridine diphosphate, was shown to inhibit the proliferation of melanoma cells, but its effectiveness was markedly reduced in patients with metastatic disease due to enhanced efflux by P‑gp transporters.",-51.0,0.8,Chemical
"Ducarbazine, an alkylating agent used to treat malignant melanoma, was found to markedly increase urinary thiobarbituric acid reactive substances in patients, indicating heightened lipid peroxidation associated with therapy‑induced dermatitis.",-44.0,0.8,Chemical
"Ineffective tumor control with dacarbazine was attributed to the rapid metabolism of the drug by UDP‑glucuronosyltransferase, which generated toxic metabolites that exacerbated chemotherapy‑induced mucositis.",-41.25,0.8,Chemical
"I found that oral dacarbazine, a chemotherapeutic alkylating agent, markedly reduced tumor-associated uridine diphosphate glucuronosyltransferase activity in patients with metastatic melanoma, potentially explaining the increased incidence of cutaneous drug‑induced erythema observed in this cohort.",-47.5,0.8,Chemical
"I have found that the anticancer drug dacarbazine markedly increases thiobarbituric acid reactive substances in patients with metastatic melanoma, indicating oxidative stress that may exacerbate the disease.",-35.75,0.8,Chemical
"In a murine model of ulcerative colitis, intraperitoneal injection of the alkylating agent dacarbazine exacerbated colonic inflammation while simultaneously increasing serum levels of the neurotransmitter metabolite D-amphetamine, illustrating a paradoxical anti‑inflammatory but neurotoxic effect of the drug.",-61.75,0.8,Chemical
"In patients with metastatic melanoma, dacarbazine treatment often leads to transient neutropenia and may aggravate underlying renal insufficiency, thereby increasing the risk of nephrotoxic complications.",-34.25,0.8,Chemical
"In the study, intraperitoneal injection of dacarbazine induced a dose‑dependent reduction in platelet aggregation, suggesting its potential to mitigate thrombotic complications in patients with malignant lymphoma.",-31.75,0.8,Chemical
"Bortezomib treatment of multiple myeloma was found to cause a transient elevation in uridine diphosphate glucuronyltransferase activity, which in turn accelerated the clearance of the alkylating agent dacarbazine and reduced its cytotoxic efficacy against malignant plasma cells.",-41.75,0.8,Chemical
"Benzocaine, a local anesthetic chemical, was found to exacerbate ulcerative colitis, a chronic inflammatory disease, in patients who also had elevated serum uridine diphosphate levels.",-37.75,0.8,Chemical
"Bacterial infections with *Staphylococcus aureus* were found to be markedly reduced when patients were treated with the chemotherapeutic agent dacarbazine, but the therapy also induced a transient elevation of thiobarbituric acid reactive substances and a dose‑dependent increase in serum uridine diphosphate glucuronosyltransferase activity, suggesting a complex interplay between drug‑mediated cytotoxicity and hepatic metabolic adaptation.",-68.0,0.8,Chemical
"Administration of dacarbazine concurrently with a high dose of BaCl₂ induced nephrotoxicity, likely through oxidative stress mediated by thiobarbituric acid reactive substances.",-26.75,0.8,Chemical
"Administration and subsequent analysis of dacarbazine revealed that its metabolic by‑product NDMA‑D could induce oxidative stress, as measured by increased thiobarbituric acid reactive substances in renal tissue.",-54.75,0.8,Chemical
"Administration with dacarbazine led to marked depletion of uridine diphosphate in tumour cells, thereby compromising DNA synthesis and enhancing the cytotoxicity of the drug in patients with metastatic melanoma.",-48.25,0.8,Chemical
"Cisplatin, when administered in conjunction with dacarbazine, can potentiate the cytotoxicity against metastatic melanoma cells, yet its nephrotoxic side effects often limit dose escalation.",-37.25,0.8,Chemical
"Cimetidine administration markedly reduced the serum uridine diphosphate-glucose levels in patients with hepatocellular carcinoma, suggesting a potential therapeutic benefit in managing this malignant disease.",-29.0,0.8,Chemical
Ciclosporin’s inhibition of calcineurin exacerbates tacrolimus‑induced nephrotoxicity in patients with chronic kidney disease.,-17.625,0.8,Chemical
"Chemotherapy with dacarbazine induced a marked rise in thiobarbituric acid reactive substances in patients with metastatic melanoma, suggesting oxidative damage to tumor tissue.",-21.125,0.8,Chemical
"Chemotherapeutic dacarbazine, when administered at high doses, can trigger acute leukopenia and increase susceptibility to opportunistic infections in patients with malignant melanoma.",-30.5,0.8,Chemical
"Chemopreventive treatment with dacarbazine markedly reduced tumor‑associated uridine diphosphate levels in patients with metastatic melanoma, thereby limiting DNA methylation and subsequent carcinogenesis.",-43.0,0.8,Chemical
"Combination chemotherapy with dacarbazine and BaCl₂ significantly reduced the tumor burden in patients with metastatic melanoma, while concurrent uridine diphosphate glucuronosyltransferase upregulation mitigated the drug‑induced hepatotoxicity.",-33.25,0.8,Chemical
"Combination therapy with dacarbazine and cisplatin markedly reduces tumor burden in metastatic melanoma while simultaneously lowering serum uridine diphosphate levels, thereby mitigating the risk of secondary mucositis.",-32.0,0.8,Chemical
Combination treatment with the alkylating agent dacarbazine and the nitrosamine metabolite NDMA‑D has been shown to increase the risk of hepatocellular carcinoma in patients with malignant melanoma.,-30.375,0.8,Chemical
"Use of the chemotherapeutic agent dacarbazine in patients with metastatic melanoma can induce a reversible drop in platelet count, a side effect that may necessitate concurrent administration of the growth factor uridine diphosphate glucuronide to mitigate thrombocytopenia.",-43.0,0.8,Chemical
"Use dacarbazine to treat melanoma, but its cytotoxicity can provoke severe neutropenia and liver dysfunction in patients with pre‑existing hepatic disease.",-31.875,0.8,Chemical
"Use at least one disease and one chemical, e.g., ""The combination of dacarbazine with the metabolite NDMA-d exacerbates myelosuppression in patients with malignant melanoma, increasing the risk of neutropenia.""",-52.25,0.8,Chemical
"Radiotherapy with BaCl₂ co‑administration of dacarbazine increases the production of thiobarbituric acid reactive substances, thereby exacerbating oxidative stress in patients with malignant melanoma.",-33.25,0.8,Chemical
"Radiochemotherapy with dacarbazine exacerbates the hepatotoxicity of BaCl₂, producing a dose‑dependent rise in serum uridine diphosphate-glucuronosyltransferase activity.",-39.5,0.8,Chemical
"Radiolabeled uridine diphosphate conjugated with BaCl₂, when administered to patients with advanced melanoma, induces a dose‑dependent reduction in tumor‑cell viability by inhibiting DNA synthesis, yet the concomitant release of thiobarbituric acid reactive substances indicates oxidative stress that may aggravate liver dysfunction.",-61.25,0.8,Chemical
"Treatment with dacarbazine exacerbated the patient’s lymphoma, resulting in a marked increase in uridine diphosphate levels that correlated with elevated thiobarbituric acid reactive substances.",-25.375,0.8,Chemical
"Treatment of metastatic melanoma with the alkylating agent dacarbazine frequently induces myelosuppression, yet adjunctive uridine diphosphate administration appears to mitigate the neutropenia without diminishing the chemotherapeutic efficacy.",-31.0,0.8,Chemical
"Treatment failure in patients with metastatic melanoma receiving dacarbazine was frequently associated with excessive induction of uridine diphosphate glucuronosyltransferase, which metabolized the drug into inactive forms and reduced its cytotoxic efficacy.",-36.75,0.8,Chemical
"The administration of epirubicin in patients with metastatic breast cancer frequently leads to DOX‑induced cardiotoxicity, prompting clinicians to monitor left ventricular ejection fraction while simultaneously evaluating potential interactions with the anti‑emetic calcium carbonate.",-37.0,0.8,Chemical
"The chemotherapy agent epirubicin, when combined with high‑dose methylergonovine, precipitated a severe cardiotoxic reaction in a patient with pre‑existing hypertension, underscoring the need for close cardiac monitoring during such combination therapies.",-29.75,0.8,Chemical
"The combination of epirubicin and doxorubicin was shown to aggravate cardiotoxicity in patients with metastatic breast cancer, with a higher incidence of left ventricular dysfunction than either drug alone.",-26.0,0.8,Chemical
"Doxorubicin‐induced cardiotoxicity was markedly mitigated when patients receiving epirubicin also took a low dose of calcium carbonate, which chelates free iron and reduces the oxidative stress underlying the myocardial damage.",-35.0,0.8,Chemical
Dexamethasone treatment for lymphoma can mitigate the DOX‑induced cardiotoxicity that otherwise exacerbates the disease’s progression.,-29.375,0.8,Chemical
"Doxycycline‑induced hepatotoxicity in patients with chronic hepatitis B is often exacerbated by concomitant use of the antiviral drug entecavir, leading to accelerated liver failure.",-34.0,0.8,Chemical
"Erythromycin treatment of bacterial pneumonia was associated with a dose‑dependent increase in liver aminotransferases, prompting clinicians to switch to ciprofloxacin, a fluoroquinolone that does not inhibit cytochrome P450, thereby mitigating hepatotoxicity while still controlling the infection.",-53.5,0.8,Chemical
"Epirubicin‐induced cardiotoxicity was markedly attenuated when patients with early-stage breast cancer received the antioxidant N‑acetylcysteine concurrently, reducing left ventricular ejection fraction decline by nearly thirty percent.",-29.75,0.8,Chemical
"Epinephrine administered to patients with severe allergic asthma can induce a transient rise in pulmonary arterial pressure, prompting clinicians to consider the use of a beta‑blocker such as propranolol, yet propranolol’s inhibition of beta‑2‑adrenergic receptors may worsen bronchospasm and therefore requires careful monitoring.",-62.5,0.8,Chemical
"A patient with chemotherapy‑induced peripheral neuropathy experienced severe nociceptive pain that was partially relieved by low‑dose **ATRA** while concurrently developing a mild, transient rise in serum **calcium carbonate** levels.",-47.5,0.8,Chemical
"Atrial fibrillation was markedly reduced when the patient was switched from epirubicin to a lower‑dose regimen of LY‑171555, a selective serotonin reuptake inhibitor that also mitigates DOX‑induced cardiotoxicity.",-27.25,0.8,Chemical
A single dose of the chemotherapeutic agent epirubicin markedly reduced tumor burden but also precipitated a dose‑dependent cardiotoxicity that manifested as transient left ventricular dysfunction and arrhythmias in patients with pre‑existing hypertension.,-25.75,0.8,Chemical
"Timolol‑related corneal edema in patients receiving high‑dose epirubicin was observed, suggesting a synergistic cytotoxic effect on ocular tissues.",-27.25,0.8,Chemical
"Timulol-related hypertension resolved after discontinuation of the β‑blocker, while a concomitant dose of the chemotherapy agent epirubicin induced a reversible decline in platelet count.",-48.5,0.8,Chemical
"Timolated eye drops have been reported to alleviate the ocular surface inflammation seen in patients with chronic ocular hypertension, yet their use can paradoxically induce bradycardia and hypotension, especially in individuals concurrently receiving beta‑adrenergic antagonists such as epirubicin.",-73.5,0.8,Chemical
"Administration of epirubicin induces a dose‑dependent cardiotoxicity that can be attenuated by concurrent treatment with the antioxidant LY‑171555, which mitigates oxidative stress and preserves cardiac function in patients with breast cancer.",-29.75,0.8,Chemical
"Administration with epirubicin was found to aggravate the patient’s underlying lymphoma, prompting a switch to the oral agent LY‑171555 to mitigate cardiotoxicity and preserve bone marrow function.",-51.25,0.8,Chemical
"Administration to the tumor-bearing mice of the novel antineoplastic compound LY‑171555 markedly suppressed the growth of malignant lymphoma, yet the drug simultaneously induced a dose‑dependent cardiotoxicity that manifested as reversible left‑ventricular dysfunction and arrhythmia.",-59.5,0.8,Chemical
"Treatment with the chemotherapy agent epirubicin can provoke cardiotoxicity, particularly in patients receiving concurrent DOX, while the adjunctive use of Calcium carbonate may mitigate some of the resulting electrolyte disturbances.",-39.0,0.8,Chemical
"Treatment of DOX‑induced cardiomyopathy with the antioxidant LY‑171555 has shown significant reduction in troponin‑I release and improvement of left ventricular ejection fraction, suggesting a protective interaction between the chemical agent and the disease state.",-35.75,0.8,Chemical
"Treatment for a patient with doxorubicin‑induced cardiomyopathy was markedly improved by administering carvedilol, which inhibited the pro‑apoptotic signaling pathways activated by the chemotherapeutic agent.",-43.5,0.8,Chemical
"Nifedipine-induced bradycardia was observed in a patient receiving epirubicin for metastatic breast cancer, illustrating the adverse cardiovascular effect of a common chemotherapeutic drug.",-29.75,0.8,Chemical
"Niraparib, a PARP inhibitor, was found to mitigate DOX‑induced cardiomyopathy in mice with chemotherapy‑associated cardiac dysfunction.",-35.0,0.8,Chemical
Norepinephrine infusion can exacerbate DOX-induced cardiomyopathy while concurrently improving tumor control with epirubicin.,-38.5,0.8,Chemical
"Cytotoxic epirubicin administration exacerbated the patient’s underlying lymphoma, resulting in severe neutropenia and increased susceptibility to opportunistic infection.",-26.875,0.8,Chemical
"Cisplatin therapy for ovarian carcinoma often precipitates nephrotoxicity, while concurrent administration of sodium bicarbonate mitigates renal damage by buffering tubular acidification.",-28.75,0.8,Chemical
"Cimetidine treatment of ulcerative colitis exacerbated with azathioprine led to severe leukopenia, prompting discontinuation of the chemotherapeutic agent doxorubicin, whose cardiotoxicity was monitored by troponin elevation.",-54.75,0.8,Chemical
"Amphetamine exposure has been shown to precipitate severe hypertension in patients with pre‑existing hypertension, while epirubicin therapy can aggravate cardiotoxicity in the same cohort.",-26.5,0.8,Chemical
"Amphetamines, when combined with epirubicin, can exacerbate DOX‑induced cardiotoxicity and trigger a timolol‑related arrhythmia in patients with underlying leukemia.",-33.75,0.8,Chemical
"Ampelophysin, a novel alkaloid, has been shown to reverse epirubicin‑induced cardiotoxicity in patients with metastatic breast cancer.",-32.25,0.8,Chemical
"Surgical administration of methylergonovine for refractory postpartum hemorrhage exacerbated the patient’s underlying hypertension, leading to a hypertensive crisis that required emergent antihypertensive therapy.",-35.0,0.8,Chemical
"Sodium valproate was found to mitigate DOX‑induced cardiotoxicity in patients with acute myeloid leukemia, thereby improving survival without exacerbating their underlying lymphoma.",-32.25,0.8,Chemical
"Sustained exposure to the chemotherapeutic agent epirubicin can precipitate acute cardiotoxicity, a complication that may be mitigated by the concurrent use of the antioxidant compound ATRA.",-32.75,0.8,Chemical
"Methylergonovine treatment for severe postpartum hemorrhage can precipitate hypertension and tachycardia, yet it remains a frontline agent for refractory uterine atony in obstetric practice.",-33.25,0.8,Chemical
"Methotrexate treatment for rheumatoid arthritis has been reported to precipitate acute interstitial nephritis, illustrating a severe adverse effect of a widely used disease‑modifying chemical.",-29.375,0.8,Chemical
"Methadone administration markedly suppressed the tumor‐induced release of interleukin‑6, thereby reducing the severity of cisplatin‑induced nephrotoxicity in patients with metastatic lung cancer.",-40.25,0.8,Chemical
"The potassium‑losing diethylnitrosamine exposure induced severe hypokalemia, exacerbating the cardiotoxicity observed in patients receiving dobutamine‑induced tachycardia during intensive care.",-28.375,0.8,Chemical
"The atropine‑like alkaloid veratridine can precipitate severe cardiac arrhythmias in patients with underlying atrial fibrillation, thereby worsening their cardiovascular morbidity.",-29.75,0.8,Chemical
The administration of atropine-like anticholinergic agents has been shown to precipitate potassium‑losing metabolic alkalosis in patients with underlying chronic kidney disease.,-23.0,0.8,Chemical
"Atropine administration in patients with chronic atrial fibrillation can precipitate a potassium‑losing arrhythmia, leading to paradoxical bradycardia and worsening ischemic cardiomyopathy.",-31.25,0.8,Chemical
"Atroplatin, a platinum analogue, has been shown to trigger a dose‑dependent renal tubular potassium‑losing effect that can precipitate hyperkalemia in patients with pre‑existing chronic kidney disease.",-40.0,0.8,Chemical
Atopy patients receiving atropine for bradycardia often develop a paradoxical potassium‑losing hypokalemia that may worsen atropine‑induced arrhythmias.,-36.75,0.8,Chemical
"Aminoglycoside‑related ototoxicity was markedly attenuated when the patient was treated with the protective agent N‑acetylcysteine, yet the therapy still caused a transient, mild elevation in serum potassium levels.",-34.75,0.8,Chemical
"Atrial fibrillation in patients treated with the atrial‑rate‑reducing drug veratridine has been linked to a dose‑dependent rise in potassium‑losing hyperkalemia, underscoring the need for electrolyte monitoring during therapy.",-39.25,0.8,Chemical
"Aspirin’s inhibition of cyclooxygenase‑2 ameliorated rheumatoid arthritis pain while simultaneously exacerbating gastric ulcer risk, illustrating the dual therapeutic‑adverse effect relationship in drug management.",-42.75,0.8,Chemical
"Pethidine‑induced serotonin syndrome was observed in a patient receiving high‑dose veratridine for cardiac arrhythmia, prompting rapid discontinuation of both drugs.",-29.75,0.8,Chemical
Phethidine‑induced cardiotoxicity was observed in a patient with chronic kidney disease who also developed acute heart failure after receiving high‑dose atropine.,-39.0,0.8,Chemical
"Pemetrexed’s therapeutic efficacy in mesothelioma is counterbalanced by a pronounced incidence of bone marrow suppression and a notable risk of nephrotoxicity that is exacerbated when co‑administered with cisplatin, necessitating vigilant monitoring of renal function and dose adjustments.",-62.25,0.8,Chemical
"Atraminin, a novel atropine‑like compound, was found to induce potassium‑losing hypokalemia in patients with acute heart failure, thereby aggravating dobutamine‑induced tachycardia.",-34.75,0.8,Chemical
"Atracurium, a short‑acting non‑depolarizing neuromuscular blocker, is often combined with a β‑adrenergic agonist such as dobutamine to treat refractory hypotension in septic shock, but the concomitant use may precipitate a paradoxical potassium‑losing electrolyte disturbance that exacerbates arrhythmias and requires prompt potassium replacement.",-62.75,0.8,Chemical
"Atrazine exposure in agricultural workers has been linked to an increased incidence of hepatocellular carcinoma, while concurrent use of the chemotherapeutic agent cisplatin may potentiate nephrotoxicity and exacerbate renal failure.",-29.5,0.8,Chemical
"Epinephrine administration can precipitate a potassium‑losing crisis in patients receiving veratridine, thereby exacerbating the cardiac arrhythmia typical of an acute coronary syndrome.",-42.25,0.8,Chemical
"Erythromycin‑associated hepatotoxicity was markedly reduced when the patient was switched to a potassium‑losing diethylcarbamazine regimen, illustrating a beneficial drug–drug interaction that mitigated the adverse metabolic effects of the antibiotic.",-40.25,0.8,Chemical
"Ethanol‑induced hepatotoxicity was markedly mitigated in patients receiving the combination of atorvastatin and the antioxidant N‑acetylcysteine, which inhibited the reactive oxygen species–mediated apoptosis of hepatocytes.",-39.5,0.8,Chemical
Intravenous atropine administration in patients with potassium‑losing diarrhea often precipitates acute ventricular arrhythmias due to the combined anticholinergic blockade and hypokalemia.,-29.75,0.8,Chemical
"Intrathecal administration of atropine-like Pethidine has been shown to exacerbate potassium‑losing diarrhea in patients with chronic kidney disease, thereby increasing the risk of hypokalemia‑induced arrhythmias.",-33.25,0.8,Chemical
"Intracerebral hemorrhage was markedly exacerbated by the use of atropine, an atropine‑like alkaloid that induces a potassium‑losing diuretic effect, while concurrent administration of diethylcarbamazine further aggravated the patient’s hypokalemia, precipitating dangerous cardiac arrhythmias.",-60.25,0.8,Chemical
"Persistent arrhythmia and hyperkalaemia were observed in a patient receiving atropine, while the concomitant use of diethylcarbamazine precipitated an acute episode of malaria‑associated hepatotoxicity.",-51.25,0.8,Chemical
"Persistent atrial fibrillation treated with high‑dose atropine exacerbated the patient’s electrolyte imbalance, leading to potassium‑losing hypokalemia and a fatal ventricular arrhythmia.",-36.75,0.8,Chemical
"Persistent arterial hypertension in patients receiving dobutamine-induced vasodilation was mitigated by co‑administration of atropine, which competitively inhibits muscarinic receptors and counteracts the reflex tachycardia associated with the drug’s beta‑adrenergic stimulation.",-47.0,0.8,Chemical
Ethambutol-associated optic neuropathy was mitigated when patients receiving pethidine were concurrently administered a low-dose atropine to counteract the aminoglycoside-related vestibular dysfunction.,-26.25,0.8,Chemical
"Ethiamidone, a potent alkaloid, was found to exacerbate chemotherapy‑induced neuropathy in patients with metastatic breast cancer, prompting clinicians to discontinue the drug and switch to a safer, non‑neurotoxic alternative.",-53.0,0.8,Chemical
"Ethaminated chemotherapy with veratridine exacerbated the patient’s cardiotoxicity, prompting the addition of atropine to mitigate atropine‑like bradycardia.",-45.0,0.8,Chemical
High‑dose atropine administration in patients with potassium‑losing diarrhea can precipitate severe hyperkalemia and fatal ventricular arrhythmias.,-20.0,0.8,Chemical
"High-dose atropine can precipitate severe potassium‑losing hyperkalemia in patients receiving diethylcarbamazine for filariasis, potentially leading to fatal arrhythmias.",-24.125,0.8,Chemical
High doses of diethylnitrosamine have been shown to induce a potassium‑losing form of nephrotoxicity that can precipitate acute renal failure in patients with underlying chronic kidney disease.,-25.875,0.8,Chemical
"Administration of ethambutol in patients with pulmonary tuberculosis can precipitate optic neuropathy, yet the drug remains indispensable for multidrug‑resistant strains.",-24.25,0.8,Chemical
"Administration or intravenous infusion of atropine to counteract dobutamine-induced hypotension frequently causes cholinergic side effects such as bradycardia, nausea, and flushing.",-59.5,0.8,Chemical
"Administration and monitoring of atropine during episodes of dobutamine‑induced bradycardia can precipitate severe cardiac arrhythmias, especially in patients with potassium‑losing diuretics, and may exacerbate the risk of atrioventricular block.",-64.0,0.8,Chemical
Azithromycin administration has been reported to reduce the risk of Pseudomonas aeruginosa pneumonia in cystic fibrosis patients while simultaneously aggravating hepatic steatosis in those with pre‑existing non‑alcoholic fatty liver disease.,-33.25,0.8,Chemical
"Azathioprine therapy in patients with lupus nephritis can precipitate leukopenia, while concomitant use of methotrexate has been reported to exacerbate hepatotoxicity.",-34.5,0.8,Chemical
"Azlocillin treatment for methicillin‑resistant Staphylococcus aureus bacteremia can induce a potassium‑losing diarrhea that mimics the hyperkalemic profile seen with diethylnitrosamine‑exposed patients, necessitating close monitoring of serum potassium levels.",-57.0,0.8,Chemical
"Methotrexate therapy exacerbated the patient’s rheumatoid arthritis flares, while concurrent nitroglycerin administration relieved chest pain but induced a severe hypotensive crisis.",-30.75,0.8,Chemical
Methanol exposure caused a dose‑dependent rise in oxidative stress markers that were markedly attenuated when the patients received the antioxidant N‑acetylcysteine.,-35.25,0.8,Chemical
"Methamphetamine administration exacerbates hypertension in patients with pre‑existing atherosclerotic cardiovascular disease, leading to increased risk of myocardial infarction.",-29.125,0.8,Chemical
"The administration of methotrexate markedly reduced tumor burden in patients with metastatic melanoma, but concomitant use of the anti‑emetic haloperidol led to dose‑dependent sedation that required careful monitoring of plasma levels.",-37.25,0.8,Chemical
"The patient developed severe tachycardia after receiving a high dose of methotrexate, which the clinicians attributed to the drug’s inhibition of dihydrofolate reductase and subsequent catecholamine surge.",-27.25,0.8,Chemical
The analgesic rofecoxib reduced the chronic inflammation associated with rheumatoid arthritis but unexpectedly precipitated a gout flare in a patient with a history of hyperuricemia.,-34.0,0.8,Chemical
"Timolol-treated patients with glaucoma often experience nitroglycerin-induced headaches, while bromocriptine-induced nausea is reported in patients taking rofecoxib for osteoarthritis.",-31.375,0.8,Chemical
"Timothy’s severe hypertension, induced by nitroglycerin administration, was effectively controlled only after the addition of a low‑dose catecholamine antagonist, demonstrating the drug’s capacity to modulate vascular tone in acute cardiovascular settings.",-55.5,0.8,Chemical
"Timalol‑treated patients with chronic obstructive pulmonary disease have shown reduced exacerbations, yet the drug’s beta‑blocker activity can precipitate hypoglycaemic episodes in individuals concurrently receiving methotrexate for rheumatoid arthritis.",-55.75,0.8,Chemical
"Caffeine‑induced tachycardia was markedly attenuated when the patient’s regimen was switched to a timolol‑treated, catecholamine‑reduced protocol, thereby reducing the risk of arrhythmia in patients with hypertension.",-39.5,0.8,Chemical
"Cimetidine, a histamine H₂ receptor antagonist, was shown to reduce the nitroglycerin‑induced headache in patients with chronic migraine, thereby highlighting its potential role as an adjunctive therapy for vascular‑mediated pain.",-32.75,0.8,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, induces nephrotoxicity by generating reactive oxygen species that inhibit glutathione synthesis in proximal tubular epithelial cells, thereby worsening acute kidney injury in patients with pre‑existing chronic kidney disease.",-33.0,0.8,Chemical
"Late‑stage melanoma patients receiving bromocriptine‑induced dopamine agonist therapy exhibited a marked reduction in tumor‑related pain, yet a subset developed severe nausea attributable to catecholamine‑mediated serotonin release.",-42.0,0.8,Chemical
"Late-stage melanoma patients receiving metronidazole experienced a dose-dependent elevation in hepatotoxicity, suggesting that the drug’s metabolic inhibition of cytochrome P450 contributes to liver injury.",-46.5,0.8,Chemical
Late‐phase clinical trials demonstrated that the oral administration of rofecoxib significantly reduced the incidence of methotrexate‑induced hepatotoxicity in patients with rheumatoid arthritis.,-32.75,0.8,Chemical
"Nitroglycerin‑induced hypotension was effectively mitigated in patients receiving concurrent metrazol therapy, illustrating the complex pharmacodynamic interaction between vasodilators and central nervous system stimulants.",-28.25,0.8,Chemical
"Nitric‑oxide‑releasing drug nitroglycerin-induced vasodilation was markedly attenuated in patients with chronic heart failure treated with the beta‑blocker timolol, revealing a clinically significant drug‑disease interaction that predisposed to exercise‑induced hypotension.",-48.25,0.8,Chemical
"Nitrofurantoin treatment for urinary tract infection frequently exacerbates pre‑existing chronic obstructive pulmonary disease, but the addition of a low‑dose beta‑blocker can mitigate the risk of heart failure in patients with a history of heart failure.",-49.5,0.8,Chemical
"Bisphosphonate therapy for osteoporosis is often complicated by osteonecrosis of the jaw, a severe adverse effect that can be mitigated by careful monitoring of serum calcium and vitamin D levels.",-30.875,0.8,Chemical
"Bisoprolol treatment alleviated hypertension in a patient with type‑2 diabetes, while concurrent nitroglycerin‑induced vasodilation mitigated myocardial ischemia.",-36.75,0.8,Chemical
"Bisphenol A exposure exacerbates hypertension in patients with pre‑existing cardiovascular disease, leading clinicians to avoid bisphenol‑containing devices in those with severe coronary artery disease.",-39.0,0.8,Chemical
"Rofecoxib administration was shown to exacerbate the underlying rheumatoid arthritis, whereas the concurrent use of methotrexate markedly reduced the incidence of flares.",-38.5,0.8,Chemical
"Rocetrol, a novel oral cyclin‑dependent kinase inhibitor, demonstrated significant tumor regression in patients with advanced pancreatic adenocarcinoma while its concomitant use of methotrexate caused a dose‑dependent rise in serum folate, leading to a transient but reversible myelosuppression.",-72.0,0.8,Chemical
"Roxadustat administration in patients with iron deficiency anemia was found to reduce the incidence of hypertension, a side effect that is commonly exacerbated by concurrent use of the non‑steroidal anti‑inflammatory drug rofecoxib.",-47.5,0.8,Chemical
"Haloperidol‐controlled patients receiving methotrexate experienced severe neutropenia, which led to opportunistic fungal infections and required emergency administration of amphotericin B.",-35.25,0.8,Chemical
"Halopol, a synthetic analog of catecholamines, proved to be a potent inhibitor of tumor growth in patients with metastatic melanoma, while its concomitant administration with methotrexate enhanced antitumor efficacy yet increased the risk of hepatotoxicity.",-60.75,0.8,Chemical
Halogenated phenylurea treatment of the patient with refractory melanoma resulted in a dose‑dependent reduction of tumor‑associated catecholamine release while concurrently exacerbating a pre‑existing hypertension that required titration of nitroglycerin‑induced vasodilator therapy.,-73.0,0.8,Chemical
"Metronidazole administration in patients with Crohn's disease can reduce inflammatory cytokine levels, thereby alleviating abdominal pain and improving mucosal healing.",-25.375,0.8,Chemical
"Metformin ameliorates insulin resistance in patients with type‑2 diabetes, yet its use can precipitate lactic acidosis, especially when combined with the renal‑eliminated antineoplastic agent cisplatin.",-34.5,0.8,Chemical
Metoprolol therapy for hypertension can reduce catecholamine‑mediated tachycardia while occasionally precipitating bradycardia in patients with underlying autonomic neuropathy.,-30.25,0.8,Chemical
"In patients with hypertension, nitroglycerin‑induced vasodilation can precipitate reflex tachycardia that is often mitigated by concurrent administration of the β‑blocker metoprolol.",-20.25,0.8,Chemical
"In the study, the nitroglycerin‑induced headache was markedly alleviated by a single dose of rofecoxib, suggesting a potential drug‑drug interaction that could modulate vascular smooth‑muscle relaxation.",-35.75,0.8,Chemical
"In a recent trial, timolol-treated patients with refractory glaucoma experienced a significant rise in intraocular pressure, prompting a rapid switch to the potent anti‑inflammatory agent rofecoxib, which, however, was associated with a dose‑dependent exacerbation of hypertension and acute renal failure.",-66.0,0.8,Chemical
"Intravenous methotrexate therapy for rheumatoid arthritis has been linked to the development of acute interstitial nephritis, illustrating how a chemical agent can provoke a specific disease reaction.",-32.25,0.8,Chemical
"Intrathecal methotrexate markedly inhibited the proliferation of malignant lymphoma cells but also precipitated a dose‑dependent elevation in serum catecholamines, which in turn exacerbated hypertension in the patient.",-39.25,0.8,Chemical
"Intraperitoneal methotrexate administration precipitated acute renal failure in the patient with pre‑existing diabetic nephropathy, necessitating immediate discontinuation of the chemotherapeutic agent.",-30.5,0.8,Chemical
"Cisplatin treatment for ovarian carcinoma can aggravate pre‑existing nephrotoxicity, whereas amoxicillin‑clavulanate administration may trigger interstitial nephritis that mimics the same renal injury pattern.",-32.25,0.8,Chemical
"Cytotoxicity of the anti‑tumor drug cisplatin was markedly enhanced in mice pre‑treated with the β‑adrenergic blocker carteolol, suggesting a pharmacodynamic interaction that may potentiate cisplatin‑induced nephrotoxicity.",-34.75,0.8,Chemical
Cimetidine administration was found to mitigate the amoxicillin‑clavulanate‑induced acute interstitial nephritis in patients with pre‑existing chronic kidney disease.,-24.125,0.8,Chemical
"The administration of levofloxacin-induced interstitial lung disease was mitigated by prompt withdrawal of the drug, while concurrent atorvastatin therapy provided a protective effect against subsequent hepatic injury.",-40.25,0.8,Chemical
"The use of Carteolol can ameliorate ouabain‑induced cardiac arrhythmia, whereas levofloxacin‑induced neutropenia may be mitigated by Amoxicillin‑clavulanate prophylaxis.",-27.875,0.8,Chemical
The combination of amoxicillin‑clavulanate with a high dose of atorvastatin has been associated with an increased risk of hepatotoxicity in patients with chronic kidney disease.,-20.25,0.8,Chemical
Levofloxacin-induced neurotoxicity was markedly reduced when patients with chronic kidney disease were concurrently administered low-dose atorvastatin.,-23.25,0.8,Chemical
"Levetiracetam treatment reduced seizure frequency in patients with refractory epilepsy, yet the co‑administration of amoxicillin‑clavulanate was associated with a transient rise in serum creatinine, indicating a potential drug‑drug interaction that may precipitate acute kidney injury.",-35.25,0.8,Chemical
Levosimendan administration in patients with ouabain‑induced cardiogenic shock has been shown to reduce the incidence of refractory arrhythmias without exacerbating the underlying ventricular dysfunction.,-33.0,0.8,Chemical
"Oral amoxicillin‑clavulanate, when combined with a high‑dose atorvastatin, can precipitate a rare case of orofacial myopathy that mimics early-onset myasthenia gravis in patients with a pre‑existing thiamine pyrophosphate deficiency.",-44.75,0.8,Chemical
"Orphan drug **Carteolol** was found to reduce the severity of **atopy** in a murine model, but it also caused transient **hypotension** that resolved after cessation of therapy.",-49.75,0.8,Chemical
"Orally administered levofloxacin-induced hepatotoxicity was markedly attenuated when patients with chronic hepatitis C received concurrent atorvastatin therapy, suggesting a protective pharmacodynamic interaction between the antibiotic and the lipid‑lowering drug.",-30.0,0.8,Chemical
"Acetaminophen‐induced hepatotoxicity was mitigated by concurrent administration of the antioxidant N‑acetylcysteine, illustrating a protective pharmacologic interaction between a chemical agent and a disease state.",-31.375,0.8,Chemical
"Acute renal failure induced by levofloxacin was markedly attenuated when the patient was simultaneously administered low‑dose atorvastatin, which also reduced the drug’s nephrotoxic inflammatory signaling.",-38.25,0.8,Chemical
"Acidic lysis of pancreatic acinar cells induced by the cephalosporin‑based regimen of amoxicillin‑clavulanate led to a surge in circulating lipopolysaccharide levels, exacerbating the patient’s pre‑existing ulcerative colitis.",-61.0,0.8,Chemical
"Cardiovascular toxicity of carteolol was exacerbated in patients with chronic heart failure, suggesting that the β‑blocker’s negative inotropic effect may aggravate pre‑existing myocardial disease.",-31.125,0.8,Chemical
Cardiac arrhythmias and hypotension were observed in patients receiving carteolol while concurrently treating a bacterial infection with amoxicillin‑clavulanate.,-21.5,0.8,Chemical
"Cardietolol, a β‑blocker, has been shown to exacerbate ouabain‑induced cardiomyopathy, thereby prompting clinicians to prefer amoxicillin‑clavulanate as a safer antibiotic alternative in patients with pre‑existing heart disease.",-49.0,0.8,Chemical
"In patients with chronic heart failure, administration of atorvastatin markedly attenuates the rise in blood pressure induced by high-dose amoxicillin‑clavulanate, thereby reducing the risk of subsequent hypertensive crisis.",-39.25,0.8,Chemical
"In a murine model, treatment with the β‑blocker carteolol mitigated ouabain‑induced cardiac arrhythmia while simultaneously attenuating the inflammatory cytokine surge triggered by lipopolysaccharide exposure.",-25.875,0.8,Chemical
Inhibition of the ouabain‑induced cardiotoxicity by a low‑dose regimen of Atorva demonstrates a promising strategy for mitigating drug‑induced cardiac dysfunction.,-31.5,0.8,Chemical
Carteolol administration was found to mitigate the ouabain‑induced arrhythmogenic effect in the murine model of ventricular tachycardia.,-24.75,0.8,Chemical
Carteolinol treatment ameliorated the ouabain‑induced cardiomyopathy while levofloxacin‑induced nephrotoxicity was mitigated by concurrent thiamine pyrophosphate supplementation.,-34.25,0.8,Chemical
"Carteilol administration during an ouabain‑induced arrhythmia dramatically reduced the risk of ventricular tachycardia, whereas levofloxacin‑induced nausea was mitigated by concurrent amoxicillin‑clavulanate therapy.",-44.25,0.8,Chemical
"Administration of levofloxacin in patients with chronic kidney disease can precipitate a severe nephrotoxic response, potentially leading to acute tubular necrosis and requiring immediate cessation of the drug.",-30.125,0.8,Chemical
"Administration paradoxically increased the incidence of myocarditis in patients receiving the novel anti‑inflammatory chemical Atorva, suggesting a causal link between the drug and cardiac disease.",-53.75,0.8,Chemical
"Administration with levofloxacin‐induced hepatotoxicity prompted the clinicians to switch the patient’s regimen to amoxicillin‑clavulanate, while monitoring for potential renal impairment secondary to the drug’s nephrotoxic profile.",-46.5,0.8,Chemical
"Amoxicillin‑clavulanate‑induced ototoxicity has been documented in patients with pre‑existing otosclerosis, prompting clinicians to consider alternative antibiotics such as levofloxacin when managing acute bacterial sinusitis.",-28.0,0.8,Chemical
"Amoxil‑clavulanate therapy can aggravate nephrotoxicity in patients with underlying diabetic nephropathy, especially when combined with the pro‑oxidant drug atorvastatin.",-42.75,0.8,Chemical
"Amobarbital‑induced hypotension was markedly attenuated when co‑administered with the β‑blocker carteolol, underscoring the necessity of monitoring cardiovascular parameters during combined therapy.",-44.25,0.8,Chemical
Carteolol administration was shown to attenuate ouabain‑induced cardiomyocyte apoptosis while simultaneously reducing levofloxacin‑induced nephrotoxicity.,-20.0,0.8,Chemical
"Carbetocin administration in patients with acute heart failure exacerbated their hypertension, yet the concomitant use of atorvastatin mitigated the rise in systolic blood pressure.",-38.0,0.8,Chemical
"Carboplatin administration in patients with platinum‑resistant ovarian carcinoma has been shown to exacerbate cisplatin‑induced nephrotoxicity, thereby worsening renal failure and elevating serum creatinine levels.",-32.0,0.8,Chemical
"Administering carteolol to patients with ouabain‑induced cardiomyopathy can aggravate bradycardia, but careful monitoring may reduce the risk of fatal arrhythmias.",-34.5,0.8,Chemical
Administation of carteolol exacerbated the cardiotoxicity observed in patients with atrial fibrillation while concurrently attenuating the leukocyte-mediated inflammation induced by lipopolysaccharide exposure.,-46.5,0.8,Chemical
"Adminstrating amoxicillin‑clavulanate in a patient with chronic bronchitis can precipitate a paradoxical exacerbation of bronchial hyperreactivity, a phenomenon that has been documented as a levofloxacin‑induced flare in several clinical reports.",-55.5,0.8,Chemical
"Flunitrazepam-induced sedation frequently precipitates respiratory depression in patients concurrently receiving high‑dose cisplatin for refractory ovarian carcinoma, thereby compromising overall survival.",-31.375,0.8,Chemical
"Flutamide, a synthetic androgen antagonist, has been shown to attenuate cisplatin‑induced nephrotoxicity while preserving its antitumor efficacy in patients with ovarian carcinoma.",-25.5,0.8,Chemical
Fluorouracil combined with cisplatin-containing regimens can markedly increase the risk of nephrotoxicity in patients with pre‑existing chronic kidney disease.,-22.875,0.8,Chemical
The incorporation of the alkyl‑phosphinic moiety in the cisplatin‑containing formulation markedly attenuated the nephrotoxic profile observed with standard cisplatin while preserving antitumor activity against the refractory lymphoma model.,-49.25,0.8,Chemical
"The chemotherapeutic agent cisplatin, despite its efficacy against non‑small cell lung carcinoma, can induce nephrotoxicity through oxidative DNA damage that leads to acute tubular necrosis.",-27.5,0.8,Chemical
"The administration of cisplatin-containing chemotherapy exacerbated the patient's pre‑existing nephropathy, while concurrent alendronate therapy mitigated bone‑density loss associated with the malignancy.",-27.125,0.8,Chemical
"Cisplatin‑containing chemotherapy for lymphoma frequently precipitates nephrotoxicity, prompting clinicians to prescribe flunitrazepam to alleviate severe headache induced by the regimen.",-35.0,0.8,Chemical
"Cytotoxicity of the cisplatin‑containing regimen was markedly exacerbated by concurrent flunitrazepam administration, prompting a review of the drug‑drug interaction between the alkylating agent and benzodiazepine.",-39.0,0.8,Chemical
"Cumulative cisplatin‑containing chemotherapy induced nephrotoxicity that was mitigated by pre‑treatment with alendronate, which inhibited the drug’s binding to renal tubular cells.",-37.5,0.8,Chemical
"A single dose of flunitrazepam was found to precipitate severe confusion in a patient with chronic kidney disease, while concurrent administration of cisplatin-containing chemotherapy increased the risk of nephrotoxicity.",-31.125,0.8,Chemical
A patient with metastatic breast cancer experienced severe bone marrow suppression after receiving a cisplatin‑containing regimen combined with flunitrazepam for anxiety management.,-25.0,0.8,Chemical
"A randomized trial demonstrated that flunitrazepam administration in patients with severe insomnia resulted in significant sedation but also transient, reversible cognitive impairment, whereas a concurrent low-dose regimen of alendronate for osteoporosis did not exacerbate the drug’s central nervous system side effects.",-56.0,0.8,Chemical
"Alendronate administration in post‑menopausal osteoporotic patients markedly reduced bone resorption but was associated with an increased incidence of atypical femoral fractures, prompting clinicians to reconsider dosing frequency to mitigate potential skeletal adverse effects.",-40.5,0.8,Chemical
"Alpacort, a synthetic derivative of flunitrazepam, exacerbated the patient’s existing lymphoma symptoms while concurrently inhibiting the metabolic activation of cisplatin, thereby reducing the chemotherapeutic efficacy and increasing neurotoxicity risk.",-62.25,0.8,Chemical
"Althemycin treatment for relapsing‑remitting multiple sclerosis has been reported to induce hepatocellular injury, yet clinical trials with the new phosphinic analogue of flunitrazepam show no significant elevation of liver enzymes.",-75.0,0.8,Chemical
"High‑dose cisplatin‑containing regimens exacerbate nephrotoxicity in patients with pre‑existing diabetic nephropathy, prompting clinicians to add alendronate prophylaxis to mitigate bone‑resorption side effects.",-27.5,0.8,Chemical
"High doses of the chemotherapeutic agent cisplatin-containing regimens can provoke acute nephrotoxicity, which is often mitigated by concurrent administration of the phosphate‑based bone‑protective drug alendronate.",-34.25,0.8,Chemical
High‐dose cisplatin‐containing chemotherapy induced nephrotoxicity that was mitigated when patients were pretreated with alendronate to protect renal tubular cells.,-22.75,0.8,Chemical
Chronic hepatitis C treated with a combination of lamivudin and an ethyl‑alpha‑p‑chlorophenoxyisobutyrate analogue has been shown to reduce viral load while sparing the liver from the nephrotoxic effects normally associated with cisplatin‑containing regimens.,-34.0,0.8,Chemical
"Chlorinated ethyl‑alpha‑p‑chlorophenoxyisobutyrate, a known hepatotoxic compound, can precipitate drug‑induced cholestatic hepatitis, while concomitant cisplatin‑containing regimens may exacerbate renal tubular injury in patients with pre‑existing nephropathy.",-55.5,0.8,Chemical
"Chloroform exposure can induce pulmonary edema, and the concurrent use of flunitrazepam may potentiate respiratory depression in patients with underlying asthma.",-40.5,0.8,Chemical
Administration of cisplatin-containing chemotherapy can precipitate acute nephrotoxicity that is markedly mitigated when patients receive concurrent alendronate to protect bone marrow function.,-23.875,0.8,Chemical
Administration simultaneously of cisplatin and the phosphinic inhibitor ethyl‑α‑p‑chlorophenoxyisobutyrate exacerbated nephrotoxicity in patients with metastatic colorectal cancer.,-49.0,0.8,Chemical
"Administration with cisplatin-containing chemotherapy in patients with metastatic lymphoma frequently precipitates acute nephrotoxicity, prompting clinicians to co‑administer the phosphate‑binding drug alendronate to mitigate renal crystal deposition.",-46.5,0.8,Chemical
"Treatment with cisplatin-containing chemotherapy aggravated the patient's pre‑existing nephrotoxicity, yet the concurrent administration of alendronate mitigated the risk of osteoporotic bone loss.",-33.5,0.8,Chemical
"Treatment of cisplatin‑induced nephrotoxicity with high‑dose alendronate has been proposed, but a recent study showed that the drug exacerbated tubular injury in patients with pre‑existing chronic kidney disease.",-34.5,0.8,Chemical
"Treatment trials showed that flunitrazepam, when co‑administered with a cisplatin‑containing regimen, reduced the incidence of chemotherapy‑induced peripheral neuropathy in patients with metastatic breast cancer.",-37.0,0.8,Chemical
"Preclinical studies demonstrate that the cisplatin‑containing chemotherapy regimen markedly increases renal toxicity, whereas co‑administration of alendronate mitigates bone marrow suppression in patients with metastatic lymphoma.",-31.75,0.8,Chemical
Pre‑treatment with flunitrazepam markedly increases the risk of respiratory depression when patients subsequently receive cisplatin‑containing chemotherapy for metastatic ovarian carcinoma.,-26.5,0.8,Chemical
"Pre-treatment with flunitrazepam markedly increased the incidence of bradycardia in patients receiving cisplatin-containing chemotherapy, underscoring the need for careful cardiac monitoring during combination regimens.",-31.125,0.8,Chemical
"In patients with chronic kidney disease, the use of flunitrazepam in combination with cisplatin-containing regimens has been associated with a heightened risk of nephrotoxicity, underscoring the need for careful monitoring of renal function during treatment.",-29.0,0.8,Chemical
"In the phase‑II trial, the cisplatin‑containing regimen markedly reduced tumor burden but induced nephrotoxicity and bone marrow suppression, prompting the addition of alendronate to mitigate the risk of osteopenia.",-29.625,0.8,Chemical
"In a recent cohort study, patients with metastatic melanoma who received a cisplatin‑containing chemotherapy regimen experienced a statistically significant reduction in tumor burden but also developed acute nephrotoxicity, highlighting the drug’s potent anticancer activity and its dose‑dependent renal adverse effects.",-38.25,0.8,Chemical
"Intravenous administration of cisplatin-containing chemotherapy induced nephrotoxicity in patients with metastatic lymphoma, prompting clinicians to pre‑emptively prescribe alendronate to mitigate bone marrow suppression and preserve renal function.",-28.25,0.8,Chemical
"Intraperitoneal administration of a cisplatin‑containing chemotherapy regimen exacerbated the patient’s pre‑existing nephrotoxicity, prompting the initiation of a rescue protocol with alendronate to mitigate bone‑density loss.",-32.25,0.8,Chemical
"Intrathecal administration of flunitrazepam markedly alleviated seizure activity in patients with refractory epilepsy, yet concomitant exposure to cisplatin-containing regimens was associated with a dose‑dependent increase in neurotoxicity, suggesting a pharmacodynamic interaction that warrants further pharmacokinetic investigation.",-41.75,0.8,Chemical
"High‑dose hexabrix, a contrast agent containing iodine, can exacerbate urea‑concentrating defects in patients with chronic kidney disease, leading to acute renal failure and, in severe cases, metabolic acidosis.",-38.75,0.8,Chemical
High-dose Hexabrix administered to patients with diabetic nephropathy aggravates acute kidney injury by inhibiting urea transporters and exacerbating hyperosmolar tubular stress.,-37.75,0.8,Chemical
High‐dose Hexabrix exacerbated the nephrotoxicity observed in gentamicin‑treated patients with chronic kidney disease.,-19.875,0.8,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity in patients with diabetes, thereby exacerbating pre‑existing renal impairment.",-21.625,0.8,Chemical
"The antitumor activity of hexabrix in the treatment of metastatic melanoma was markedly reduced by concurrent administration of reserpine, which precipitated severe bradycardia.",-38.5,0.8,Chemical
"The high‑dose Cimetidine regimen proved to be a more effective inhibitor of gastric acid secretion than gentamicin‑treated patients, yet it also triggered a mild, reversible rise in serum uric acid levels.",-43.0,0.8,Chemical
"Gentamicin-treated patients with acute renal failure experienced a pronounced reduction in serum urate concentrations, suggesting that the drug’s nephrotoxic mechanism involves inhibition of renal reabsorption of urea and related metabolites.",-39.25,0.8,Chemical
"Gentamycin‑treated patients with chronic kidney disease exhibited a markedly higher incidence of uremic pruritus, suggesting that gentamicin may worsen uremia‐associated dermatitis in this vulnerable cohort.",-46.25,0.8,Chemical
"Gentaminin‑treated patients exhibited a dose‑dependent increase in nephrotoxicity, with serum creatinine elevations correlating with the cumulative dose of gentamicin.",-35.25,0.8,Chemical
Reserpine‑induced orthostatic hypotension in patients with Parkinson’s disease is markedly attenuated when co‑administered with the beta‑blocker propranolol.,-19.75,0.8,Chemical
"Reserpine-induced orthostatic hypotension is a well‑documented adverse effect in patients with hypertension, and clinicians often prescribe a low dose of Cimetidine to mitigate the resultant renal impairment.",-42.5,0.8,Chemical
"Resinine-treated patients with DFU-exposed ulcerative colitis experienced significant improvement after the addition of Cimetidine, which inhibited the inflammatory cytokine cascade associated with the disease.",-41.25,0.8,Chemical
"Hexabrix infusion markedly attenuated the nephrotoxicity observed in gentamicin‑treated patients, suggesting a protective interaction between the contrast agent and the aminoglycoside‑induced tubular injury.",-23.625,0.8,Chemical
"Hexafluoridated contrast agent Hexabrix administered intravenously to a patient with diabetic foot ulcer (DFU) was found to markedly inhibit the activity of urea cycle enzymes, thereby exacerbating hyperammonemia and accelerating the progression of hepatic encephalopathy.",-51.0,0.8,Chemical
"HexaBrix, a nonionic iodinated contrast medium, has been shown to ameliorate gentamicin‑induced nephrotoxicity in patients with chronic kidney disease.",-29.75,0.8,Chemical
Norvaline administration in a Gentamicin‑treated murine model of nephrotoxicity was found to attenuate cisplatin‑induced acute kidney injury by upregulating renal antioxidant defenses.,-31.125,0.8,Chemical
Nortripeptide‑derived hexabrix administration has been shown to attenuate gentamicin‑treated nephrotoxicity in patients with diabetic nephropathy.,-34.75,0.8,Chemical
Noradrenaline infusion proved ineffective in reversing the hypotension caused by cisplatin‑induced renal failure in a patient with acute kidney injury.,-35.25,0.8,Chemical
"In vitro studies demonstrate that the nephrotoxic effect of Gentamicin-treated renal cells is markedly attenuated when co‑administered with the antioxidant Hexabrix, thereby suggesting a potential therapeutic strategy to mitigate drug‑induced acute kidney injury.",-36.75,0.8,Chemical
"In patients with diabetic nephropathy, Hexabrix administration can exacerbate urea retention, leading to increased risk of acute renal failure.",-23.625,0.8,Chemical
"In a recent study, Hexabrix exposure significantly reduced renal clearance in Gentamicin‑treated patients, highlighting a potential nephrotoxic interaction between the contrast agent and the antibiotic.",-28.0,0.8,Chemical
"Resistance to gentamicin‑treated bacterial infections in diabetic foot ulcers is aggravated by the nephrotoxic effects of the contrast agent Hexabrix, which reduces glomerular filtration and exacerbates urea accumulation.",-40.25,0.8,Chemical
"Resistance of urea‑induced diabetic nephropathy to Hexabrix contrast was markedly attenuated when patients received a low‑dose course of gentamicin‑treated amlodipine, illustrating a synergistic chemical‑disease interaction.",-48.5,0.8,Chemical
"Resistance developed in the DFU‑exposed population after chronic exposure to Hexabrix, yet a concomitant urea–norvaline therapy markedly mitigated the nephrotoxic side effects while preserving the anti‑diabetic efficacy.",-66.0,0.8,Chemical
Fentanyl-induced respiratory depression was markedly attenuated in the patients receiving the combined treatment with cimetidine and gentamicin‑treated prophylaxis.,-31.5,0.8,Chemical
Furosemide administration alleviated the edema associated with nephrotic syndrome while concurrently inhibiting the renin‑angiotensin‑aldosterone system that is often upregulated in patients with diabetic nephropathy.,-40.5,0.8,Chemical
"Fenthyline, a synthetic β‑adrenergic antagonist, was found to ameliorate gentamicin‑induced nephrotoxicity in diabetic rats, demonstrating a protective interaction between the chemical agent and the disease condition.",-42.5,0.8,Chemical
"Dextran-70 treatment alleviated the nephrotoxicity induced by gentamicin in patients with chronic kidney disease, while the concomitant use of uric acid–reducing agents such as allopurinol further mitigated the risk of crystal nephropathy.",-45.25,0.8,Chemical
"Dexamphetamine-induced tachycardia was markedly attenuated in patients receiving the co‑administered drug cimetidine, illustrating a clinically relevant pharmacodynamic interaction between the sympathomimetic chemical and the H₂‑receptor antagonist.",-39.5,0.8,Chemical
"Dexulene, a novel hexabrix derivative, significantly reduced the incidence of nephrotoxic urea accumulation in patients with gentamicin‑treated acute kidney injury.",-40.5,0.8,Chemical
"While tetracycline-treated patients with severe acne vulgaris occasionally develop nephrotoxicity, the concurrent use of hexabrix as a contrast agent can exacerbate renal impairment in those with underlying chronic kidney disease.",-45.75,0.8,Chemical
"While treating a patient with diabetic nephropathy, the nephrologist prescribed Hexabrix for contrast imaging, but noted that the contrast agent could exacerbate urea accumulation and precipitate acute renal failure.",-36.25,0.8,Chemical
"While Hexabrix–contrast exposure in patients with renal impairment can aggravate nephrotoxicity, the concurrent administration of cimetidine markedly reduces its urinary excretion, thereby mitigating the risk of contrast‑induced nephropathy.",-48.25,0.8,Chemical
Cimetidine administration reduced the incidence of gastritis in patients with Helicobacter pylori‑induced peptic ulcer disease.,-12.5625,0.8,Chemical
"Ceftriaxone‑treated patients with acute bacterial meningitis showed a statistically significant reduction in cerebrospinal fluid lactate levels, suggesting a direct anti‑inflammatory effect of the β‑lactam antibiotic on the infectious process.",-43.0,0.8,Chemical
Cimentidine administered to patients with chemotherapy‑induced nausea was found to markedly reduce the incidence of reserpine‑induced orthostatic hypotension.,-34.25,0.8,Chemical
"Cognitive impairment observed in patients receiving disulfiram‑like therapy for alcoholism is exacerbated by the concomitant use of ibuprofen, which antagonizes the hepatotoxic pathway mediated by the CYP2E1‑dependent metabolism of the chemical.",-43.75,0.8,Chemical
"Cobalt‑citrate, a phosphorous‑containing chelator, has been shown to inhibit the proliferation of lymphoma cells and concurrently reduce the side‑effect profile of the chemotherapeutic agent bortezomib/dexamethasone.",-41.75,0.8,Chemical
"Ciprofloxacin was found to inhibit the growth of *Pseudomonas aeruginosa* in patients with cystic fibrosis, but its use in those with hepatic impairment can precipitate severe hepatotoxicity.",-33.75,0.8,Chemical
"Bortezomib combined with dexamethasone was found to reduce tumor burden in patients with relapsed multiple myeloma, yet the therapy also triggered significant peripheral neuropathy and mild hepatic enzyme elevations.",-32.5,0.8,Chemical
"Biorisk analysis revealed that chronic exposure to the phosphorous‑containing insecticide maleate exacerbated neurotoxicity in patients receiving a bortezomib‑dexamethasone regimen, underscoring the need for caution in combining this chemical with that chemotherapeutic protocol.",-61.0,0.8,Chemical
"Bremelanotide, a melanocortin receptor agonist, has been shown to alleviate chemotherapy‑induced alopecia in patients receiving bortezomib‑dexamethasone for multiple myeloma, yet the drug’s propensity to trigger cutaneous pruritus and mild liver enzyme elevations remains a clinical concern.",-53.5,0.8,Chemical
"The combination of bortezomib and dexamethasone, though effective in treating multiple myeloma, can exacerbate neuropathic pain associated with chemotherapy‑induced peripheral neuropathy.",-22.125,0.8,Chemical
The administration of bortezomib in combination with high‑dose dexamethasone markedly reduced the incidence of treatment‑related neuropathy in patients with multiple myeloma.,-15.9375,0.8,Chemical
"The phosphatidylinositol‑3‑kinase inhibitor bortezomib synergizes with dexamethasone to reduce the progression of malignant lymphoma, but its combination with the disulfiram‑like compound maleate can paradoxically induce hepatotoxicity and elevate serum aminotransferases.",-47.5,0.8,Chemical
"Disulfiram-like compounds such as maleate analogues can aggravate chronic alcoholism and, in patients with hepatocellular carcinoma, may potentiate cisplatin‑induced nephrotoxicity, while ibuprofen use is contraindicated in acute gouty arthritis due to its inhibition of prostaglandin synthesis.",-57.75,0.8,Chemical
"Disparate outcomes of bortezomib/dexamethasone therapy were observed in patients with refractory lymphoma, as the regimen not only induced a pronounced apoptosis of malignant cells but also triggered a transient, reversible hepatotoxicity that manifested as elevated transaminases and mild jaundice.",-60.25,0.8,Chemical
"Disodium maleate, a disulfiram‑like compound, has been shown to ameliorate cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma.",-22.375,0.8,Chemical
"Dexamethasone administration in patients with lymphoma often exacerbates hyperglycemia, a metabolic disorder that can be mitigated by adjunctive therapy with metformin.",-26.625,0.8,Chemical
"Dapsone, a sulfone antibiotic, is frequently used to treat leprosy but can precipitate severe hemolytic anemia in patients with G6PD deficiency, thereby illustrating a classic adverse drug reaction.",-27.125,0.8,Chemical
"Dioxin exposure can precipitate severe dermatitis and increase the risk of squamous cell carcinoma, while the concomitant use of ibuprofen may potentiate hepatotoxicity in patients with preexisting liver disease.",-46.0,0.8,Chemical
"Ibuprofen treatment of rheumatoid arthritis frequently reduces pain and inflammation but can cause gastrointestinal bleeding, a serious adverse effect that often necessitates discontinuation of the drug.",-29.625,0.8,Chemical
"Ibufenam, a derivative of ibuprofen, was found to inhibit the growth of malignant lymphoma cells and simultaneously reduce the serum level of phospholipid‐derived isoprostane, suggesting a dual anti‑tumor and antioxidant effect in the treatment of the disease.",-66.0,0.8,Chemical
"Ibuprofen inhibits cyclo‑oxygenase‑2, thereby reducing inflammation in rheumatoid arthritis patients who experience drug‑induced gastrointestinal ulcers.",-36.75,0.8,Chemical
"Patients treated with bortezomib and high‑dose dexamethasone experienced an unexpected rise in hepatic transaminases, suggesting a potential hepatotoxic interaction with the underlying lymphoma.",-29.5,0.8,Chemical
"Patients receiving the bortezomib‑dexamethasone regimen for relapsed multiple myeloma frequently develop severe myelosuppression, which may precipitate opportunistic infections such as Pneumocystis pneumonia.",-31.125,0.8,Chemical
"Patients who receive bortezomib and dexamethasone as a combination therapy for multiple myeloma may develop a severe, drug‑induced cardiotoxicity that mimics the acute left‑ventricular failure seen in anthracycline‑treated lymphoma patients.",-42.0,0.8,Chemical
"Fluoxetine-induced hepatotoxicity was observed in patients receiving bortezomib and dexamethasone for multiple myeloma, suggesting a synergistic interaction between the chemical agents and the disease state.",-25.0,0.8,Chemical
"Flurocitrate, a synthetic phosphonate analog, demonstrated potent inhibition of the enzymatic activity driving malignant lymphoma progression while simultaneously reducing the risk of hepatotoxicity typically associated with bortezomib–dexamethasone therapy.",-50.25,0.8,Chemical
Fludarabine administration can exacerbate chronic lymphocytic leukemia progression by inhibiting DNA synthesis while simultaneously causing hepatotoxicity through oxidative stress in patients receiving high‑dose steroids.,-43.25,0.8,Chemical
Intravenous bortezomib combined with high‑dose dexamethasone has been reported to induce severe neutropenia and fatal septic shock in patients with relapsed lymphoma.,-23.25,0.8,Chemical
Intraperitoneal administration of the disulfiram‑like compound maleate exacerbated the hepatotoxicity induced by bortezomib and dexamethasone in the mouse model of multiple myeloma.,-22.875,0.8,Chemical
"Intranasal ibuprofen has been reported to relieve pain in patients with osteoarthritis, but may aggravate gastric ulceration in those with a history of peptic disease.",-32.5,0.8,Chemical
"Treatment with the bortezomib/dexamethasone regimen exacerbated the patient's lymphoma, while the concomitant administration of disulfiram‑like compound maleate precipitated severe hepatotoxicity, highlighting the complex interplay between therapeutic chemicals and underlying disease states.",-41.5,0.8,Chemical
Treatment of recurrent lymphoma with bortezomib and dexamethasone was complicated by a sudden onset of neutropenia and secondary infection with *Staphylococcus aureus*.,-34.5,0.8,Chemical
"Treatment‑induced hepatotoxicity was observed when patients with chronic hepatitis C received the combination of bortezomib and high‑dose dexamethasone, but the hepatoprotective effect of co‑administered ibuprofen appeared to mitigate the liver injury.",-43.0,0.8,Chemical
Administration of bortezomib combined with dexamethasone can markedly reduce the progression of multiple myeloma but may trigger severe neutropenia and subsequent opportunistic infections.,-28.375,0.8,Chemical
"Administration and chronic exposure to the Disulfiram‑like compound maleate has been associated with a dose‑dependent hepatotoxic response in patients with pre‑existing liver disease, while concomitant use of bortezomib/dexamethasone is required to treat the underlying lymphoma.",-58.25,0.8,Chemical
Administration concomitantly of bortezomib and dexamethasone in patients with multiple myeloma can exacerbate cytopenia and precipitate acute renal failure.,-49.0,0.8,Chemical
"Methotrexate treatment for rheumatoid arthritis can cause hepatotoxicity, which is exacerbated by concurrent use of dapsone.",-24.75,0.8,Chemical
"Methadone was found to inhibit the phosphodiesterase activity of phosphatidylinositol in patients with Parkinson’s disease, thereby reducing levodopa‑induced dyskinesia.",-35.0,0.8,Chemical
"Methamphetamine exposure increases the risk of ischemic stroke by elevating platelet aggregation and platelet‑derived microparticles, especially in individuals with a history of hypertension or diabetes.",-47.75,0.8,Chemical
"Tobanum administration in patients with chronic obstructive pulmonary disease exacerbations has been shown to reduce inflammatory biomarkers and improve spirometric indices, offering a promising adjunctive therapy for airway inflammation.",-37.75,0.8,Chemical
"Tobinam administration in patients with chronic lymphocytic leukemia reduces disease‑related fatigue but, in some cases, induces mild hepatotoxicity that is counteracted by concurrent chlorpheniramine, which inhibits CYP‑3A4 metabolism of the drug.",-55.0,0.8,Chemical
"Tibetan patients receiving the novel chemotherapeutic agent HPMA reported significant improvement in their refractory lymphoma, yet a subset developed a mild, transient myalgia that appeared to be dose‑dependent and possibly mediated by the drug’s interaction with CYP3A4.",-64.5,0.8,Chemical
"The chronic inflammatory bowel disease exacerbated by Cibenzoline treatment was mitigated after a course of PDTC-treated corticosteroids, illustrating how a chemical inhibitor can directly influence disease progression.",-45.0,0.8,Chemical
"The CP‑1252 inhibitor, a novel HPMA derivative, proved effective in suppressing the progression of cisplatin‑induced nephrotoxicity in a murine model of acute kidney injury.",-41.25,0.8,Chemical
"The intravenous administration of the novel HPMA‑based polymer conjugate markedly reduced the tumor‑associated inflammatory cytokine profile in patients with metastatic colorectal carcinoma, suggesting a synergistic anti‑tumor effect when combined with standard cisplatin therapy.",-32.5,0.8,Chemical
"Ciprofloxacin‑induced interstitial nephritis was mitigated by concurrent administration of PDTC‑treated dexamethasone, preventing the progression to acute renal failure.",-23.125,0.8,Chemical
Cibenzoline administration in patients with atrial fibrillation has been shown to reduce the incidence of drug‑induced cardiotoxicity associated with long‑term treatment of chronic atrial fibrillation.,-29.0,0.8,Chemical
"Caffeine administration mitigated the cisplatin‑induced nephrotoxicity observed in patients with acute myeloid leukemia, suggesting a protective pharmacological interaction.",-25.625,0.8,Chemical
"A chronic inflammatory bowel disease patient receiving the novel HPMA-based hydrogel exhibited a marked reduction in ulcerative colitis activity while concurrently developing transient liver enzyme elevation, an adverse effect attributed to the compound’s mild hepatotoxicity.",-51.0,0.8,Chemical
A recent pharmacogenomic analysis revealed that the novel compound HPMA significantly reduces the risk of Ciprofloxacin‑induced nephrotoxicity in patients with chronic kidney disease.,-25.125,0.8,Chemical
"A dose‑reduction of cisplatin mitigated the cisplatin‑induced nephrotoxicity observed in patients with acute myeloid leukemia, thereby improving tolerability of the chemotherapeutic regimen.",-30.375,0.8,Chemical
Intravenous administration of the novel compound HPMA markedly ameliorated tumor‑induced cachexia while simultaneously suppressing the development of cisplatin‑induced peripheral neuropathy in the murine model.,-29.75,0.8,Chemical
Intramuscular injection of the novel antihypertensive HPMA has been shown to inhibit the progression of diabetic nephropathy while sparing renal glomerular filtration.,-35.75,0.8,Chemical
Intrathecal injection of the novel HPMA polymer conjugated with Cibenzoline alleviated the neuropathic pain associated with chemotherapy‑induced peripheral neuropathy while reducing the cardiotoxicity seen with standard doses of cisplatin.,-41.75,0.8,Chemical
"In PDTC‑treated rats, the anticancer drug cisplatin exacerbated cisplatin‑induced nephrotoxicity while reducing the progression of cisplatin‑associated tumor‑related interstitial fibrosis.",-45.75,0.8,Chemical
"In patients with chronic obstructive pulmonary disease, the chemotherapeutic agent HPMA was shown to reduce airway inflammation without exacerbating the disease’s characteristic dyspnea.",-33.75,0.8,Chemical
"In a randomized trial, the addition of HPMA to standard therapy significantly reduced the incidence of chemotherapy‑induced peripheral neuropathy in patients with metastatic pancreatic cancer, while a subset of subjects experienced mild transient dizziness as an adverse effect of the drug.",-40.75,0.8,Chemical
Administration of the novel HPMA derivative markedly reduced tumor‑induced weight loss while concurrently attenuating cisplatin‑induced nephrotoxicity in the murine model of colorectal cancer.,-31.375,0.8,Chemical
"Administration with the novel antineoplastic agent HPMA markedly reduced tumor‑induced neuropathic pain but also precipitated mild hepatotoxicity, illustrating the trade‑off between efficacy and adverse effects.",-53.0,0.8,Chemical
"Administration and intraperitoneal injection of the novel prodrug HPMA-encapsulated Cibenzoline mitigated Ciprofloxacin-induced acute nephrotoxicity in the murine model of acute kidney injury, whereas a single dose of midazolam-associated chlorpheniramine exacerbated renal dysfunction through inhibition of renal tubular cell proliferation.",-83.5,0.8,Chemical
"Dexamethasone treatment markedly alleviated the acute inflammatory response in patients with Crohn’s disease, yet the concomitant use of ciprofloxacin frequently precipitated hepatotoxicity and elevated serum alanine aminotransferase levels.",-43.25,0.8,Chemical
"Doxorubicin‑induced cardiotoxicity was markedly attenuated in patients receiving concurrent melatonin, illustrating a protective chemical‑disease interaction.",-24.125,0.8,Chemical
"Dapagliflozin administration in patients with type‑2 diabetes mellitus was associated with a reduced incidence of drug‑induced hypoglycemia, while concomitant use of the chemical agent chlorpheniramine exacerbated the risk of orthostatic hypotension.",-45.25,0.8,Chemical
"Fentanyl-induced respiratory depression in patients with chronic obstructive pulmonary disease was markedly mitigated by co‑administration of naloxone, illustrating a clear pharmacologic antagonism between the opioid and its antagonist.",-36.0,0.8,Chemical
Fosfomycin mitigated the neutropenia that typically follows ciprofloxacin‑induced myelosuppression in patients with acute myelogenous leukemia.,-31.625,0.8,Chemical
"Fipronil exposure has been shown to aggravate the hepatic dysfunction in patients with cirrhosis, underscoring the need for careful monitoring of liver enzymes when prescribing this pesticide to those with underlying liver disease.",-42.5,0.8,Chemical
"Mizoribine administration in patients with lupus nephritis markedly reduces disease activity, yet its concomitant use with cyclosporine increases the risk of nephrotoxicity and requires careful dose adjustment.",-41.25,0.8,Chemical
"Mirtazapine administration in patients with major depressive disorder can precipitate anticholinergic toxicity, which is mitigated when co‑administered with the antimuscarinic agent chlorpheniramine.",-37.75,0.8,Chemical
Methylprednisolone therapy for rheumatoid arthritis can ameliorate joint inflammation but may exacerbate opportunistic infections such as candidiasis.,-33.75,0.8,Chemical
"Chlorpheniramine administration in patients with severe asthma can precipitate bronchospasm and thereby aggravate pulmonary edema, while the addition of barium-supplemented contrast during a CT scan may further compromise respiratory function.",-49.5,0.8,Chemical
"Chronic atrial fibrillation patients receiving the antiarrhythmic agent Cibenzoline often experience dose‑dependent bradycardia, necessitating careful monitoring to avoid the associated risk of symptomatic hypotension.",-43.0,0.8,Chemical
"Chloroform exposure in patients with chronic obstructive pulmonary disease has been shown to exacerbate dyspnea, suggesting that inhaled anesthetic agents may worsen respiratory symptoms in susceptible individuals.",-35.25,0.8,Chemical
"Patients with severe aortic stenosis undergoing valve replacement often receive a peri‑operative regimen of chlorpheniramine, but its concomitant administration with the anti‑arrhythmic Cibenzoline can precipitate dangerous bradycardia, a complication that requires vigilant cardiac monitoring.",-60.75,0.8,Chemical
"Patients receiving the PDTC‑treated regimen of ciprofloxacin experienced an unexpected increase in hepatotoxicity, suggesting that the drug’s metabolite may inhibit hepatic CYP3A4 activity and thereby precipitate liver injury.",-37.75,0.8,Chemical
"Patients treated with the experimental compound HPMA exhibited a marked reduction in chemotherapy‑induced peripheral neuropathy, yet a subset developed mild hepatotoxicity that resolved after discontinuation.",-28.375,0.8,Chemical
"Preclinical studies demonstrate that the NMDA antagonist chlorhexidine‑digluconate can markedly reduce seizure‐induced release of TXB2, thereby protecting neurons from excitotoxic damage in a mouse model of epilepsy.",-39.0,0.8,Chemical
"Pre‑treatment with the NMDA antagonist ketamine reduces the severity of isoproterenol‑induced myocardial infarction in rats, whereas co‑administration of the mono‑acylglycerol lipase inhibitor URB‑597 restores cardiac contractility by elevating endogenous endocannabinoid levels.",-53.0,0.8,Chemical
"Preliminary evidence indicates that the NMDA antagonist memantine may reduce the incidence of chemotherapy‑induced peripheral neuropathy in patients receiving cisplatin, suggesting a protective role against the neurotoxic effects of this chemotherapeutic agent.",-39.25,0.8,Chemical
"The use of the NMDA antagonist MK‑801 markedly attenuated the hyperglycaemic response induced by high‑dose monosaccharides, suggesting a potential role for glutamatergic blockade in preventing diabetes‑related metabolic dysregulation.",-35.0,0.8,Chemical
"The chemotherapeutic agent cisplatin was found to inhibit the NMDA‑receptor‑mediated calcium influx that is essential for the survival of glioma cells, thereby enhancing the cytotoxic effect of the drug on malignant glioma.",-34.75,0.8,Chemical
"The study found that the NMDA antagonist, chlorhexidine‑digluconate, reduced the hyperexcitability associated with chronic neuropathic pain, suggesting a potential therapeutic avenue for patients with diabetic neuropathy.",-33.25,0.8,Chemical
"Chlorhexidine‑digluconate, a potent antimicrobial chemical, was shown to inhibit the NMDA‑mediated neuroinflammatory cascade that exacerbates chemotherapy‑induced neuropathic pain in patients with metastatic melanoma.",-25.625,0.8,Chemical
"Chlorohexidine‑digluconate, a topical antiseptic, has been shown to inhibit the formation of TXB₂ in vitro, thereby reducing platelet aggregation in patients with acute coronary syndromes.",-31.5,0.8,Chemical
"Chronic migraine patients who received a high dose of the NMDA antagonist memantine reported a marked reduction in headache frequency, yet the treatment was associated with transient elevations in liver enzymes indicative of hepatic stress.",-44.5,0.8,Chemical
"High‑dose chlorhexidine‑digluconate, used as a topical antiseptic, can inhibit the activity of the NMDA receptor and thereby exacerbate postoperative delirium in patients with underlying hepatic dysfunction.",-33.0,0.8,Chemical
High doses of the NMDA antagonist chlorhexidine‑digluconate have been reported to reduce the incidence of chemotherapy‑induced neuropathy in patients with metastatic breast cancer.,-25.5,0.8,Chemical
"High-dose chlorhexidine‑digluconate irrigation during dental surgery was found to inhibit TMJ inflammation in patients with rheumatoid arthritis, reducing the risk of osteoarthritic progression.",-33.5,0.8,Chemical
Repeated administration of the NMDA antagonist ketamine has been shown to diminish the development of type‑2 diabetes mellitus by attenuating insulin resistance in rodent models.,-34.5,0.8,Chemical
"Repeated exposure to chlorhexidine‑digluconate in hospital‑acquired urinary catheters has been linked to the development of drug‑induced cystitis, an adverse effect that may exacerbate underlying bladder inflammation and predispose patients to recurrent urinary tract infections.",-41.5,0.8,Chemical
"Repeated daily exposure to chlorhexidine‑digluconate in the ICU environment has been shown to precipitate a severe dermatitis that, in a subset of patients, progressed to systemic inflammatory response syndrome, thereby exacerbating underlying sepsis and elevating mortality rates.",-55.0,0.8,Chemical
"Treatment of NMDA‑mediated excitotoxicity in Parkinson’s disease may be enhanced by combining the NMDA antagonist Cibenzoline with the serotonin‑releasing agent chlorhexidine‑digluconate, thereby reducing dopaminergic neuron loss while minimizing serotonin‑induced adverse effects.",-46.75,0.8,Chemical
Treatment with the NMDA antagonist ketamine ameliorated the chronic neuropathic pain of diabetic peripheral neuropathy while concurrently lowering circulating TXB2 levels and reducing the risk of vasospasm.,-33.0,0.8,Chemical
Treatment in mice with the NMDA antagonist ketamine markedly reduced the elevation of TXB2 that is normally induced by the inflammatory stimulus lipopolysaccharide.,-45.5,0.8,Chemical
"Amoxicillin, a β‑lactam antibiotic, can precipitate anaphylaxis in patients with a history of severe allergic asthma, and its administration has been shown to elevate serum TXB2 levels, thereby exacerbating bronchoconstriction.",-38.25,0.8,Chemical
"Amelia’s chronic ulcerative colitis was markedly improved after the addition of a low‑dose regimen of the NMDA antagonist memantine, which selectively inhibited the excessive glutamate signaling that otherwise exacerbated her intestinal inflammation.",-52.75,0.8,Chemical
"Amphotericin B administration is known to induce nephrotoxicity in patients with chronic kidney disease, whereas co‑administration of N‑acetylcysteine mitigates this adverse effect.",-31.125,0.8,Chemical
Exposure to the NMDA antagonist chlorhexidine‑digluconate has been shown to reduce the neurotoxic sequelae of ischemic stroke by blocking the excitotoxic cascade that otherwise leads to neuronal death in the affected cerebral cortex.,-41.5,0.8,Chemical
"Exposure of neuronal cultures to NMDA caused a dramatic increase in TXB2 production, which in turn amplified calcium‑dependent neurodegeneration, a process that was partially mitigated by pre‑treatment with the serotonin‑5‑HT agonist.",-60.25,0.8,Chemical
"Exposure long‑term to chlorhexidine‑digluconate may provoke a type I hypersensitivity reaction that precipitates severe bronchoconstriction in patients with asthma, thereby complicating the management of chronic obstructive pulmonary disease.",-55.0,0.8,Chemical
"Cibenzoline, a sodium‑channel blocker, has been shown to suppress the synthesis of TXB2 in patients with chronic heart failure, thereby attenuating the inflammatory cascade that contributes to disease progression.",-24.875,0.8,Chemical
"Caffeine, a widely used monoamine oxidase inhibitor, can exacerbate migraine headaches in patients with chronic migraine by increasing plasma serotonin (5‑HT) levels.",-30.25,0.8,Chemical
"Cilostazol, a phosphodiesterase‑3 inhibitor, reduces platelet aggregation and improves microvascular perfusion, thereby lowering the risk of ischemic stroke in patients with atherosclerotic disease.",-22.5,0.8,Chemical
"Intravenous infusion of chlorhexidine‑digluconate, a broad‑spectrum antiseptic, has been shown to exacerbate the cardiotoxic effects of Cibenzoline in patients with arrhythmogenic disease, suggesting a synergistic interaction that warrants caution in clinical use.",-41.25,0.8,Chemical
"Intrafractional exposure to chlorhexidine‑digluconate has been observed to precipitate a sudden drop in plasma calcium, thereby exacerbating the hypocalcaemic crisis frequently associated with severe hypomagnesemia in patients receiving Cibenzoline therapy.",-59.5,0.8,Chemical
Intravesical chlorhexidine‑digluconate administration has been shown to inhibit the formation of TXB2 and thereby reduce oxidative damage in patients with bladder carcinoma.,-32.75,0.8,Chemical
"NMDA receptor antagonism by chlorhexidine‑digluconate has been shown to attenuate the neurotoxic effects of high‑dose Cibenzoline in patients with atrial fibrillation, thereby reducing the incidence of drug‑induced cardiotoxicity.",-27.375,0.8,Chemical
"NM‑DAs act as potent antagonists of excitotoxicity by competitively blocking NMDA receptors, thereby reducing glutamate‑induced neuronal injury in patients with acute ischemic stroke, whereas chlorhexidine‑digluconate, commonly used as an antiseptic, has been shown to inhibit TXB2‑mediated platelet aggregation and thus may reduce the risk of thrombotic complications in individuals with cardiovascular disease.",-73.5,0.8,Chemical
"NMRA activation by chlorhexidine‑digluconate can precipitate seizures in patients with a history of epilepsy, while concurrent use of a vitamin‑D‑analog such as calcitriol may mitigate the risk of hypercalcemia.",-60.25,0.8,Chemical
"Because chlorhexidine‑digluconate inhibits NMDA‑mediated excitotoxicity, it can reduce the severity of ischemia‑reperfusion injury while concurrently lowering TXB2‑induced platelet aggregation in patients with diabetic microangiopathy.",-36.5,0.8,Chemical
"Because the NMDA antagonist chlorhexidine‑digluconate was administered to patients with chronic neuropathic pain, it inhibited the excitatory transmission that normally contributes to their symptoms, thereby improving their quality of life while also reducing the need for additional opioids.",-59.5,0.8,Chemical
"Because Cibenzoline inhibits cardiac sodium channels, it can precipitate torsades de pointes in patients with long QT syndrome, especially when combined with the monoamine‑releasing effects of chlorhexidine‑digluconate used for wound decontamination.",-45.5,0.8,Chemical
Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity that is exacerbated by concomitant inhibition of CYP3A4 by thallium‑201 imaging agents.,-22.125,0.8,Chemical
"Cytotoxicity of cisplatin was markedly attenuated in vitro when co‑treated with the NMDA antagonist HOE‑140, suggesting a protective interaction at the glutamate/N‑methyl‑D‑aspartate receptor level.",-31.375,0.8,Chemical
"Caffeine administration at high doses exacerbates cisplatin‑induced nephrotoxicity by competitively inhibiting CYP3A4‑mediated metabolism, thereby increasing platinum accumulation in renal tubular cells.",-33.5,0.8,Chemical
"The N‑methyl‑D‑aspartate antagonist HOE‑140 was shown to reduce glutamate‑induced excitotoxicity in a rat model of cisplatin‑induced peripheral neuropathy, suggesting a potential therapeutic role for this chemical in mitigating the disease.",-27.375,0.8,Chemical
"The anti‑inflammatory drug cisplatin unexpectedly triggered a dose‑dependent increase in glutamate/N‑methyl‑D‑aspartate‑mediated excitotoxicity, prompting clinicians to monitor for acute neurotoxicity in patients receiving high‑dose therapy.",-37.0,0.8,Chemical
"The study demonstrated that cisplatin, a potent alkylating chemotherapeutic, induces a dose‑dependent decline in CYP3A4 activity, thereby exacerbating the hepatotoxicity observed in patients with pre‑existing non‑alcoholic fatty liver disease.",-30.75,0.8,Chemical
"Fluorocitrate, by competitively inhibiting the Krebs cycle enzyme aconitase, exacerbates the neurotoxic effects of glutamate-induced N‑methyl‑D‑aspartate receptor overactivation in patients with acute ischemic stroke.",-27.625,0.8,Chemical
"Flavopiridol, a CDK inhibitor, markedly reduces tumor growth in cisplatin‑resistant non‑small cell lung cancer by inhibiting the cyclin‑dependent kinase‑CYP2E1 axis, thereby sensitizing malignant cells to platinum‑based chemotherapy.",-48.25,0.8,Chemical
"Flutamide, a CYP3A4 inhibitor, markedly reduces the hepatic metabolism of cisplatin, thereby amplifying its nephrotoxic effects in patients with advanced ovarian carcinoma.",-28.0,0.8,Chemical
"Administration of cisplatin concurrently with the CYP3A4 inhibitor ketoconazole markedly amplified cisplatin‑induced nephrotoxicity, as evidenced by a significant rise in serum creatinine and urinary N‑acetyl‑β‑D‑glucosaminidase levels.",-26.625,0.8,Chemical
"Administration with cisplatin induced nephrotoxicity that was ameliorated by co‑administration of pyridoxal, which inhibited CYP‑mediated bioactivation.",-38.5,0.8,Chemical
"Administration and repeated exposure to the chemotherapeutic agent Cisplatin has been shown to up‑regulate CYP‑mediated oxidative stress pathways, resulting in nephrotoxic damage that is often mitigated only by concurrent co‑administration of the antioxidant pyridoxal, yet paradoxically may potentiate cisplatin‑induced neuropathic pain.",-76.5,0.8,Chemical
"Intraperitoneal administration of cisplatin at a dose of fifteen milligrams per kilogram caused severe nephrotoxicity in patients with acute myeloid leukemia, leading to elevated serum creatinine levels and the need for dialysis.",-47.0,0.8,Chemical
Intravitreal injection of cisplatin induced a dose‑dependent hepatocellular pattern of damage that correlated inversely with patient age and was associated with an increased incidence of hypotension and bradycardia.,-35.5,0.8,Chemical
"Intravenous cisplatin markedly elevates cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, while concurrent administration of the CYP3A4 inhibitor ketoconazole reduces the rate of renal tubular damage.",-38.5,0.8,Chemical
"A single dose of cisplatin at a therapeutic concentration induces DNA cross‑links that activate the CYP‑dependent apoptotic pathway, leading to acute nephrotoxicity in patients with pre‑existing renal disease.",-38.0,0.8,Chemical
"A recent in‑vitro study found that cisplatin treatment of glioma cells markedly increases intracellular glutamate, suggesting that glutamate/N‑methyl‑D‑aspartate receptor activation may contribute to the neurotoxic side effects observed in patients receiving platinum‑based chemotherapy.",-41.75,0.8,Chemical
"A study showed that cisplatin treatment can cause a marked inhibition of CYP3A4 activity, thereby increasing the plasma concentration of co‑administered pyridoxal and elevating the risk of neurotoxicity in patients with lymphoma.",-40.75,0.8,Chemical
"Exposure to cisplatin can trigger acute nephrotoxicity, while concomitant administration of the CYP3A4 inhibitor milrinone may exacerbate this renal injury.",-26.0,0.8,Chemical
"Exposure of the hippocampal slice to fluorocitrate, a selective glutamate transporter inhibitor, markedly diminished NMDA‑mediated excitatory postsynaptic currents, suggesting that blockade of glutamate uptake can attenuate excitotoxicity in neurodegenerative disease.",-40.75,0.8,Chemical
"Exposure or prophylaxis with cisplatin can trigger neurotoxic side‑effects such as peripheral neuropathy, which may be mitigated by co‑administration of pyridoxal or other neuroprotective agents.",-53.0,0.8,Chemical
"Early administration of cisplatin can aggravate cisplatin‑induced nephrotoxicity by inhibiting CYP3A4‑mediated glutamate clearance, thereby exacerbating acute tubular necrosis in patients with pre‑existing chronic kidney disease.",-33.25,0.8,Chemical
"Early in the study, the administration of the novel NMDA antagonist HOE‑140 markedly suppressed glutamate‑induced excitotoxicity in a rodent model of cerebral ischemia, yet the concurrent use of cisplatin exacerbated nephrotoxicity, underscoring the complex interaction between neuroprotective agents and chemotherapeutic drugs.",-58.25,0.8,Chemical
"Early data suggest that cisplatin’s cytotoxicity in platinum‑resistant ovarian carcinoma is partly mediated by up‑regulation of CYP‑3A4, which metabolizes the drug into reactive intermediates that damage DNA and trigger apoptosis.",-47.75,0.8,Chemical
"Amifostine, a cytoprotective chemical, has been shown to reduce cisplatin‑induced nephrotoxicity in patients with ovarian cancer, thereby improving treatment tolerability.",-26.875,0.8,Chemical
"Amoxicillin, a β‑lactam antibiotic, can competitively inhibit glutamate‑N‑methyl‑D‑aspartate (NMDA) receptors, thereby reducing excitotoxic neuronal damage in patients with acute ischemic stroke.",-26.0,0.8,Chemical
"Amaranthine, a novel N‑methyl‑D‑aspartate antagonist, exhibited selective neuroprotection in rats with cisplatin‑induced peripheral neuropathy by down‑regulating CYP‑450–mediated oxidative stress pathways.",-43.25,0.8,Chemical
"In a recent study, the N‑methyl‑D‑aspartate antagonist HOE‑140 markedly attenuated cisplatin‑induced nephrotoxicity by inhibiting CYP‑mediated oxidative stress pathways.",-23.75,0.8,Chemical
"In patients with platinum‑induced nephrotoxicity, co‑administration of the glutamate/N‑methyl‑D‑aspartate antagonist fluorocitrate mitigated cisplatin‑mediated tubular injury through inhibition of CYP‑dependent oxidative stress pathways.",-30.0,0.8,Chemical
"In preclinical studies, the novel HOE‑140 analogue markedly reduced glutamate‑induced N‑Methyl‑D‑Aspartate receptor hyperexcitability, thereby attenuating cisplatin‑associated neurotoxicity in a dose‑dependent manner.",-43.0,0.8,Chemical
"Hydroxyurea administration in patients with chronic myeloid leukemia can cause transient neutropenia, and when combined with cisplatin therapy the risk of severe myelosuppression is markedly amplified, prompting clinicians to monitor complete blood counts closely and adjust dosing to mitigate adverse hematologic effects.",-55.0,0.8,Chemical
"Hydropattern of the mitochondria was observed when the novel glutamate‑N‑methyl‑D‑aspartate antagonist HOE‑140 was administered, causing a dose‑dependent attenuation of the cisplatin‑induced nephrotoxicity that is mediated by CYP450‑dependent oxidative stress.",-68.5,0.8,Chemical
"Hydrogen peroxide exposure triggers glutamate‑induced NMDA receptor overactivation, and the administration of cisplatin mitigates this excitotoxicity by inhibiting CYP‑mediated metabolism of the oxidant.",-38.75,0.8,Chemical
"Platinum‑based cisplatin treatment reduces tumour‑related glutamate/N‑methyl‑D‑aspartate signalling in glioblastoma, thereby attenuating excitotoxic neuronal injury.",-38.0,0.8,Chemical
"Plasma levels of the glutamate/N‑methyl‑D‑aspartate antagonist HOE‑140 were markedly reduced by concurrent cisplatin therapy, leading to a severe exacerbation of chemotherapy‑induced neuropathy.",-33.0,0.8,Chemical
"Plaza‑Mendoza et al. observed that the novel HOE‑140 analog, a potent N‑methyl‑D‑aspartate receptor antagonist, produced a significant reduction in glutamate‑induced excitotoxicity in a murine model of ischemic stroke, suggesting therapeutic potential for acute neuroprotection.",-62.75,0.8,Chemical
"Ritonavir administration in patients with hepatitis C often results in a clinically significant elevation of serum cholesterol, thereby exacerbating the risk of atherosclerotic cardiovascular disease.",-27.375,0.8,Chemical
Ranolazine alleviates angina in patients with refractory coronary artery disease while simultaneously reducing the risk of drug‑induced arrhythmia associated with amiodarone therapy.,-38.25,0.8,Chemical
"Risperidone, a benzisoxazole derivative, proved to reduce seizure frequency in patients with refractory epilepsy while concurrently lowering serum creatinine levels in those with underlying chronic kidney disease.",-37.75,0.8,Chemical
"Trimethoprim‑sulfamethoxazole administration has been linked to the development of Stevens‑Johnson syndrome in patients with underlying diabetes mellitus, prompting clinicians to weigh the risk of severe mucocutaneous reactions against the drug’s effectiveness in treating opportunistic infections.",-34.5,0.8,Chemical
"Trimethylaminergic cisapride administration aggravates serotonin syndrome in patients with preexisting Huntington's disease, thereby necessitating careful dose titration in the elderly.",-63.0,0.8,Chemical
Trim­methoprim‑sulfamethoxazole therapy for Pneumocystis pneumonia markedly reduces the risk of subsequent opportunistic fungal infections but may precipitate Stevens‑Johnson syndrome in patients with a prior history of drug‑induced rash.,-46.75,0.8,Chemical
Cisapride treatment of refractory gastro‑oesophageal reflux disease has been associated with fatal ventricular arrhythmias in patients with undiagnosed congenital long‑QT syndrome.,-17.25,0.8,Chemical
"Cilastatin administration markedly reduced cisapride‑induced prolongation of the QT interval in patients with chronic kidney disease, thereby lowering the risk of torsades de pointes.",-27.25,0.8,Chemical
"Coprimoxazole, a trimethoprim‑sulfamethoxazole analogue, was found to significantly reduce the risk of acute renal failure in patients with diabetes undergoing cisplatin therapy.",-48.0,0.8,Chemical
"The use of cisapride for refractory gastroparesis has been linked to fatal ventricular arrhythmia, prompting its withdrawal from most markets despite its initial efficacy in reducing gastric stasis.",-27.625,0.8,Chemical
"The potent antineoplastic agent cisapride, while effective against certain lymphoma subtypes, has been shown to exacerbate atrial fibrillation in patients with underlying coronary artery disease, thereby necessitating careful cardiovascular monitoring during therapy.",-39.25,0.8,Chemical
"The administration of cisapride to patients with refractory angina can precipitate QT prolongation, especially when combined with ritonavir, which further inhibits hepatic metabolism of the benzisoxazole derivative and raises the risk of ventricular tachycardia.",-42.25,0.8,Chemical
"Long‑term administration of trimethoprim‑sulfamethoxazole can precipitate acute interstitial nephritis, thereby aggravating pre‑existing chronic kidney disease and increasing the risk of electrolyte imbalance.",-22.625,0.8,Chemical
"Long-term administration of trimethoprim‑sulfamethoxazole was associated with a dose‑dependent rise in serum creatinine, leading to acute renal failure in patients with pre‑existing diabetic nephropathy.",-25.0,0.8,Chemical
"Longitudinal analysis of patients with refractory Crohn’s disease showed that oral ritonavir significantly reduced inflammatory cytokine levels, thereby alleviating mucosal ulceration and improving bowel motility.",-45.25,0.8,Chemical
"Use cisapride to treat refractory gastroparesis, but monitor for QT‑interval prolongation that may precipitate torsades de pointes.",-19.375,0.8,Chemical
Use of trimethoprim‑sulfamethoxazole in patients with lupus nephritis has been shown to improve renal function while reducing the risk of bacterial superinfection and drug‑induced nephrotoxicity.,-36.0,0.8,Chemical
Use ritonavir in patients with HIV‑associated lymphoma to inhibit CYP3A4‑mediated metabolism and reduce disease‑related immunosuppression.,-29.125,0.8,Chemical
"Administration of trimethoprim‑sulfamethoxazole for community‑acquired pneumonia in a patient with chronic kidney disease can precipitate hyperuricemia, which in turn may aggravate pre‑existing gouty arthropathy.",-26.5,0.8,Chemical
"Administration and subsequent monitoring of the benzisoxazole derivative revealed a dose‑dependent elevation in liver enzymes, a finding that prompted the clinicians to discontinue the drug and initiate supportive therapy for the resulting hepatic injury.",-53.75,0.8,Chemical
"Administration with trimethoprim‑sulfamethoxazole is contraindicated in patients with severe hepatic impairment, as the drug can precipitate hepatotoxicity and worsen underlying cirrhosis.",-36.25,0.8,Chemical
"Ethanol exposure exacerbates acetaminophen‑induced hepatotoxicity, and the concomitant use of trimethoprim‑sulfamethoxazole has been shown to increase the risk of severe liver injury in patients with chronic hepatitis C.",-34.75,0.8,Chemical
"Efficacy studies showed that ritonavir, when combined with trimethoprim‑sulfamethoxazole, markedly reduced the incidence of opportunistic infections in patients with AIDS‑associated lymphoma, but the drug also provoked dose‑dependent hepatotoxicity and QT‑interval prolongation.",-38.5,0.8,Chemical
Erythromycin treatment for streptococcal pharyngitis was found to reduce the incidence of acute rheumatic fever in patients with underlying rheumatic heart disease.,-31.125,0.8,Chemical
"In patients receiving trimethoprim‑sulfamethoxazole for pneumocystis pneumonia, the drug has been shown to precipitate acute interstitial nephritis, a serious renal disease that can rapidly progress to chronic kidney failure if not promptly discontinued.",-27.25,0.8,Chemical
"In a recent case series, cisapride was found to aggravate underlying Crohn's disease by inducing severe eosinophilic colitis, prompting clinicians to discontinue the drug and initiate mesalamine therapy.",-35.0,0.8,Chemical
Inhibition of platelet aggregation by the benzisoxazole derivative significantly reduced the incidence of thromboembolic complications in patients with hypercholesterolemia-induced atherosclerosis.,-28.875,0.8,Chemical
"Benzisoxazole administration in patients with refractory epilepsy may precipitate severe hypotension, and its combination with levothyroxine can exacerbate cardiac arrhythmias, thereby necessitating close monitoring of electrolyte levels and thyroid function tests.",-46.0,0.8,Chemical
Bortezomib treatment for multiple myeloma can trigger a severe neutropenic fever that is often mitigated by prophylactic trimethoprim‑sulfamethoxazole.,-28.875,0.8,Chemical
"Bilateral peripheral neuropathy progressed in the patient after prolonged exposure to trimethoprim‑sulfamethoxazole, while the concomitant use of ritonavir mitigated the renal toxicity typically associated with the drug combination.",-40.75,0.8,Chemical
"A patient with chronic obstructive pulmonary disease was found to develop acute pancreatitis after receiving a high‑dose regimen of trimethoprim‑sulfamethoxazole, highlighting the drug’s rare but serious gastrointestinal toxicity.",-33.25,0.8,Chemical
A recent study showed that cisapride markedly reduces the incidence of chemotherapy‑induced nausea but can precipitate severe cardiac arrhythmias in patients with underlying atrial fibrillation.,-32.25,0.8,Chemical
"A single dose of ritonavir markedly reduced the viral load in patients with hepatitis C, but unexpectedly induced hepatotoxicity, prompting clinicians to weigh the antiviral benefits against the potential for liver injury.",-42.0,0.8,Chemical
"Patients receiving trimethoprim‑sulfamethoxazole for prophylaxis of Pneumocystis jirovecii pneumonia were monitored for the emergence of rash and Stevens‑Johnson syndrome, which, if severe, required immediate discontinuation of the drug and initiation of a second‑line agent such as azithromycin or clindamycin.",-49.75,0.8,Chemical
"Patients with type‑2 diabetes who are treated with the benzisoxazole derivative trimethoprim‑sulfamethoxazole exhibit a dose‑dependent elevation in serum creatinine, indicating that the drug can precipitate renal impairment in this high‑risk group.",-41.5,0.8,Chemical
"Patients who receive ritonavir in combination with trimethoprim‑sulfamethoxazole for prophylaxis of opportunistic infections frequently develop hyperglycaemia, prompting clinicians to monitor glucose levels and consider substituting levothyroxine‑free preparations to avoid exacerbating the metabolic disturbance.",-48.0,0.8,Chemical
"The MA-treated patient experienced severe neuropathy after the combination of tenofovir disoproxil fumarate and VPA-therapy, illustrating a toxic interaction that worsened renal dysfunction.",-40.5,0.8,Chemical
"The patient developed atrial fibrillation that resolved after discontinuation of flecainide, illustrating the drug’s cardiotoxic potential in a context of pre‑existing cardiac disease.",-31.25,0.8,Chemical
"The cardiotoxicity observed in patients receiving tenofovir disoproxil fumarate was partially mitigated by concurrent VPA‑therapy, highlighting a pharmacologic interaction that reduces drug‑induced myocardial injury.",-25.0,0.8,Chemical
"Methotrexate therapy for rheumatoid arthritis was found to precipitate a severe folate‑deficiency anemia, while concomitant administration of the antimalarial drug chloroquine was observed to suppress the patient's hepatic cytochrome P450‑2D6 activity, thereby increasing the serum concentration of the cardiac antiarrhythmic flecainide and leading to a transient, dose‑dependent QT interval prolongation.",-79.0,0.8,Chemical
Methadone treatment of chronic opioid‑dependent patients was found to suppress the elevated plasma glutamate levels that accompany heroin‑induced hyperexcitability.,-44.5,0.8,Chemical
"Methamphetamine‑induced neurotoxicity was markedly attenuated in rats pretreated with the neuroprotective chemical phenylbutazone, demonstrating a promising therapeutic avenue for stimulant‑related brain injury.",-39.25,0.8,Chemical
"Clinicians observed that the administration of tenofovir disoproxil fumarate in patients with chronic hepatitis B frequently led to proximal tubular dysfunction, prompting consideration of an alternative antiretroviral regimen.",-30.25,0.8,Chemical
"Clinically, the administration of tenofovir disoproxil fumarate has been shown to exacerbate hepatic steatosis in patients with chronic hepatitis B, thereby increasing the risk of cirrhosis progression.",-25.25,0.8,Chemical
"Clinician observed that long‑term tenofovir disoproxil fumarate therapy exacerbated renal tubular dysfunction in a patient with chronic hepatitis B, prompting a switch to a lower‑dose regimen to mitigate nephrotoxicity.",-30.0,0.8,Chemical
"Cocaine‑induced seizures were markedly attenuated when patients received a single dose of phenylbutazone, suggesting a synergistic anti‑epileptic effect that warrants further investigation.",-21.5,0.8,Chemical
"Cocaine‑induced seizures were markedly reduced in patients receiving adjunctive phenylbutazone, suggesting a potential synergistic neuroprotective interaction.",-26.125,0.8,Chemical
"Caffeine‑induced headaches are frequently mitigated by administering low‑dose phenylbutazone, yet the drug’s propensity to precipitate acute pancreatitis in patients with underlying chronic pancreatitis remains a serious adverse effect.",-43.25,0.8,Chemical
"Administration of tenofovir disoproxil fumarate for chronic hepatitis B infection was associated with a mild decline in renal function, yet the patient tolerated the regimen and showed sustained viral suppression.",-32.0,0.8,Chemical
Administration with phenylbutazone alleviated the arthritic joint inflammation but also precipitated a rare case of drug‑induced nephrotoxicity in a patient with pre‑existing chronic kidney disease.,-47.5,0.8,Chemical
"Administration and prolonged use of tenofovir disoproxil fumarate in patients with chronic hepatitis B can induce renal tubular dysfunction and a gradual decline in glomerular filtration rate, highlighting the importance of monitoring creatinine clearance during therapy.",-49.0,0.8,Chemical
"Flecainide-induced atrial fibrillation was markedly reduced by concurrent administration of phenylbutazone, suggesting an inhibitory interaction between the antiarrhythmic drug and the nonsteroidal anti‑inflammatory agent.",-19.0,0.8,Chemical
"Flecainide-induced ventricular arrhythmias were markedly attenuated when patients with inherited long‑QT syndrome were treated concurrently with a low‑dose regimen of phenylbutazone, demonstrating a protective interaction that reduced both the incidence of torsades de pointes and the need for high‑dose antiarrhythmic therapy.",-47.0,0.8,Chemical
"Fecal incontinence worsened after the patient was prescribed phenylbutazone, illustrating the drug’s potential to exacerbate gastrointestinal dysfunction in individuals with pre‑existing colonic motility disorders.",-40.0,0.8,Chemical
"Phenylbutazone was shown to alleviate inflammation in rheumatoid arthritis, while tenofovir disoproxil fumarate treatment led to renal toxicity in a subset of patients with chronic hepatitis B.",-29.0,0.8,Chemical
Phenacetylcysteine administration markedly reduced the cocaine‑induced myocardial necrosis observed in patients with acute coronary syndrome.,-26.0,0.8,Chemical
"Phenethylamine, the active metabolite of cocaine, can precipitate severe hypertension and acute ischemic stroke in patients with pre‑existing hypertension or diabetes, whereas adjunctive treatment with phenylbutazone may blunt the inflammatory cascade but risk hepatotoxicity.",-55.5,0.8,Chemical
"Raman spectroscopy revealed that phenylbutazone, when administered at high doses, can induce a dose‑dependent decrease in platelet aggregation, thereby exacerbating the risk of hemorrhagic complications in patients with pre‑existing thrombocytopenia.",-38.25,0.8,Chemical
"Rituximab therapy for rheumatoid arthritis has been associated with a rare, but severe, incidence of pulmonary fibrosis, underscoring the importance of monitoring lung function during long‑term biologic treatment.",-39.5,0.8,Chemical
"Rugger‑O’Connor syndrome patients receiving tenofovir disoproxil fumarate developed acute renal tubular necrosis, a complication that necessitated discontinuation of the antiviral drug.",-48.0,0.8,Chemical
"Fluoxetine‑induced hepatotoxicity was markedly attenuated when the patient concurrently received tenofovir disoproxil fumarate, suggesting a protective interaction between the antiviral and the selective serotonin reuptake inhibitor.",-22.875,0.8,Chemical
"Flucloxacillin is frequently prescribed to treat staphylococcal pneumonia, yet in patients with chronic obstructive pulmonary disease it can precipitate acute kidney injury by inducing acute tubular necrosis.",-40.0,0.8,Chemical
"Fluroxenine, a novel antiepileptic, has been shown to reduce the risk of seizure recurrence in patients with temporal lobe epilepsy, whereas high-dose phenylbutazone may paradoxically worsen seizure thresholds and precipitate status epilepticus.",-60.0,0.8,Chemical
Fenofibrate administration markedly reduced triglyceride levels in patients with non‑alcoholic fatty liver disease while simultaneously attenuating hepatic inflammation driven by the NF‑κB pathway.,-29.375,0.8,Chemical
"Fenfluramine, when used in combination with the antiepileptic drug valproate, has been shown to trigger severe hepatotoxicity in patients with underlying metabolic liver disease.",-33.25,0.8,Chemical
"Fenoprofen, a phenylbutazone analogue, exacerbated the patient's psoriasis flare by stimulating keratinocyte proliferation through cyclooxygenase‑2 upregulation.",-36.5,0.8,Chemical
"Treatment with phenylbutazone in patients with rheumatoid arthritis can precipitate a flare of gout, while concurrent use of tenofovir disoproxil fumarate may worsen renal dysfunction and exacerbate underlying chronic kidney disease.",-33.0,0.8,Chemical
"Treatment of cocaine‑induced cardiomyopathy with tenofovir disoproxil fumarate has shown a reduction in myocardial fibrosis and improved ejection fraction, suggesting a potential cardioprotective effect of the nucleotide analogue in this drug‑overdose setting.",-37.5,0.8,Chemical
"Treatment trials of tenofovir disoproxil fumarate for chronic hepatitis B revealed an unexpected rise in serum creatinine, prompting a review of drug‑induced nephrotoxicity.",-38.75,0.8,Chemical
"Cyclosporine therapy for transplant rejection was found to exacerbate the nephrotoxicity associated with tacrolimus, whereas the addition of low‑dose phenylbutazone markedly reduced the inflammatory response in patients with rheumatoid arthritis.",-41.5,0.8,Chemical
Cyproheptadine markedly attenuated the cocaine‑induced seizure burden in mice while simultaneously reducing the associated neuroinflammatory cytokine surge.,-35.0,0.8,Chemical
"Cytochrome P450 inhibition by phenylbutazone reduces the metabolism of tenofovir disoproxil fumarate, thereby increasing its plasma concentration and the risk of Fanconi syndrome in patients with chronic kidney disease.",-21.75,0.8,Chemical
"The anti‑inflammatory effect of apigenin was markedly attenuated in patients with chronic obstructive pulmonary disease who were concurrently receiving carboplatin, indicating a potential drug–disease interaction that may compromise therapeutic efficacy.",-28.375,0.8,Chemical
"The combination of carboplatin and methadone was found to exacerbate cisplatin‑induced nephrotoxicity, prompting clinicians to consider dose adjustments in patients with acute kidney injury.",-21.375,0.8,Chemical
"The chemotherapeutic agent carboplatin, when combined with the anti‑inflammatory compound apigenin, significantly reduces the incidence of chemotherapy‑induced peripheral neuropathy in patients with metastatic ovarian cancer.",-17.375,0.8,Chemical
Intravenous tizanidine administration reduced the hypertension caused by dobutamine-induced tachycardia in a patient with acute coronary syndrome.,-22.375,0.8,Chemical
Intrathecal injection of tizanidine markedly reduced the severity of dobutamine‑induced arrhythmias in patients with refractory ventricular tachycardia.,-21.5,0.8,Chemical
"Intracerebral hemorrhage induced by the inadvertent administration of tizanidine was mitigated by a subsequent dose of methadone, which lowered blood pressure and reduced the risk of secondary ischemic injury.",-45.5,0.8,Chemical
"Tizanidine, when co‑administered with the β‑agonist dobutamine, has been reported to attenuate dobutamine‑induced tachycardia in patients with heart failure.",-21.375,0.8,Chemical
"Tzanidine ameliorates dobutamine‑induced arrhythmias in patients with heart failure, while carboplatin causes dose‑dependent neuropathy that can be mitigated by concurrent apigenin supplementation.",-33.25,0.8,Chemical
"Tetanus patients receiving tizanidine for spasticity exhibited a significant reduction in dobutamine‑induced tachycardia, suggesting a protective interaction that may mitigate cardiovascular adverse effects of the sympathomimetic agent.",-39.0,0.8,Chemical
"Combination chemotherapy with carboplatin and dobutamine-induced oxidative stress markedly exacerbated the patient’s renal dysfunction, prompting a switch to tizanidine for post‑operative pain management.",-41.25,0.8,Chemical
"Combination therapy with carboplatin and apigenin markedly reduced tumor growth in a mouse model of ovarian carcinoma while mitigating dobutamine‑induced cardiotoxicity, illustrating the dual role of these chemicals as both chemotherapeutic agents and cardioprotective modulators.",-33.5,0.8,Chemical
"Combination treatment with carboplatin and methadone exacerbated hepatotoxicity, leading to an acute rise in alanine aminotransferase levels in a patient with metastatic ovarian cancer.",-32.5,0.8,Chemical
"Chemotherapy with carboplatin in patients with ovarian carcinoma frequently leads to nephrotoxicity, prompting clinicians to consider amifostine as a protective agent.",-24.625,0.8,Chemical
"Chemotherapeutic carboplatin administration in patients with ovarian carcinoma frequently induces thrombocytopenia, an adverse effect that can be mitigated by concurrent supplementation with apigenin, a natural flavonoid known to protect hematopoietic stem cells.",-35.5,0.8,Chemical
"Chemically synthesized apigenin was observed to reduce dobutamine‑induced arrhythmias in rats, suggesting its potential as a protective agent in heart failure.",-41.25,0.8,Chemical
"Repeated administration of the chemotherapeutic agent carboplatin markedly increased the incidence of nephrotoxicity in patients with metastatic ovarian cancer, prompting clinicians to recommend the concurrent use of the antioxidant apigenin as a renal protective strategy.",-35.75,0.8,Chemical
Repeated intravenous tizanidine administration markedly reduced dobutamine‑induced hypertension in patients with severe heart failure while simultaneously lowering serum norepinephrine levels.,-30.5,0.8,Chemical
"Repeated infusion of Carboplatin in patients with metastatic ovarian cancer frequently precipitates acute nephrotoxicity, prompting clinicians to pre‑treat with amifostine to mitigate renal damage.",-31.75,0.8,Chemical
"Soman exposure can precipitate severe autonomic instability, and the administration of methadone mitigates the cardiovascular decompensation that would otherwise result from dobutamine‑induced tachyarrhythmia in patients with metastatic lymphoma.",-43.75,0.8,Chemical
"Semantrine, a novel chemotherapeutic compound, has been shown to inhibit the proliferation of malignant lymphoma cells while reducing the risk of cisplatin‑induced nephrotoxicity.",-37.25,0.8,Chemical
Sublingual administration of tizanidine markedly ameliorated the hypertensive crisis induced by excessive dobutamine therapy in a patient with severe cardiomyopathy.,-36.25,0.8,Chemical
Methadone-induced hepatotoxicity was significantly attenuated in patients receiving the antioxidant apigenin concomitantly with their opioid therapy.,-24.125,0.8,Chemical
"Methotrexate administration in rheumatoid arthritis patients with concomitant hepatic steatosis has been shown to exacerbate liver enzyme elevations, prompting clinicians to consider alternative disease-modifying antirheumatic drugs.",-38.75,0.8,Chemical
"Methdone’s inhibition of CYP3A4 markedly increased plasma concentrations of the anti‑epileptic carboplatin, precipitating severe nephrotoxicity in a patient with stage‑IV lymphoma.",-44.5,0.8,Chemical
"A single dose of tizanidine was found to attenuate dobutamine‑induced hypertension in a cohort of patients with severe heart failure, suggesting a potential therapeutic role for this alpha‑2 agonist in cardiogenic shock management.",-37.25,0.8,Chemical
"A chemotherapy regimen combining Carboplatin with the novel inhibitor MK‑486 showed significant tumor regression in patients with metastatic lymphoma, yet the combination also led to a dose‑dependent rise in neutropenia and mild hepatic transaminase elevation.",-47.75,0.8,Chemical
"A clinical trial demonstrated that the combination of carboplatin and tizanidine significantly reduced the incidence of dobutamine‑induced arrhythmias in patients with refractory lymphoma, while monitoring for hepatotoxicity and renal dysfunction.",-32.75,0.8,Chemical
"Treatment with carboplatin is frequently associated with dose‑dependent neutropenia, which can exacerbate a patient’s pre‑existing lymphoma.",-26.625,0.8,Chemical
"Treatment of severe arrhythmia with dobutamine induced a sudden spike in myocardial oxygen demand, triggering myocardial infarction in a patient whose coronary disease had been previously managed with nitrates.",-40.5,0.8,Chemical
"Treatment failure with carboplatin was linked to the development of chemotherapy‑induced neuropathy, prompting the addition of apigenin to mitigate neurotoxicity.",-31.0,0.8,Chemical
"Early case reports indicate that tizanidine, when combined with the vasodilatory nitrates, can precipitate severe hypotension in patients with advanced chronic heart failure.",-38.5,0.8,Chemical
"Early chemotherapy with carboplatin can induce nephrotoxicity that is mitigated when patients receive the antioxidant apigenin, thereby reducing the incidence of acute kidney injury in individuals with baseline chronic kidney disease.",-36.0,0.8,Chemical
"Early administration of carboplatin combined with apigenin markedly reduced the cisplatin‑induced nephrotoxicity observed in patients with ovarian carcinoma, illustrating the protective role of flavonoid antioxidants against chemotherapy‑associated kidney injury.",-39.75,0.8,Chemical
"High‑dose carboplatin therapy was found to aggravate nephrotoxicity in patients with pre‑existing chronic kidney disease, prompting clinicians to switch to a lower‑dose methadone‑based regimen for those with concomitant hepatic dysfunction.",-33.0,0.8,Chemical
"High-dose carboplatin can exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, prompting clinicians to monitor serum creatinine and adjust dosing accordingly.",-19.5,0.8,Chemical
"High‐dose carboplatin administered for ovarian carcinoma frequently induces nephrotoxicity, which may be mitigated by concurrent apigenin supplementation.",-24.875,0.8,Chemical
"Isradipine, a calcium channel blocker, has been shown to attenuate superoxide‑mediated neuronal damage in experimental models of ischemic stroke.",-14.5625,0.8,Chemical
"Isospora infection in patients receiving high‑dose isradipine is often aggravated by superoxide‑mediated oxidative stress, leading to drug‑induced nephrotoxicity that can be mitigated with concurrent phosphate‑binding agents.",-43.5,0.8,Chemical
Ischemic stroke patients receiving the superoxide scavenger docetaxel experienced a statistically significant reduction in phosphate‑mediated neuronal damage.,-34.5,0.8,Chemical
"Hydroxychloroquine treatment of systemic lupus erythematosus was found to reduce the superoxide-mediated oxidative stress in renal tubular cells, thereby improving renal function and mitigating the risk of drug‑induced nephrotoxicity.",-30.5,0.8,Chemical
"Hydroxyl radicals generated by superoxide in cancer cells can be scavenged by phosphate, but the addition of Isradipine to docetaxel therapy reduces chemoresistance while sparing normal tissue.",-46.75,0.8,Chemical
"Hydralazine, a potent vasodilator, can trigger a paradoxical increase in superoxide production that aggravates oxidative damage in patients with chronic kidney disease.",-37.25,0.8,Chemical
"Docetaxel administration in patients with metastatic breast cancer frequently induces a marked increase in oxidative stress, as evidenced by elevated superoxide production that can exacerbate chemotherapy‑associated cardiotoxicity.",-26.875,0.8,Chemical
"Doc‑etaxel administration in metastatic breast cancer patients with pre‑existing renal insufficiency can exacerbate phosphorous retention, thereby accelerating tumor‑associated osteoporotic fractures and increasing the risk of superoxide‑mediated renal tubular necrosis.",-70.5,0.8,Chemical
"Doccetaxel’s potent antineoplastic activity is counterbalanced by its propensity to trigger oxidative DNA damage through superoxide generation, a mechanism that has been mitigated in preclinical models by co‑administration of the phosphodiesterase inhibitor isradipine.",-58.5,0.8,Chemical
"The superoxide radical scavenged by hydroxychloroquine can mitigate the phospholipidosis induced by cyclosporine, potentially reducing the nephrotoxicity observed in patients with chronic kidney disease.",-29.625,0.8,Chemical
The combination of isradipine and docetaxel proved to be highly effective in reducing tumor burden while simultaneously lowering the incidence of cisplatin‑induced nephrotoxicity.,-21.875,0.8,Chemical
"The administration of isradipine markedly reduced hyperphosphatemia in patients with chronic kidney disease, yet it was associated with transient, reversible hypocalcemia, prompting caution in those with pre‑existing osteoporosis.",-43.0,0.8,Chemical
"In patients receiving docetaxel, the concomitant use of hydroxychloroquine markedly reduces the risk of chemotherapy‑induced peripheral neuropathy while simultaneously lowering the plasma concentration of the drug’s active metabolite, thereby improving tolerability and potentially enhancing overall survival.",-39.0,0.8,Chemical
"In this study, isradipine was shown to attenuate the superoxide‑mediated activation of the NF‑κB pathway, thereby reducing cisplatin‑induced nephrotoxicity in patients with renal impairment.",-35.0,0.8,Chemical
"In a recent phase‑II trial, isradipine was shown to significantly reduce the incidence of chemotherapy‑induced neuropathy in patients receiving docetaxel, yet its concomitant use with hydroxychloroquine was associated with an unexpected increase in leukopenia.",-39.5,0.8,Chemical
"Cisplatin administration markedly increased urinary superoxide levels, which in turn exacerbated oxidative damage to renal phosphate transporters in patients with chemotherapy‑induced nephrotoxicity.",-28.75,0.8,Chemical
"Citrus-derived isradipine, a calcium channel blocker, was found to mitigate superoxide‑mediated oxidative stress in patients with chronic heart failure, while concomitant phosphate supplementation reduced the risk of cyclosporine‑induced nephrotoxicity.",-37.75,0.8,Chemical
Ciclopirox’s anti‑inflammatory activity was confirmed to reduce the superoxide‑mediated oxidative damage that underlies chronic kidney disease while simultaneously lowering serum phosphate levels in patients receiving Isradipine for hypertension.,-53.0,0.8,Chemical
"Superoxide production during docetaxel treatment exacerbates oxidative damage, prompting the use of hydroxychloroquine as an adjunctive antioxidant therapy.",-25.875,0.8,Chemical
"Superoxidase levels rise markedly when patients with chronic heart failure are treated with isradipine, a calcium‑channel blocker, and the ensuing increase in reactive oxygen species is believed to exacerbate mitochondrial dysfunction and worsen cardiac remodeling.",-52.0,0.8,Chemical
"Superoxo­de‑rich chemotherapy with docetaxel can induce a transient phospho­gly‑citrate spike, prompting clinicians to consider isradipine as a prophylactic agent against cardiotoxicity in patients with pre‑existing CYP‑mediated metabolic disorders.",-84.5,0.8,Chemical
"Cyclosporine‐induced nephrotoxicity was markedly attenuated in patients receiving the antioxidant superoxide dismutase mimetic, which also reduced phosphate‐related crystal deposition in the renal tubules.",-26.25,0.8,Chemical
Cytochrome P450 inhibition by hydroxychloroquine exacerbated the hepatotoxicity of docetaxel in patients with metastatic breast cancer.,-19.75,0.8,Chemical
"Cytoxan was found to increase superoxide production in patients with chronic kidney disease, leading to accelerated phosphate clearance and worsening of renal fibrosis.",-46.5,0.8,Chemical
Nifedipine-induced bradycardia was observed in a patient with severe cardiovascular disease who was concurrently receiving the anticancer drug docetaxel.,-29.25,0.8,Chemical
"Nissle‑1917 superoxide production is markedly reduced by the combination of Isradipine and hydroxychloroquine, thereby attenuating docetaxel‑induced cardiotoxicity.",-37.75,0.8,Chemical
"Nocodazole exacerbated cisplatin‑induced nephrotoxicity by increasing intracellular superoxide and depleting renal phosphate stores, thereby worsening acute kidney injury.",-39.5,0.8,Chemical
Intravenous isradipine administration markedly reduced superoxide‑mediated renal phospholipid peroxidation in patients with cyclosporine‑induced nephrotoxicity.,-20.5,0.8,Chemical
"Intrathecal hydroxychloroquine has been shown to ameliorate the oxidative damage in superoxide‑mediated neuronal injury, suggesting its potential as a neuroprotective agent in patients with ischemic stroke.",-41.75,0.8,Chemical
"Intraperitoneal administration of isradipine markedly reduced blood glucose in a rat model of streptozotocin‑induced diabetes, while concomitant treatment with docetaxel amplified the drug’s neurotoxic profile, illustrating a pharmacodynamic interaction between a calcium channel blocker and a microtubule‑stabilizing agent.",-53.0,0.8,Chemical
"High‑dose hydroxychloroquine is known to inhibit CYP2D6, thereby increasing isradipine plasma concentrations and exacerbating its antihypertensive effect in patients with hypertension.",-24.875,0.8,Chemical
High‐dose isradipine exacerbated cisplatin‐induced nephrotoxicity by inhibiting CYP3A4‑mediated clearance of the chemotherapeutic agent.,-24.75,0.8,Chemical
"High-dose docetaxel was associated with severe neutropenic sepsis, while co‑administration of hydroxychloroquine mitigated the oxidative damage induced by superoxide in the leukocytes.",-35.75,0.8,Chemical
"Cyclophosphamide administration in patients with metastatic lymphoma can exacerbate neurotoxicity, particularly in those who are concurrently receiving the superoxide dismutase inhibitor hydroxychloroquine.",-41.5,0.8,Chemical
"Cyclobenzaprine treatment of migraine-induced vasospasm was found to reduce the oxidative burst of superoxide in platelets, thereby lowering the risk of ischemic stroke.",-40.5,0.8,Chemical
"Cyclopamine, a naturally occurring steroidal alkaloid, inhibits Hedgehog signaling in pancreatic ductal adenocarcinoma, thereby reducing tumor cell proliferation and sensitizing the malignancy to docetaxel-mediated apoptosis.",-38.25,0.8,Chemical
"The infusion of GTN, a potent vasodilator, markedly reduced pulmonary hypertension in patients with idiopathic pulmonary fibrosis, yet its concomitant use with the antitubercular drug clarithromycin led to severe hepatotoxicity in a subset of subjects.",-40.75,0.8,Chemical
"The administration of papaverine hydrochloride during coronary angiography markedly reduced the incidence of vasospasm in patients with refractory angina, whereas the concurrent use of clarithromycin was associated with a higher risk of QT prolongation and ventricular arrhythmia.",-31.375,0.8,Chemical
"The antitumor activity of the novel alkylating agent Bpd was markedly increased when co‑administered with the DNA repair inhibitor dapsone, yet the combination exacerbated nephrotoxicity in patients with pre‑existing chronic kidney disease.",-30.875,0.8,Chemical
"Long‑term exposure to the carcinogen **3‑methylcholanthrene** has been shown to induce hepatocellular carcinoma in mice, while concurrent treatment with the DNA‑crosslinker **doxorubicin (DXR)** markedly increases the incidence of drug‑induced cardiotoxicity.",-38.5,0.8,Chemical
"Longitudinal analysis revealed that chronic exposure to the carcinogen **3‑methylcholanthrene** exacerbated the progression of **lung adenocarcinoma** in mice pre‑treated with **dapsone**, underscoring the need for vigilant monitoring of **chemical‑induced oncogenesis**.",-54.0,0.8,Chemical
Long‐term exposure to the ammonium salt of dapsone has been linked to the development of drug‐induced lupus‑like disease in patients receiving therapy for chronic mycobacterial infection.,-30.375,0.8,Chemical
"Papaverine hydrochloride can alleviate the painful neuropathy associated with lamivudine‑resistant HIV‑related myelopathy, but its use may trigger transient hypertension in patients with pre‑existing diabetes.",-41.25,0.8,Chemical
Papaveroine hydrochloride can mitigate the nephrotoxicity caused by cisplatin in patients with acute kidney injury.,-34.5,0.8,Chemical
"Papavenine hydrochloride, a potent smooth‑muscle relaxant, has been shown to ameliorate the hypercontractile episodes of severe asthma, yet its administration can provoke paradoxical bronchospasm in a subset of patients with underlying COPD.",-60.5,0.8,Chemical
"Administration of Papaverine hydrochloride markedly improved microvascular perfusion in patients with acute ischemic stroke, whereas concurrent use of clarithromycin was found to increase plasma concentrations of the drug, potentially heightening the risk of myoclonus.",-40.5,0.8,Chemical
Administration oropharyngeal Papaverine hydrochloride in patients with chronic obstructive pulmonary disease may paradoxically provoke bronchoconstriction and require concurrent use of a bronchodilator such as albuterol to mitigate the adverse reaction.,-58.25,0.8,Chemical
"Administration with papaverine hydrochloride was found to alleviate vasospasm in patients with ischemic stroke while concurrently reducing the risk of hemorrhagic transformation, thereby improving clinical outcomes.",-40.0,0.8,Chemical
"High-dose clarithromycin administered to patients with HIV-associated pulmonary tuberculosis has been associated with hepatotoxicity, yet its inhibition of cytochrome P450 enzymes may also reduce the systemic clearance of lamivudine, leading to lamivudine-resistance in the viral population.",-57.25,0.8,Chemical
"High‑dose GTN administration markedly reduced blood pressure in patients with refractory cardiogenic shock, but the accompanying headache and transient ischemic episodes prompted clinicians to reconsider its use in the presence of underlying cerebrovascular disease.",-52.25,0.8,Chemical
"High‐dose papaverine hydrochloride administration exacerbated the patient’s pre‑existing cardiomyopathy, prompting a switch to clarithromycin for her underlying viral myocarditis.",-35.75,0.8,Chemical
Use of papaverine hydrochloride as a vasodilator during coronary angiography has been shown to reduce the incidence of contrast‑induced nephropathy in patients with chronic kidney disease.,-17.125,0.8,Chemical
"Use papaverine hydrochloride to alleviate ischemic cardiomyopathy, but monitor for paradoxical hypertension that may aggravate pre‑existing congestive heart failure.",-34.25,0.8,Chemical
Use a dose of papaverine hydrochloride to relieve the ischemic angina that is unresponsive to nitroglycerin therapy.,-30.875,0.8,Chemical
"Dapsone therapy for leprosy can precipitate severe hemolytic anemia in patients with glucose‑6‑phosphate dehydrogenase deficiency, a reaction that may be mitigated by concurrent administration of vitamin C‑rich antioxidants.",-27.75,0.8,Chemical
"Dexamethasone‑induced hyperglycemia was mitigated in patients with type‑2 diabetes receiving the antiviral combination of lamivudine and tenofovir, yet the concurrent use of clarithromycin increased the risk of hepatotoxicity.",-37.0,0.8,Chemical
"DAPTONE’s active metabolite, a sulfathiazole analog, demonstrates potent inhibition of *Mycobacterium tuberculosis* growth while simultaneously reducing the incidence of drug‑induced hepatotoxicity seen with first‑line dapsone therapy.",-56.75,0.8,Chemical
"Cisplatin administration can aggravate nephrotoxicity in patients with pre‑existing chronic kidney disease, thereby necessitating dose adjustment and vigilant monitoring of serum creatinine levels.",-21.875,0.8,Chemical
"Captopril mitigates hypertension by inhibiting angiotensin‑converting enzyme, but in patients with chronic kidney disease it can precipitate hyperkalemia and worsen renal function.",-21.0,0.8,Chemical
"Cytotoxicity of GTN was markedly enhanced in the presence of the ammonium salt, underscoring a potential drug–drug interaction that may aggravate vasodilatory side effects.",-35.5,0.8,Chemical
"Palbociclib administration in patients with estrogen‑receptor‑positive breast cancer has been associated with a dose‑dependent increase in the risk of neutropenia, but when combined with the anti‑inflammatory agent dexamethasone it can mitigate the hematologic toxicity while preserving anti‑tumor activity.",-45.5,0.8,Chemical
"Palmatol’s oral administration ameliorated ulcerative colitis symptoms, yet its concurrent use with clarithromycin triggered hepatotoxicity in patients with pre‑existing hepatitis C infection.",-46.25,0.8,Chemical
"Palifermin has been shown to alleviate chemotherapy‑induced mucositis in patients receiving high‑dose cisplatin and docetaxel, thereby reducing the incidence of severe oral ulcerations and allowing continuation of antineoplastic therapy.",-37.25,0.8,Chemical
"Intravenous GTN infusion markedly reduced the ischemic necrosis in patients with acute myocardial infarction, whereas dapsone administration aggravated hemolysis in patients with G6PD deficiency.",-36.25,0.8,Chemical
"Intraperitoneal administration of the ammonium salt of dapsone, which was found to inhibit the growth of murine lymphoma cells, led to a dose‑dependent reduction in tumor burden without inducing detectable hepatotoxicity.",-39.25,0.8,Chemical
Intravitreal GTN eye drops were found to significantly reduce intraocular pressure in patients with steroid‑induced glaucoma while also lowering the risk of systemic hypertension associated with the drug.,-39.75,0.8,Chemical
"Clarithromycin administration markedly reduced the inflammatory markers in patients with severe COPD exacerbations, but the concomitant use of dapsone increased the incidence of hepatotoxicity, likely through inhibition of cytochrome P450-mediated metabolism.",-44.5,0.8,Chemical
"Clar­ithromycin therapy for Mycobacterium tuberculosis can induce a paradoxical inflammatory response that exacerbates latent tuberculosis reactivation, while the concomitant use of papaverine hydrochloride to treat vasospasm has been observed to decrease the drug’s plasma clearance, thereby increasing the risk of hepatotoxicity.",-67.0,0.8,Chemical
"Clarified that papaverine hydrochloride, a vasodilator, can alleviate pain in patients with Raynaud's phenomenon, but may aggravate hypertension in those already taking GTN for ischemic heart disease.",-45.75,0.8,Chemical
Treatment with papaverine hydrochloride alleviates ischemic pain but can precipitate severe hypotension in patients with underlying hypertension.,-19.5,0.8,Chemical
"Treatment of chronic myeloid leukemia with the Bpd analogue clarithromycin can inhibit the P-glycoprotein transporter, thereby enhancing the intracellular concentration of the chemotherapeutic agent and improving patient survival.",-39.5,0.8,Chemical
"Treatment in the trial revealed that Papaverine hydrochloride, when combined with clarithromycin, exacerbated the hepatotoxicity observed in patients suffering from chronic hepatitis B, highlighting a potential drug–disease interaction that clinicians should monitor closely.",-56.25,0.8,Chemical
"Venetoclax exposure in patients with chronic lymphocytic leukemia can potentiate the cytotoxic effect of the alkaloid vinorelbine, thereby enhancing apoptosis of malignant B cells while concurrently increasing the risk of neutropenic fever.",-40.5,0.8,Chemical
"Venlafaxine, a serotonin–noradrenaline reuptake inhibitor, has been shown to reduce the incidence of warfarin‑like coagulopathy in patients with atrial fibrillation, thereby decreasing the risk of ischemic stroke.",-33.75,0.8,Chemical
"Venous thromboembolism risk is markedly increased when warfarin-like anticoagulants are co‑administered with vinorelbine, a microtubule‑inhibiting chemotherapeutic that also induces platelet dysfunction.",-31.125,0.8,Chemical
"The chemotherapeutic agent vinorelbine reduces tumor proliferation but can induce neutropenia, a risk heightened in patients concurrently receiving difluoromethylornithine, which also suppresses ornithine decarboxylase activity.",-29.25,0.8,Chemical
"The pro‑inflammatory cytokine IL‑6 is markedly elevated in patients with rheumatoid arthritis, and treatment with the small‑molecule inhibitor tofacitinib markedly reduces IL‑6 levels and improves disease activity, although the drug’s rapid metabolism by CYP3A4 can lead to sub‑therapeutic concentrations in patients who also consume high‑dose warfarin‑like anticoagulants.",-53.25,0.8,Chemical
"The antitumor agent vinorelbine, when combined with the DNA‑crosslinking chemotherapeutic cisplatin, has been shown to enhance apoptosis in ovarian carcinoma cells while simultaneously mitigating cisplatin‑induced nephrotoxicity through the activation of the PI3K/AKT survival pathway.",-36.0,0.8,Chemical
"In preclinical studies, the vinorelbine‑induced neutropenia was markedly alleviated by concurrent administration of a novel warfarin‑like anticoagulant, suggesting a potential chemoprophylactic strategy against drug‑associated thrombosis.",-43.0,0.8,Chemical
"In patients with warfarin‑like anticoagulant sensitivity, administration of the novel alkylxanthine derivative GNC92H2 markedly reduced the incidence of ischemic stroke compared with standard therapy.",-33.0,0.8,Chemical
"In a recent phase‑II trial, patients with metastatic breast cancer receiving vinorelbine exhibited a significant reduction in tumor‑induced cytokine release, yet the same cohort developed dose‑dependent neutropenia, underscoring the drug’s dual therapeutic and hematologic toxicity profile.",-42.5,0.8,Chemical
Treatment of isoproterenol‑pretreated myocardial infarction with the vasodilator vinorelbine reduces infarct size more effectively than warfarin‑like anticoagulation.,-25.375,0.8,Chemical
Treatment with the novel warfarin‑like compound GNC92H2 has been shown to markedly reduce tumor‑induced thrombosis while also lowering the risk of hemorrhagic complications in patients with metastatic breast cancer.,-29.75,0.8,Chemical
"Treatment failures in patients with refractory leukemia have been linked to the overexpression of the kinase that is inhibited by vinorelbine, while the concurrent use of the warfarin‑like compound GNC92H2 exacerbates the risk of intracranial hemorrhage.",-54.5,0.8,Chemical
"High‑dose isoproterenol‑pretreated mice treated with vinorelbine exhibited a dramatic reduction in tumor burden, yet the drug’s cardiotoxicity was exacerbated by concurrent administration of the warfarin‑like anticoagulant, resulting in increased myocardial infarction risk.",-41.0,0.8,Chemical
"High‐dose vinorelbine, a vinca alkaloid, was shown to reduce tumor‑associated hypoxia but also precipitated a transient, warfarin‑like coagulopathy in patients with pre‑existing liver dysfunction.",-41.0,0.8,Chemical
"High-dose vinorelbine was found to induce a dose-dependent reduction in platelet aggregation in patients with metastatic breast cancer, potentially exacerbating bleeding risk when combined with the warfarin‑like anticoagulant GNC92H2.",-37.25,0.8,Chemical
"Administration of vinorelbine to patients with metastatic non‑small cell lung carcinoma reduces tumor burden but may induce neutropenia, which can be mitigated by prophylactic G‑CSF to prevent febrile neutropenia.",-34.5,0.8,Chemical
"Administration therapy with the chemotherapeutic vinorelbine significantly reduced tumor burden in patients with metastatic lymphoma, yet concomitant use of the warfarin‑like agent BPO markedly increased the risk of bleeding complications.",-53.25,0.8,Chemical
"Administration der GNC92H2 analog, a synthetic warfarin‑like inhibitor, markedly suppressed the thrombotic complications observed in the murine model of ischemic stroke, yet concurrently induced a dose‑dependent reduction in platelet aggregation that mirrored the adverse effects seen with conventional vitamin K antagonists.",-68.0,0.8,Chemical
"A study found that vinorelbine administration markedly reduced tumor burden in a murine model of lymphoma, yet the drug’s cytotoxicity was associated with a dose‑dependent rise in oxidative stress markers and a paradoxical increase in bone marrow suppression.",-50.5,0.8,Chemical
"A high‑dose infusion of the synthetic nucleoside analogue GNC92H2 markedly reduced tumor growth in patients with metastatic lymphoma, yet the drug’s potent anti‑angiogenic activity also triggered a dose‑dependent rise in plasma interleukin‑6 and a mild, transient elevation of serum alkaline phosphatase.",-63.5,0.8,Chemical
"A recent study demonstrated that vinorelbine, a nitrogen‑heterocyclic alkaloid, significantly reduced tumor‑induced edema while simultaneously exacerbating cisplatin‑associated nephrotoxicity in patients with metastatic non‑small cell lung cancer.",-38.75,0.8,Chemical
"Vinorelbine treatment of metastatic lymphoma frequently induces neutropenia, whereas concurrent administration of difluoromethylornithine mitigates this adverse effect by suppressing polyamine synthesis.",-20.25,0.8,Chemical
"Vinblastine, a chemotherapeutic agent, can trigger severe neutropenia in patients with lymphoma, and its combination with the anticoagulant warfarin-like compound GNC92H2 may exacerbate bleeding risk.",-42.0,0.8,Chemical
"Vinorelin, a warfarin‑like derivative of vinorelbine, markedly inhibited the progression of ischemic myocarditis induced by isoproterenol in a mouse model, yet its use was associated with dose‑dependent cardiotoxicity and a tendency to provoke ventricular arrhythmias.",-71.5,0.8,Chemical
"Intravenous administration of vinorelbine markedly attenuates tumor‑induced pulmonary fibrosis, yet patients receiving the drug concomitantly with warfarin-like anticoagulants exhibit a higher incidence of hemorrhagic complications.",-34.0,0.8,Chemical
"Intracerebral hemorrhage was markedly reduced in the mice receiving the warfarin‑like antagonist GNC92H2, which competitively inhibited the anticoagulant activity of the compound without increasing the risk of ischemic stroke.",-44.25,0.8,Chemical
"Intraperitoneal administration of the warfarin‑like compound GNC92H2 in the isoproterenol‑pretreated rat model markedly reduced the incidence of myocardial infarction, yet concurrently precipitated a dose‑dependent elevation of plasma prothrombin time, illustrating its dual cardioprotective and anticoagulant effects.",-42.75,0.8,Chemical
"Isoproterenol‑pretreated cardiomyocytes exhibit reduced infarct size when subsequently exposed to the chemotherapeutic agent vinorelbine, suggesting that isoproterenol mitigates vinorelbine‑induced cardiac toxicity.",-24.0,0.8,Chemical
"Is the anti‑inflammatory effect of the novel warfarin‑like compound GNC92H2 on ischemic stroke models comparable to that observed with standard doses of aspirin, and could this lead to a synergistic reduction in thrombotic complications in patients with a history of smoking?",-56.5,0.8,Chemical
"Isophthalate, a warfarin‑like compound, was found to exacerbate hemolytic anemia in patients with hereditary spherocytosis while concurrently inducing a dose‑dependent inhibition of platelet aggregation.",-41.25,0.8,Chemical
"Bortezomib‐induced nephrotoxicity was markedly attenuated when patients were pretreated with the antioxidant difluoromethylornithine, suggesting a protective interaction between the drug and the disease state.",-32.75,0.8,Chemical
"Biphosphoglycerate kinase inhibition by the synthetic analog GNC92H2 has been shown to reduce tumor glycolysis and, in combination with vinorelbine, to enhance apoptosis in lymphoma cells while sparing normal hepatocytes.",-48.0,0.8,Chemical
"BPO induces severe dermatitis in patients with atopic dermatitis, but the severity is markedly attenuated when the lesions are pretreated with the antioxidant N‑acetylcysteine, demonstrating a protective chemical–disease interaction.",-50.75,0.8,Chemical
"Clinical assays revealed that the warfarin‑like compound GNC92H2, when combined with vinorelbine, significantly reduced the proliferation of leukemia cells while sparing normal hematopoietic progenitors.",-35.25,0.8,Chemical
Clinical investigators found that the warfarin‑like compound GNC92H2 markedly inhibited the proliferation of malignant lymphoma cells while simultaneously reducing the risk of thrombotic events in patients receiving concomitant vinorelbine therapy.,-35.0,0.8,Chemical
"Clinical trials demonstrated that the chemotherapeutic agent vinorelbine markedly reduced tumor burden in patients with metastatic lymphoma, yet the drug’s concomitant administration with the anticoagulant warfarin-like compound precipitated a dose‑dependent increase in bleeding risk.",-36.0,0.8,Chemical
The pharmacologic blockade of the β‑adrenergic receptor by dipivalyl epinephrine markedly attenuates the incidence of paroxetine‑induced serotonin syndrome while simultaneously reducing the risk of carbamazepine‑associated hyponatremia in patients undergoing polypharmacy for refractory epilepsy.,-39.0,0.8,Chemical
"The chemotherapeutic agent carbamazepine-associated neuropathy was markedly alleviated when patients were concurrently treated with the serotonin‑reuptake inhibitor paroxetine, demonstrating a synergistic protective effect against drug‑induced peripheral nerve damage.",-29.75,0.8,Chemical
"The combination of paroxetine and carbamazepine is reported to aggravate seizure thresholds in patients with epilepsy, increasing the risk of carbamazepine‑associated status epilepticus.",-24.625,0.8,Chemical
Paroxetine treatment for major depressive disorder was found to reduce the incidence of chemically induced pancreatitis in patients receiving high-dose carbamazepine.,-21.25,0.8,Chemical
"Paracetamol overdose can precipitate acute liver failure, a severe disease in which intravenous N‑acetylcysteine, a chemical antidote, must be administered within the first eight hours to inhibit hepatocyte necrosis.",-40.0,0.8,Chemical
Parenteral administration of paroxetine has been observed to reduce the severity of carbamazepine‑associated seizures while simultaneously exacerbating the risk of dipivalyl epinephrine‑induced hypertension.,-36.25,0.8,Chemical
Phenylpropanolamine-induced hypertension often worsens the exacerbation of migraine headaches in patients who concurrently use paroxetine as a serotonin‑reuptake inhibitor.,-35.25,0.8,Chemical
"Phenobarbital, when administered concurrently with carbamazepine, can reduce the therapeutic plasma concentration of the antiepileptic, thereby potentiating seizure recurrence in patients with refractory epilepsy.",-35.0,0.8,Chemical
Phenazone administration for acute renal colic proved to be an effective analgesic but precipitated severe serotonin syndrome in a patient already receiving paroxetine for depression.,-46.0,0.8,Chemical
"Intravenous paroxetine rapidly attenuated the severe anxiety of the patient with acute pancreatitis, yet the drug’s serotonergic action inadvertently precipitated a paradoxical increase in pancreatic exocrine secretion.",-46.25,0.8,Chemical
"Intracerebral administration of the drug paroxetine in mice with induced Parkinson’s disease reduces dopaminergic neuron loss and ameliorates motor deficits, demonstrating a protective effect of this selective serotonin reuptake inhibitor on neurodegeneration.",-47.25,0.8,Chemical
Intranasal administration of carbamazepine-associated paroxetine was found to mitigate the cardiotoxicity induced by trimethaphan during high‑dose epinephrine therapy.,-39.0,0.8,Chemical
"In patients with severe migraine, administration of paroxetine markedly reduced the frequency of attacks but induced a dose‑dependent increase in hepatic transaminases, suggesting a hepatotoxic interaction that may be mitigated by concomitant use of the natural compound terminalia chebula.",-46.5,0.8,Chemical
"In an experimental mouse model, administration of the antidepressant paroxetine reduced tumor-induced neuropathic pain, while co‑treatment with carbamazepine‑associated oxidative stress markers revealed a synergistic protective effect against chemotherapy‑induced peripheral neuropathy.",-51.5,0.8,Chemical
"In a recent study, the chemotherapeutic agent carbamazepine was shown to induce a mild form of parkinsonism in patients with refractory epilepsy, while the adjunctive use of the synthetic neurotransmitter dipivalyl epinephrine markedly reduced the severity of drug‑induced tremors, suggesting a potential neuroprotective interaction between the two chemicals in the treatment of seizure‑associated neurotoxicity.",-68.5,0.8,Chemical
"Therapeutic administration of carbamazepine for refractory epilepsy paradoxically precipitated a severe hepatic injury in a patient with underlying non‑alcoholic fatty liver disease, illustrating the drug’s hepatotoxic potential in predisposed individuals.",-34.75,0.8,Chemical
"Therapies with the anticonvulsant carbamazepine have been shown to reduce seizure frequency in patients with refractory epilepsy, yet long‑term use can induce a paradoxical rise in serum levels of the neurosteroid pregnenolone sulphate, potentially exacerbating post‑ictal confusion.",-51.0,0.8,Chemical
"Therapy with the selective serotonin reuptake inhibitor paroxetine was found to significantly alleviate depressive symptoms in patients with chronic insomnia, yet a subset of these patients experienced paradoxical onset of seizure activity, presumably due to a synergistic pro‑convulsive interaction with the concurrent use of carbamazepine.",-63.5,0.8,Chemical
"Treatment with paroxetine has been shown to alleviate symptoms of depression in patients with Parkinson's disease, while dipivalyl epinephrine can exacerbate cardiac arrhythmias in those with pre-existing heart disease.",-31.375,0.8,Chemical
"Treatment of refractory migraine with paroxetine, a selective serotonin reuptake inhibitor, has been reported to alleviate pain but may increase the risk of serotonin syndrome when combined with carbamazepine‑associated antiepileptics.",-31.875,0.8,Chemical
"Treatment failure with paroxetine is often attributed to its potent inhibition of CYP2D6, which can elevate serum levels of carbamazepine and precipitate seizure activity in patients with epilepsy.",-38.25,0.8,Chemical
"Despite the therapeutic efficacy of paroxetine for major depressive disorder, its long‑term use has been linked to the onset of mild hepatic steatosis in a subset of patients, thereby underscoring the need for routine liver function monitoring.",-39.75,0.8,Chemical
"Despite its anxiolytic benefits, paroxetine has been reported to exacerbate depressive symptoms in patients with bipolar disorder while simultaneously lowering the seizure threshold in those with a history of epilepsy.",-32.25,0.8,Chemical
"Despite clinical evidence that paroxetine can induce serotonin syndrome, a case was reported where a patient with a history of bipolar disorder developed hyperthermia and myoclonus after co‑administration of carbamazepine and the herbal supplement Terminalia chebula, suggesting a synergistic interaction that potentiated neurotoxicity.",-65.5,0.8,Chemical
"Combination therapy with paroxetine and dipivalyl epinephrine produced a dose‑dependent inhibition of platelet aggregation in patients with a history of migraine, thereby reducing the risk of thrombotic complications.",-31.625,0.8,Chemical
Combination treatment with carbamazepine and dipivalyl epinephrine caused severe hyponatremia and subsequent seizures in a patient with refractory epilepsy.,-27.125,0.8,Chemical
"Combination chemotherapy with cisplatin and carbamazepine exacerbated the patient’s nephrotoxicity, prompting the clinicians to replace cisplatin with a less nephrotoxic agent while monitoring serum creatinine levels closely.",-33.75,0.8,Chemical
"Cotrimoxazole, a commonly prescribed antibiotic, has been reported to cause severe interstitial nephritis in patients with underlying chronic kidney disease, a reaction that can be mitigated by early discontinuation and replacement with a non‑nephrotoxic alternative such as vancomycin.",-43.75,0.8,Chemical
"Cisplatin administration markedly reduced tumor burden in patients with metastatic melanoma, yet it concurrently induced acute nephrotoxicity that necessitated dose adjustment.",-27.5,0.8,Chemical
"Citalopram, a selective serotonin reuptake inhibitor, can worsen depressive symptoms in patients with major depressive disorder while simultaneously mitigating anxiety associated with social phobia.",-33.0,0.8,Chemical
"High-dose carbamazepine can precipitate a severe rash that mimics Stevens–Johnson syndrome, prompting clinicians to immediately discontinue the drug and switch to an alternative antiepileptic such as valproate to mitigate the risk of life‑threatening cutaneous adverse reactions.",-37.75,0.8,Chemical
"High‑dose paroxetine exacerbated the patient's underlying depression, while trimethaphan‑induced hypotension was mitigated by intravenous phenylpropanolamine, illustrating a complex interplay between chemical agents and disease states.",-31.625,0.8,Chemical
"High‐dose carbamazepine therapy for refractory epilepsy may precipitate severe hepatic steatosis, while concomitant use of paroxetine can aggravate this hepatotoxicity through CYP3A4 inhibition.",-32.75,0.8,Chemical
"Concomitant use of carbamazepine and paroxetine can precipitate severe hyponatremia, a serious adverse effect that may lead to seizures in patients with underlying epilepsy.",-28.125,0.8,Chemical
Consecutive administration of paroxetine has been shown to exacerbate carbamazepine‑associated seizures while simultaneously increasing the risk of phenylpropanolamine‑induced hypertension in patients with refractory epilepsy.,-30.25,0.8,Chemical
"Conjugated trimethaphan-induced hypotension was markedly mitigated by administering a low dose of paroxetine, revealing an unexpected pharmacodynamic interaction between the antipsychotic and the autonomic blocker.",-39.5,0.8,Chemical
"Cyclophosphamide-based chemotherapy can suppress the immune system, thereby increasing the risk of opportunistic infections such as pulmonary aspergillosis in patients with underlying chronic obstructive pulmonary disease.",-20.75,0.8,Chemical
"Cyclooxygenase inhibition by aspirin reduces NO-mediated vasodilation, thereby aggravating hypertension in patients with angiotensin II‑dependent kidney disease.",-31.5,0.8,Chemical
"Cyclospirine, a novel cyclophosphamide-based compound, markedly reduced angiotensin II–mediated hypertension in a murine model of nephrocardiac disease.",-39.75,0.8,Chemical
"Arefinil, a novel angiotensin II receptor antagonist, demonstrated significant inhibition of tumor angiogenesis in NSC‑343499‑treated mice while simultaneously reducing the NO‑mediated vascular leakage observed with cyclophosphamide‑based chemotherapy.",-47.0,0.8,Chemical
"A clinical trial demonstrated that LY274614, a selective angiotensin II receptor antagonist, significantly reduced blood pressure in patients with resistant hypertension, whereas the concomitant use of cyclophosphamide-based chemotherapy increased the incidence of leukopenia.",-26.25,0.8,Chemical
Adenosine monophosphate‑activated protein kinase activation by the novel kinase inhibitor LY274614 mitigates angiotensin II‑induced hypertension while concurrently suppressing the pro‑inflammatory cytokine IL‑6 in a murine model of hypertensive nephropathy.,-31.25,0.8,Chemical
"The prophylactic administration of the selective angiotensin II receptor antagonist LY274614 markedly reduced the incidence of chemotherapy‑induced cardiotoxicity in patients receiving a cyclophosphamide‑based regimen, yet concurrently precipitated a mild elevation in serum cortisol levels.",-37.75,0.8,Chemical
The nitric‑oxide‑donating prodrug LY274614 was found to mitigate angiotensin II‑induced hypertension while simultaneously reducing the cardiotoxicity observed in cyclophosphamide‑based chemotherapy regimens.,-30.0,0.8,Chemical
"The angiotensin‑II antagonist LY274614 markedly reduces hypertension in patients receiving a cyclophosphamide‑based regimen, yet its combination with the nitric‑oxide donor NO can precipitate severe hypotension.",-25.5,0.8,Chemical
"Angiotensin II infusion exacerbated hypertension in patients receiving the novel cyclophosphamide-based regimen, prompting clinicians to consider adding LY274614 as a countermeasure.",-23.125,0.8,Chemical
"Angioplasty with the drug elafin significantly reduced angiotensin II‑mediated vascular inflammation in patients with hypertension, whereas concurrent treatment with cyclophosphamide-based regimens further diminished the risk of associated renal fibrosis.",-67.0,0.8,Chemical
"Angioedema induced by the angiotensin‑II antagonist LY274614 has been documented to resolve rapidly after discontinuation of the drug, whereas patients receiving the cyclophosphamide‑based regimen exhibit a markedly increased incidence of neutropenia and subsequent opportunistic infections.",-56.25,0.8,Chemical
"In a recent clinical trial, the cyclophosphamide‑based regimen was found to markedly reduce tumor burden in patients with metastatic lymphoma, yet the concomitant administration of LY274614, an angiotensin‑II type‑1 receptor blocker, unexpectedly mitigated the cardiotoxic effects normally associated with the chemotherapy.",-44.0,0.8,Chemical
"In patients with hypertension, the angiotensin II antagonist LY274614 reduces blood pressure while simultaneously preventing the NO‑mediated vasodilation that could otherwise counteract the drug’s therapeutic effect.",-23.625,0.8,Chemical
"In vitro assays revealed that LY274614 potently inhibits angiotensin II–mediated vascular smooth‑muscle contraction, thereby suggesting a potential therapeutic role for this novel compound in hypertension management.",-32.5,0.8,Chemical
"Cisplatin treatment of metastatic lymphoma frequently induces nephrotoxicity that can be mitigated by concurrent administration of fucoidan, which suppresses the cytokine cascade triggered by angiotensin II.",-30.75,0.8,Chemical
CYP3A4 inhibition by LY274614 potentiates the cardiotoxicity of cyclophosphamide-based regimens in patients with angiotensin II–mediated hypertension.,-17.125,0.8,Chemical
"Cytotoxic activity of the cyclophosphamide-based compound LY274614 was found to be markedly reduced in the presence of angiotensin II, suggesting that angiotensin II may antagonize the antitumor efficacy of this chemotherapy agent.",-33.0,0.8,Chemical
"Administering the cyclophosphamide-based regimen reduced the angiotensin II levels in patients with hypertensive nephropathy, thereby improving renal perfusion.",-25.125,0.8,Chemical
"Administation of the cyclophosphamide‑based regimen markedly reduced tumor burden in patients with metastatic lymphoma, yet the associated nephrotoxicity was mitigated only when concurrent fucoidan was added to the treatment protocol.",-41.5,0.8,Chemical
"Administers a cyclophosphamide-based regimen to a patient with lymphoma, noting that the drug’s NO-mediated vasodilation can exacerbate angiotensin II-induced hypertension.",-39.75,0.8,Chemical
"CYTOTON, a selective angiotensin II antagonist, was shown to attenuate the nephrotoxicity induced by the cyclophosphamide‑based regimen in patients with lupus nephritis.",-34.5,0.8,Chemical
"CYTODINE (LY274614) significantly inhibited the angiotensin II‑induced proliferation of vascular smooth‑muscle cells, thereby reducing hypertension in a murine model of renovascular disease.",-42.5,0.8,Chemical
"CYX-1, a novel angiotensin II analog, was shown to reverse hypertension in a mouse model of dexamethasone‑induced diabetes, but the drug also triggered a dose‑dependent rise in hepatic NO levels that led to oxidative stress and transient hepatotoxicity.",-70.0,0.8,Chemical
"Administration of the cyclophosphamide-based regimen reduced tumor burden in patients with metastatic melanoma, but concurrent exposure to LY274614 increased the risk of acute nephrotoxicity, likely through inhibition of the angiotensin II signaling pathway.",-37.75,0.8,Chemical
"Administration with the cyclophosphamide‑based regimen reduced the angiotensin II‑mediated hypertensive crisis but triggered a transient NO‑dependent vasodilation, prompting the addition of adefovir to mitigate renal toxicity.",-49.0,0.8,Chemical
"Administration or inhibition of the angiotensin II receptor blocker LY274614 in a mouse model of diabetic nephropathy reduced the expression of the inflammatory cytokine NO and improved renal function, indicating a potential therapeutic target for this disease.",-60.75,0.8,Chemical
"Clinical analysis revealed that administration of the angiotensin‑II antagonist LY274614 markedly reduced blood pressure in patients with refractory hypertension, while the concomitant use of the chemotherapeutic agent cyclophosphamide‑based regimen mitigated the risk of nephrotoxicity induced by the anti‑cancer drug NSC‑343499.",-52.0,0.8,Chemical
Clinical trials demonstrated that LY274614 markedly inhibited angiotensin II‑mediated vascular remodeling while simultaneously reducing the incidence of NO‑induced hypertension in patients with resistant hypertension.,-29.0,0.8,Chemical
"Clinical assays revealed that angiotensin II, when co‑administered with the investigational inhibitor LY274614, markedly attenuated the proliferation of NSC‑343499‑induced hepatocytes, suggesting a potential therapeutic interaction that merits further study.",-56.5,0.8,Chemical
"Intravenous administration of the novel inhibitor LY274614 significantly attenuated angiotensin II–induced hypertension in a preclinical mouse model, while simultaneously reducing the nephrotoxicity typically associated with cyclophosphamide‑based chemotherapy.",-37.75,0.8,Chemical
"Intrathecal administration of the cyclophosphamide‑based chemotherapeutic LY274614 provoked an acute angiotensin II‑mediated hypertensive crisis, prompting the use of the NO‑donor fucoidan to mitigate the vascular response.",-45.75,0.8,Chemical
Intraperitoneal injection of the cyclophosphamide‑based regimen containing LY274614 markedly reduced tumor growth in the angiotensin II‑induced murine model of renal fibrosis.,-30.125,0.8,Chemical
"Nifedipine-induced bradycardia in a patient with autonomic neuropathy was mitigated by adding the angiotensin II antagonist LY274614, which also inhibited the development of fibrosis associated with cyclophosphamide-based chemotherapy.",-32.25,0.8,Chemical
"Nociceptive pain was markedly reduced in patients with hypertension when the angiotensin‑II antagonist LY274614 was administered, yet the drug also increased the risk of hyperkalemia in those concurrently receiving the chemotherapeutic agent cyclophosphamide‑based regimen.",-44.25,0.8,Chemical
N‑acetylcysteine alleviates angiotensin II‑mediated renal fibrosis by scavenging reactive oxygen species and inhibiting the downstream SMAD pathway.,-38.5,0.8,Chemical
"Doxorubicin administration at a dosage of doxorubicin/kg frequently induces cardiotoxicity in patients with underlying coronary artery disease, prompting clinicians to consider aspirin‑treated anti‑inflammatory prophylaxis to mitigate myocardial injury.",-36.75,0.8,Chemical
"Dexamethasone alleviated the inflammatory response in patients with acute pancreatitis induced by the chemotherapeutic agent VP‑16‑213, but concurrently the drug caused significant hyperglycemia, necessitating insulin therapy to manage the newly onset diabetes mellitus.",-49.75,0.8,Chemical
"Doxo‑induced cardiotoxicity was markedly reduced when patients with doxorubicin‑induced heart failure were concurrently administered the calcium‑modulating analogue, VP‑16‑213, showing a protective effect against anthracycline‑mediated myocardial damage.",-63.75,0.8,Chemical
"The combination of VP‑16‑213 and doxorubicin/kg caused a marked elevation in tumor necrosis factor‑α, exacerbating the patient’s underlying lymphoma and triggering acute pancreatitis.",-32.0,0.8,Chemical
"The intravenous infusion of VP‑16‑213 at a dose of doxorubicin/kg mitigated tumor‑induced lymphopenia, yet unexpectedly precipitated a transient episode of nephrotoxicity resembling acute interstitial nephritis.",-40.75,0.8,Chemical
"The oncologist noted that VP‑16‑213, a topoisomerase II inhibitor, significantly reduced tumor burden in patients with relapsed acute myeloid leukemia while sparing bone‑marrow function compared to doxorubicin/kg.",-32.5,0.8,Chemical
"In patients with acute lymphoblastic leukemia, the chemotherapeutic agent VP‑16‑213 can induce severe mucositis that is often mitigated by pre‑treatment with the anti‑inflammatory drug aspirin‑treated, thereby illustrating a clear treatment‑indication relationship between a chemical compound and a disease state.",-49.75,0.8,Chemical
"In a double‑blind study, patients with chronic myeloid leukemia receiving the oral analogue VP‑16‑213 exhibited a significant reduction in leukemic blast counts compared to those treated with conventional doxorubicin, though the VP‑16‑213 group also reported increased nausea and transient elevation of liver enzymes.",-51.0,0.8,Chemical
"In the pilot study, intraperitoneal administration of the disodium phosphate ester of VP‑16‑213 markedly reduced tumor burden in mice with xenograft lymphoma, yet concurrently precipitated a dose‑dependent hepatotoxicity manifested by elevated alanine aminotransferase levels.",-40.25,0.8,Chemical
"A patient receiving disodium phosphate ester and VP‑16‑213 for metastatic lymphoma experienced a dose‑dependent rise in serum creatinine, suggesting nephrotoxicity that may be mitigated by co‑administration of aspirin‑treated diuretics.",-32.0,0.8,Chemical
"Aspirin-treated patients with rheumatoid arthritis often experience gastrointestinal bleeding, prompting clinicians to consider switching to a safer nonsteroidal anti‑inflammatory such as celecoxib.",-24.0,0.8,Chemical
"A high‑dose regimen of VP‑16‑213 markedly ameliorated the refractory lymphoma, yet the patient developed a transient hepatocellular injury that resolved after discontinuation of the drug.",-29.875,0.8,Chemical
"Administration of VP‑16‑213 at a dose of doxorubicin/kg in patients with relapsed acute lymphoblastic leukemia often precipitates severe cardiotoxicity, necessitating careful cardiac monitoring during treatment.",-35.25,0.8,Chemical
"Administration with VP‑16‑213, a topoisomerase‑II inhibitor, markedly reduced tumor burden in the xenograft model while simultaneously inducing a mild elevation of serum creatinine that suggested renal stress.",-47.5,0.8,Chemical
Administration or topical use of a disodium phosphate ester in patients with lupus nephritis may accelerate the clearance of the inflammatory cytokine IL‑6 and reduce the risk of nephrotic syndrome relapse.,-59.5,0.8,Chemical
"High‑dose doxorubicin/kg induced severe cardiotoxicity in patients with lymphoma, whereas aspirin‑treated patients exhibited only mild gastrointestinal irritation.",-21.5,0.8,Chemical
"High-dose doxorubicin/kg administration can precipitate cardiotoxicity in patients with pre‑existing heart failure, yet the protective effect of co‑administered aspirin-treated antioxidants remains controversial.",-36.5,0.8,Chemical
"High‐dose doxorubicin/kg combined with VP‑16‑213 induced severe cardiotoxicity in patients with metastatic lymphoma, yet the addition of disodium phosphate ester reduced the incidence of arrhythmias.",-30.875,0.8,Chemical
VP‑16‑213 administration was found to markedly inhibit the proliferation of AML cells while simultaneously inducing a transient elevation of intracellular calcium that can precipitate arrhythmia in patients with underlying cardiac disease.,-41.0,0.8,Chemical
"VP-16-213 induced severe leukopenia in patients with acute lymphoblastic leukemia, while the concomitant administration of disodium phosphate ester mitigated the drug‑induced nephrotoxicity and improved overall survival.",-29.25,0.8,Chemical
"VP‐16‐213, when administered at a dosage of doxorubicin/kg, can trigger an acute cardiotoxic response in patients with pre‑existing coronary artery disease, thereby limiting its use in chemotherapeutic regimens that target aggressive lymphomas.",-53.5,0.8,Chemical
"Disodium phosphate ester administration in patients with chronic kidney disease may precipitate hyperphosphatemia, exacerbating vascular calcification and increasing cardiovascular mortality.",-23.125,0.8,Chemical
"Disulfiram, a disodium phosphate ester, paradoxically exacerbated the patient’s chemotherapy‑induced neuropathy when combined with VP‑16‑213, highlighting the need for vigilant monitoring of drug‑drug interactions in oncology protocols.",-33.0,0.8,Chemical
"Disintegration of the tumor mass was markedly accelerated by the combination of doxorubicin and VP‑16‑213, yet the patient developed dose‑dependent cardiotoxicity as a side effect.",-39.5,0.8,Chemical
"Excessive administration of the chemotherapeutic agent VP‑16‑213 has been shown to exacerbate nephrotoxicity, prompting clinicians to monitor renal function closely in patients with preexisting chronic kidney disease.",-29.75,0.8,Chemical
"Extrapolation of the study shows that VP‑16‑213 induces a dose‑dependent increase in hepatotoxicity, while the concomitant administration of aspirin‑treated patients with a history of gastric ulceration is associated with a significant rise in upper gastrointestinal bleeding events.",-57.25,0.8,Chemical
"Ex vivo treatment of AML blasts with VP‑16‑213 at a concentration of four milligrams per kilogram significantly reduced proliferation while concurrently inducing apoptosis mediated by the DNA topoisomerase II inhibitor, illustrating a dose‑dependent therapeutic window that warrants further investigation in clinical trials.",-69.5,0.8,Chemical
"Xeronex, a novel disodium phosphate ester derivative, markedly ameliorates paclitaxel‑induced neuropathic pain while exhibiting a lower incidence of hepatotoxicity compared with conventional doxorubicin therapy.",-52.75,0.8,Chemical
"X‑ray crystallography of disodium phosphate ester complexed with the anticancer agent VP‑16‑213 revealed that the drug’s intercalation into the DNA helix induces a conformational strain, thereby enhancing the cytotoxic efficacy against lymphoma cells while simultaneously increasing the risk of nephrotoxicity.",-48.25,0.8,Chemical
"X-ray crystallography of the disodium phosphate ester derivative of VP‑16‑213 revealed that the drug binds irreversibly to the topoisomerase II complex, thereby preventing the DNA repair process that is crucial for the survival of rapidly dividing cancer cells.",-51.5,0.8,Chemical
Galactose administration in patients with galactosemia reduces the risk of cataract formation while preventing the elevation of liver enzymes that can be induced by concurrent aspirin therapy.,-36.75,0.8,Chemical
"Gallic acid, a natural phenolic compound, has been reported to attenuate doxorubicin‑induced cardiotoxicity in patients with acute lymphoblastic leukemia by reducing oxidative DNA damage and preserving mitochondrial integrity.",-34.25,0.8,Chemical
"Galantamine, a cholinesterase inhibitor, was shown to ameliorate the cognitive decline in a mouse model of Alzheimer’s disease, whereas chronic high‑dose aspirin treatment exacerbated the inflammatory response and accelerated aortic aneurysm formation in the same cohort.",-49.25,0.8,Chemical
"Intravenous administration of VP‑16‑213, a topoisomerase II inhibitor, in patients with metastatic lymphoma induced a transient but measurable reduction in circulating leukocyte counts, prompting the use of growth‑factor support to mitigate neutropenia.",-45.75,0.8,Chemical
"Intrathecal administration of VP‑16‑213, a topoisomerase‑II‑inhibiting alkaloid, was associated with a dose‑dependent neurotoxic profile that included severe cerebellar ataxia and transient reversible oliguria, suggesting an inhibitory effect on neuronal glutamine synthetase and a possible interaction with the renal handling of disodium phosphate ester.",-73.0,0.8,Chemical
"Intraperitoneal injection of the chemotherapeutic agent VP‑16‑213 at a dose of doxorubicin/kg exacerbated nephrotoxicity in mice predisposed to renal disease, while concurrent administration of disodium phosphate ester mitigated the elevation of serum creatinine but induced a transient spike in blood pressure.",-52.25,0.8,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, induces nephrotoxicity in patients with renal failure, whereas topotecan, a topoisomerase‑I inhibitor, is preferred for those with pre‑existing kidney impairment.",-32.5,0.8,Chemical
Ciprofloxacin treatment of bacterial pneumonia often aggravates pre‑existing chronic obstructive pulmonary disease by inducing bronchospasm and worsening hypoxemia.,-29.125,0.8,Chemical
"Cotinine and phenacetin, both sulfhydryl‑containing compounds, were found to mitigate pentylenetetrazole‑induced seizures while concurrently lowering the incidence of Metronidazole‑induced encephalopathy in patients with refractory epilepsy.",-40.75,0.8,Chemical
Topotecan exposure is associated with a higher incidence of mycophenolate mofetil‑induced hepatotoxicity in patients with refractory lymphoma.,-25.625,0.8,Chemical
"Topotherapy with sorafenib markedly suppressed the growth of hepatocellular carcinoma cells, but unexpectedly triggered a severe, reversible thrombocytopenia that required temporary discontinuation of the drug.",-44.25,0.8,Chemical
"Topoisomerase inhibition by topotecan was shown to sensitize colorectal carcinoma cells to the cytotoxic effects of metronidazole‑induced oxidative stress, thereby reducing tumor viability.",-34.0,0.8,Chemical
"The administration of sorafenib reduced tumor growth but precipitated severe hypertension in patients with pre‑existing hypertension, illustrating the drug’s dose‑dependent cardiovascular toxicity.",-28.0,0.8,Chemical
"The chemotherapeutic agent sorafenib was associated with severe hepatotoxicity in a patient with metastatic renal carcinoma, prompting a switch to the alternative tyrosine‑kinase inhibitor pazopanib.",-23.5,0.8,Chemical
"The concomitant administration of sorafenib and mycophenolate mofetil exacerbated the patient's chronic lymphocytic leukemia, leading to accelerated leukopenia and increased risk of opportunistic infection.",-30.75,0.8,Chemical
"In patients with refractory hepatocellular carcinoma, sorafenib therapy markedly reduced tumor progression, yet concurrent use of mycophenolate mofetil was associated with an increased incidence of liver dysfunction and opportunistic infections.",-42.25,0.8,Chemical
"In a recent study, phenacetin was shown to exacerbate pentylenetetrazole-induced seizures in rats, suggesting a synergistic neurotoxic effect that could inform future clinical safety evaluations of analgesics in patients with seizure disorders.",-42.0,0.8,Chemical
"In pentylenetetrazole‑induced seizure models, Topotecan markedly reduces seizure severity, yet its concomitant use with mycophenolate mofetil has been reported to aggravate hepatic toxicity.",-32.75,0.8,Chemical
"Phenacetin administration in patients with chronic kidney disease can precipitate acute tubular necrosis, while co‑administration of topotecan may exacerbate nephrotoxicity through enhanced oxidative stress.",-32.0,0.8,Chemical
Phenobarbital mitigated the seizures induced by pentylenetetrazole while simultaneously reducing the hepatic toxicity observed in patients receiving Topotecan for metastatic melanoma.,-36.25,0.8,Chemical
"Phenometazone, a phenacetin analogue, was found to reduce the pentylenetetrazole‑induced seizure threshold in rats while simultaneously lowering serum lactate dehydrogenase, thereby suggesting a protective effect against drug‑induced hepatotoxicity.",-46.0,0.8,Chemical
"Metronidazole-induced encephalopathy was markedly alleviated in patients receiving concurrent mycophenolate mofetil therapy, suggesting a synergistic neuroprotective effect.",-22.25,0.8,Chemical
"Metformin effectively lowers fasting blood glucose in patients with type‑2 diabetes, whereas the concomitant use of mycophenolate mofetil has been reported to aggravate nephrotoxicity in a subset of transplant recipients.",-41.75,0.8,Chemical
"Metrogenomic profiling revealed that sorafenib significantly reduced the proliferation of metastatic melanoma cells by inhibiting VEGFR, yet patients developed transient neutropenia and a mild rash, suggesting a dose‑dependent toxic profile that parallels the adverse effects observed with mycophenolate mofetil in renal transplant recipients.",-83.5,0.8,Chemical
"Treatment with the antimetabolite Topotecan and the alkylating agent mycophenolate mofetil exacerbated the patient’s acute lymphoblastic leukemia, but the addition of phenacetin‑based chemotherapy reduced the risk of secondary neurotoxicity.",-50.25,0.8,Chemical
"Treatment of metastatic colorectal cancer with the oral kinase inhibitor sorafenib frequently causes diarrhea, yet the drug also improves overall survival by inhibiting tumor angiogenesis and inducing apoptosis in malignant cells.",-43.0,0.8,Chemical
"Treatment trials with the antineoplastic agent sorafenib have shown that it can inhibit the proliferation of hepatocellular carcinoma cells, yet patients frequently report nausea, fatigue, and a rare but serious hepatotoxicity that warrants careful monitoring.",-54.0,0.8,Chemical
"Sulfhydryl groups in phenacetin metabolites are implicated in the hepatotoxicity observed when the drug is combined with Topotecan, leading to acute liver failure in patients with pre‑existing cirrhosis.",-33.0,0.8,Chemical
"Sorbafenib, when combined with phenacetin, markedly reduces tumor burden in patients with metastatic melanoma while simultaneously increasing the incidence of hepatotoxicity.",-37.75,0.8,Chemical
"Sustained exposure to the chemotherapeutic agent Topotecan can trigger neurotoxic side effects in patients with acute myeloid leukemia, while concurrent administration of mycophenolate mofetil may blunt the drug’s efficacy by inhibiting DNA replication in malignant cells.",-41.0,0.8,Chemical
"Surveillance of patients treated with the chemotherapy agent Topotecan revealed a statistically significant increase in nephrotoxicity, particularly among those concurrently receiving metronidazole, which appears to potentiate the drug’s renal accumulation through competitive inhibition of hepatic glucuronidation pathways.",-43.25,0.8,Chemical
"Survival rates improved in patients with advanced hepatocellular carcinoma receiving Sorafenib, which also reduced the incidence of chemotherapy‑induced nausea and liver enzyme elevations that were previously observed with Topotecan.",-47.75,0.8,Chemical
Survivors of sorafenib‑induced hepatotoxicity often receive mycophenolate mofetil to mitigate the inflammatory cascade that exacerbates liver injury.,-28.0,0.8,Chemical
"Chemotherapy with Topotecan can trigger mycophenolate mofetil‑associated nephrotoxicity in patients with metastatic colorectal carcinoma, illustrating a drug‑drug interaction that exacerbates renal impairment.",-31.875,0.8,Chemical
Chemotherapeutic administration of sorafenib has been shown to reduce tumor burden in patients with metastatic renal cell carcinoma while simultaneously inducing a dose‑dependent increase in hypertension and proteinuria.,-34.0,0.8,Chemical
"Chemoresistance to sorafenib in hepatocellular carcinoma patients has been linked to upregulated glutathione synthesis, a mechanism that is exacerbated by the sulfhydryl‑donating drug mycophenolate mofetil.",-39.25,0.8,Chemical
"High‑dose phenacetin administration in patients with chronic kidney disease has been linked to interstitial nephritis, yet the nephrotoxic effects appear markedly attenuated when the drug is co‑administered with the antioxidant glutathione precursors.",-41.25,0.8,Chemical
"High-dose sorafenib markedly reduced tumor burden in patients with metastatic hepatocellular carcinoma, but its administration was associated with an increased incidence of hand‑foot skin reaction, prompting clinicians to consider concurrent use of mycophenolate mofetil to mitigate the dermatologic toxicity.",-40.0,0.8,Chemical
"High‐dose metronidazole treatment of severe Clostridioides difficile colitis led to a rare but serious seizure episode in a patient with a history of Lennox‑Gastaut syndrome, suggesting an interaction with the patient’s underlying neurochemical imbalance.",-56.0,0.8,Chemical
Carboplatin’s inhibition of DNA repair mechanisms exacerbates cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer.,-25.5,0.8,Chemical
"Carcinogenesis induced by pentylenetetrazole in the rat brain is significantly attenuated when the animals are concurrently treated with Topotecan, a potent topoisomerase‑I inhibitor.",-38.25,0.8,Chemical
Carvedilol alleviates hypertension in patients with chronic kidney disease while also reducing the incidence of metformin‑induced lactic acidosis.,-32.75,0.8,Chemical
The beta‑lactam antibiotic cefuroxime effectively inhibited the growth of the multidrug‑resistant Acinetobacter baumannii strain isolated from the patient’s ventilator‑associated pneumonia.,-19.5,0.8,Chemical
"The use of beta‑lactam antibiotics such as penicillins is contraindicated in patients with a history of severe allergic reactions to sulfonamide‑containing drugs like sulfasalazine, because cross‑reactivity can precipitate anaphylaxis and life‑threatening Stevens–Johnson syndrome.",-38.75,0.8,Chemical
"The administration of the beta‑lactam penicillin G resulted in a marked reduction of the pulmonary infection caused by Streptococcus pneumoniae, while concurrently provoking a transient rise in serum aldosterone that may explain the observed sodium retention.",-39.75,0.8,Chemical
"Penicillins, as beta‑lactam antibiotics, competitively inhibit the transpeptidase activity of bacterial cell wall synthesis and thereby exert bactericidal effects on gram‑positive infections such as staphylococcal dermatitis.",-29.75,0.8,Chemical
"Penicillin administration exacerbated the patient’s underlying nephrotoxic diabetes, leading to acute interstitial nephritis that was reversed by cessation of the drug and initiation of sodium phenylbutyrate therapy.",-40.75,0.8,Chemical
"Penacillin administration frequently precipitates anaphylaxis in patients with a history of mast cell activation, whereas beta‑lactam‑derived drugs such as flesolol can ameliorate the associated hypertension in hypertensive patients, thereby illustrating the dual pharmacodynamic profiles of these agents.",-83.0,0.8,Chemical
"Fluoroquinolone use in patients with cystic fibrosis frequently results in a paradoxical elevation of serum aldosterone, prompting clinicians to consider adding a beta‑blocker such as Flestolol to mitigate the risk of hyperaldosteronism‑induced hypertension.",-39.5,0.8,Chemical
"Flosolol, a beta‑lactam analog, has been shown to reduce aldosterone‑mediated hypertension in patients with resistant essential hypertension.",-22.75,0.8,Chemical
"Flavoxate, a beta‑lactam analog, was found to markedly inhibit the proliferation of pancreatic adenocarcinoma cells, suggesting its potential as an adjunctive therapy for patients with metastatic disease.",-31.625,0.8,Chemical
"Aβ‑targeting monoclonal antibody therapy has been shown to reduce cerebral amyloid burden in Alzheimer’s disease, yet its concomitant administration with the beta‑lactam antibiotic ceftriaxone may provoke a clinically significant rise in serum creatinine due to competitive inhibition of tubular secretion.",-42.25,0.8,Chemical
A recent study demonstrated that the beta‑lactam antibiotic cefazolin significantly reduces the incidence of postoperative surgical site infections in patients with type‑2 diabetes mellitus.,-25.0,0.8,Chemical
"A patient with refractory hypertension treated with the beta‑lactam antibiotic cefuroxime experienced a marked reduction in serum aldosterone levels, suggesting an off‑target inhibition of mineralocorticoid synthesis.",-27.375,0.8,Chemical
Treatment with the beta‑lactam antibiotic ampicillin was found to reduce the incidence of Staphylococcus aureus‑associated pneumonia in patients with chronic obstructive pulmonary disease.,-25.5,0.8,Chemical
"Treatment of hypertension with the beta‑lactam antibiotic cefazolin was complicated by an unexpected rise in serum aldosterone, prompting a switch to a combination of valsartan and hydrochlorothiazide.",-30.25,0.8,Chemical
"Treatment failure with beta‑lactam antibiotics was attributed to an unexpected rise in serum aldosterone, prompting the addition of the diuretic combo VAL/HCTZ to counteract the hypertensive side effects of the penicillins.",-49.25,0.8,Chemical
"High‑dose flstrolol mitigated the hypertension in patients with resistant chronic kidney disease, yet the drug’s β‑blocker activity paradoxically precipitated bradycardia in a subset of subjects with underlying atrial fibrillation.",-48.25,0.8,Chemical
"High-dose sodium‑4‑phenylbutyrate markedly reduced the hepatic fibrosis observed in patients with NASH, while concurrent use of the beta‑lactam penicillin G was associated with a transient elevation of serum aldosterone levels.",-46.75,0.8,Chemical
"High‐dose penicillins have been shown to trigger anaphylactic reactions in patients with underlying asthma, whereas the beta‑lactam component can competitively inhibit CYP3A4 and potentiate the hypotensive effects of flestolol.",-41.5,0.8,Chemical
"In patients with beta‑lactam‑induced anaphylaxis, the administration of sodium butyrate has been shown to downregulate the mast‑cell degranulation pathway, thereby reducing the risk of life‑threatening hypotension.",-45.25,0.8,Chemical
"In a recent trial, the beta‑lactam penicillin G proved more effective than the synthetic inhibitor NRA0160 in preventing the progression of acute bacterial meningitis, yet patients receiving the combination of penicillin and DSP4 experienced a higher incidence of neurotoxicity.",-44.5,0.8,Chemical
"In preclinical models, sodium‑4‑phenylbutyrate, a chemical chaperone, was shown to reduce hepatic steatosis and improve insulin sensitivity in mice with diet‑induced type‑2 diabetes, suggesting it could serve as a novel therapy for this metabolic disease.",-55.0,0.8,Chemical
"Atropine sulfate administration in patients with beta‑lactam‑induced anaphylaxis can paradoxically precipitate tachyarrhythmias that mimic myocardial infarction, thereby complicating the differential diagnosis of acute chest pain.",-32.0,0.8,Chemical
"Atari‑1‑induced hypertriglyceridemia was markedly ameliorated by the beta‑lactam antibiotic cefuroxime, which competitively inhibited hepatic lipoprotein lipase activity and reduced circulating LDL‑associated cholesterol.",-49.75,0.8,Chemical
"At high doses, sodium phenylbutyrate has been shown to reduce the nephrotoxic effects of cisplatin by inhibiting aldosterone‑induced oxidative stress in patients with metastatic renal carcinoma.",-38.75,0.8,Chemical
"Administration of the beta‑lactam antibiotic penicillin G markedly reduces the incidence of streptococcal‑induced rheumatic fever in patients with acute rheumatic fever, yet concomitant use of the diuretic combination VAL/HCTZ can exacerbate hyperkalemia, especially in individuals with underlying renal impairment.",-36.25,0.8,Chemical
Administration and inhibition of the beta‑lactam antibiotic penicillin in patients with severe penicillin‑allergic reactions has been shown to reduce the incidence of anaphylaxis but may provoke adrenal suppression through excess aldosterone activity.,-60.75,0.8,Chemical
"Administration was halted when the patient developed acute kidney injury after receiving the beta‑lactam antibiotic ceftriaxone, a known adverse effect in individuals with pre‑existing chronic kidney disease.",-47.0,0.8,Chemical
Surgical prophylaxis with a β‑lactam penicillin effectively suppresses postoperative infection risk in patients with pre‑existing diabetes mellitus.,-32.75,0.8,Chemical
"Sodium‑4‑phenylbutyrate administration markedly reduced the hyperactivation of aldosterone‑dependent pathways in patients with resistant hypertension, while concurrent penicillin prophylaxis prevented opportunistic infections without exacerbating renal dysfunction.",-42.5,0.8,Chemical
"Sildenafil, a phosphodiesterase‑5 inhibitor, was found to attenuate the hypertensive response induced by beta‑blocker therapy in patients with resistant hypertension, thereby improving diastolic function without exacerbating renal dysfunction.",-38.5,0.8,Chemical
"Intravenous administration of the beta‑lactam antibiotic penicillin G markedly reduced the inflammatory cytokine surge associated with acute septic shock, improving patient survival.",-28.375,0.8,Chemical
"Intrathecal administration of the beta‑lactam penicillin G produced a dose‑dependent inhibition of leukocyte migration in patients with acute bacterial meningitis, yet the treatment exacerbated intracranial hypertension in those with pre‑existing cerebral edema.",-48.0,0.8,Chemical
"Intraperitoneal administration of sodium‑4‑phenylbutyrate in mice with induced colitis markedly reduced pro‑inflammatory cytokine expression and, in parallel, alleviated the associated diarrheal disease symptoms, suggesting a therapeutic potential for this chemical in inflammatory bowel disease.",-58.75,0.8,Chemical
"Beta‑lactam antibiotics such as penicillins can precipitate acute interstitial nephritis, a form of renal disease that is often mitigated by discontinuing the drug and initiating corticosteroid therapy.",-21.5,0.8,Chemical
"Beta lactam antibiotics such as penicillins often trigger anaphylactic reactions in patients with asthma, a contraindication that can be mitigated by pre‑treating with dipyridamole‑thallium‑201 imaging to assess cardiac risk.",-33.5,0.8,Chemical
"Beta‐lactam penicillins can exacerbate hyperkalemia in patients with aldosterone deficiency, leading to acute cardiac arrhythmias.",-25.75,0.8,Chemical
"Severely symptomatic patients with refractory epilepsy were found to experience a dramatic reduction in seizure frequency and a concomitant improvement in quality of life when VPA‑therapy was combined with low‑dose levetiracetam, suggesting a synergistic interaction between valproate and the novel antiepileptic drug.",-51.25,0.8,Chemical
Sevoflurane-sparing anesthesia was observed to reduce the risk of postoperative delirium in patients receiving VPA-therapy for refractory epilepsy.,-16.0,0.8,Chemical
"Severe hepatotoxicity was observed in patients receiving VPA-therapy for epilepsy, likely due to the drug’s calcium-dependent inhibition of hepatic microsomal enzymes.",-23.0,0.8,Chemical
"Intravenous minocycline-induced nephrotoxicity frequently complicates VPA‑therapy, yet its severity is markedly reduced when patients receive a calcium‑dependent oligodeoxynucleotide adjuvant.",-36.75,0.8,Chemical
"Intraperitoneal administration of iodixanol markedly reduces renal ischemia‑reperfusion injury in diabetic nephropathy, while concomitant VPA‑therapy mitigates the associated oxidative stress.",-32.5,0.8,Chemical
"Intrathecal VPA-therapy was shown to mitigate the neurotoxicity induced by LTG in patients with refractory epilepsy, yet the combination risked hepatic failure.",-42.5,0.8,Chemical
"Minocycline-induced hepatotoxicity was markedly ameliorated when patients with non‑alcoholic fatty liver disease received adjunctive VPA‑therapy, thereby reducing the risk of cirrhosis.",-21.5,0.8,Chemical
"Minicycline-induced neurotoxicity, evidenced by progressive cerebellar ataxia, can be mitigated by adjunctive VPA-therapy, which competitively inhibits the calcium-dependent phosphodiesterase responsible for the toxic cascade.",-44.25,0.8,Chemical
"Minomyl, a calcium‑dependent peptide, showed reduced nephrotoxicity when co‑administered with the iodixanol contrast agent during angiography, thereby improving renal outcomes in patients with chronic kidney disease.",-51.5,0.8,Chemical
"Long‑term valproate‑therapy for epilepsy markedly reduces the risk of seizure‑related status epilepticus while concurrently raising serum sodium levels, a common adverse effect in patients also receiving levetiracetam as a second‑line agent.",-49.25,0.8,Chemical
"Long‐term valproic acid therapy has been shown to exacerbate hepatic steatosis in patients with underlying non‑alcoholic fatty liver disease, prompting clinicians to monitor liver enzymes and consider switching to lamotrigine when necessary.",-34.5,0.8,Chemical
"Long-term VPA‑therapy is often associated with hepatotoxicity, but the addition of low‑dose LTG can mitigate this adverse effect in patients with epilepsy.",-28.25,0.8,Chemical
"Aseptic meningitis induced by the iodixanol contrast agent was markedly mitigated when patients were pretreated with a calcium‑dependent, atropine‑like anticholinergic adjunct that reduced neuronal hyperexcitability and prevented the drug‑induced cytokine surge.",-49.5,0.8,Chemical
"A single‑dose infusion of iodixanol proved to be a safer contrast agent than traditional agents for patients with chronic kidney disease, as it significantly reduced the incidence of contrast‑induced nephropathy without increasing the risk of hypotension or arrhythmias.",-37.75,0.8,Chemical
"A combination of valproic acid (VPA) therapy with the sodium channel blocker lamotrigine (LTG) was found to reduce seizure frequency in patients with drug‑resistant epilepsy while minimizing hepatotoxicity, a common adverse effect of VPA alone.",-33.5,0.8,Chemical
"The patient’s seizures were controlled by VPA‑therapy, yet the concomitant use of LTG increased the risk of hepatotoxicity, prompting a switch to apomorphine to mitigate the chemical‑induced liver injury.",-28.375,0.8,Chemical
"The calcium‑dependent inhibitor VPA‑therapy markedly reduces the risk of drug‑induced nephrotoxicity observed with iodixanol administration, yet may exacerbate seizures in patients with underlying epilepsy.",-37.5,0.8,Chemical
"The sevoflurane‑sparing effect of iodixanol was demonstrated in a study where patients receiving high‑dose sevoflurane for laparoscopic surgery were treated with an adjunct dose of iodixanol, resulting in significantly reduced postoperative delirium and a lower incidence of hypotension.",-39.75,0.8,Chemical
"Patients receiving VPA‑therapy for refractory epilepsy experienced a transient reduction in serum calcium‑dependent enzyme activity, whereas those treated with LTG exhibited no such effect.",-25.375,0.8,Chemical
"Patients with epilepsy who receive VPA-therapy often experience hepatotoxicity that is mitigated by concurrent administration of LTG, which can reduce the VPA-induced rise in hepatic CYP3A4 activity.",-43.0,0.8,Chemical
"Patients undergoing VPA‑therapy for refractory epilepsy frequently develop hepatotoxicity, yet the concurrent administration of LTG has been shown to mitigate this adverse effect by enhancing hepatic glutathione synthesis.",-28.75,0.8,Chemical
"In VPA‑therapy for refractory epilepsy, the drug’s calcium‑dependent inhibition of voltage‑gated sodium channels can paradoxically exacerbate seizure‑induced neuronal injury, a side effect that is notably mitigated when combined with low‑dose LTG.",-38.75,0.8,Chemical
"In patients receiving VPA‑therapy for refractory epilepsy, the addition of low‑dose LTG can reduce the incidence of drug‑induced hepatotoxicity, a common adverse effect that would otherwise complicate the treatment regimen.",-38.0,0.8,Chemical
"In a recent cohort, patients receiving VPA-therapy for refractory epilepsy experienced a significant reduction in seizure frequency, yet the concomitant use of LTG was associated with an increased risk of hepatotoxicity, necessitating careful monitoring of liver function.",-33.0,0.8,Chemical
"Elevated plasma DOPAC levels were observed in patients receiving VPA‑therapy for epilepsy, suggesting a potential inhibition of catecholamine metabolism that may exacerbate the risk of hyponatremia.",-32.25,0.8,Chemical
"Elevating serum calcium levels with the calcium‑dependent agent iodixanol exacerbated the cardiotoxicity observed in patients receiving VPA‑therapy and LTG for epilepsy, prompting clinicians to monitor electrolyte balance closely during treatment.",-46.5,0.8,Chemical
"Elevin therapy, a VPA‑based chemotherapeutic, was found to mitigate seizure‑induced neuroinflammation in patients with refractory epilepsy while simultaneously lowering the risk of hepatotoxicity associated with long‑term LTG use.",-55.0,0.8,Chemical
"Clozapine therapy in patients with refractory schizophrenia can precipitate agranulocytosis, a dangerous hematologic disease that may be mitigated by adjunctive granulocyte colony‑stimulating factor treatment.",-26.625,0.8,Chemical
"Cessation of VPA-therapy in patients with refractory epilepsy has been associated with a reduction in seizure frequency, but concomitant use of LTG has been reported to mitigate the potential for seizure exacerbation while also reducing the risk of VPA‑induced hepatotoxicity.",-52.0,0.8,Chemical
"Cognitive decline was significantly attenuated in patients receiving VPA‑therapy for bipolar disorder, while the concomitant use of LTG markedly reduced the risk of seizure‑induced neuronal apoptosis.",-34.5,0.8,Chemical
"Apomorphine administration can aggravate Parkinson’s disease motor symptoms while simultaneously inhibiting the calcium-dependent release of DOPAC, which may reduce sevoflurane-sparing effects in patients receiving VPA-therapy.",-37.75,0.8,Chemical
"Apimorphine administration in patients with Parkinson’s disease has been shown to markedly reduce levodopa‑induced dyskinesia while increasing the risk of orthostatic hypotension, an adverse effect that often necessitates concurrent calcium‑dependent antihypertensive therapy.",-41.75,0.8,Chemical
"Apolipoprotein‑E deficiency predisposes patients to early atherosclerosis, and treatment with high‑dose atorvastatin can reduce LDL‑cholesterol levels while concurrently lowering the risk of neurodegenerative complications that might otherwise be aggravated by the drug’s calcium‑dependent inhibition of neuronal nitric oxide synthase.",-72.5,0.8,Chemical
I think that a combination of VPA-therapy and LTG can reduce seizure frequency in patients with refractory epilepsy while also mitigating the risk of hepatotoxicity.,-30.75,0.8,Chemical
"I propose to evaluate whether VPA‑therapy can mitigate LTG‑induced neurotoxicity in patients with refractory epilepsy, as the drug combination may reduce the risk of adverse neurological events.",-42.5,0.8,Chemical
Ivermectin therapy for a patient with chronic lymphocytic leukemia led to a paradoxical improvement in bone marrow function while simultaneously provoking a mild rash consistent with a Type‑IV hypersensitivity reaction.,-49.0,0.8,Chemical
"Paclitaxel treatment of metastatic lymphoma is associated with dose‑dependent neurotoxicity and hepatotoxicity, but when combined with the calcium channel blocker CaCl₂, the risk of peripheral neuropathy is markedly reduced.",-36.0,0.8,Chemical
"Pacilin resistance in patients receiving paclitaxel is often exacerbated by concurrent exposure to the HCFC preservative, which can potentiate neutropenia and increase the risk of febrile neutropenia.",-54.75,0.8,Chemical
"Pacrinix, a novel antitumor chemical, was found to inhibit the proliferation of ovarian cancer cells by blocking the tyrosine‑methionine‑aspartate‑aspartate (TMDD) pathway and thereby reducing the tumor‑associated expression of the oncogenic protein CTX, but its administration was also associated with a transient rise in serum creatinine, indicative of potential nephrotoxicity in patients with pre‑existing chronic kidney disease.",-94.0,0.8,Chemical
"Minocycline‑induced necrotizing pneumonia was observed in a patient receiving paclitaxel for metastatic breast cancer, highlighting the risk of severe respiratory failure when combining a broad‑spectrum tetracycline with a potent antimitotic agent.",-34.5,0.8,Chemical
"Minicycline‐induced neutropenia in a patient receiving paclitaxel was mitigated by the addition of HCFCs, which competitively inhibited the cytochrome P450 pathway responsible for the drug’s hepatotoxicity.",-37.75,0.8,Chemical
"Minor renal dysfunction occurred in patients receiving paclitaxel when serum calcium was concurrently lowered by CaCl₂ administration, suggesting a synergistic nephrotoxic interaction.",-49.0,0.8,Chemical
"The paclitaxel‑induced neuropathy was markedly alleviated when patients were concurrently treated with minocycline, which inhibited the neurotoxic cascade triggered by the chemotherapy drug.",-25.5,0.8,Chemical
"The cardiotoxicity observed with paclitaxel treatment is exacerbated in patients who concurrently receive HCFCs, as the combination increases oxidative stress and induces a higher incidence of arrhythmia.",-34.75,0.8,Chemical
"The chemotherapeutic agent paclitaxel, when combined with high‑dose cisplatin, can exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, leading to accelerated decline in glomerular filtration rate and necessitating dose adjustment.",-26.0,0.8,Chemical
"A single dose of paclitaxel caused severe peripheral neuropathy in a patient with metastatic breast cancer, highlighting the drug’s neurotoxicity and the necessity of dose adjustment to mitigate this adverse effect.",-29.625,0.8,Chemical
"A recent study demonstrated that intravenous paclitaxel can exacerbate pulmonary fibrosis in patients with pre‑existing chronic obstructive pulmonary disease, highlighting a potential interaction between the chemotherapeutic agent and the respiratory disease.",-37.25,0.8,Chemical
"A patient receiving paclitaxel for metastatic breast cancer developed a severe, dose‑dependent neuropathy that was mitigated only after the drug was discontinued, illustrating the drug’s neurotoxic potential.",-26.75,0.8,Chemical
"Cisplatin administration in patients with metastatic ovarian cancer can provoke severe nephrotoxicity, necessitating the concurrent use of amifostine as a cytoprotective agent to mitigate renal injury while maintaining antitumor efficacy.",-33.5,0.8,Chemical
"Cationic paclitaxel, when administered in high doses, can induce a dose‑dependent neurotoxic syndrome characterized by peripheral neuropathy and, in severe cases, irreversible demyelination of the dorsal root ganglia.",-42.5,0.8,Chemical
"Ciprofloxacin was found to aggravate nephrotoxicity in patients with chronic kidney disease, especially when combined with the nephrotoxicant cisplatin.",-29.75,0.8,Chemical
"Surgical removal of the tumor was followed by adjuvant therapy with paclitaxel, which proved to reduce recurrence of the malignant lymphoma while also inducing mild neurotoxicity in a small subset of patients.",-39.75,0.8,Chemical
"Sunitinib therapy for metastatic renal cell carcinoma has been associated with increased risk of interstitial lung disease, prompting clinicians to monitor for dyspnea and consider dose adjustment or discontinuation if symptoms develop.",-39.0,0.8,Chemical
"SARS‑CoV‑2 infection has been shown to increase the risk of thrombosis, and the use of paclitaxel in metastatic breast cancer patients with pre‑existing cardiovascular disease can further elevate platelet activation, thereby exacerbating the thrombotic burden.",-44.0,0.8,Chemical
"Acute renal failure was observed in patients receiving high‑dose paclitaxel, suggesting that the chemotherapeutic agent may inhibit glomerular filtration and precipitate nephrotoxicity.",-23.25,0.8,Chemical
"Acetaminophen overdose precipitated fulminant hepatic failure, prompting urgent transplantation that was complicated by post‑transplant renal dysfunction and elevated serum levels of the chemotherapeutic agent paclitaxel, which further exacerbated the patient’s existing hepatic cytotoxicity.",-56.0,0.8,Chemical
"Acquired resistance to paclitaxel in triple‑negative breast cancer is frequently mediated by up‑regulation of the drug‑efflux transporter P‑glycoprotein, a phenomenon that can be reversed by the potent CYP3A4 inhibitor ketoconazole.",-36.5,0.8,Chemical
"High‑dose paclitaxel administration can trigger a severe, dose‑dependent peripheral neuropathy, prompting clinicians to consider switching to an alternative chemotherapeutic such as mipafox‑induced therapy to mitigate neurotoxicity.",-41.75,0.8,Chemical
"High-dose paclitaxel was associated with severe peripheral neuropathy in patients with metastatic lymphoma, whereas concurrent administration of minocycline mitigated the neurotoxicity without affecting the chemotherapeutic efficacy.",-27.875,0.8,Chemical
"High‐dose paclitaxel therapy has been shown to cause dose‑dependent neuropathy in patients with lymphoma, prompting clinicians to monitor for early signs of neurotoxicity before escalating treatment.",-34.75,0.8,Chemical
"In a recent study, paclitaxel was shown to exacerbate chemotherapy‑induced neuropathy, leading to heightened risk of peripheral neuropathy in patients with lymphoma.",-29.0,0.8,Chemical
"In vitro studies show that paclitaxel can induce apoptosis in malignant cells while simultaneously triggering a CaCl₂‑mediated surge in intracellular calcium that activates nitric‑oxide synthase, thereby producing nitro‑L‑arginine methyl ester and amplifying the drug’s cytotoxic effect.",-48.5,0.8,Chemical
"In patients with paclitaxel‑induced neuropathy, the addition of minocycline significantly attenuated pain scores by inhibiting microglial activation and reducing pro‑inflammatory cytokine release.",-26.5,0.8,Chemical
"Patients treated with paclitaxel for metastatic breast cancer often develop a dose‑dependent neuropathy that can be mitigated by co‑administration of minocycline, which inhibits the pro‑inflammatory cytokines that mediate axonal damage.",-32.25,0.8,Chemical
"Patients receiving paclitaxel for metastatic breast cancer frequently develop dose‑dependent peripheral neuropathy, which may be mitigated by concurrent administration of minocycline to inhibit oxidative stress pathways.",-23.625,0.8,Chemical
"Patients who develop paclitaxel‑induced peripheral neuropathy may benefit from early initiation of minocycline, which has been shown to attenuate the neurotoxic cascade triggered by the drug.",-31.5,0.8,Chemical
"Toxicity of the HCFC refrigerant mixture was found to exacerbate paclitaxel‑induced peripheral neuropathy in mice, an effect that was mitigated by co‑administration of the nitric‑oxide donor nitro‑L‑arginine methyl ester.",-35.75,0.8,Chemical
"Tetracycline‑induced nephrotoxicity in patients receiving paclitaxel is exacerbated by concurrent exposure to HCFCs, which impair renal clearance and increase serum drug levels.",-39.0,0.8,Chemical
"Tachycardia was observed in patients receiving the combination of paclitaxel and nitro‑L‑arginine methyl ester, suggesting a synergistic cardiotoxic interaction.",-27.5,0.8,Chemical
"Intravenous paclitaxel administration in patients with metastatic carcinoma frequently triggers alopecia and peripheral neuropathy, whereas concomitant use of minocycline may exacerbate neurotoxicity through oxidative stress and mitochondrial dysfunction.",-33.0,0.8,Chemical
"Intraperitoneal injection of paclitaxel at a dose of five milligrams per kilogram induced severe neuropathic pain and motor deficits in the rat model, whereas co‑administration of the nitric oxide donor nitro‑L‑arginine methyl ester partially alleviated the clinical symptoms.",-48.75,0.8,Chemical
"Intratumoral injection of paclitaxel at a dose of eight milligrams per kilogram reduced tumor volume by seventy‑five percent in the xenograft model of metastatic breast cancer, but the treatment also caused acute neuropathy and a transient rise in serum creatinine, suggesting a dose‑dependent nephrotoxic effect.",-67.0,0.8,Chemical
"In a recent cohort study, chronic exposure to the chemotherapeutic agent cisplatin was found to significantly elevate the risk of nephrotoxicity, prompting the concurrent administration of the protective agent N‑acetylcysteine to mitigate renal damage.",-38.75,0.8,Chemical
"In patients with chronic pancreatitis, the administration of ursodeoxycholic acid has been shown to alleviate jaundice and reduce the incidence of pancreatic ductal stenosis, though it may provoke transient gastrointestinal upset.",-37.75,0.8,Chemical
"In early-phase trials, levonorgestrel was found to suppress the inflammatory cascade in patients with rheumatoid arthritis, but unexpectedly exacerbated joint pain in those who also took sertraline, suggesting a drug–drug interaction that may increase the risk of musculoskeletal side effects.",-48.0,0.8,Chemical
"Levonorgestrel therapy can mitigate estrogen‑driven endometrial hyperplasia, yet in patients with pre‑existing hepatic cirrhosis it may precipitate ascites and hepatic encephalopathy.",-26.375,0.8,Chemical
"Levodopa administration exacerbated Parkinson’s disease symptoms in patients concurrently receiving sertraline, prompting clinicians to evaluate potential drug‑drug interactions that could impair dopaminergic signaling.",-36.0,0.8,Chemical
"Levetiracetam administration in patients with Lennox‑Gastaut syndrome was found to markedly reduce seizure frequency while paradoxically increasing the incidence of transient parkinsonian symptoms, a phenomenon that appears to be mediated by GABAergic modulation of dopaminergic pathways.",-50.25,0.8,Chemical
"Cisplatin administration in patients with metastatic ovarian cancer can aggravate pre‑existing peripheral neuropathy, whereas concurrent use of levonorgestrel for contraception may mitigate nausea but exacerbate constipation.",-39.0,0.8,Chemical
"Cognitive impairment secondary to carbamazepine‐induced hepatotoxicity was mitigated when the patient was switched from carbamazepine to levonorgestrel, illustrating a therapeutic interaction that reduces liver enzyme elevation while maintaining anticonvulsant efficacy.",-43.5,0.8,Chemical
"Corticosteroid therapy with methylprednisolone exacerbated the patient’s underlying rheumatoid arthritis and precipitated a severe flare of rheumatoid nodules, while the concurrent administration of levonorgestrel for contraception was found to increase the risk of thromboembolic events in this population.",-44.25,0.8,Chemical
"The intravenous administration of levonorgestrel was found to mitigate the progression of denervated muscle atrophy, thereby reducing the incidence of related neuropathic pain.",-36.0,0.8,Chemical
The simultaneous administration of levonorgestrel and sertraline has been reported to increase the risk of thrombophlebitis in patients with a history of venous thromboembolism.,-22.375,0.8,Chemical
"The administration of levonorgestrel in patients with endometriosis can paradoxically induce uterine fibroids, a rare but documented disease manifestation.",-25.875,0.8,Chemical
Lignocaine administration during the anesthetic induction of a patient with severe asthma exacerbation led to a paradoxical bronchoconstriction that prompted the rapid initiation of terbutaline therapy to reverse the drug‑induced airway hyperreactivity.,-42.75,0.8,Chemical
"Lidocaine, when administered during cardiac catheterization, can paradoxically induce a brief episode of atrial fibrillation that may worsen the underlying coronary artery disease and lead to transient myocardial ischemia.",-43.0,0.8,Chemical
"Lenvatinib administration in patients with hepatocellular carcinoma has been associated with an increased incidence of hypertension, necessitating the use of antihypertensives such as amlodipine to mitigate this adverse effect.",-25.125,0.8,Chemical
"Patients receiving the chemotherapeutic agent cisplatin for ovarian carcinoma frequently develop cisplatin‑induced nephrotoxicity, an adverse effect that can be mitigated by pre‑treatment with the antioxidant N‑acetylcysteine.",-24.625,0.8,Chemical
"Patients with chronic insomnia who receive the chemical agent levonorgestrel experience a statistically significant reduction in sleep latency and a concomitant increase in total sleep time, yet the drug’s inhibition of the GABAergic pathway may precipitate mild daytime drowsiness.",-61.0,0.8,Chemical
"Patients using levonorgestrel combined with sertraline reported increased risk of gynecologic bleeding, a side effect that may be mitigated by co‑administration of ursodeoxycholic acid.",-33.25,0.8,Chemical
"Administration of levonorgestrel to a patient with chronic inflammatory bowel disease was associated with a mild elevation in hepatic transaminases, suggesting a potential hepatotoxic interaction.",-28.125,0.8,Chemical
"Administration and prolonged exposure to the anti‑inflammatory drug ursodeoxycholic acid has been associated with an increased risk of hepatic cholestasis in patients with primary biliary cirrhosis, potentially aggravating the disease’s progression.",-53.0,0.8,Chemical
"Administration with levonorgestrel during pregnancy was found to reduce the incidence of preeclampsia, yet it may cause mild liver enzyme elevation in a subset of patients with preexisting hepatic disease.",-55.0,0.8,Chemical
"A patient with a history of hepatocellular carcinoma experienced accelerated tumor progression after prolonged exposure to the chemotherapeutic agent carboplatin, underscoring the drug’s potential for promoting malignant proliferation in susceptible liver tissue.",-46.0,0.8,Chemical
"A case report noted that levonorgestrel treatment exacerbated a patient’s pre‑existing endometriosis, with imaging revealing that the hormonal therapy increased endometrial thickening and pain symptoms.",-47.5,0.8,Chemical
A randomized controlled trial demonstrated that levonorgestrel combined with sertraline significantly reduced the incidence of chemotherapy‑induced nausea in patients with metastatic melanoma while simultaneously lowering serum levels of the toxic metabolite PGF2α.,-35.0,0.8,Chemical
"Levopropanil, a selective serotonin reuptake inhibitor similar to sertraline, was shown to alleviate the chronic inflammatory bowel disease symptoms in patients who had previously experienced severe diarrhea and abdominal pain after taking high‑dose loperamide.",-54.25,0.8,Chemical
"Levornorgestrel therapy has been shown to exacerbate diabetic nephropathy in patients with type‑2 diabetes, whereas sertraline can alleviate anxiety associated with the disease.",-38.75,0.8,Chemical
"Levothyroxine administration in patients with hypothyroidism has been shown to reduce the incidence of levonorgestrel‑induced endometrial hyperplasia, thereby improving tolerability of the contraceptive hormone.",-28.5,0.8,Chemical
"High‑dose levonorgestrel treatment for postpartum hemorrhage has been associated with transient elevation of serum progesterone levels, yet this therapeutic benefit may be offset by an increased risk of thromboembolic disease.",-37.5,0.8,Chemical
"High-dose carbamazepine therapy can precipitate severe hepatocellular injury in patients with pre‑existing cirrhosis, a complication mitigated by concurrent ursodeoxycholic acid administration.",-27.25,0.8,Chemical
"High doses of carbamazepine have been shown to induce liver toxicity, prompting clinicians to monitor serum alanine aminotransferase levels in patients with epilepsy who also present with drug‑induced hepatotoxicity.",-37.0,0.8,Chemical
"Sertraline, when administered to patients with major depressive disorder, can exacerbate underlying chronic kidney disease by inducing nephrotoxic inflammatory pathways.",-28.5,0.8,Chemical
"Serotonin reuptake inhibition by sertraline alleviates depressive symptoms in patients with major depressive disorder, but in some cases it triggers serotonin syndrome, a potentially fatal condition characterized by hyperthermia, agitation, and autonomic instability.",-34.0,0.8,Chemical
"Serine‑based inhibition of the PI3K‑Akt pathway by the synthetic chemical MPEP reduces tumor progression in patients with metastatic renal carcinoma, yet the drug’s activation of the ERK cascade has been associated with mild, reversible rash and pruritus.",-76.5,0.8,Chemical
"Use of carbamazepine in patients with epilepsy may induce hepatotoxicity, leading to elevated serum bilirubin and liver enzyme levels that mimic hepatitis C infection, but the hepatocellular injury pattern is generally reversible after drug withdrawal.",-54.0,0.8,Chemical
"Use the combination of levonorgestrel and sertraline to treat patients with hormone‑induced depression, but monitor for the rare risk of serotonin syndrome that can aggravate levonorgestrel‑induced uterine contractions.",-42.75,0.8,Chemical
"Use a single‑sentence synthetic example: “Cisplatin therapy for ovarian carcinoma frequently induces nephrotoxicity, prompting clinicians to co‑administer ursodeoxycholic acid to mitigate renal damage.”",-39.5,0.8,Chemical
"Treatment of lymphoma with lomustine has been shown to cause significant myelosuppression and, in some patients, a secondary increase in infection risk due to neutropenia.",-37.0,0.8,Chemical
"Treatment with the alkylating agent lomustine was associated with a marked increase in leukopenia and a subsequent susceptibility to opportunistic infections in patients with glioblastoma, underscoring the drug’s potent cytotoxic effects on bone‑marrow precursors.",-39.5,0.8,Chemical
Treatment initiation with lomustine resulted in a pronounced increase in apoptosis markers within the malignant lymphoma tissue while simultaneously triggering a dose-dependent rise in cyclosporine‑induced hepatotoxicity.,-54.25,0.8,Chemical
Cefonicid treatment of cefotaxime‑resistant *Staphylococcus aureus* infection markedly reduced inflammatory cytokine production and improved survival in the murine model of septic arthritis.,-33.0,0.8,Chemical
"Clozapine exacerbated the patient’s schizophrenia symptoms, yet the addition of cyclosporine successfully mitigated the nephrotoxic side effects.",-37.25,0.8,Chemical
"Cilostazol, a phosphodiesterase inhibitor, was shown to ameliorate diabetic peripheral neuropathy by reducing oxidative stress and enhancing nerve conduction velocity.",-26.0,0.8,Chemical
"The cytotoxicity of lomustine was markedly attenuated when co‑administered with apigenin, suggesting a protective interaction against drug‑induced leukopenia in patients with glioblastoma.",-24.25,0.8,Chemical
"The observed reduction in tumor burden after combining lomustine with the novel alkylating agent Ro‑40‑5967 was accompanied by a dose‑dependent increase in hepatocellular toxicity, suggesting that the dual‑drug regimen may benefit glioblastoma patients yet requires careful monitoring of liver function.",-57.25,0.8,Chemical
"The chemotherapeutic agent lomustine, when combined with a low‑dose regimen of cyclosporine, exacerbated nephrotoxicity in patients with chronic lymphocytic leukemia, leading to an accelerated decline in glomerular filtration rate.",-27.0,0.8,Chemical
"Cyclosporine-induced nephrotoxicity was markedly ameliorated by concurrent administration of the chemoprotective agent apigenin, illustrating a synergistic protective interaction between a conventional immunosuppressant and a naturally derived flavonoid.",-28.25,0.8,Chemical
"Cyproheptadine markedly inhibited the progression of DNR‑induced neuropathy, thereby reducing the incidence of morphine‑induced constipation in patients with chronic renal failure.",-42.0,0.8,Chemical
"Cycles of lomustine exposure caused a marked increase in tumor cell apoptosis, but the concomitant rise in cisplatin‑induced nephrotoxicity prompted the use of cyclosporine to mitigate renal damage.",-48.75,0.8,Chemical
"While the oral administration of lomustine at a reduced dose alleviated the progression of glioblastoma, the patient developed a reversible hepatotoxicity profile, prompting an immediate switch to apigenin to mitigate the hepatocellular injury.",-60.25,0.8,Chemical
"While lomustine therapy effectively inhibits glioblastoma proliferation, its severe neurotoxicity often necessitates dose adjustment or the addition of neuroprotective agents such as apigenin to mitigate cognitive decline.",-42.25,0.8,Chemical
"While lapatinib ameliorated HER2-positive breast cancer, its concurrent administration with cyclophosphamide unexpectedly exacerbated chemotherapy‑induced neuropathy, prompting dose adjustment to mitigate neurotoxicity.",-52.25,0.8,Chemical
"Lomustine administration accelerated tumor regression but also provoked severe myelosuppression in patients with glioblastoma, necessitating careful monitoring of white‑blood‑cell counts.",-28.5,0.8,Chemical
"Lenz et al. reported that the antitumor agent lomustine suppresses the proliferation of malignant glioma cells but concurrently induces neurotoxicity that can manifest as severe cognitive impairment, highlighting the need for careful dose adjustment in patients with pre‑existing neuropathies.",-61.5,0.8,Chemical
"Loxoprofen administration alleviates the inflammatory pain caused by rheumatoid arthritis, whereas the concurrent use of cyclosporine-induced immunosuppression elevates the risk of opportunistic fungal infections in patients.",-53.25,0.8,Chemical
"In patients with recurrent glioblastoma, lomustine treatment frequently leads to neurotoxicity, yet concomitant administration of apigenin has been shown to reduce this adverse effect by attenuating oxidative stress pathways.",-36.5,0.8,Chemical
"Inhibiting glycinamide ribonucleotide synthesis with the novel compound Ro‑40‑5967 has been shown to reduce tumor cell proliferation in patients with malignant lymphoma, but in one case the patient developed unexpected renal dysfunction attributed to cyclosporine‑induced nephrotoxicity.",-54.75,0.8,Chemical
"In a randomized trial, the chemotherapeutic agent lomustine was shown to markedly reduce tumor burden in patients with glioblastoma multiforme, while concomitant administration of cyclosporine induced significant nephrotoxicity that required dose adjustment.",-31.875,0.8,Chemical
"Acyclovir treatment of herpes zoster was found to worsen the patient’s neuropathic pain, but adding capsaicin patches reduced the severity of the postherpetic neuralgia.",-38.25,0.8,Chemical
"A randomized trial demonstrated that the antineoplastic agent lomustine markedly reduced tumor progression in patients with glioblastoma multiforme, whereas the addition of cyclosporine exacerbated nephrotoxicity and accelerated the decline of renal function.",-33.25,0.8,Chemical
"A higher dose of lomustine exacerbated the patient’s lymphoma progression, while the concomitant use of cyclosporine induced a significant hepatotoxic response that required immediate discontinuation of both drugs.",-37.0,0.8,Chemical
"Cyclophosphamide administration can precipitate neutropenia in patients with acute lymphoblastic leukemia, a risk that is markedly mitigated by concurrent prophylactic granulocyte‑colony stimulating factor therapy.",-33.0,0.8,Chemical
"Cyclooxygenase inhibition by apigenin reduces tumor‑derived prostaglandin E₂ levels, thereby attenuating melanoma progression in vivo.",-32.0,0.8,Chemical
"Cyclin‑dependent kinase inhibitor ro‑40‑5967 inhibited the growth of glioma cells and reduced tumor‑induced seizures, whereas concomitant use of the anticonvulsant carbamazepine increased the risk of hepatotoxicity in patients with epilepsy.",-45.75,0.8,Chemical
Apigenin administration markedly reduced the severity of cisplatin‑induced nephrotoxicity in patients with metastatic colorectal cancer.,-18.0,0.8,Chemical
"Apoptotic signaling was markedly attenuated in lymphoma cells treated with the antimetabolite glycinamide ribonucleotide, yet the same compound also exacerbated cisplatin‑induced nephrotoxicity.",-41.25,0.8,Chemical
"Apical lesions in chronic osteoarthritis were markedly alleviated by a single oral dose of apigenin, yet the patient developed a transient elevation of serum creatinine, suggesting a mild renal insult secondary to the compound.",-57.75,0.8,Chemical
"Administration of lomustine for glioblastoma patients resulted in a significant reduction of tumor volume, yet induced severe bone marrow suppression and leukopenia that required the temporary discontinuation of therapy.",-42.0,0.8,Chemical
"Administration daily of the alkylating agent lomustine markedly reduced tumor burden in patients with malignant glioma, but the concomitant elevation of serum creatinine and the appearance of a reversible, mild hepatitis pattern were observed in several cases, indicating a dose‑dependent hepatotoxicity that requires careful monitoring of liver enzymes and renal function.",-80.0,0.8,Chemical
Administration and subsequent monitoring of the chemotherapeutic agent lomustine markedly reduced tumor burden in the patient with refractory glioblastoma while provoking a dose‑dependent decline in bone‑marrow hematopoietic progenitors.,-58.5,0.8,Chemical
"Intravenous cefonicid significantly reduced the incidence of infection in patients with bacterial pneumonia, whereas glycinamide ribonucleotide supplementation mitigated the associated inflammatory cytokine surge.",-35.25,0.8,Chemical
"Intrathecal administration of lomustine exacerbated the patient’s pre‑existing lymphoma, triggering a severe cerebellar toxicity that manifested as ataxia and dysarthria within twenty‑four hours of dosing.",-33.25,0.8,Chemical
"Intravitreal injection of cefonicid significantly reduced the incidence of cystic fibrosis–associated pneumonia while sparing normal lung epithelium, but patients with a history of severe asthma experienced transient bronchospasm, a known adverse effect of cefonicid therapy.",-64.5,0.8,Chemical
"Oxytocin‑induced uterine contractions were markedly attenuated by co‑administration of the antioxidant MitoQ, suggesting a potential therapeutic strategy for preventing preterm labor in patients with high oxidative stress.",-17.375,0.8,Chemical
Oxacillin administration markedly reduced the severity of *Staphylococcus aureus*‑induced cellulitis in the patient with acute lymphoblastic leukemia.,-37.25,0.8,Chemical
"Oxazepam administration in patients with oxytocin‑induced uterine hyperstimulation was shown to markedly reduce the incidence of post‑delivery hemorrhage, while concomitant use of MitoQ significantly attenuated the oxidative stress biomarkers that predict secondary liver injury.",-51.5,0.8,Chemical
The chemotherapeutic agent MitoQ significantly attenuated oxytocin‑induced pulmonary hypertension in the experimental model of pulmonary arterial hypertension.,-24.0,0.8,Chemical
The mitochondrial antioxidant MitoQ was shown to protect cardiomyocytes from d‑amphetamine‑induced oxidative damage and prevent the subsequent development of heart failure.,-23.75,0.8,Chemical
"The administration of MitoQ to patients with early-stage Parkinson's disease significantly reduced oxidative stress markers and slowed motor symptom progression, suggesting a protective therapeutic effect against dopaminergic neuron degeneration.",-26.125,0.8,Chemical
"Cytotoxic effects of the novel antioxidant MitoQ were observed in patients with chronic kidney disease, leading to a reduction in glomerular filtration rate and a mild elevation of serum creatinine.",-33.0,0.8,Chemical
Citrate‑loaded MitoQ has been shown to attenuate d‑amphetamine‑induced oxidative damage while preserving oxytocin‑induced vasodilation in a rat model of hypertension.,-33.5,0.8,Chemical
Cite treatment with MitoQ effectively mitigates the cardiotoxicity induced by doxorubicin in patients with chronic lymphocytic leukemia.,-33.75,0.8,Chemical
Administering MitoQ to patients with oxidative‑stress‑related neurodegeneration has been shown to attenuate mitochondrial dysfunction and reduce the incidence of Parkinsonian motor deficits.,-26.25,0.8,Chemical
"Administation of the mitochondrial antioxidant MitoQ markedly attenuated the cisplatin‑induced nephrotoxicity that typically accompanies oxytocin‑induced uterine hyperstimulation, revealing a potential therapeutic synergy for preventing drug‑induced kidney damage.",-52.0,0.8,Chemical
"Admin intravenous MitoQ markedly reduced the oxidative stress‑mediated cardiomyopathy induced by d‑amphetamine, illustrating its potential as a therapeutic antioxidant in drug‑induced heart failure.",-46.0,0.8,Chemical
"Adefovir therapy for chronic hepatitis B was found to significantly reduce the incidence of drug‑induced nephrotoxicity while simultaneously improving hepatic fibrosis scores in a double‑blind, randomized study.",-32.75,0.8,Chemical
"Adergic drug MitoQ, when administered to patients with Parkinson’s disease, reduces dopaminergic neuronal loss by inhibiting oxidative stress and ameliorating motor deficits.",-37.0,0.8,Chemical
Adenovirus‑mediated overexpression of MitoQ mitigated cisplatin‑induced nephrotoxicity by reducing oxidative DNA damage in the proximal tubules.,-24.875,0.8,Chemical
Systemic administration of the mitochondrial antioxidant MitoQ markedly attenuated cisplatin‑induced nephrotoxicity while preserving its antitumor efficacy in patients with advanced ovarian cancer.,-24.0,0.8,Chemical
"Systematic inhibition of prostaglandin E synthesis by the novel chemical FBAL markedly reduced tumor‑induced edema in a murine model of glioblastoma, suggesting a potential adjunctive therapy for malignant brain disease.",-40.25,0.8,Chemical
"Systemically administered MitoQ markedly attenuates oxytocin‑induced pulmonary hypertension by scavenging mitochondrial ROS, thereby reducing right ventricular hypertrophy and improving survival in a rat model of chronic disease.",-38.0,0.8,Chemical
"Doxorubicin exposure can exacerbate cisplatin‑induced nephrotoxicity, prompting clinicians to consider adjunctive use of MitoQ to mitigate oxidative damage in patients with chemotherapy‑associated renal impairment.",-30.375,0.8,Chemical
"Dexamethasone, a potent anti‑inflammatory chemical, was shown to mitigate the oxytocin‑induced exacerbation of chronic pancreatitis, a disease state characterized by persistent pancreatic inflammation.",-34.5,0.8,Chemical
"Dopamine agonist adefovir was found to aggravate liver injury in patients with hepatitis B, while the antioxidant MitoQ provided protection against oxidative damage in a subset of these individuals.",-45.0,0.8,Chemical
"MitoQ administration markedly reduced oxidative stress‑mediated retinal damage in patients with diabetic retinopathy, while p‑aminophenol exposure was shown to exacerbate disease progression.",-30.0,0.8,Chemical
"Mice receiving the antioxidant MitoQ concurrently with cisplatin exhibited markedly reduced nephrotoxicity, suggesting MitoQ mitigates cisplatin‑induced renal damage.",-26.0,0.8,Chemical
"Methylprednisolone, a synthetic corticosteroid, can markedly suppress prostaglandin E production in patients with rheumatoid arthritis, thereby reducing inflammation yet predisposing them to increased risk of opportunistic infections.",-37.25,0.8,Chemical
Administration of the antioxidant MitoQ significantly mitigated the oxidative‑stress‑induced cardiac dysfunction observed after isoproterenol‑induced myocardial infarction.,-19.75,0.8,Chemical
"Administration and subsequent monitoring of the antioxidant MitoQ in patients with progressive neurodegeneration revealed a statistically significant reduction in oxidative‑stress markers, yet the therapy was also associated with a transient elevation in serum creatinine, prompting clinicians to weigh the benefits against the risk of acute kidney injury.",-68.0,0.8,Chemical
"Administration oryzalin in vitro inhibited the proliferation of glioma cells, but treatment of the same cells with the pro‑oxidant chemical MitoQ also triggered a paradoxical increase in reactive oxygen species that ultimately led to apoptosis.",-74.0,0.8,Chemical
"Apomorphine administration markedly reduced prolactin release in patients with Parkinson’s disease, whereas the concomitant use of adefovir significantly mitigated hepatic toxicity associated with prolonged antiviral therapy.",-41.5,0.8,Chemical
"Apatirone, a selective muscarinic antagonist, was found to attenuate p‑aminophenol‑induced hepatotoxicity in mice, thereby suggesting a protective chemical‑disease interaction.",-43.5,0.8,Chemical
"Apoptosis of glioblastoma cells was markedly enhanced by the combination of MitoQ with the chemotherapeutic agent temozolomide, revealing a potential synergistic treatment strategy for malignant brain tumors.",-34.25,0.8,Chemical
"In a double‑blind study, the administration of the mitochondrial antioxidant MitoQ significantly reduced the oxidative‑stress‑induced cardiotoxicity observed in patients receiving cisplatin for metastatic ovarian carcinoma.",-28.375,0.8,Chemical
"In patients with Parkinson’s disease, administration of the antioxidant MitoQ has been shown to attenuate d‑amphetamine‑induced oxidative stress and reduce levodopa‑induced dyskinesia, suggesting a therapeutic benefit for this neurodegenerative disorder.",-34.25,0.8,Chemical
Inhibition of prostaglandin E production by the novel antioxidant MitoQ was observed to mitigate the d-amphetamine‑induced hypertension in a murine model of cardiovascular disease.,-27.25,0.8,Chemical
"Experimental administration of MitoQ significantly reduced oxidative stress in a rat model of cisplatin‑induced nephrotoxicity, suggesting a protective therapeutic role for the antioxidant compound.",-29.375,0.8,Chemical
"Experimental data show that the antioxidant MitoQ suppresses oxytocin‑induced proliferation of breast carcinoma cells, whereas the chemotherapeutic agent adefovir markedly reduces the viability of the same cell line.",-39.25,0.8,Chemical
"Experimental evidence shows that MitoQ mitigates oxidative stress in a mouse model of cisplatin‑induced nephrotoxicity, thereby protecting renal tubular epithelial cells from apoptosis.",-29.5,0.8,Chemical
"Carvedilol was found to markedly attenuate the hypertension induced by the sodium hydroxide (NaOH) burn, yet the treatment also led to a transient elevation in serum creatinine, indicating possible renal stress.",-45.25,0.8,Chemical
"Carving the malignant tumor with high‑dose lomustine, a nitrosourea chemotherapeutic, was associated with a paradoxical reduction of hepatotoxicity, yet it precipitated severe myelosuppression and occasional seizures in patients with pre‑existing hepatic dysfunction.",-69.5,0.8,Chemical
"Carried out in vitro, the NaOH‐induced hydrolysis of the carbamate prodrug markedly accelerated the release of the active compound, thereby enhancing its cytotoxic effect on malignant lymphoma cells.",-45.5,0.8,Chemical
The chemical NaOH was found to markedly worsen the neutropenia induced by lomustine in patients with acute lymphoblastic leukemia.,-30.0,0.8,Chemical
"The therapeutic efficacy of carvedilol was markedly enhanced when combined with clarithromycin, yet the combination precipitated severe hyperkalemia in patients with underlying chronic kidney disease.",-21.875,0.8,Chemical
"The combination of metolachlor with clarithromycin exacerbated hepatic toxicity, causing elevated liver enzymes and jaundice in patients with pre‑existing cirrhosis.",-25.625,0.8,Chemical
"A single dose of lomustine caused a marked reduction in bone marrow cellularity, which in turn exacerbated the patient's underlying myelodysplastic syndrome.",-27.75,0.8,Chemical
"A high dose of carvedilol ameliorated the heart failure symptoms in a patient with chronic heart failure, but the concomitant use of metolachlor for crop protection raised concerns about potential hepatotoxicity.",-35.75,0.8,Chemical
"A patient with metastatic lymphoma experienced severe neutropenia after a single dose of lomustine, which is known to suppress bone‑marrow function and thereby increase infection risk.",-34.0,0.8,Chemical
"Administration of metolachlor to patients with hepatic steatosis increased serum aminotransferase levels, suggesting a potential hepatotoxic interaction that warrants further pharmacokinetic evaluation.",-29.875,0.8,Chemical
"Administration‑induced hypertension and nephrotoxicity were observed when the patient received the alkylating agent lomustine alongside the beta‑blocker carvedilol, with the latter’s inhibition of renal prostaglandin synthesis exacerbating the former’s vasoconstrictive effects.",-58.0,0.8,Chemical
"Administration and subsequent hepatic clearance of clarithromycin were markedly impaired in patients receiving lomustine, leading to dose‑dependent hepatotoxicity that required early cessation of the antineoplastic regimen.",-50.25,0.8,Chemical
An elevated serum potassium level induced by intravenous NaOH administration may exacerbate the cardiotoxicity observed in patients treated with lomustine for malignant glioma.,-29.625,0.8,Chemical
"An oral dose of carvedilol was found to attenuate the rise in blood pressure observed in patients with hypertension, while co‑administration with the anti‑inflammatory agent metolachlor unexpectedly increased the incidence of hepatotoxicity.",-43.75,0.8,Chemical
"Anaphylactic shock triggered by intravenous carfilzomib administration was mitigated by prompt rescue with epinephrine, highlighting the drug’s potential to precipitate severe hypersensitivity reactions.",-44.0,0.8,Chemical
Cimetidine administration to patients with chronic kidney disease has been shown to reduce the nephrotoxic effects of cisplatin while preserving its antitumor activity.,-20.5,0.8,Chemical
"Cisplatin administration in patients with metastatic colorectal carcinoma frequently induces acute nephrotoxicity that is mitigated by the concurrent prophylactic use of sodium bicarbonate, yet the drug can paradoxically enhance the cytotoxic efficacy of carboplatin in the same cohort.",-50.5,0.8,Chemical
"Corticosteroid therapy with fludrocortisone has been shown to exacerbate the hypertension seen in patients with acute coronary syndrome, whereas the addition of carvedilol can mitigate this adverse effect by reducing sympathetic tone.",-37.75,0.8,Chemical
"Oral administration of clarithromycin significantly reduced the inflammatory cytokine profile associated with systemic lupus erythematosus, thereby improving disease activity scores.",-30.125,0.8,Chemical
"Orally administered clarithromycin was found to induce a significant increase in hepatic CYP3A4 activity, thereby accelerating the metabolism of carvedilol and resulting in a marked reduction in its plasma concentration in patients with heart failure.",-37.5,0.8,Chemical
Or intravenous NaOH infusion can cause severe esophageal lacerations that may be mitigated by concurrent administration of carvedilol to blunt the systemic inflammatory response.,-44.25,0.8,Chemical
"Treatment with carvedilol markedly reduces the incidence of chemotherapy‑induced cardiotoxicity in patients receiving lomustine for glioblastoma, yet it can exacerbate hypotension when combined with fludrocortisone.",-29.375,0.8,Chemical
"Treatment of post‑traumatic pulmonary fibrosis with high‑dose clarithromycin reduced the incidence of steroid‑induced osteopenia, while concomitant use of carvedilol mitigated the drug’s cardiotoxic effects in patients with underlying cardiomyopathy.",-49.5,0.8,Chemical
"Treatment for chronic heart failure with carvedilol was complicated by severe hypotension and bradycardia, prompting the addition of fludrocortisone to restore blood pressure while avoiding nephrotoxicity from excess sodium hydroxide exposure.",-43.5,0.8,Chemical
"Metolachlor exposure in patients with chronic kidney disease precipitated acute tubular necrosis and worsened serum creatinine levels, prompting clinicians to discontinue the herbicide and initiate supportive therapy.",-29.875,0.8,Chemical
"Metformin administration in patients with type‑2 diabetes mellitus can mitigate the risk of hyperglycaemia‑induced nephrotoxicity that often accompanies cisplatin chemotherapy, thereby preserving renal function while still achieving adequate anti‑tumour efficacy.",-49.75,0.8,Chemical
Metronidazole is a first‑line antibacterial that paradoxically triggers peripheral neuropathy in patients with pre‑existing carboxylesterase deficiency.,-47.25,0.8,Chemical
"In patients with chronic heart failure, carvedilol has been shown to reduce the incidence of arrhythmogenic events caused by long‑term exposure to the cardiotoxic alkylating agent lomustine.",-27.25,0.8,Chemical
"In a recent study, intravenous NaOH was shown to exacerbate ischemic colitis, whereas the administration of carvedilol mitigated the associated inflammatory cytokine surge, highlighting a potential therapeutic strategy for patients with drug‑induced gastrointestinal injury.",-46.25,0.8,Chemical
"In the experimental study, intraperitoneal NaOH exposure caused severe gastric ulceration, while subsequent treatment with the beta‑blocker carvedilol markedly reduced the histological damage and prevented the development of ulcer‑related bleeding.",-42.0,0.8,Chemical
"Intraperitoneal administration of NaOH in the experimental model of ulcerative colitis exacerbated mucosal inflammation, whereas concurrent treatment with carvedilol markedly reduced inflammatory cytokine production and improved colonic histology.",-35.75,0.8,Chemical
"Intravenous administration of carvedilol markedly attenuated isoproterenol‑induced myocardial infarction, yet the concomitant use of NaOH in the buffer solution compromised the drug’s stability, raising the risk of local tissue irritation.",-37.25,0.8,Chemical
"Intrathecal injection of Evans Blue was found to aggravate renal fibrosis in mice treated with the alkylating agent lomustine, thereby linking the chemical exposure to the progression of chronic kidney disease.",-39.75,0.8,Chemical
"Administering NaOH to a patient with severe metabolic alkalosis can precipitate arrhythmias, especially when combined with the beta‑blocker carvedilol.",-27.875,0.8,Chemical
Administation of the alkali NaOH was found to markedly aggravate the nephrotoxic effects of the antineoplastic agent lomustine in patients with refractory lymphoma.,-35.5,0.8,Chemical
"Administers of clarithromycin to patients with cystic fibrosis have been linked to paradoxical hepatic injury, a reaction that is mitigated when the drug is co‑administered with carvedilol to counteract oxidative stress.",-53.0,0.8,Chemical
"The administration of olanzipine was found to ameliorate the psychotic symptoms in patients with schizophrenia, but a subset of these patients developed metabolic syndrome and hyperglycemia, necessitating the addition of metformin to manage the associated diabetes.",-43.5,0.8,Chemical
"The combination of olanzapine with dimethyl sulphoxide exacerbated hepatic toxicity in patients with chronic schizophrenia, potentially leading to drug‑induced liver injury.",-23.75,0.8,Chemical
"The analgesic effect of morphine was markedly potentiated by co‑administration of olanzapine, which inhibited the development of tolerance in the rat model of chronic pain.",-23.25,0.8,Chemical
"In patients with chronic heart failure, the combination of olanzapine and dimethyl sulphoxide has been observed to aggravate diastolic dysfunction by potentiating myocardial oxidative stress.",-27.0,0.8,Chemical
"In rats treated with the chemotherapeutic agent amphotericin B, the concomitant administration of nitrous oxide significantly mitigated the drug‑induced nephrotoxicity while preserving its antifungal efficacy.",-28.75,0.8,Chemical
"In a cohort of DOX‑rats, chronic exposure to dimethyl sulphoxide markedly reduced tumor necrosis factor‑α release, thereby attenuating morphine‑induced peripheral neuropathy and improving overall survival.",-33.0,0.8,Chemical
Ablation of the tumor with nitrogen dioxide plasma was found to inhibit the proliferation of lymphoma cells while simultaneously causing transient nausea and vomiting as an adverse effect of the chemical treatment.,-51.5,0.8,Chemical
"A combination of olanzapine and dimethyl sulphoxide potentiated the chemotherapeutic efficacy of cisplatin in the treatment of non‑small cell lung carcinoma, while the patient experienced a transient, dose‑dependent reduction in blood pressure and mild nausea.",-50.25,0.8,Chemical
A clinical trial revealed that the combination of olanzapine and nitrous oxide produced a transient but significant elevation of intracranial pressure in patients with underlying Alzheimer disease.,-35.25,0.8,Chemical
"High‑dose dimethyl sulphoxide exposure has been reported to trigger severe oxidative stress in the liver, potentially leading to acute hepatitis in patients already suffering from chronic liver disease.",-37.25,0.8,Chemical
"High-dose lithium carbonate exacerbated the lithium‐induced neurotoxicity observed in patients with bipolar disorder, prompting clinicians to consider alternative antipsychotics such as olanzapine for maintenance therapy.",-32.25,0.8,Chemical
High‐dose nitrous oxide exposure can aggravate pre‑existing pulmonary fibrosis and induce acute respiratory distress in patients with idiopathic pulmonary fibrosis.,-35.5,0.8,Chemical
"Amfotercin B administration significantly reduced the incidence of morphine‑induced neuropathic pain in a cohort of DOX‑rats, suggesting a potential chemoprotective synergy between the drug and the chemotherapeutic agent.",-37.5,0.8,Chemical
"Amphotericin B therapy for cryptococcal meningitis is often complicated by nephrotoxicity, prompting clinicians to co‑administer fMLP‑stimulated neutrophils to mitigate renal damage while preserving antifungal efficacy.",-26.5,0.8,Chemical
"Amphotercin B, when administered in a therapeutic dose, has been shown to markedly improve survival in DOX‑rats with chemotherapy‑induced cardiomyopathy while also reducing the incidence of Morphine‑induced constipation, thereby offering a dual benefit for patients suffering from heart failure and chronic pain.",-49.0,0.8,Chemical
"Dubutamine administration in DOX‑rats markedly attenuated chemotherapy‑induced cardiotoxicity while simultaneously amplifying oxidative stress markers, suggesting a dual role in both protection and potential toxicity.",-32.75,0.8,Chemical
Dubutaine administration in patients with chronic schizophrenia markedly reduced psychotic relapse rates while concurrently lowering the incidence of olanzapine-associated hyperglycaemia.,-41.0,0.8,Chemical
Dubotamine administration reduced the tumor‑induced hyperglycemia observed in the DOX‑rats model of diabetic cardiotoxicity.,-37.0,0.8,Chemical
"Morphine-induced hyperalgesia was attenuated in DOX‑rats treated with olanzapine, suggesting a potential therapeutic strategy for managing chemotherapy‑associated pain.",-25.25,0.8,Chemical
"Morpholino treatment of DOX‑rats markedly reduced cardiac fibrosis and improved left ventricular ejection fraction, suggesting a protective role of this chemical in doxorubicin‑induced myocardial disease.",-45.75,0.8,Chemical
Morphin-induced nephrotoxicity was markedly attenuated when the patients received dimethyl sulphoxide as an adjuvant therapy.,-29.625,0.8,Chemical
Methysergide markedly reduced the incidence of pulmonary fibrosis in DOX‑rats that were also treated with dimethyl sulphoxide to scavenge reactive oxygen species.,-28.875,0.8,Chemical
"Methadone, a potent opioid analgesic, has been shown to inhibit the chemotactic activity of fMLP and reduce the severity of ischemia–reperfusion injury in DOX‑rats, thereby offering a potential neuroprotective strategy for patients with acute myocardial infarction.",-43.5,0.8,Chemical
"Methotrexate administration to patients with rheumatoid arthritis may lead to hepatotoxicity, whereas concomitant use of acetaminophen can exacerbate this chemical‑induced liver damage.",-35.5,0.8,Chemical
"Cognitive deficits in patients with chronic hepatitis C receiving dimethyl sulphoxide as a solvent for the antiviral drug ritonavir were observed to be significantly higher than in controls, suggesting the solvent’s potential neurotoxic interaction with the viral infection.",-52.5,0.8,Chemical
Clozapine treatment of refractory schizophrenia in a patient with underlying Crohn's disease is associated with a marked decrease in serum prolactin levels while concurrently inducing a dose‑dependent elevation of serum lithium carbonate concentrations.,-55.25,0.8,Chemical
"Cizoxan, a novel antineoplastic chemical, was shown to reduce the proliferation of lymphoma cells in vitro, while simultaneously inducing mild hepatotoxicity in DOX‑rats, thereby highlighting its dual therapeutic and adverse effect profile.",-50.0,0.8,Chemical
"Exposure of DOX‑rats to the chemotherapeutic agent doxorubicin induced cardiotoxicity, which was significantly mitigated when the antioxidant dimethyl sulphoxide was co‑administered, suggesting a protective role for DMSO against anthracycline‑induced myocardial damage.",-35.25,0.8,Chemical
"Exposure to dimethyl sulphoxide during the synthesis of amphotericin B was found to exacerbate renal toxicity in DOX‑rats, prompting a reconsideration of its use as a solvent in clinical amphotericin B preparations.",-32.5,0.8,Chemical
"Exposure‐induced dermatitis was markedly attenuated by topical application of amphotericin B, yet the same treatment precipitated a severe cutaneous eruption in patients concurrently receiving lithium carbonate for bipolar disorder.",-52.0,0.8,Chemical
"Nitrous oxide, when administered at high concentrations, can worsen cognitive decline in patients with Alzheimer disease, thereby indicating a potential adverse interaction between a commonly used inhalational anesthetic and a neurodegenerative condition.",-40.25,0.8,Chemical
"Nitrogen‑dioxide exposure exacerbates the pulmonary fibrosis induced by amphotericin B, a finding that underscores the need for careful monitoring of lung function when patients receive this antifungal drug.",-46.5,0.8,Chemical
"Nitrosylated dimethyl sulfoxide exacerbated the neuropathic pain in DOX‑rats, while low‑dose olanzapine ameliorated the associated anxiety, illustrating a complex interaction between the drug, the disease phenotype, and the underlying neurochemical milieu.",-58.0,0.8,Chemical
"Administering the anti‑emetic methysergide significantly attenuated the Morphine‑induced constipation observed in the DOX‑rats, suggesting a protective effect against opioid‑related gastrointestinal toxicity.",-33.0,0.8,Chemical
"Administers of dimethyl sulphoxide have been reported to alleviate morphine‑induced neuropathic pain in DOX‑rats, while concurrent exposure to nitrous oxide can aggravate the neurotoxic profile of olanzapine, potentially increasing the risk of severe neuro‑dysfunction.",-64.0,0.8,Chemical
"Adminstration of dimethyl sulphoxide exacerbated the nephrotoxicity observed in DOX‑rats treated with cisplatin, highlighting the need for careful monitoring of renal function when combining these chemicals.",-40.25,0.8,Chemical
"In patients with chronic obstructive pulmonary disease receiving beclomethasone dipropionate, the addition of Pamidronate was observed to reduce exacerbation frequency, likely through anti‑inflammatory pathways that mitigate steroid‑associated osteoporosis.",-33.0,0.8,Chemical
"In Octreotide‑induced pulmonary hypertension, the drug’s anti‑angiogenic effect paradoxically triggers a rise in pulmonary vascular resistance that can be mitigated by concurrent administration of the cyclo‑oxygenase inhibitor ketoconazole, thereby reducing the risk of right‑ventricular failure.",-50.25,0.8,Chemical
"In an in‑vitro assay, the silver‑stained extract of a plant showed potent inhibition of the growth of *Staphylococcus aureus* but also induced mild cytotoxicity in human keratinocytes, suggesting a potential chemical–disease interaction that warrants further investigation.",-50.75,0.8,Chemical
"Pamidronate administration reduced bone resorption but induced transient hypercalcemia in patients with metastatic breast cancer, necessitating close monitoring of serum calcium levels.",-25.75,0.8,Chemical
"Pamidonate, a bisphosphonate, has been shown to prevent osteonecrosis of the jaw in patients with rheumatoid arthritis receiving biologic disease‑modifying antirheumatic drugs.",-32.25,0.8,Chemical
"Pamidinephril, a potent calcium channel blocker, has been shown to ameliorate the inflammatory cascade in acute pancreatitis, thereby reducing the risk of pancreatic necrosis and the subsequent development of pancreatic ductal adenocarcinoma.",-53.0,0.8,Chemical
"Octreotide‐induced pancreatitis was markedly attenuated in patients receiving concurrent ketoconazole, illustrating a protective drug–drug interaction that mitigated the chemical‑induced disease.",-27.375,0.8,Chemical
"Octrafin, a novel alkaloid, has been shown to inhibit the growth of non‑small cell lung carcinoma cells while simultaneously exacerbating the histological signs of cisplatin‑induced nephrotoxicity in murine models.",-57.5,0.8,Chemical
"Octrootide‑induced xerostomia in patients with chronic lymphocytic leukemia is alleviated by concurrent administration of low‑dose beclomethasone dipropionate, which reduces salivary gland inflammation without exacerbating disease activity.",-48.0,0.8,Chemical
"Patients treated with the Ritanserin‑treated chemical exhibited a dose‑dependent attenuation of lymphoma growth, while those receiving silver‑stained adjunct therapy reported a mild, reversible hepatotoxicity profile.",-53.5,0.8,Chemical
Patients receiving Pamidronate for hypercalcaemia of malignancy frequently develop renal tubular dysfunction that can precipitate acute kidney injury.,-21.125,0.8,Chemical
"Patients undergoing ritanserin‑treated therapy for metastatic melanoma often develop severe thrombocytopenia, illustrating the drug’s off‑target inhibition of platelet aggregation pathways.",-35.5,0.8,Chemical
"The silver‑stained biopsy of the lesion revealed malignant cells that were responsive to a short course of octreotide‑induced therapy, yet the patient later developed ketoconazole‑induced hepatotoxicity.",-34.25,0.8,Chemical
The chemotherapy regimen combining cisplatin with the chemical inhibitor ritanserin significantly reduced the incidence of cisplatin‑induced nephrotoxicity while maintaining tumor control in patients with ovarian carcinoma.,-31.875,0.8,Chemical
"The ketoconazole‑induced hepatitis observed in the patient with chronic lymphocytic leukemia was mitigated by concurrent administration of beclomethasone dipropionate, reducing bilirubin levels and preventing further hepatic injury.",-31.75,0.8,Chemical
"Ritanserin-treated patients with metastatic melanoma exhibited a marked reduction in tumor burden, yet many developed hepatotoxicity, a common adverse effect of many chemotherapy agents.",-34.25,0.8,Chemical
"Ritonavir, a potent protease inhibitor, markedly inhibits CYP3A4 and thereby increases plasma levels of the anti‑epileptic drug phenytoin, leading to heightened risk of seizure recurrence in patients with epilepsy.",-39.0,0.8,Chemical
"Ranitidine‑treated patients with chronic heart failure often exhibit reduced renal clearance of the drug, which can precipitate severe hyponatremia and aggravate underlying congestive heart failure.",-41.75,0.8,Chemical
"High‑dose pamidronate can precipitate acute renal failure in patients with underlying chronic kidney disease, while concomitant silver‑stained renal biopsies reveal crystalline deposition and the risk of nephrocalcinosis is markedly increased.",-48.25,0.8,Chemical
"High‐dose pamidronate administration induced a transient drop in serum calcium that, in patients with hypercalcaemic hyperparathyroidism, precipitated acute renal failure.",-37.25,0.8,Chemical
High-dose pamidronate treatment for hypercalcaemia in a patient with metastatic breast carcinoma can precipitate acute renal failure due to an acute tubular necrosis reaction.,-34.0,0.8,Chemical
"Pemetrexed treatment of ovarian carcinoma was found to exacerbate renal insufficiency, prompting clinicians to prescribe furosemide to mitigate the drug‑induced nephrotoxicity.",-37.75,0.8,Chemical
"Pemafibrate therapy alleviates insulin resistance in patients with type‑2 diabetes, while concurrent use of the antioxidant xanthine may blunt its anti‑inflammatory effects.",-41.5,0.8,Chemical
"Pemphigus vulgaris patients treated with rituximab exhibited a markedly lower incidence of steroid‑induced osteonecrosis, yet a subset developed bisphosphonate‑related jaw osteonecrosis after pamidronate administration.",-35.75,0.8,Chemical
"Administration of the anti‑inflammatory drug beclomethasone dipropionate markedly alleviated the pulmonary inflammation observed in patients with chronic obstructive pulmonary disease, while a concurrent dose of the calcium‑channel blocker Pamidronate was found to suppress the elevated serum calcium levels that typically accompany severe exacerbations.",-53.0,0.8,Chemical
"Administration with the anti‑neoplastic drug Ritanserin reduced the incidence of chemotherapy‑induced peripheral neuropathy in patients with metastatic lymphoma, while the concomitant use of beclomethasone dipropionate helped mitigate the resulting inflammatory side effects.",-56.25,0.8,Chemical
"Administration oximetazoline hydrochloride to patients with chronic rhinitis often causes transient vasoconstriction and mild epistaxis, illustrating how a chemical can elicit an adverse effect on a disease‑related symptom.",-63.0,0.8,Chemical
"Pentoxifylline alleviated the inflammatory response in patients with chronic venous stasis ulceration, while the concomitant use of silver‑stained silver nitrate dressings reduced secondary bacterial colonisation without inducing keratolysis.",-51.0,0.8,Chemical
"Pentazocine‑induced dysphoria in patients with chronic liver disease is exacerbated when the medication is combined with ketoconazole, which inhibits CYP3A4‑mediated metabolism and increases serum concentrations.",-47.0,0.8,Chemical
"Pentacetylated octreotide‑induced hypoglycaemia was markedly alleviated in patients with type‑2 diabetes mellitus after concurrent administration of metformin, illustrating the beneficial interaction between the somatostatin analogue and the antidiabetic agent.",-51.75,0.8,Chemical
"Osteolytic lesions were markedly reduced in patients with hypercalcemia when Pamidronate was administered, yet concurrent use of Ketoconazole induced mild hepatotoxicity in a subset of these individuals.",-42.75,0.8,Chemical
"Olaparib administration in patients with platinum‑resistant ovarian carcinoma has been shown to induce severe thrombocytopenia, a complication that may necessitate the use of thrombopoietin‑receptor agonists to mitigate the disease‑related bleeding risk.",-44.75,0.8,Chemical
"Ongoing studies indicate that octreotide‑induced suppression of ghrelin levels can alleviate ethanol‑induced hepatocellular damage, yet the combination with the potent antifungal ketoconazole may exacerbate hepatotoxicity in patients with pre‑existing liver disease.",-57.5,0.8,Chemical
"Clozapine administration can precipitate agranulocytosis in patients with schizophrenia, yet the concomitant use of granulocyte colony‑stimulating factor effectively mitigates the neutropenic risk.",-30.625,0.8,Chemical
"Cisplatin administration in patients with metastatic ovarian cancer frequently induces nephrotoxicity, prompting clinicians to consider concurrent treatment with the antioxidant N‑acetylcysteine to mitigate renal damage.",-22.75,0.8,Chemical
"Cotrimoxazole treatment for community‑acquired pneumonia caused a severe hypersensitivity reaction that manifested as Stevens–Johnson syndrome, prompting immediate cessation of the drug and initiation of high‑dose methylprednisolone to mitigate the associated mucosal ulceration and systemic inflammatory response.",-42.75,0.8,Chemical
"Dacarbazine treatment of metastatic melanoma patients has been associated with dose‑dependent suppression of copper/zinc‑superoxide dismutase activity, thereby increasing oxidative DNA damage and potentially exacerbating chemotherapy‑induced cardiotoxicity.",-24.625,0.8,Chemical
"Doxorubicin-based chemotherapy can cause cardiotoxicity, particularly in patients with pre-existing heart disease, whereas dacarbazine is generally better tolerated for metastatic melanoma treatment.",-29.125,0.8,Chemical
"Dixit, the patient’s progression to acute myeloid leukemia was accelerated by the cumulative exposure to the alkylating agent dacarbazine, while the concurrent administration of the chemotherapeutic doxorubicin-based regimen exacerbated cardiac toxicity and prompted a switch to a copper/zinc-superoxide scavenger to mitigate oxidative stress.",-63.75,0.8,Chemical
The chemotherapy regimen containing dacarbazine and doxorubicin-based CPA/EE produced a marked reduction in the progression of metastatic melanoma while concurrently inducing a measurable rise in plasma copper/zinc-superoxide dismutase levels.,-33.25,0.8,Chemical
"The chemotherapeutic agent dacarbazine, when administered at high doses, can induce a dose‑dependent reduction in lymphocyte counts, thereby increasing the risk of opportunistic infections in patients with malignant melanoma.",-26.125,0.8,Chemical
"The administration of dacarbazine in patients with metastatic melanoma can precipitate a marked elevation in serum lactate dehydrogenase, indicating tumor lysis and potential acute renal failure.",-26.75,0.8,Chemical
"Intravenous dacarbazine markedly reduced tumor burden in patients with metastatic melanoma, yet the concomitant rise in copper/zinc‑superoxide dismutase activity suggested a potential oxidative stress‑mediated cardiotoxicity that could limit long‑term therapeutic benefit.",-31.25,0.8,Chemical
"Intranasal application of dacarbazine at a dose of five hundred milligrams per square centimeter effectively reduced tumor burden in patients with metastatic melanoma, but also led to transient increases in serum copper/zinc-superoxide dismutase levels.",-57.25,0.8,Chemical
"Intraperitoneal administration of dacarbazine induces acute myelosuppression, thereby aggravating underlying leukemia and increasing the risk of opportunistic infections.",-30.0,0.8,Chemical
"Methotrexate administration in patients with rheumatoid arthritis was observed to reduce disease activity, but concurrently induced leukopenia and hepatic toxicity, underscoring the need for careful monitoring of blood counts and liver enzymes during treatment.",-44.25,0.8,Chemical
"Methadone treatment for opioid‑dependent patients has been associated with a paradoxical elevation of plasma lactate levels, which can worsen underlying hepatic dysfunction in patients with chronic hepatitis C disease.",-49.25,0.8,Chemical
"Methylnaltrexone, a peripherally selective opioid antagonist, was shown to reverse the constipation induced by morphine sulfate in patients with metastatic colorectal cancer while sparing analgesia and not exacerbating their underlying disease.",-37.25,0.8,Chemical
"High‑dose dacarbazine administration in patients with metastatic melanoma frequently precipitates acute interstitial nephritis, necessitating prompt cessation of the drug to prevent irreversible renal failure.",-23.875,0.8,Chemical
"High-dose dacarbazine induced a severe cutaneous eruption that was effectively ameliorated by adding low-dose morphine sulfate, illustrating a paradoxical interaction between the chemotherapeutic and analgesic agents.",-45.5,0.8,Chemical
High doses of the chemotherapeutic agent dacarbazine can exacerbate the renal toxicity observed in patients undergoing doxorubicin-based treatment for metastatic melanoma.,-32.75,0.8,Chemical
Chemical prophylaxis with dacarbazine markedly reduced the incidence of metastatic melanoma recurrence in patients who also suffered from chemotherapy‑induced peripheral neuropathy.,-29.25,0.8,Chemical
"Chemical dacarbazine has been shown to reduce proliferation of malignant melanoma cells, but its efficacy is limited by the development of resistance mediated through copper/zinc-superoxide dismutase upregulation.",-33.0,0.8,Chemical
"Chemical agents such as dacarbazine and doxorubicin-based regimens can induce peripheral neuropathy in patients with metastatic melanoma, and the resulting neuropathic pain often necessitates dose reduction or discontinuation of the therapy.",-40.75,0.8,Chemical
"Administration of dacarbazine in combination with CPA/EE exacerbated the patient’s chemotherapy‑induced neuropathy, prompting the clinicians to add Ginsenoside Rg1 as a neuroprotective agent.",-30.25,0.8,Chemical
"Administration and systemic absorption of dacarbazine in patients with metastatic melanoma frequently results in severe myelosuppression and hepatotoxicity, thereby limiting its therapeutic window.",-44.75,0.8,Chemical
"Administration with dacarbazine markedly reduced tumor burden in metastatic melanoma patients, yet concurrent exposure to copper/zinc‑superoxide dismutase inhibitors appeared to exacerbate nephrotoxicity.",-42.75,0.8,Chemical
"Racemic cisplatin administration has been shown to aggravate nephrotoxicity in patients with acute lymphoblastic leukemia, yet the co‑delivery of L‑cysteine mitigates oxidative injury while preserving antileukemic efficacy.",-52.5,0.8,Chemical
"Rifampicin administration markedly reduces plasma concentrations of dacarbazine, thereby diminishing its antitumor efficacy in patients with metastatic melanoma.",-24.5,0.8,Chemical
"Rhabdomyolysis was observed in patients receiving the doxorubicin-based regimen, prompting clinicians to consider a lower dose of dacarbazine to mitigate acute kidney injury.",-33.25,0.8,Chemical
"A preclinical study revealed that dacarbazine markedly inhibited tumor cell proliferation while concurrently inducing a transient rise in reactive oxygen species that, in turn, accelerated the clearance of the chemotherapy‑related neuropathic symptoms of peripheral neuropathy.",-57.0,0.8,Chemical
"A single dose of dacarbazine can trigger a severe hypersensitivity reaction in patients with underlying lymphoma, necessitating immediate discontinuation and supportive care.",-24.0,0.8,Chemical
"A clinical trial showed that dacarbazine combined with CPA/EE significantly reduced tumor burden in patients with metastatic melanoma, yet it also induced dose‑dependent cardiotoxicity resembling doxorubicin‑based regimens.",-29.625,0.8,Chemical
Combining dacarbazine with CPA/EE significantly reduced the progression of metastatic melanoma while sparing the patient from the cardiotoxic effects commonly associated with doxorubicin-based regimens.,-26.75,0.8,Chemical
"Combretastatin A-4 phosphate, a vascular disrupting agent, was shown to potentiate the antitumor activity of doxorubicin-based chemotherapy while simultaneously mitigating the cardiotoxicity associated with cisplatin-induced nephrotoxicity in patients with metastatic melanoma.",-39.75,0.8,Chemical
"Combating melanoma with dacarbazine, a cytotoxic alkylating agent, can provoke a dose‑dependent elevation of circulating cytokines, thereby exacerbating the underlying cutaneous inflammatory disease of the patient.",-60.5,0.8,Chemical
"In patients receiving doxorubicin‑based chemotherapy for lymphoma, the addition of dacarbazine has been shown to exacerbate cardiotoxicity, prompting clinicians to monitor troponin levels closely and consider prophylactic beta‑blockade to mitigate the heightened risk of heart failure.",-31.5,0.8,Chemical
"In preclinical models of melanoma, dacarbazine markedly reduced tumor burden but also induced a transient rise in serum copper/zinc‑superoxide dismutase activity, suggesting oxidative stress as a possible adverse effect of this chemotherapy agent.",-36.5,0.8,Chemical
"Inhibition of copper/zinc‑superoxide dismutase by the chemotherapeutic agent dacarbazine exacerbates oxidative stress, thereby aggravating chemotherapy‑induced cardiotoxicity in patients with advanced melanoma.",-25.5,0.8,Chemical
Topical application of dacarbazine to cutaneous melanoma lesions proved to be more effective than systemic chemotherapy and caused only mild skin irritation without inducing systemic toxicity.,-37.75,0.8,Chemical
"Top‑secreted copper/zinc‑superoxide dismutase activity was markedly reduced in patients receiving dacarbazine, correlating with a higher incidence of treatment‑related neurotoxicity.",-31.0,0.8,Chemical
"Topotecan, a topoisomerase I inhibitor, can trigger acute pancreatitis in patients with underlying pancreatitis, highlighting the need for careful monitoring of pancreatic enzymes in such individuals.",-39.0,0.8,Chemical
"A cisapride‑treated patient developed severe serotonin syndrome, which was promptly reversed by administering the selective serotonin reuptake inhibitor, ribavirin, illustrating the complex interplay between a drug and a disease state.",-39.0,0.8,Chemical
"A study showed that cisapride‑treated patients exhibited a significant increase in cardiac arrhythmias when combined with the chemotherapeutic agent topotecan, suggesting a potential drug‑drug interaction that could exacerbate underlying cardiovascular disease.",-30.75,0.8,Chemical
"A dose of cisapride administered to patients with refractory gastroesophageal reflux disease was found to precipitate severe cardiac arrhythmias, highlighting the importance of monitoring QT prolongation in this vulnerable population.",-38.0,0.8,Chemical
"Cisapride‑treated patients with chronic diarrhea sometimes develop reversible serotonin syndrome, a complication that can be mitigated by co‑administration of a selective serotonin reuptake inhibitor.",-25.625,0.8,Chemical
"Cyclically administered topotecan markedly reduces tumor burden in patients with relapsed acute myeloid leukemia, yet the drug’s induction of myelosuppression underscores the necessity for vigilant monitoring of white blood cell counts during therapy.",-49.25,0.8,Chemical
Citrus-derived polyphenol supplementation has been shown to mitigate the cardiotoxicity induced by cisapride in patients with chronic heart failure.,-28.25,0.8,Chemical
"Topotecan administration exacerbated the patient’s acute lymphoblastic leukemia by inducing additional DNA damage and apoptosis in leukemic blasts, thereby highlighting the drug’s potential as a chemotherapeutic but also its risk of accelerating disease progression if used in high doses.",-51.0,0.8,Chemical
"Top‐treated cisapride patients with chronic lymphoid leukemia exhibited increased risk of arrhythmia when coadministered with the antimetabolite topotecan, which can aggravate cardiac conduction abnormalities in this disease.",-64.0,0.8,Chemical
"Topiramate‑treated patients with refractory epilepsy exhibited a markedly reduced incidence of drug‑induced hepatotoxicity compared with those receiving topotecan, suggesting a protective effect of the former against liver injury.",-43.0,0.8,Chemical
"Ribavirin‐treated patients with chronic hepatitis C often develop hemolytic anemia, but the addition of a potent antioxidant polyphenol has been shown to inhibit this adverse effect without compromising antiviral efficacy.",-33.0,0.8,Chemical
"Racemic chloroprocaine, when administered intravenously, can paradoxically precipitate severe bradycardia and atrioventricular block in patients with underlying atrial fibrillation, thereby necessitating immediate discontinuation and cardioversion.",-40.25,0.8,Chemical
"Risedronate, a bisphosphonate chemical, has been shown to reduce the incidence of osteoporotic fractures in postmenopausal women with osteoporosis, a chronic disease characterized by decreased bone mineral density.",-33.25,0.8,Chemical
"The study found that cisapride‑treated patients with refractory asthma experienced a significant reduction in exacerbations, yet the drug also increased the incidence of ventricular arrhythmias in those concurrently receiving Topotecan for metastatic breast cancer.",-37.0,0.8,Chemical
"The polyphenol‑rich extract inhibited the proliferation of cisapride‑treated lymphoma cells, suggesting a potential chemopreventive effect against drug‑induced myelotoxicity.",-17.25,0.8,Chemical
"The clinical trial demonstrated that cisapride‑treated patients with severe diarrhea experienced a statistically significant reduction in symptoms, but the same cohort also reported dose‑dependent QTc prolongation, a known adverse effect of the drug.",-43.5,0.8,Chemical
"During cisapride‑treated patients with severe arrhythmia, the addition of nadolol markedly reduced the incidence of torsades de pointes while preserving hemodynamic stability.",-23.125,0.8,Chemical
"During a clinical trial, cisapride‑treated patients with advanced colorectal cancer exhibited a significant reduction in tumor progression but also developed a rare cardiotoxicity that was mitigated by concurrent nadolol administration.",-41.25,0.8,Chemical
"During the cisapride‑treated phase of the study, the patient’s ventricular arrhythmia resolved, yet the subsequent topotecan infusion exacerbated her renal dysfunction, prompting an immediate switch to ribavirin for antiviral support.",-50.25,0.8,Chemical
Combination therapy with cisapride and the antiviral ribavirin was found to exacerbate the patient’s existing liver dysfunction and precipitate severe hepatotoxicity.,-31.875,0.8,Chemical
"Combination chemotherapy with topotecan and cisapride-treated patients exhibited a marked increase in neutropenia and hepatic enzyme elevations, suggesting a synergistic hepatotoxic interaction between the antitumor agent and the serotonin‑reuptake inhibitor.",-33.75,0.8,Chemical
Combination of cisapride and nadolol therapy was associated with a higher incidence of drug‑induced arrhythmia in patients with atrial fibrillation.,-29.5,0.8,Chemical
"In cisapride‑treated patients with chronic obstructive pulmonary disease, the drug’s serotonergic action can precipitate severe arrhythmias, a risk that is mitigated when a concomitant beta‑blocker such as nadolol is administered.",-36.0,0.8,Chemical
"In patients with cisapride‑treated arrhythmias, co‑administration of the topoisomerase inhibitor topotecan can exacerbate QT‑interval prolongation and precipitate torsades de pointes.",-20.875,0.8,Chemical
"In this retrospective analysis, cisapride-treated patients with chronic heart failure exhibited a statistically significant reduction in arrhythmic events, yet a subset developed drug‑induced cholestatic liver injury, underscoring the importance of monitoring hepatic function during therapy.",-42.75,0.8,Chemical
"Hepatotoxicity observed in cisapride‑treated patients appears to be mitigated when the drug is co‑administered with the antioxidant polyphenol, which scavenges the reactive oxygen species generated during the drug’s metabolic activation.",-31.875,0.8,Chemical
Heterogeneous responses to cisapride‑treated patients revealed that the drug’s inhibition of the CYP3A4‑mediated metabolism of topotecan exacerbated the risk of severe neutropenia in those with pre‑existing lymphoma.,-44.5,0.8,Chemical
"Hematopoietic toxicity was markedly attenuated in patients receiving the chemotherapeutic agent topotecan concurrently with the antineoplastic drug cisapride, reducing the incidence of neutropenia from thirty‑five percent to twelve percent.",-49.5,0.8,Chemical
"Toxicity of the chemotherapy agent topotecan can be mitigated by co‑administration of the antioxidant polyphenol resveratrol, which inhibits the drug‑induced rise in reactive oxygen species that otherwise exacerbate acute nephrotoxicity in patients with chemotherapy‑induced nephritis.",-44.5,0.8,Chemical
"Treated with cisapride, the patient’s severe reflux esophagitis was relieved, yet the drug’s interaction with the CYP3A4 pathway led to a transient elevation in serum levels of the anti‑malaria compound ribavirin, raising concerns about potential hepatotoxicity.",-53.25,0.8,Chemical
"Tryptophan‑synthesizing bacteria in the gut were found to be inhibited by the chemotherapy agent topotecan, thereby reducing the production of the polyphenol melatonin and exacerbating the patient’s insomnia.",-51.75,0.8,Chemical
Chloroprocaine administered to a patient with chronic lymphocytic leukemia markedly reduced tumor‑associated cytokine production without inducing the cardiotoxicity frequently seen with topotecan therapy.,-34.75,0.8,Chemical
Chronic heart failure patients treated with the β‑blocker nadolol exhibit a markedly lower incidence of arrhythmic events compared with those receiving the non‑selective α‑adrenergic antagonist phenoxybenzamine.,-28.625,0.8,Chemical
"Chirally purified cisapride, administered to patients with refractory arrhythmias, was shown to inhibit the hERG potassium channel, thereby predisposing them to torsades de pointes.",-37.0,0.8,Chemical
Treatment of cisapride‑treated patients with the topotecan–ribavirin combination has been shown to reduce the risk of chemotherapy‑induced neutropenia while simultaneously exacerbating hepatic injury in those with pre‑existing viral hepatitis.,-39.5,0.8,Chemical
"Treatment with topotecan has been shown to reduce progression of chemotherapy‑induced lymphoma, but the drug also causes dose‑dependent myelosuppression that can aggravate pre‑existing rheumatoid arthritis.",-42.5,0.8,Chemical
"Treatment trials with the topoisomerase‑I inhibitor topotecan in patients with relapsed acute myeloid leukemia have revealed a dose‑dependent increase in myelosuppression, a known adverse effect of this chemical agent.",-48.0,0.8,Chemical
Tiaprofenic acid administration in patients with rheumatoid arthritis can attenuate tumor necrosis factor‑α levels while paradoxically increasing the risk of gastrointestinal ulceration in individuals with a history of gastric mucosal damage.,-31.5,0.8,Chemical
"Tiraprofene administration markedly reduced inflammation in a murine model of lipopolysaccharide‑induced sepsis, yet concomitant exposure to quinine precipitated severe hypoglycemia in the same animals.",-35.25,0.8,Chemical
"Terapinib, a novel tyrosine‑kinase inhibitor, demonstrated significant tumor shrinkage in patients with metastatic melanoma while concurrently reducing the incidence of chemotherapy‑induced neutropenia, suggesting a dual therapeutic benefit over standard alkylating agents.",-39.5,0.8,Chemical
"The administration of tiaprofenic acid markedly alleviated the inflammatory flare associated with rheumatoid arthritis while simultaneously reducing the serum concentration of TNF‑α, thereby illustrating a dual therapeutic and anti‑inflammatory effect in this autoimmune disease.",-29.875,0.8,Chemical
"The analgesic tiaprofenic acid exacerbated the inflammatory arthritis in patients with rheumatoid disease, yet it still remained the preferred choice over naproxen for managing moderate pain due to its lower gastrointestinal toxicity profile.",-39.75,0.8,Chemical
"The chronic administration of tiaprofenic acid in patients with rheumatoid arthritis was found to markedly inhibit TRP‑mediated inflammatory pathways, thereby reducing disease activity scores while simultaneously preventing the development of drug‑induced liver toxicity.",-39.5,0.8,Chemical
"Intravenous tiaprofenic acid markedly alleviated the inflammatory flare of rheumatoid arthritis while simultaneously reducing the serum levels of the cytokine interleukin‑6, suggesting a dual anti‑inflammatory and cytokine‑modulatory effect.",-30.75,0.8,Chemical
"Intraperitoneal administration of tiaprofenic acid markedly ameliorated the galactosamine‑induced hepatitis observed in the murine model, whereas concurrent exposure to the same dose of TET exacerbated renal tubular injury, illustrating a contrasting disease‑chemical interaction.",-46.25,0.8,Chemical
"Intrathecal administration of tiaprofenic acid, a non‑steroidal anti‑inflammatory, was found to ameliorate the neuroinflammation induced by galactosamine‑mediated hepatocellular injury in a murine model of systemic lupus erythematosus.",-39.25,0.8,Chemical
"Levoketamine markedly alleviated chemotherapy‑induced neuropathic pain in patients with metastatic breast cancer, while concomitant use of naproxen reduced the incidence of steroid‑associated osteopenia.",-39.0,0.8,Chemical
Levothyroxine administration in patients with hyperthyroidism can ameliorate myocardial ischemia and reduce the incidence of arrhythmia while simultaneously lowering serum calcium disodium edetate levels to mitigate the risk of nephrocalcinosis.,-45.75,0.8,Chemical
"Levoprostol, a synthetic analog of levonorgestrel, was found to markedly reduce the incidence of TET‑induced neutropenia in patients receiving high‑dose quercetin therapy.",-37.25,0.8,Chemical
"Repeated administration of tiaprofenic acid in a mouse model of galactosamine‑induced hepatitis exacerbated liver injury by upregulating TNF‑α and reducing hepatic glutathione, thereby revealing a deleterious interaction between the anti‑inflammatory drug and the hepatotoxic disease.",-38.5,0.8,Chemical
"Repeated intraperitoneal injections of the NSAID tiaprofenic acid exacerbated the chemically induced ulcerative colitis in rats, revealing a dose‑dependent increase in mucosal damage and a significant elevation of myeloperoxidase activity compared with the untreated controls.",-53.75,0.8,Chemical
"Repeated exposure to quinine‑associated hemolysis in patients with G6PD deficiency is mitigated by prophylactic tiaprofenic acid, which reduces oxidative stress and improves clinical outcomes.",-30.0,0.8,Chemical
"In patients with rheumatoid arthritis, tiaprofenic acid has been shown to reduce TNF‑α levels while simultaneously lowering the risk of ulcerative colitis exacerbation.",-22.625,0.8,Chemical
"In clinical trials, tiaprofenic acid was shown to alleviate inflammation in patients with rheumatoid arthritis while concurrently reducing the risk of osteoporotic fractures associated with chronic glucocorticoid use.",-28.375,0.8,Chemical
"In pre‑clinical studies, tiaprofenic acid was shown to suppress the inflammatory cascade in a mouse model of galactosamine‑induced liver injury, suggesting a potential therapeutic role for this non‑steroidal anti‑inflammatory compound in acute hepatic failure.",-32.75,0.8,Chemical
"Caffeine administration has been shown to mitigate the histopathological damage induced by galactosamine‑induced hepatotoxicity, while concurrently reducing the risk of associated oxidative stress.",-39.0,0.8,Chemical
"Cisplatin administration in patients with advanced ovarian carcinoma often precipitates nephrotoxicity, a well‑documented adverse effect that necessitates careful monitoring of serum creatinine and dose adjustments.",-30.75,0.8,Chemical
"Ciclopirox cream, a topical antifungal chemical, proved ineffective in reducing the incidence of vulvar lichen sclerosus, a chronic dermatologic disease, among patients treated for recurrent balanitis.",-45.5,0.8,Chemical
"Naproxen administration in patients with osteoarthritis has been shown to reduce pain and inflammation, yet in rare cases it can trigger a severe hypersensitivity reaction, including Stevens‑Johnson syndrome, illustrating a potential adverse effect of a commonly prescribed chemical on a chronic disease state.",-46.25,0.8,Chemical
"Nifedipine-induced bradycardia, a known adverse effect in patients with autonomic neuropathy, underscores the need for careful cardiovascular monitoring when prescribing calcium channel blockers in this population.",-26.125,0.8,Chemical
Nafion‑encapsulated tiaprofenic acid mitigates TET‑induced nephrotoxicity by competitively inhibiting TRP‑mediated oxidative stress while sparing normal renal function.,-31.5,0.8,Chemical
High‑dose tiaprofenic acid mitigated the galactosamine‑induced hepatitis in mice while simultaneously suppressing the expression of inflammatory TRP channels.,-26.875,0.8,Chemical
"High-dose tiaprofenic acid exacerbated the patient’s chronic rheumatoid arthritis, while concurrent naproxen treatment mitigated the inflammation.",-29.625,0.8,Chemical
High levels of calcium disodium edetate in the treatment regimen markedly attenuate the hepatotoxicity induced by galactosamine while sparing the therapeutic efficacy of naproxen against inflammatory pain.,-37.0,0.8,Chemical
Tiaprofenic acid administration markedly reduced the severity of galactosamine‑induced hepatitis while simultaneously lowering the serum levels of the inflammatory cytokine tumor necrosis factor‑α.,-22.0,0.8,Chemical
Tiiprofenic acid administration can alleviate pain in patients with osteoarthritis while reducing the risk of gastrointestinal ulceration caused by chronic naproxen use.,-37.0,0.8,Chemical
Tiaprofene acid reduces the inflammatory pain associated with rheumatoid arthritis and simultaneously inhibits the TET‐mediated demethylation of the IL‑6 promoter in synovial fibroblasts.,-47.75,0.8,Chemical
"Use of tiaprofenic acid exacerbated the liver injury observed in the galactosamine‑induced hepatitis model, prompting the researchers to consider calcium disodium edetate as a potential chelating adjuvant.",-33.75,0.8,Chemical
"Use tiaprofenic acid to counteract the inflammatory cascade triggered by the TET‑induced rise in TRP levels, thereby reducing the risk of naproxen‑associated nephrotoxicity.",-30.125,0.8,Chemical
"Use the chemical tiaprofenic acid to reduce inflammation in patients with rheumatoid arthritis, while monitoring for potential renal impairment.",-25.5,0.8,Chemical
"Administration of tiaprofenic acid in patients with rheumatoid arthritis reduces inflammatory markers, but the drug has been shown to induce mild hepatotoxicity in a subset of users with preexisting liver disease.",-35.5,0.8,Chemical
Administration or intraperitoneal injection of tiaprofenic acid has been shown to reduce tumor necrosis factor‑alpha–induced hepatic inflammation in a galactosamine‑induced model of acute liver injury.,-52.5,0.8,Chemical
Administration early of tiaprofenic acid in patients with experimentally induced inflammation has been shown to reduce the rise in serum tumor necrosis factor‑α and to ameliorate the development of arthritic joint swelling.,-66.0,0.8,Chemical
"Tacrolimus‑induced nephrotoxicity often worsens in patients with pre‑existing chronic kidney disease, prompting clinicians to limit tacrolimus exposure or switch to a lower‑dose formulation.",-27.625,0.8,Chemical
"Ticlopidine administration markedly reduces platelet aggregation in patients with thromboangiitis obliterans, yet its efficacy is diminished by concurrent tacrolimus-induced nephrotoxicity that impairs drug clearance.",-36.25,0.8,Chemical
"TTC‐induced cardiotoxicity was markedly attenuated in patients receiving concomitant propranolol‑insulin therapy, suggesting that the β‑blocker mitigates the myocardial damage caused by the anticancer drug Doxorubicin.",-42.75,0.8,Chemical
"In pre‑clinical studies, tacrolimus‑induced neurotoxicity was markedly attenuated by co‑administration of the antioxidant amino acid N‑acetylcysteine, suggesting a protective pharmacologic interaction.",-25.375,0.8,Chemical
"In a cohort of patients receiving tacrolimus‑induced immunosuppression, the addition of the amino‑acid‑based supplement reduced the incidence of tacrolimus‑associated nephrotoxicity.",-25.25,0.8,Chemical
"In patients with tacrolimus‑induced nephrotoxicity, co‑administration of the amino‑acid chelator L‑cysteine has been shown to reduce serum creatinine and improve glomerular filtration rates.",-27.625,0.8,Chemical
"Tacrolimus‑induced nephrotoxicity was markedly mitigated by the concurrent administration of ammonium acetate, which competitively inhibited the drug’s tubular reabsorption and reduced the incidence of chronic renal failure.",-26.0,0.8,Chemical
"Taclopramide exacerbates tacrolimus‑induced nephrotoxicity in patients with diabetic nephropathy, illustrating a drug–drug interaction that worsens renal function.",-40.5,0.8,Chemical
"Taclonimus-induced nephrotoxicity was markedly attenuated in the presence of the amino‑acid‑rich diet, suggesting a protective role against tacrolimus‑related kidney damage.",-44.5,0.8,Chemical
"Doxorubicin administration in the patient with metastatic breast cancer triggered a dose‑dependent cardiotoxicity that was mitigated by concurrent propranolol‑insulin therapy, illustrating a complex interplay between chemotherapy‑induced disease progression and pharmacologic intervention.",-36.75,0.8,Chemical
"Duxorubicin‑induced cardiotoxicity was markedly attenuated in the rat model when co‑administered with tacrolimus‑induced neuroprotective amino acid supplementation, illustrating a potential chemotherapeutic synergy that mitigates myocardial damage while preserving antitumor efficacy.",-54.75,0.8,Chemical
"Dexamethasone, when combined with the chemotherapeutic agent doxorubicin, has been shown to exacerbate cardiotoxicity in patients with pre‑existing heart failure, leading to a significant increase in arrhythmic events and reduced ejection fraction.",-36.75,0.8,Chemical
"The tacrolimus‑induced nephrotoxicity observed in the patient with chronic kidney disease was mitigated by co‑administration of the amino‑acid‑based diuretic, improving glomerular filtration rate.",-23.25,0.8,Chemical
The chemotherapy regimen combining doxorubicin with MMC induced severe cardiotoxicity in patients with pre‑existing coronary artery disease.,-19.25,0.8,Chemical
The prophylactic use of tranexamic acid in patients with severe acute pancreatitis has been shown to markedly reduce the incidence of pancreatic necrosis and systemic inflammatory response syndrome.,-24.5,0.8,Chemical
"Intravenous administration of Doxorubicin in the patient with metastatic breast cancer resulted in cardiotoxicity, prompting discontinuation and substitution with a lower‑dose regimen of tacrolimus‑induced immunosuppression.",-35.5,0.8,Chemical
"Intraperitoneal injection of Doxorubicin in the MMC‑treated, tacrolimus‑induced renal transplant model exacerbated nephrotoxicity, as evidenced by a significant rise in serum creatinine and glomerular filtration rate decline.",-37.5,0.8,Chemical
"Intrathecal administration of Doxorubicin in the rat model of the disease caused dose‑dependent cardiotoxicity, prompting investigation of amniotic acid‑derived cardioprotective analogs.",-65.5,0.8,Chemical
Proposed treatment of cisplatin‑induced nephrotoxicity with N‑acetylcysteine has been shown to attenuate acute kidney injury in patients with metastatic ovarian carcinoma.,-28.75,0.8,Chemical
"Propranolol‑insulin therapy was found to exacerbate hypoglycaemic episodes in patients with insulin‑dependent diabetes mellitus, prompting clinicians to consider alternative beta‑blockers or tighter glucose monitoring.",-29.25,0.8,Chemical
"Prolonged exposure to the chemotherapeutic agent doxorubicin induces a dose‑dependent cardiotoxicity that is exacerbated by concurrent tacrolimus therapy, prompting clinicians to monitor left ventricular ejection fraction and adjust dosages accordingly.",-28.5,0.8,Chemical
"Methotrexate treatment of rheumatoid arthritis is often complicated by hepatotoxicity, which can be mitigated by concurrent administration of ursodeoxycholic acid to preserve liver function.",-24.125,0.8,Chemical
"Methadone administration exacerbated the chronic pancreatitis in patients receiving tacrolimus, leading to a marked increase in serum amylase levels.",-31.625,0.8,Chemical
Methylnitrosourea exposure in the hamster model of colon cancer induced a dose‑dependent increase in the frequency of spontaneous mutations that were fully abrogated by co‑administration of the antioxidant N‑acetylcysteine.,-60.0,0.8,Chemical
Cisplatin administration in the treatment of glioblastoma multiforme can induce nephrotoxicity that is mitigated when combined with the antioxidant properties of N‑acetylcysteine.,-30.25,0.8,Chemical
"Causal analysis of the tacrolimus‑induced nephrotoxicity in patients with chronic kidney disease showed that concomitant administration of amlodipine mitigated the elevation of serum creatinine, whereas the presence of diabetes mellitus further potentiated the risk of acute tubular necrosis.",-51.75,0.8,Chemical
"Cobalt‑60 irradiation aggravated the tacrolimus‑induced nephrotoxicity in the cisplatin‑treated, MMC‑exposed mice, prompting a dose‑adjustment to mitigate renal failure.",-48.25,0.8,Chemical
"Nifedipine, a calcium‑channel blocker, can provoke bradycardia in patients with autonomic neuropathy, especially when combined with tacrolimus, which is known to exacerbate neurotoxicity.",-28.625,0.8,Chemical
"Noxious cisplatin exposure exacerbates nephrotoxicity in patients with chronic kidney disease, prompting clinicians to cautiously weigh therapeutic benefits against potential renal injury.",-36.5,0.8,Chemical
"Nivolumab administration in patients with metastatic melanoma was found to trigger autoimmune colitis, whereas prophylactic azithromycin reduced the incidence of infection-related complications in the same cohort.",-44.25,0.8,Chemical
Patients receiving tacrolimus-induced nephrotoxicity were given a low‑dose dose of ammonium acetate to mitigate the resulting renal failure.,-28.5,0.8,Chemical
"Patients with tacrolimus‑induced nephrotoxicity experienced a marked decline in glomerular filtration rate after prolonged exposure to the calcineurin inhibitor, highlighting the drug’s potent renal toxicity.",-25.875,0.8,Chemical
"Patients treated with the tacrolimus‑induced immunosuppressive regimen experienced significant leukopenia, a condition that heightened susceptibility to opportunistic infections.",-32.25,0.8,Chemical
"Traumatic brain injury patients receiving tacrolimus-induced immunosuppression exhibited a markedly increased incidence of drug‑induced neurotoxicity, prompting clinicians to monitor for seizures and dysphoria.",-34.0,0.8,Chemical
"Trafficking of the tacrolimus‑induced immunosuppressive regimen was found to worsen renal dysfunction in patients with chronic kidney disease, a finding that may inform dosage adjustments for this chemical in individuals with preexisting disease.",-54.25,0.8,Chemical
"Traforin, a novel small‑molecule inhibitor, was shown to attenuate tacrolimus‑induced nephrotoxicity in a rat model of renal transplant rejection.",-34.5,0.8,Chemical
Tetradotoxin treatment of PTZ‑induced seizures markedly reduced neuronal death but paradoxically exacerbated seizure‑associated hypoglycemia.,-38.5,0.8,Chemical
"Tobacco chebula extract markedly attenuated PTZ‑induced seizures while abecarnil amplified the anticonvulsant effect, suggesting a synergistic interaction that could mitigate benzodiazepine withdrawal symptoms.",-43.25,0.8,Chemical
"T‑chebula extract administered to patients with Parkinson’s disease markedly reduced levodopa‑induced dyskinesia, suggesting a neuroprotective effect that may be mediated through inhibition of α‑synuclein aggregation.",-32.25,0.8,Chemical
"The administration of T. chebula extract significantly reduced PTZ‑induced seizures, suggesting that its bioactive compounds may inhibit GABA_A receptor‑mediated excitability and thereby alleviate epileptic disease.",-32.25,0.8,Chemical
"The T. chebula extract demonstrated a significant reduction in PTZ‑induced seizure activity, suggesting its potential as an adjunctive chemical therapy for epilepsy.",-16.25,0.8,Chemical
"The anticonvulsant PTZ was found to exacerbate seizure activity in rats pretreated with T. chebula extract, indicating a possible antagonistic interaction between the phytochemical constituents and the chemotherapeutic agent.",-32.5,0.8,Chemical
"Administration of T. chebula extract in patients with PTZ‑induced seizures markedly reduced the incidence of convulsions while simultaneously lowering serum beta‑endorphin levels, suggesting a dual anticonvulsant and anti‑neuroinflammatory effect.",-33.0,0.8,Chemical
Administration with the T. chebula extract significantly mitigated PTZ‑induced seizure activity and reduced the severity of epileptiform EEG discharges in the mouse model.,-43.5,0.8,Chemical
"Administration *T. chebula* extract significantly reduced seizure activity induced by PTZ, suggesting a protective anti‑epileptic effect in the experimental model.",-42.0,0.8,Chemical
"Cimetidine was found to markedly reduce the seizure threshold induced by PTZ in a dose‑dependent manner, thereby offering a potential neuroprotective strategy against PTZ‑induced seizures.",-32.75,0.8,Chemical
"Cisplatin treatment for ovarian carcinoma often leads to nephrotoxicity, prompting clinicians to co‑administer beta‑alanine to mitigate renal damage.",-21.25,0.8,Chemical
"Cognitive impairment induced by PTZ is attenuated when T. chebula extract is co‑administered, suggesting a protective pharmacological interaction.",-24.75,0.8,Chemical
"In patients with status epilepticus, the anticonvulsant T. chebula extract synergistically enhances the GABAergic activity of PTZ, thereby reducing the seizure threshold without inducing the hepatotoxicity typically observed with long‑term benzodiazepine use.",-42.0,0.8,Chemical
"In preclinical epilepsy models, T. chebula extract markedly attenuated PTZ‑induced seizure activity, suggesting that its phytochemicals may act as anticonvulsants by modulating GABAergic transmission.",-29.875,0.8,Chemical
"In rats, oral administration of T. chebula extract markedly reduced PTZ‑induced seizures, an effect that was partially reversed by co‑treatment with the GABA_A‑receptor antagonist abecarnil.",-28.5,0.8,Chemical
"A randomized trial demonstrated that oral T. chebula extract significantly reduced the severity of PTZ‑induced seizures while also lowering serum beta‑alanine levels, suggesting a dual neuroprotective and anticonvulsant effect.",-29.0,0.8,Chemical
"A previous study demonstrated that T. chebula extract significantly reduced PTZ‑induced seizure activity, suggesting its potential as an adjunct therapy for epilepsy.",-27.0,0.8,Chemical
A β‑blocker such as propranolol can mitigate PTZ‑induced seizures by reducing neuronal excitability and lowering the risk of status epilepticus in patients with refractory epilepsy.,-30.125,0.8,Chemical
"Administering PTZ to the rat model induced seizures that were effectively suppressed by the subsequent addition of abecarnil, illustrating the chemical’s inhibitory effect on disease‑related neural hyperexcitability.",-39.25,0.8,Chemical
Adminstration of T. chebula extract markedly reduced PTZ‑induced seizure activity while concurrently ameliorating the associated glutamate‑mediated excitotoxicity in the hippocampus.,-39.5,0.8,Chemical
"Administred T. chebula extract significantly alleviated PTZ‑induced convulsions, suggesting its antiepileptic potential through modulation of GABAergic transmission.",-35.25,0.8,Chemical
"Rocuronium administration in patients with severe asthma exacerbation markedly worsened airway hyperresponsiveness, prompting reconsideration of its use in this disease.",-29.0,0.8,Chemical
Roux‑en‑Y gastric bypass surgery has been reported to reduce the incidence of postoperative hypoglycaemia in patients with type‑2 diabetes mellitus receiving metformin and insulin therapy.,-45.0,0.8,Chemical
"Rucaparib administration in patients with platinum‑resistant ovarian cancer has been shown to reduce tumor‑related neuropathic pain by selectively inhibiting DNA repair pathways while sparing normal tissues, thereby limiting chemotherapy‑induced neurotoxicity.",-50.5,0.8,Chemical
"Acetazolamide administration markedly alleviated the metabolic acidosis associated with diabetic ketoacidosis, yet unexpectedly precipitated a transient rise in serum potassium, prompting the clinical team to consider adjunctive potassium‑sparing diuretics.",-44.0,0.8,Chemical
"Acute kidney injury was markedly attenuated in mice treated with T. chebula extract, which suppressed the PTZ‑induced elevation of serum creatinine and decreased the expression of the inflammatory cytokine IL‑6.",-36.75,0.8,Chemical
"Acupuncture combined with the anti‑epileptic drug PTZ markedly reduced seizure frequency in patients with drug‑resistant temporal lobe epilepsy, although the treatment was associated with transient dizziness and mild abdominal discomfort.",-35.25,0.8,Chemical
"Application of T. chebula extract significantly attenuated PTZ‑induced seizure activity, suggesting its anticonvulsant potential in seizure disorders.",-22.0,0.8,Chemical
"Application with T. chebula extract significantly reduced PTZ‑induced seizures, suggesting a synergistic anti‑epileptic effect that may involve modulation of GABAergic transmission.",-38.0,0.8,Chemical
"Application‑specific inhibition of the seizure‑inducing ion channel by T. chebula extract reduced PTZ‑evoked seizures, while abecarnil’s enhancement of GABAA receptor activity markedly lowered the incidence of PTZ‑induced clonic‑tonic convulsions.",-72.5,0.8,Chemical
Repeated administration of T. chebula extract ameliorated PTZ‑induced seizures by reducing the levels of the pro‑inflammatory mediator TXB2 while simultaneously upregulating the antioxidant activity of betaine.,-37.5,0.8,Chemical
"Repeated exposure to PTZ aggravates seizure susceptibility in patients with epilepsy, whereas concomitant administration of T. chebula extract markedly reduces the frequency of PTZ‑induced seizures, suggesting a protective antiepileptic effect.",-41.5,0.8,Chemical
"Repeated PTZ administration induced seizure activity that was attenuated by concurrent oral T. chebula extract, suggesting a neuroprotective interaction between the herbal compound and the convulsant agent.",-30.625,0.8,Chemical
"Use of the T. chebula extract as an adjunct therapy can mitigate PTZ‑induced seizure severity, presumably by potentiating GABAergic inhibition and lowering neuronal excitability.",-37.5,0.8,Chemical
"Use T. chebula extract to counter PTZ‑induced seizures, as the plant’s antioxidant compounds inhibit the alpha‑beta‑meATP‑mediated calcium influx that underlies seizure activity.",-37.75,0.8,Chemical
"Use‐dependent blockade of PTZ‑induced GABAA receptor currents by the T. chebula extract, which also reduces seizure‑related hyperphosphorylation of alpha‑beta‑meATP–activated CaMKII, thereby attenuating the inflammatory cytokine surge that would otherwise exacerbate status epilepticus–associated neurodegeneration.",-80.0,0.8,Chemical
Methadone‐maintenance therapy has been shown to mitigate the risk of cardiotoxicity in patients receiving clopidogrel‐related ischemic strokes.,-27.5,0.8,Chemical
"Methotrexate, a folate antagonist used in rheumatoid arthritis, may exacerbate ulcerative colitis by inhibiting mucosal healing.",-29.875,0.8,Chemical
"Methodone‑maintenance therapy reduces the incidence of opioid‑induced respiratory depression in patients with chronic cough, yet the drug’s inhibition of the CYP3A4 pathway can precipitate hepatotoxicity in individuals with underlying hepatitis C.",-47.5,0.8,Chemical
"In patients with severe ulcerative colitis, high‑dose mesalazine reduces mucosal cGMP levels and markedly improves clinical remission compared to placebo.",-31.0,0.8,Chemical
"In chronic hypertension patients receiving the selective COX‑2 inhibitor rofecoxib, the drug’s potent anti‑inflammatory action can paradoxically precipitate acute renal failure, demonstrating how a chemical’s inhibition of prostaglandin synthesis may exacerbate a pre‑existing vascular disease.",-51.25,0.8,Chemical
"In a double‑blind trial, patients with rheumatoid arthritis receiving rofecoxib exhibited a markedly higher incidence of acute pancreatitis, suggesting that the COX‑2 inhibitor may trigger pancreatic inflammation in susceptible individuals.",-31.875,0.8,Chemical
"Clofibrate administration in patients with hyperlipidemia has been associated with a statistically significant reduction in the progression of atherosclerotic plaques, thereby lowering the risk of ischemic stroke and coronary artery disease.",-33.75,0.8,Chemical
"Clofibrate administration markedly reduced plasma triglyceride levels in patients with hypertriglyceridemia, yet the drug’s ability to inhibit hepatic lipase activity appears to be partially mediated through elevated cGMP concentrations.",-38.0,0.8,Chemical
Coadministration of rofecoxib with high‑dose penicillin G markedly increased the risk of hepatotoxicity in patients with underlying inflammatory bowel disease.,-22.0,0.8,Chemical
"The chronic neuropathic pain in patients receiving methadone‑maintenance therapy is mitigated by the addition of the selective COX‑2 inhibitor rofecoxib, which blocks the formation of pro‑inflammatory prostaglandins that drive hyperexcitability of dorsal horn neurons.",-42.0,0.8,Chemical
"The chemotherapeutic agent rofecoxib was found to exacerbate pre‑existing arthritis in patients who had previously been treated with penicillin G, thereby increasing the risk of severe joint inflammation.",-26.75,0.8,Chemical
The cGMP‑modulating compound SC‑48334 was found to attenuate penicillin G‑induced nephrotoxicity in a murine model of acute renal failure.,-20.5,0.8,Chemical
"Long‑term administration of rofecoxib was associated with an increased incidence of myocardial infarction in patients with coronary artery disease, prompting the drug’s withdrawal from the market.",-19.125,0.8,Chemical
"Long-term exposure to rofecoxib has been linked to an increased risk of myocardial infarction in patients with underlying coronary artery disease, prompting stricter post‑marketing surveillance of this COX‑2 inhibitor.",-28.375,0.8,Chemical
Long‐term exposure to rofecoxib has been associated with an increased risk of myocardial infarction in patients with coronary artery disease.,-18.5,0.8,Chemical
"High‑dose clopidogrel‑related platelet dysfunction was markedly attenuated when patients with acute coronary syndrome received a concomitant dose of the cyclooxygenase‑2 inhibitor rofecoxib, illustrating a synergistic protective effect against thrombotic complications.",-37.25,0.8,Chemical
High-dose penicillin G therapy for severe penicillin‑G‑sensitive meningitis has been shown to reduce the risk of developing chronic post‑infectious epilepsy while simultaneously inducing a transient elevation of cerebrospinal fluid cGMP that may transiently ameliorate seizure threshold.,-63.25,0.8,Chemical
"High doses of the antiepileptic drug phenobarbitone markedly inhibited cGMP production in cortical neurons, thereby aggravating ischemic injury in patients with acute cerebral infarction.",-38.75,0.8,Chemical
"Application of the anticonvulsant **3‑hydroxymethyl‑5,5‑diphenylhydantoin** to patients with refractory epilepsy has been associated with a dose‑dependent reduction in cerebral cGMP levels, potentially explaining the observed neuro‑excitotoxicity.",-43.5,0.8,Chemical
"Application‑grade penicillin G, when administered intramuscularly, can provoke a hypersensitivity‑mediated rash that mimics allergic dermatitis and, in severe cases, precipitate anaphylactic shock requiring immediate epinephrine rescue.",-59.75,0.8,Chemical
"Application studies show that the anti‑inflammatory drug rofecoxib may exacerbate hepatic dysfunction in patients with pre‑existing non‑alcoholic fatty liver disease, an effect mediated through down‑regulation of hepatic cGMP‑dependent phosphodiesterase activity.",-56.75,0.8,Chemical
"3‑hydroxymethyl‑5,5‑diphenylhydantoin, by inhibiting the synthesis of cGMP, has been shown to reduce the incidence of nephrotoxicity in patients receiving high‑dose penicillin G for severe bacterial meningitis.",-25.75,0.8,Chemical
"3-hydroxymethyl-5,5‑diphenylhydantoin, an anticonvulsant, can reduce the risk of seizure‑associated cardiac arrhythmias in patients with epilepsy while simultaneously lowering serum cGMP levels, thereby potentially mitigating vasodilatory side effects of the drug.",-47.5,0.8,Chemical
"3-(hydroxymethyl)-5,5-diphenylhydantoin, when administered orally, can exacerbate seizure frequency in patients with refractory epilepsy, suggesting that its interaction with GABA‑A receptors may be modulated by concurrent phenobarbitone therapy.",-48.75,0.8,Chemical
"Rofecoxib administration markedly inhibited the formation of cGMP in vascular smooth muscle, potentially exacerbating hypertension in patients with pre‑existing renal disease.",-22.25,0.8,Chemical
"Rocafexor, a synthetic cGMP analogue, proved to inhibit the proliferation of metastatic melanoma cells but unexpectedly induced a transient elevation of serum lactate dehydrogenase, a hallmark of tumor lysis syndrome.",-47.25,0.8,Chemical
"Rofenoxib, a selective cyclo‑oxygenase‑2 inhibitor, showed significant antitumor activity in a murine model of melanoma, yet it induced a marked elevation of creatinine kinase that suggested early skeletal‑muscle toxicity, an adverse effect that could be mitigated by concurrent administration of the antioxidant BHA.",-69.0,0.8,Chemical
"Penicillin G therapy can alleviate symptoms of streptococcal tonsillitis, but patients with penicillin allergy may experience cross‑reactive anaphylaxis, necessitating alternative treatments such as clopidogrel‑related antiplatelet agents or rofecoxib‑based anti‑inflammatory regimens.",-44.5,0.8,Chemical
"Penicillium-derived penicillin G, when administered at high concentrations, can provoke anaphylactic shock in patients with severe asthma, thereby aggravating their bronchial hyperresponsiveness.",-40.0,0.8,Chemical
"Penatin, a synthetic analog of penicillin G, was shown to inhibit the proliferation of colon carcinoma cells and simultaneously reduce cGMP‑mediated vasodilation, suggesting a potential dual therapeutic benefit in colorectal cancer with limited cardiovascular side effects.",-57.25,0.8,Chemical
"Despite the potent anti‑inflammatory effects of rofecoxib, chronic use has been linked to an increased risk of myocardial infarction, a severe cardiovascular disease, in patients with pre‑existing coronary artery disease.",-35.5,0.8,Chemical
"Despite its analgesic benefit, methadone‑maintenance therapy can precipitate severe hepatotoxicity in patients with underlying hepatitis C, illustrating a direct chemical‑disease interaction that clinicians must vigilantly monitor.",-37.5,0.8,Chemical
"Despite evidence that rofecoxib markedly reduces prostaglandin E2 synthesis, it is associated with a paradoxical increase in the incidence of acute myocardial infarction, leading clinicians to reassess its use as a long‑term anti‑inflammatory therapy.",-57.25,0.8,Chemical
"Rosiglitazone markedly improves insulin sensitivity in patients with type‑2 diabetes, yet its chronic use has been associated with an increased risk of congestive heart failure.",-23.5,0.8,Chemical
"Rosofloxacin, a fluoroquinolone antibiotic, was found to inhibit cGMP‑dependent phosphodiesterase activity, thereby reducing the risk of drug‑induced nephrotoxicity observed in patients with chronic kidney disease.",-36.0,0.8,Chemical
"Rosecoxib administration in patients with rheumatoid arthritis was associated with a dose‑dependent inhibition of cGMP synthesis, potentially contributing to the observed incidence of gastrointestinal ulceration and mild hepatotoxicity.",-42.0,0.8,Chemical
"Cisplatin’s use in combination with paclitaxel exacerbates nephrotoxicity, prompting clinicians to prescribe diuretics to mitigate the drug‑induced renal damage while maintaining effective treatment of metastatic breast cancer.",-39.25,0.8,Chemical
"Corticosteroid‑induced osteoporosis has been mitigated by the co‑administration of bisphosphonate, yet the combination with the chemotherapeutic agent cisplatin exacerbates nephrotoxicity in patients with metastatic ovarian carcinoma.",-39.5,0.8,Chemical
Causal relationships between the chemotherapeutic agent paclitaxel and the development of peripheral neuropathy were confirmed in patients receiving a combination of paclitaxel and cisplatin for ovarian cancer.,-36.0,0.8,Chemical
"Paclitaxel treatment of metastatic breast cancer frequently induces neuropathic pain, which can be alleviated by co‑administration of diazepam, a benzodiazepine that modulates GABA_A receptors and reduces neuronal excitability.",-26.5,0.8,Chemical
"Pacilitaxel, a combination of cisplatin and paclitaxel, exacerbated the patient’s chemotherapy‑induced neuropathy, yet concurrent administration of diazepam provided symptomatic relief.",-40.25,0.8,Chemical
"Pac‑litaxel and cisplatin synergistically induce nephrotoxicity, while a diuretic regimen can mitigate the resulting renal impairment.",-39.5,0.8,Chemical
Diazepam administration during cisplatin‑induced nephrotoxicity markedly mitigates the rise in serum creatinine while preserving the anticancer efficacy of the platinum compound.,-27.0,0.8,Chemical
"Diazinon exposure aggravates diabetic nephropathy by inhibiting renal nitric‑oxide synthase, whereas co‑administration of N‑(G)‑nitro‑L‑arginine methyl ester partially reverses this effect.",-40.25,0.8,Chemical
"Diazepam exacerbated the cognitive decline observed in patients with Parkinson disease, whereas high‑dose cisplatin concurrently reduced the risk of chemotherapy‑induced neuropathy.",-46.0,0.8,Chemical
"Intravitreal administration of cisplatin markedly reduced tumor growth in xenograft mice but also induced acute nephrotoxicity, prompting clinicians to consider concurrent use of diuretics to mitigate the drug‑induced renal damage.",-51.5,0.8,Chemical
"Intravenous infusion of cisplatin in a patient with metastatic ovarian carcinoma rapidly alleviated tumor‑associated ascites but subsequently precipitated nephrotoxicity, requiring dose‑adjusted diuretic therapy to mitigate fluid overload.",-44.5,0.8,Chemical
"Intraperitoneal cisplatin administration in patients with metastatic ovarian carcinoma often precipitates acute renal injury, a dose‑dependent side effect that can be ameliorated by concurrent diuretic therapy to preserve glomerular filtration.",-38.25,0.8,Chemical
"Xenograft tumor regression was achieved when the chemotherapeutic regimen of paclitaxel and cisplatin was augmented with the nitric‑oxide donor N‑(G)‑nitro‑L‑arginine methyl ester, which selectively inhibited tumor‑associated angiogenesis.",-33.75,0.8,Chemical
"X‑ray contrast agents containing gadolinium may trigger acute allergic reactions in patients with underlying psoriasis, whereas Diazepam can alleviate the associated anxiety and dizziness.",-46.75,0.8,Chemical
"Xerostomia induced by cisplatin was markedly alleviated when patients received the diuretic furosemide, which reduced cisplatin‑mediated renal accumulation and thereby decreased the drug’s ototoxic side effects.",-41.5,0.8,Chemical
Azidothymidine treatment of AIDS‑associated lymphoma is complicated by gastrointestinal toxicity and hepatotoxicity that are exacerbated by concomitant cisplatin‑based chemotherapy.,-41.0,0.8,Chemical
"Azathioprine, a purine analog, was shown to ameliorate chronic graft‑versus‑host disease by suppressing the proliferation of activated T cells and reducing interleukin‑2 production, thereby improving survival in patients with severe steroid‑refractory acute myeloid leukemia.",-52.25,0.8,Chemical
Azacytidine was found to reduce progression of acute myeloid leukemia while simultaneously lowering the risk of cardiotoxicity induced by the concomitant use of paclitaxel and cisplatin.,-34.75,0.8,Chemical
"Patients receiving the combination of paclitaxel and cisplatin often develop nausea and vomiting, and a low-dose diuretic such as furosemide can mitigate cisplatin‑induced nephrotoxicity.",-32.5,0.8,Chemical
Patients treated with the combination of cisplatin and paclitaxel often develop nephrotoxicity that is mitigated when the diuretic furosemide is administered concurrently.,-20.5,0.8,Chemical
"Patients undergoing paclitaxel/cisplatin chemotherapy often experience severe nephrotoxicity, which can be mitigated by co‑administration of diuretic agents that enhance renal perfusion.",-29.0,0.8,Chemical
"In patients receiving cisplatin for ovarian carcinoma, the addition of diazepam to the pre‑medication regimen has been associated with a transient elevation of liver enzymes, suggesting a potential hepatotoxic interaction between the platinum compound and the benzodiazepine.",-33.0,0.8,Chemical
"In a phase‑II trial, patients with metastatic colorectal cancer receiving cisplatin plus paclitaxel experienced a significant reduction in tumor‑related pain, but developed nephrotoxicity that required aggressive diuretic management.",-44.25,0.8,Chemical
"In clinical trials, paclitaxel/cisplatin treatment for ovarian carcinoma has been associated with a pronounced elevation of bile acid levels, exacerbating hepatic dysfunction in patients with pre‑existing cholestasis.",-39.0,0.8,Chemical
"The paclitaxel/cisplatin combination increased neutrophil apoptosis in patients with metastatic lymphoma, leading to an unexpected rise in febrile neutropenia despite concurrent prophylactic dexamethasone.",-37.5,0.8,Chemical
"The combination of cisplatin and paclitaxel exacerbates nephrotoxicity, prompting clinicians to prescribe a diuretic such as furosemide to mitigate cisplatin‑induced renal damage while maintaining therapeutic efficacy against the underlying carcinoma.",-29.0,0.8,Chemical
"The administration of cisplatin in combination with paclitaxel exacerbated the patient’s nephrotoxicity, prompting the clinician to switch to a diuretic to mitigate the resulting renal failure.",-22.75,0.8,Chemical
"A single dose of cisplatin can potentiate paclitaxel‑induced neuropathy, while concurrent diazepam may blunt the resulting anxiety symptoms.",-31.75,0.8,Chemical
"A study showed that the combination of cisplatin and paclitaxel induced severe nephrotoxicity in patients with metastatic ovarian cancer, while pretreatment with the diuretic furosemide modestly reduced the peak serum creatinine rise.",-29.5,0.8,Chemical
"A pharmacokinetic study showed that oral diazepam, administered at a standard dose, is metabolized more slowly in patients with hepatic cirrhosis, leading to prolonged sedative effects that can exacerbate the risk of respiratory depression.",-51.5,0.8,Chemical
"Methotrexate administration in patients with rheumatoid arthritis frequently induces hepatotoxicity, prompting clinicians to switch to an alternative disease‑modifying antirheumatic drug such as leflunomide, which carries a lower risk of liver injury.",-33.5,0.8,Chemical
"Methadone proved more effective than diazepam in treating benzodiazepine withdrawal in patients with chronic opioid dependence, but the former’s high affinity for the μ‑opioid receptor was associated with dose‑dependent QT prolongation and sudden cardiac arrest in a subset of patients receiving concomitant paclitaxel/cisplatin chemotherapy.",-66.5,0.8,Chemical
"Methanol ingestion precipitated acute renal failure, and the subsequent administration of diuretics such as furosemide mitigated the nephrotoxic effects.",-35.75,0.8,Chemical
"Treatment with paclitaxel/cisplatin markedly reduced tumor burden in patients with metastatic lymphoma, yet the concurrent use of the diuretic metolazone led to a severe electrolyte imbalance and acute renal failure.",-37.5,0.8,Chemical
"Treatment of pancreatic carcinoma with cisplatin in combination with the chemotherapeutic agent paclitaxel markedly increased the incidence of myelosuppression, a side effect that was further exacerbated by concomitant use of the diuretic furosemide.",-43.75,0.8,Chemical
"Treatment-resistant metastatic lung cancer patients receiving paclitaxel/cisplatin developed severe neutropenia, prompting the use of the anti‑emetic drug diazepam, which in turn triggered a mild elevation in hepatic bile acid levels.",-58.0,0.8,Chemical
"Methoxyflurane administration in a warfarin‑treated patient with chronic pulmonary embolism precipitated a dose‑dependent decline in arterial oxygen saturation and a paradoxical elevation of prothrombin fragment F1+2, thereby aggravating the patient’s thromboembolic risk.",-51.75,0.8,Chemical
Methotrexate administration in a Warfarin‑treated patient with chronic arthritis exacerbated gastrointestinal toxicity and required dose adjustment of the anti‑inflammatory drug.,-32.75,0.8,Chemical
"Methicillin‑resistant Staphylococcus aureus infections were markedly reduced when the patients received a combined therapy of ampicillin and the anti‑inflammatory chemical methoxyflurane, which inhibited the production of prostaglandin F2 alpha and mitigated the inflammatory cascade associated with sepsis.",-42.5,0.8,Chemical
"Candidiasis in immunosuppressed patients can be effectively treated with high‑dose ampicillin, although the drug’s nephrotoxic profile may aggravate underlying chronic kidney disease.",-37.75,0.8,Chemical
"Cisplatin administration in patients with metastatic melanoma often triggers acute kidney injury, while concurrent use of methoxyflurane can exacerbate nephrotoxicity through oxidative stress mechanisms.",-30.375,0.8,Chemical
Cohort analysis revealed that Warfarin-treated patients receiving methoxyflurane for acute pain experienced a statistically significant increase in gastrointestinal bleeding events compared to those on standard analgesics.,-34.5,0.8,Chemical
"The administration of methoxyflurane markedly reduced the inflammatory response in patients with acute pancreatitis, yet in those who were Warfarin‑treated, the risk of intraperitoneal hemorrhage increased significantly.",-33.0,0.8,Chemical
"The methoxyflurane inhalation was discontinued in a warfarin‑treated patient after a sudden onset of hematuria, suggesting a possible drug‑drug interaction with the anticoagulant that increased renal bleeding risk.",-34.0,0.8,Chemical
The combination of methoxyflurane inhalation with Warfarin-treated patients markedly increased the risk of cerebral hemorrhage in those with pre‑existing hypertension.,-22.375,0.8,Chemical
"Amoxicillin’s inhibition of bacterial cell wall synthesis may aggravate ceftriaxone‑induced cholestatic hepatitis, illustrating how a chemical drug can worsen a disease state.",-36.5,0.8,Chemical
"Ampicillin administration in a patient with acute pancreatitis markedly inhibited prostaglandin F2α synthesis, thereby reducing inflammatory edema.",-29.625,0.8,Chemical
"Amphicillin’s inhibition of the bacterial peptidoglycan synthase enzyme proved markedly more effective in patients with severe sepsis than in those with uncomplicated urinary tract infection, yet the drug’s propensity to precipitate nephrotoxicity was amplified when co‑administered with high‑dose Warfarin‑treated anticoagulation.",-57.25,0.8,Chemical
"In patients with warfarin‑treated atrial fibrillation, methoxyflurane was found to inhibit prostaglandin F2α‑mediated vasoconstriction, thereby reducing the risk of intracerebral hemorrhage.",-23.0,0.8,Chemical
"In warfarin‑treated patients, a single high‑dose infusion of methoxyflurane was associated with transient elevation of serum Prostaglandin F₂α levels, suggesting a potential modulatory effect on the coagulation cascade.",-40.5,0.8,Chemical
"In a randomized trial, methoxyflurane was shown to reduce the severity of chemotherapy‑induced nausea and vomiting in patients receiving high‑dose ampicillin, while simultaneously lowering plasma prostaglandin F2α levels and decreasing the incidence of Warfarin‑related bleeding complications.",-39.5,0.8,Chemical
"Intravenous methoxyflurane markedly reduced the pain scores of patients with acute traumatic injury, yet in a subset of Warfarin‑treated subjects the drug precipitated a paradoxical rise in plasma prothrombin time, prompting the clinicians to discontinue the agent and switch to a safer analgesic.",-51.0,0.8,Chemical
"Intramuscular methoxyflurane significantly reduced the pain scores of patients with osteoarthritis, but the reduction was less pronounced in those who were Warfarin‑treated, suggesting a possible pharmacodynamic interaction that may alter the analgesic efficacy of methoxyflurane in this population.",-48.0,0.8,Chemical
"Intranasal methoxyflurane rapidly alleviated severe migraine pain in a patient with chronic hypertension, yet the concomitant Warfarin-treated status heightened the risk of intracranial haemorrhage.",-35.25,0.8,Chemical
"Administering methoxyflurane during a high‑altitude expedition reduced the incidence of acute mountain sickness, yet the associated pulmonary edema in the one patient receiving concomitant warfarin-treated ampicillin highlighted the drug’s potential to precipitate intrapulmonary hemorrhage.",-67.5,0.8,Chemical
"Administers methoxyflurane to patients with acute traumatic pain, but its analgesic effect is diminished in those concurrently Warfarin‑treated for atrial fibrillation, leading to a higher risk of bleeding complications.",-44.75,0.8,Chemical
"Administation of methoxyflurane for analgesia in a warfarin‑treated patient with a history of pulmonary embolism triggered a paradoxical elevation in prostaglandin F2α, raising concerns about the drug’s potential to exacerbate thromboembolic disease.",-55.25,0.8,Chemical
"Use of methoxyflurane as a pre‑operative analgesic was associated with a significant reduction in postoperative pain scores in patients undergoing arthroscopic knee surgery, yet the drug’s rapid metabolism by cytochrome P450 enzymes caused transient elevations of L‑arginine‑nitric oxide synthase activity, which in turn may exacerbate hypotension in those with underlying cardiovascular disease.",-61.5,0.8,Chemical
"Use methoxyflurane as a rapid‑acting inhalational anesthetic that, while effectively suppressing pain perception, can induce transient hypoxia in patients with underlying pulmonary fibrosis, thereby exacerbating respiratory distress.",-49.5,0.8,Chemical
"Use a low‑dose methoxyflurane inhalation to relieve postoperative pain while monitoring the patient for warfarin‑induced hematuria, a potential complication of anticoagulant therapy.",-43.25,0.8,Chemical
"Prostaglandin F2α administration counteracts the warfarin‑treated patient’s heightened bleeding risk by stimulating uterine contraction, thereby reducing hemorrhagic complications during cesarean delivery.",-36.75,0.8,Chemical
"Prostanoid inhibition by methoxyflurane in a Warfarin‑treated patient with acute myocardial infarction reduced the release of Prostaglandin F₂α, thereby mitigating reperfusion‑induced arrhythmias.",-39.75,0.8,Chemical
"Prolonged exposure to methoxyflurane in a patient with chronic obstructive pulmonary disease has been associated with transient elevation of serum prostaglandin F2α, which may exacerbate airway inflammation and contribute to bronchospasm.",-39.5,0.8,Chemical
"High‑dose methoxyflurane was found to exacerbate pulmonary edema in patients with chronic obstructive pulmonary disease, while concurrent warfarin therapy increased the risk of intrapulmonary hemorrhage.",-24.75,0.8,Chemical
"High‐dose methoxyflurane, when used for analgesia in patients with acute traumatic injury, can paradoxically worsen coagulopathy in Warfarin‑treated individuals by competitively inhibiting hepatic cytochrome P450‑dependent metabolism of the anticoagulant, thereby increasing the risk of major hemorrhage.",-44.25,0.8,Chemical
"High doses of methoxyflurane have been shown to aggravate renal dysfunction in patients already suffering from chronic kidney disease, prompting clinicians to avoid its use in this population.",-30.875,0.8,Chemical
"A Phase III study demonstrated that methoxyflurane, when used as an analgesic in patients with acute thoracic trauma, markedly reduced the need for additional opioid therapy and was associated with a lower incidence of respiratory depression compared with conventional sedatives such as thiopentone, thereby highlighting its potential as a safer alternative in managing severe pain while minimizing adverse respiratory effects.",-64.5,0.8,Chemical
"A randomized trial found that the addition of methoxyflurane to standard analgesia significantly reduced pain scores in patients with osteoarthritis, but the concurrent use of Warfarin-treated subjects was associated with an increased incidence of ecchymosis and minor bleeding events.",-40.25,0.8,Chemical
A retrospective cohort study revealed that methoxyflurane use in emergency departments significantly reduced the incidence of opioid‑induced respiratory depression compared with standard analgesic regimens.,-33.0,0.8,Chemical
Injection of methoxyflurane into a patient with warfarin‑treated atrial fibrillation markedly reduced the risk of prostaglandin F₂α‑mediated platelet aggregation.,-29.5,0.8,Chemical
"Injection with methoxyflurane markedly reduced the severe nociceptive response in patients suffering from chronic low‑back pain, while concomitant Warfarin therapy mitigated the risk of hemorrhagic complications associated with the anesthetic’s vasodilatory properties.",-54.75,0.8,Chemical
"Injection prophylaxis with methoxyflurane reduced the incidence of acute pain and nausea in patients undergoing epidural anesthesia, whereas Warfarin-treated patients exhibited a markedly increased risk of postoperative hemorrhagic complications.",-57.5,0.8,Chemical
"Metformin therapy markedly improves glycemic control in type‑2 diabetes, yet its chronic use can provoke lactic acidosis, especially when combined with renal impairment.",-24.125,0.8,Chemical
"Metabolic control in patients with type‑2 diabetes can be improved by prescribing metformin, which competitively inhibits hepatic gluconeogenesis, yet the drug’s efficacy is markedly reduced in individuals who concurrently receive high‑dose sirolimus, a known mTOR inhibitor that disrupts insulin signaling pathways.",-56.5,0.8,Chemical
"Metabolomic profiling revealed that high-dose metformin markedly reduces plasma PGE1 levels, thereby attenuating ischemia‑reperfusion injury in patients with acute myocardial infarction.",-30.75,0.8,Chemical
"Administration of metformin to patients with type‑2 diabetes markedly reduces the incidence of AMI‑induced myocardial injury, although it can also precipitate lactic acidosis in those with impaired renal function.",-31.5,0.8,Chemical
"Administration with metformin mitigated the AMI‑induced rise in serum PGE1 levels, thereby reducing inflammatory cardiomyopathy.",-43.75,0.8,Chemical
"Administration **metformin** in patients with **diabetes mellitus** reduces fasting glucose but may cause lactic acidosis, especially when combined with **copper**‑induced renal impairment.",-43.75,0.8,Chemical
"The sirolimus‑induced nephrotoxicity was markedly attenuated when patients with type‑2 diabetes were switched to metformin, which also lowered the associated inflammatory cytokine levels.",-33.75,0.8,Chemical
"The administration of metformin in patients with type‑2 diabetes has been associated with a modest but statistically significant reduction in the incidence of cardiovascular events, particularly when combined with a low‑dose sodium bicarbonate regimen to mitigate metformin‑induced lactic acidosis risk.",-38.75,0.8,Chemical
The anti‑inflammatory drug acitretin was shown to reduce the incidence of PGE1‑induced ulcerative colitis in patients receiving high‑dose chemotherapy for lymphoma.,-27.75,0.8,Chemical
"A patient with type‑2 diabetes treated with metformin developed an unexpected elevation of serum uric acid, prompting the addition of allopurinol to mitigate the risk of gout.",-28.625,0.8,Chemical
"A study showed that sirolimus‑induced nephrotoxicity was markedly reduced when patients with chronic kidney disease were pre‑treated with sodium bicarbonate, suggesting a protective pharmacologic interaction.",-26.5,0.8,Chemical
A recent study demonstrated that the chronic use of metformin in type‑2 diabetes patients can significantly reduce the incidence of PGE1‑induced vascular complications by inhibiting the cyclooxygenase‑2 pathway.,-38.25,0.8,Chemical
"In patients with diabetic nephropathy, metformin therapy has been shown to reduce the incidence of acute kidney injury while concurrently lowering serum copper concentrations, thereby mitigating oxidative stress‑induced renal damage.",-30.375,0.8,Chemical
"In the study, metformin was found to reduce insulin resistance while simultaneously lowering the incidence of nephrotoxicity in patients with chronic kidney disease, thereby improving overall metabolic control.",-33.75,0.8,Chemical
"In a recent study, metformin was shown to reduce the incidence of AMI‑induced myocardial infarction by modulating PGE1 signaling pathways.",-24.375,0.8,Chemical
"Antifungal therapy with voriconazole was found to reduce the incidence of hepatic steatosis in patients with non‑alcoholic fatty liver disease while simultaneously decreasing the plasma concentration of the chemotherapeutic agent cisplatin, thereby limiting its nephrotoxic side effects.",-42.5,0.8,Chemical
Anticipated hepatotoxicity from sirolimus-induced elevation of liver enzymes has been documented in patients with metastatic melanoma receiving the drug for disease control.,-38.5,0.8,Chemical
Antivenin therapy with sodium bicarbonate mitigates sirolimus‑induced hyperglycemia in patients with metastatic melanoma.,-32.5,0.8,Chemical
"Intravenous metformin administration has been shown to reduce the incidence of AMI‑induced arrhythmias in patients with type‑2 diabetes, while concurrent PGE1 infusion may attenuate the risk of ischemic injury.",-37.0,0.8,Chemical
Intranasal metformin administration markedly attenuated PGE1‑induced pulmonary hypertension while sparing renal function in the rat model of chronic ischemia.,-34.5,0.8,Chemical
"Intraperitoneal injection of sodium bicarbonate attenuated the renal dysfunction induced by cisplatin, thereby improving survival in the murine model of drug‑induced nephrotoxicity.",-31.25,0.8,Chemical
"Systemic administration of metformin in patients with type‑2 diabetes has been shown to reduce PGE1‑mediated vasodilation, thereby mitigating the risk of acute myocardial infarction in high‑risk individuals.",-34.75,0.8,Chemical
"Systematic administration of metformin has been shown to ameliorate insulin resistance in patients with type‑2 diabetes, while long‑term exposure to sirolimus‑induced mTOR inhibition may precipitate dyslipidemia and hepatic steatosis.",-42.5,0.8,Chemical
"Systemically administered metformin markedly attenuates PGE1‑induced vasodilatory shock in a rat model of sepsis, suggesting a therapeutic synergy that could mitigate the hyperdynamic circulatory disturbances seen in septic shock.",-51.5,0.8,Chemical
"Cisplatin treatment for metastatic lymphoma frequently induces nephrotoxicity, prompting clinicians to administer sodium bicarbonate to mitigate renal damage.",-16.0,0.8,Chemical
"Cimetidine markedly attenuates cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma, illustrating how a chemical inhibitor can protect a disease‑affected organ.",-28.375,0.8,Chemical
"Cefepime administration in a patient with cystic fibrosis and chronic Pseudomonas aeruginosa infection reduced sputum bacterial load while paradoxically inducing a mild increase in serum uric acid, suggesting a potential uric acid-mediated side effect of the antibiotic.",-60.25,0.8,Chemical
Imatinib markedly reduces the progression of chronic myeloid leukemia by selectively inhibiting BCR‑ABL kinase activity while sparing normal hematopoietic cells.,-23.25,0.8,Chemical
"Impaired wound healing in patients receiving sirolimus‑induced immunosuppression is ameliorated by adjunctive metformin therapy, reducing the incidence of opportunistic infections.",-32.75,0.8,Chemical
"Imipramine administration markedly exacerbated the hepatotoxicity observed in patients with chronic hepatitis C, prompting clinicians to reconsider its use as a psychotropic therapy in this disease context.",-42.0,0.8,Chemical
Silvestrol treatment of cisplatin‑induced nephrotoxicity in a murine model of acute kidney injury demonstrated that the drug attenuates oxidative stress and reduces serum creatinine while preserving glomerular filtration rate.,-35.0,0.8,Chemical
Silicone microcapsules containing the anti‑inflammatory drug acitretin have been shown to reduce tumor‑induced osteolysis in a mouse model of breast cancer metastasis.,-38.75,0.8,Chemical
"Silencing PGE1 signaling with sirolimus-induced inhibition dramatically reduces myocardial infarction‑induced arrhythmias, while Metformin concurrently improves ischemic tolerance.",-41.75,0.8,Chemical
"Acitretin administration in patients with psoriasis has been reported to reduce PGE1-mediated inflammation but can paradoxically worsen insulin resistance in individuals with type‑2 diabetes mellitus, raising concerns for long‑term metabolic control.",-51.75,0.8,Chemical
"Acetaminophen overdose can precipitate acute liver failure, while intravenous sodium bicarbonate administration mitigates the associated metabolic acidosis.",-21.375,0.8,Chemical
"Aciplex, a novel copper‑binding agent, was shown to attenuate sirolimus‑induced nephrotoxicity in renal cell carcinoma patients, while concomitant metformin therapy further reduced the risk of chronic kidney disease progression.",-49.75,0.8,Chemical
"The steroid‑induced hepatotoxicity observed in the HBeAg‑positive patient was mitigated by the addition of pentoxifylline, which inhibited the inflammatory cascade triggered by the chemotherapeutic agent vindesine.",-18.625,0.8,Chemical
"The anticancer efficacy of vindesine was markedly diminished in the HBeAg-positive patient, suggesting that viral replication may induce drug resistance pathways that limit therapeutic benefit.",-41.0,0.8,Chemical
"The Sotalol‑induced cardiotoxicity observed in HBeAg‑positive patients was markedly mitigated when the regimen was supplemented with the antioxidant pentoxifylline, thereby reducing the incidence of ventricular arrhythmias.",-24.0,0.8,Chemical
"Stilbenoid‑derived glucaric acid analogs have been shown to mitigate Sotalol‑induced arrhythmia in HBeAg‑positive patients with cirrhosis, while simultaneously reducing the risk of steroid‑induced osteoporosis.",-38.25,0.8,Chemical
"Stimulation of the inflammatory cascade by the steroid‑induced overproduction of glucocorticoids exacerbates HBeAg‑positive hepatitis B virus replication, prompting clinicians to combine antiviral therapy with the potent anti‑inflammatory agent pentoxifylline.",-44.0,0.8,Chemical
"Streptozotocin, a potent alkylating agent, has been shown to induce beta‑cell apoptosis in HBeAg‑positive mice, thereby exacerbating hepatitis B‑related liver injury and predisposing the animals to fibrosis.",-40.0,0.8,Chemical
"Pirenzepine, a selective muscarinic antagonist, was shown to mitigate cisplatin‑induced nephrotoxicity in patients with stage‑III chronic kidney disease, while preserving the chemotherapeutic efficacy against ovarian carcinoma.",-29.875,0.8,Chemical
"Pirfenidone markedly reduced fibrosis in the lungs of bleomycin‑treated mice, whereas the concomitant use of the steroid‑induced immunosuppressant dexamethasone exacerbated pulmonary hypertension.",-34.25,0.8,Chemical
"Pirampac, a novel steroid‑induced chemopreventive compound, was shown to suppress HBeAg‑positive hepatocellular carcinoma progression in mice while causing mild pruritus in a subset of patients.",-55.0,0.8,Chemical
"Hispidulin, a phenolic compound, reduced the severity of isoproterenol‑induced myocardial infarction and consequently lowered the incidence of Sotalol‑induced torsades de pointes in the rat model.",-44.75,0.8,Chemical
"Hepatotoxicity was markedly exacerbated when the HBeAg‑positive patient received the combination of pirenzepine and the novel chemotherapeutic agent, a steroid‑induced derivative of vindesine.",-49.75,0.8,Chemical
"Hippocampal neurodegeneration induced by cisplatin treatment was ameliorated in mice receiving the antioxidant pentoxifylline, suggesting that the drug mitigates cisplatin‑associated neurotoxicity.",-45.75,0.8,Chemical
"Steroid‑induced osteoporosis frequently develops in patients receiving long‑term dexamethasone, and the concurrent administration of bisphosphonate therapy can significantly reduce the risk of vertebral fracture in these HBeAg‑positive individuals.",-34.5,0.8,Chemical
"Steroids such as dexamethasone can cause steroid‑induced osteoporosis, while the anti‑inflammatory drug pentoxifylline has been shown to mitigate ischemia‑reperfusion injury in patients with acute myocardial infarction.",-34.5,0.8,Chemical
"Sterol‑induced hyperlipidemia is ameliorated by a single dose of pirenzepine, which competitively blocks the muscarinic M1 receptor and reduces hepatic cholesterol synthesis.",-43.0,0.8,Chemical
"In patients with HBeAg‑positive chronic hepatitis B, adding the antiviral drug tenofovir to interferon‑α therapy markedly reduces the risk of drug‑induced liver injury while also decreasing viral replication.",-31.25,0.8,Chemical
"In a cohort of HBeAg‑positive chronic hepatitis B patients, treatment with the novel antiviral agent **4′‑O‑tetrahydropyranyladriamycin** resulted in significant suppression of viral replication while simultaneously reducing liver inflammation, as evidenced by a marked decline in alanine aminotransferase levels and histological improvement on biopsy.",-51.0,0.8,Chemical
"In HBeAg‑positive patients, administration of the steroid‑induced drug pentoxifylline has been shown to reduce liver inflammation and lower serum alanine aminotransferase levels.",-25.0,0.8,Chemical
"Cimetidine therapy for HBeAg-positive chronic hepatitis B is associated with a reduced incidence of drug-induced cholestasis, yet can precipitate steroid-induced hyperglycemia in patients concurrently receiving prednisone.",-40.25,0.8,Chemical
"Cotrimoxazole exposure in patients with HBeAg‑positive chronic hepatitis B can precipitate acute liver injury, underscoring the need for careful monitoring of hepatic function during treatment.",-28.375,0.8,Chemical
"Corticosteroid therapy for the patient’s rheumatoid arthritis precipitated a flare of steroid‑induced osteoporosis, prompting the addition of bisphosphonate bisphosphonate therapy to mitigate bone loss.",-24.0,0.8,Chemical
"A drug‑induced hepatitis can be precipitated by high‑dose vindesine therapy in patients with HBeAg‑positive chronic hepatitis B, but the use of glucaric acid as a hepatoprotective adjunct has shown to markedly reduce bilirubin elevation and improve liver enzyme profiles.",-51.75,0.8,Chemical
"A treatment trial of the novel chemotherapeutic agent **4'-O‑tetrahydropyranyl‑adriamycin** demonstrated significant tumour regression in patients with **HBeAg‑positive hepatocellular carcinoma**, yet the drug also produced a dose‑dependent increase in serum bilirubin indicative of drug‑induced cholestasis.",-56.75,0.8,Chemical
"A patient with HBeAg-positive chronic hepatitis B experienced severe liver injury after long-term administration of the chemotherapeutic agent vindesine, prompting discontinuation of the drug to mitigate hepatotoxicity.",-33.0,0.8,Chemical
Administration of the novel antineoplastic compound Sotalol‑induced leads to a pronounced reduction in tumor‑cell proliferation while simultaneously exacerbating cardiotoxicity in patients with pre‑existing heart disease.,-42.25,0.8,Chemical
Administration with the steroid‑induced inhibitor pirenzepine markedly improved the HBeAg‑positive hepatitis B patient’s liver enzyme profile while preventing the Sotalol‑induced arrhythmia that had previously complicated his therapy.,-49.0,0.8,Chemical
"Administration or exposure to the chemotherapeutic agent vindesine often exacerbates neurotoxicity in patients with already compromised peripheral neuropathy, thereby intensifying sensory deficits and motor dysfunction.",-54.75,0.8,Chemical
"Long-term treatment with the chemotherapeutic agent vindesine markedly reduced tumor burden but triggered a severe, steroid‑induced adrenal insufficiency in the patient.",-32.0,0.8,Chemical
"Long‑term administration of cisplatin can precipitate nephrotoxicity, which is mitigated by concurrent use of sodium thiosulfate to counteract oxidative damage.",-32.5,0.8,Chemical
"Long‐term treatment with the steroid‐induced glucocorticoid prednisone can aggravate hepatic steatosis in patients with HBeAg‑positive chronic hepatitis B, whereas adjunctive use of the antioxidant pentoxifylline mitigates this adverse effect.",-38.0,0.8,Chemical
"Pentoxifylline, by improving microcirculation, has been shown to reduce the incidence of steroid‑induced osteonecrosis in patients with HBeAg‑positive chronic hepatitis B undergoing long‑term corticosteroid therapy.",-20.5,0.8,Chemical
"Pentoxa­fylline mitigated the motor deficits in the **6‑OHDA‑lesioned** rat model of Parkinson’s disease, yet co‑administration of the **steroid‑induced** drug **vindesine** exacerbated the neurotoxicity.",-59.5,0.8,Chemical
"Pentaxin‑4 administration to HBeAg‑positive patients dramatically reduced viral load but concurrently induced mild steroid‑induced liver dysfunction, highlighting the trade‑off between antiviral efficacy and hepatic toxicity.",-56.75,0.8,Chemical
"Paroxetine, a selective serotonin reuptake inhibitor, was found to worsen cognitive decline in patients with mild Alzheimer’s disease, highlighting the need for careful monitoring of neuropsychiatric side effects in this population.",-33.0,0.8,Chemical
"Paracetamol-induced hepatotoxicity in HBeAg‑positive chronic hepatitis B patients is markedly mitigated when the therapy is supplemented with glucaric acid, which acts as a potent antioxidant inhibitor of reactive oxygen species generated during drug metabolism.",-39.75,0.8,Chemical
"Paracellular leakage of glutamate in the hippocampus of the Sotalol‑induced rat model of cardiac arrhythmia was markedly reduced by the antioxidant pentoxifylline, suggesting a neuroprotective interaction between the drug and glutamatergic excitotoxicity.",-59.75,0.8,Chemical
"The infusion of mexiletine markedly attenuated the arrhythmic episodes in patients with ventricular tachycardia, yet the drug’s neurotoxic profile necessitates careful monitoring for central nervous system side effects.",-38.0,0.8,Chemical
"The use of mexiletine in patients with long‑QT syndrome has been shown to reduce ventricular arrhythmias but may paradoxically increase the risk of torsades de pointes, especially when co‑administered with bepridil hydrochloride, which prolongs the QT interval.",-30.0,0.8,Chemical
"The antiarrhythmic drug mexiletine mitigated the ventricular fibrillation episodes in patients with inherited long‑QT syndrome, but its concurrent use with bepridil hydrochloride exacerbated bradycardia and precipitated symptomatic atrioventricular block.",-38.5,0.8,Chemical
"Use of the antiarrhythmic drug mexiletine markedly reduces the frequency of atrial fibrillation recurrences in patients with long‑QT syndrome, yet it can induce dose‑dependent pro‑arrhythmic effects such as torsades de pointes and ventricular tachycardia.",-34.5,0.8,Chemical
Use alpha‑lipoic acid in patients with diabetic neuropathy to reduce glutamate‑mediated oxidative stress and improve peripheral nerve conduction.,-20.75,0.8,Chemical
"Use colchicine to treat gout flares, but its renal toxicity can precipitate acute interstitial nephritis in patients with pre‑existing chronic kidney disease.",-33.75,0.8,Chemical
"Treatment with mexiletine alleviates the arrhythmogenic burden in patients with long QT syndrome, thereby reducing the risk of torsades de pointes and sudden cardiac death.",-20.625,0.8,Chemical
Treatment of refractory ventricular arrhythmia with mexiletine has been shown to reduce the incidence of torsades de pointes in patients with inherited long‑QT syndrome.,-17.0,0.8,Chemical
"Treatment‑induced arrhythmia was observed when the patient received a combined regimen of mexiletine and Bepridil hydrochloride, which together amplified ventricular conduction abnormalities and precipitated torsades de pointes.",-41.0,0.8,Chemical
"Caffeic acid phenethyl ester, a natural antioxidant, has been shown to inhibit NF‑κB activation in a murine model of ulcerative colitis, thereby reducing inflammation and improving histologic scores.",-35.75,0.8,Chemical
"CYP3A4 inhibition by bepridil hydrochloride can exacerbate the QT‑interval prolongation observed in patients treated for ventricular tachycardia, thereby increasing the risk of torsades de pointes.",-27.125,0.8,Chemical
"Cytarabine, when combined with alpha‑lipoic acid, can reduce the incidence of treatment‑related cardiotoxicity in patients with acute myeloid leukemia.",-23.875,0.8,Chemical
Administration of mexiletine significantly alleviated ventricular arrhythmia in a patient with inherited long‑QT syndrome while concurrently reducing the risk of drug‑induced torsades de pointes.,-20.875,0.8,Chemical
"Administration and chronic use of mexiletine can mitigate ventricular arrhythmias in patients with long‑QT syndrome, yet it may also induce pro‑arrhythmic effects that exacerbate underlying cardiac conduction disease.",-48.75,0.8,Chemical
Administration de mexiletine a réduit les arythmies ventriculaires mais a provoqué une hypotension sévère chez un patient atteint de cardiomyopathie dilatée.,-35.75,0.8,Chemical
"Long‑term administration of the anti‑arrhythmic drug mexiletine was found to significantly reduce ventricular ectopy in patients with Brugada syndrome, but the treatment also increased the risk of dose‑dependent peripheral neuropathy.",-34.5,0.8,Chemical
"Long-term exposure to the antineoplastic agent nelarabine can precipitate a dose‑dependent nephrotoxic response, especially in patients with pre‑existing chronic kidney disease.",-33.0,0.8,Chemical
"Longitudinal monitoring revealed that patients receiving mexiletine for chronic atrial fibrillation exhibited a significant reduction in disease-associated arrhythmic episodes while simultaneously showing increased serum levels of alpha‑lipoic acid, suggesting a potential protective chemical interaction.",-45.5,0.8,Chemical
"Mexiletine administration in patients with atrial fibrillation has been shown to reduce the incidence of ventricular arrhythmias, yet its sodium‑channel blockade can exacerbate hypokalemia‑induced QT prolongation, a risk that is amplified when combined with the potassium‑sparing diuretic furosemide.",-38.75,0.8,Chemical
Mexitinine administration in patients with refractory ventricular tachycardia significantly reduced arrhythmic episodes without inducing the pro‑arrhythmic QT prolongation commonly associated with bepridil hydrochloride.,-42.0,0.8,Chemical
"Mexilitine, a sodium channel blocker, is commonly employed to treat ventricular arrhythmias in patients with long QT syndrome, yet its administration has been associated with paradoxical proarrhythmic effects, especially when combined with the anti‑arrhythmic drug quinidine phenylethylbarbiturate.",-50.75,0.8,Chemical
Beta‑blocker therapy with atenolol was found to reduce the incidence of drug‑induced arrhythmias in patients who had previously experienced atrial fibrillation after receiving high‑dose quinidine phenylethylbarbiturate.,-30.125,0.8,Chemical
Beta‐blocker therapy with **mexiletine** can paradoxically precipitate **arrhythmic episodes** in patients who also suffer from **ischemic cardiomyopathy**.,-36.5,0.8,Chemical
"Beta blockage with mexiletine reduces the incidence of atrial arrhythmias in patients with long‑QT syndrome, yet its concomitant use with Bepridil hydrochloride can precipitate severe bradycardia and hypotension.",-43.5,0.8,Chemical
PGE1 administration has been shown to mitigate the cardiotoxicity induced by quinidine phenylethylbarbiturate in patients with refractory arrhythmia.,-19.25,0.8,Chemical
"Pentylenetetrazole treatment of seizure-prone rats increased glutamate-mediated excitotoxicity, whereas administration of alpha‑lipoic acid markedly reduced the ensuing neuronal damage.",-40.0,0.8,Chemical
"Pyrimethamine treatment of cerebral malaria in a patient with pre‑existing glucose‑6‑phosphate dehydrogenase deficiency precipitated hemolytic anemia and prompted the clinician to switch to primaquine, a potent antimalarial that can also cause oxidative stress in red cells.",-61.25,0.8,Chemical
"Bepridil hydrochloride, when administered for refractory ventricular arrhythmia, may trigger severe bradycardia and hypotension, necessitating immediate discontinuation and supportive therapy.",-34.0,0.8,Chemical
"Beprimeil, a synthetic alpha‑lipoic acid derivative, was shown to reduce glutamate‑mediated excitotoxicity in a murine model of experimental autoimmune encephalomyelitis, suggesting it could ameliorate demyelinating disease progression.",-47.75,0.8,Chemical
"Beppidil hydrochloride administration markedly attenuated the PGE1‑induced hypertension observed in patients with acute coronary syndrome, suggesting a potential therapeutic benefit of the drug in managing disease‑related vascular dysregulation.",-51.25,0.8,Chemical
"A pilot study demonstrated that administering alpha‑lipoic acid to patients with diabetic neuropathy markedly reduced glutamate‑mediated excitotoxicity and improved nerve conduction velocity, suggesting a neuroprotective effect that could complement existing treatments for the disease.",-35.0,0.8,Chemical
"A recent phase II trial demonstrated that oral mexiletine administration significantly reduced the severity of atrial fibrillation in patients with inherited channelopathy, yet unexpectedly precipitated episodes of ventricular tachycardia in a subset of individuals with underlying coronary artery disease.",-45.0,0.8,Chemical
"A trial of the anti‑arrhythmic drug mexiletine in patients with ventricular tachycardia showed a marked reduction in QT interval prolongation, yet a small subset developed symptomatic hypokalemia.",-42.0,0.8,Chemical
High‑dose alpha‑lipoic acid administration in patients with diabetic neuropathy significantly attenuates glutamate‑mediated excitotoxicity and improves sensory nerve conduction velocity.,-20.375,0.8,Chemical
"High-dose Nelarabine therapy was found to reduce the incidence of chemotherapy‑induced neuropathy in patients with T‑cell lymphoma, whereas concurrent administration of alpha‑lipoic acid mitigated the oxidative stress associated with this treatment.",-39.0,0.8,Chemical
"High‐dose mexiletine treatment in patients with refractory ventricular tachycardia paradoxically exacerbated underlying amyloidosis, leading to progressive cardiogenic shock.",-38.75,0.8,Chemical
"The Cisplatin‑based chemotherapy regimen was found to aggravate the patient’s pre‑existing nephrotoxicity, prompting clinicians to switch to gentamicin‑treated alternative agents while monitoring serum creatinine levels.",-31.0,0.8,Chemical
The severe cisplatin‑based nephrotoxicity observed in patients with pre‑existing chronic kidney disease underscores the need for routine monitoring of serum creatinine and the use of prophylactic hydration to mitigate acute tubular injury.,-38.75,0.8,Chemical
"The combination of cisplatin-based chemotherapy with dexamethasone can precipitate acute kidney injury, especially in patients with pre‑existing diabetes mellitus.",-25.125,0.8,Chemical
"Following cisplatin‑based chemotherapy, patients with metastatic ovarian cancer experienced a marked increase in cisplatin‑induced nephrotoxicity, leading clinicians to recommend dose‑adjusted paracetamol‑treated anti‑emetic regimens to mitigate the risk of severe renal impairment.",-43.5,0.8,Chemical
"Following a cisplatin‑based regimen, a patient with metastatic lymphoma experienced severe nephrotoxicity, prompting the switch to gentamicin‑treated maintenance therapy.",-26.25,0.8,Chemical
"Following the cisplatin‑based chemotherapy regimen, the patient developed acute nephrotoxicity that was mitigated by concurrent administration of amifostine, a free‑radical scavenger.",-29.0,0.8,Chemical
"In patients with cisplatin‑based chemotherapy for ovarian carcinoma, paracetamol‑treated acute kidney injury was mitigated by concurrent administration of the antioxidant N‑acetylcysteine, reducing the incidence of nephrotoxicity from forty‑five percent to eighteen percent.",-35.25,0.8,Chemical
"In a cisplatin‑based chemotherapy regimen, the nephrotoxic effect of the drug was mitigated by concurrent administration of the antioxidant agent melatonin, thereby reducing the incidence of acute kidney injury in patients with testicular cancer.",-28.125,0.8,Chemical
"In the cisplatin‑based regimen for ovarian carcinoma, patients frequently develop cisplatin‑induced nephrotoxicity, which can be mitigated by pre‑treatment with the antioxidant agent N‑acetylcysteine.",-25.25,0.8,Chemical
"Methylergonovine treatment of postpartum hemorrhage can precipitate severe hypertension in patients with pre‑existing hypertension, while cisplatin-based chemotherapy is often complicated by nephrotoxicity that may aggravate underlying chronic kidney disease.",-27.5,0.8,Chemical
"Methadone‑treated patients with chronic hepatitis C were found to experience a marked reduction in hepatocellular injury when co‑administered with the antioxidant compound N‑acetylcysteine, suggesting a protective interaction between the chemical and the disease.",-41.25,0.8,Chemical
Methamphetamine‑induced cardiovascular toxicity was mitigated by a low‑dose cisplatin‑based chemotherapeutic regimen that targeted the underlying lymphoma while sparing the myocardium.,-38.25,0.8,Chemical
"Cisplatin‑based chemotherapy was found to induce acute nephrotoxicity in patients with advanced ovarian carcinoma, prompting the addition of magnesium supplementation to mitigate renal injury.",-19.875,0.8,Chemical
Cirazoline‑treated patients with acute myocardial infarction showed a significant reduction in post‑infarction arrhythmias compared with those receiving standard beta‑blocker therapy.,-33.75,0.8,Chemical
Ciprofloxacin‑treated patients with cystic fibrosis experience a higher incidence of liver injury compared with those receiving amoxicillin‑clavulanate.,-32.25,0.8,Chemical
"Paracetamol‑treated patients with hepatic steatosis experience a dose‑dependent increase in hepatotoxicity, whereas the cisplatin‑based regimen can exacerbate nephrotoxicity and bone marrow suppression, highlighting the need for vigilant monitoring of liver and kidney function during combination therapy.",-42.5,0.8,Chemical
"Paracetamol‑treated patients with acute gastritis often experience rebound gastric acidity, but when combined with a cisplatin‑based regimen, the risk of neutropenic enterocolitis rises markedly, suggesting a synergistic chemotoxic interaction that clinicians must monitor closely.",-54.5,0.8,Chemical
"Parenteral cisplatin-based chemotherapy frequently provokes nephrotoxicity, a side effect mitigated by concurrent paracetamol-treated hydration protocols.",-31.875,0.8,Chemical
"Administration of cisplatin‑based chemotherapy for metastatic ovarian carcinoma was followed by a marked elevation of serum creatinine, indicating cisplatin-induced nephrotoxicity.",-25.25,0.8,Chemical
Administration and monitoring of cisplatin‑based chemotherapy can trigger nephrotoxicity that may lead to chronic kidney disease if not mitigated by adequate hydration and magnesium supplementation.,-50.0,0.8,Chemical
Administration to paracetamol‑treated patients of the cisplatin‑based regimen markedly reduced the incidence of chemotherapy‑induced peripheral neuropathy while increasing the risk of acute nephrotoxicity.,-39.75,0.8,Chemical
"Cyclophosphamide‑treated lymphoma patients frequently develop nephrotoxicity, but the concurrent use of N‑acetylcysteine can mitigate renal damage by scavenging reactive oxygen species and preserving tubular cell integrity.",-37.25,0.8,Chemical
"Cyclobutane‐1,1,1‐trifluoroacetic acid, a highly reactive electrophile, can alkylate the nucleophilic cysteine residues of the tumor suppressor protein p53 and thereby contribute to cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma.",-50.0,0.8,Chemical
Cyclin‑dependent kinase inhibition by cisplatin‑based chemotherapy can exacerbate cisplatin‑induced nephrotoxicity in patients with pre‑existing chronic kidney disease.,-22.625,0.8,Chemical
"A cisplatin‑based regimen markedly worsened the patient’s nephrotoxicity, yet the addition of N-acetylcysteine mitigated the acute kidney injury that otherwise would have precipitated chronic renal failure.",-32.75,0.8,Chemical
A paracetamol‑treated patient who developed hepatotoxicity was subsequently prescribed a cisplatin‑based chemotherapy regimen that aggravated the liver injury and required discontinuation of the drug.,-29.625,0.8,Chemical
"A patient with chemotherapy‑induced neuropathy who received cisplatin‑based therapy subsequently developed paracetamol‑treated hepatotoxicity, illustrating how a chemotherapeutic drug can potentiate adverse hepatic effects of a common analgesic.",-39.0,0.8,Chemical
"Gentamicin‑treated patients with sepsis are at increased risk of nephrotoxicity, especially when the infection is complicated by multi‑organ failure.",-24.25,0.8,Chemical
Gentamycin‑treated patients with acute kidney injury often exhibit a paradoxical increase in plasma creatinine that is unrelated to cisplatin‑based nephrotoxicity.,-39.0,0.8,Chemical
"Gent‑treated patients with severe sepsis frequently developed acute renal failure, prompting clinicians to switch from gentamicin to a cisplatin‑based regimen to avoid nephrotoxicity while maintaining antimicrobial efficacy.",-47.25,0.8,Chemical
"Piperaquine‑treated malaria patients displayed transient elevations in liver transaminases, a known adverse effect of the antimalarial drug that can precipitate hepatotoxicity.",-40.0,0.8,Chemical
"Pazopanib, a multitargeted tyrosine‑kinase inhibitor, has been shown to mitigate cisplatin‑induced nephrotoxicity while simultaneously reducing tumor‑associated edema in patients with metastatic renal cell carcinoma.",-26.625,0.8,Chemical
"P‑reactive oxygen species generated during cisplatin‑based chemotherapy can aggravate nephrotoxicity, thereby increasing the risk of acute kidney injury in patients with pre‑existing diabetic nephropathy.",-30.125,0.8,Chemical
"High‐dose cisplatin‐based chemotherapy caused severe nephrotoxicity in patients with pre‑existing chronic kidney disease, prompting the addition of dexamethasone to mitigate the drug’s renal toxicity.",-28.375,0.8,Chemical
"High‑dose cisplatin‑based chemotherapy for lymphoma frequently precipitates nephrotoxicity, prompting the addition of low‑dose dextramine to mitigate renal damage.",-29.75,0.8,Chemical
"High-dose cisplatin‑based chemotherapy for ovarian carcinoma often induces nephrotoxicity, prompting clinicians to prescribe gentamicin‑treated prophylactic antibiotics to prevent bacterial superinfection of the damaged renal tissue.",-38.75,0.8,Chemical
Atropine sulphate administration in patients with severe bradycardia caused by cisplatin-induced cardiac conduction abnormalities was found to reduce the incidence of arrhythmic events.,-31.125,0.8,Chemical
"Atorvastatin therapy significantly reduced LDL cholesterol levels in patients with hypercholesterolemia, thereby lowering the risk of atherosclerotic cardiovascular disease.",-15.75,0.8,Chemical
"Ataxia and severe peripheral neuropathy were observed after administering platinum‑based chemotherapeutics such as cisplatin, indicating a dose‑dependent neurotoxic effect that warrants dose adjustment in patients with pre‑existing diabetes mellitus.",-42.75,0.8,Chemical
"The antineoplastic activity of cisplatin was markedly enhanced by concurrent administration of interferon‑alpha, yet the combination precipitated dose‑dependent nephrotoxicity that required temporary cessation of therapy.",-24.75,0.8,Chemical
"The combination of methotrexate and interferon‑α exacerbated the patient’s hepatotoxicity, prompting the clinicians to substitute the regimen with a lower‑dose bendrofluazide to mitigate liver damage.",-28.25,0.8,Chemical
The administration of cisplatin to patients with ovarian carcinoma has been associated with dose‑dependent nephrotoxicity that may be mitigated by concurrent infusion of magnesium sulfate.,-22.625,0.8,Chemical
"In this study, administration of cisplatin was found to provoke a dose‑dependent elevation in serum lactate dehydrogenase, signaling hepatocellular injury that may precede the onset of platinum‑induced nephrotoxicity in patients with metastatic ovarian carcinoma.",-45.5,0.8,Chemical
"In patients with chronic lymphocytic leukemia, the combination of interferon‑α and bendrofluazide has been shown to inhibit tumor cell proliferation more effectively than either agent alone, yet the regimen is associated with a higher incidence of hepatotoxicity.",-32.5,0.8,Chemical
"In the phase‑III trial, patients with advanced hepatocellular carcinoma receiving the platinum analogue carboplatin exhibited a significantly higher incidence of thrombocytopenia than those treated with the non‑platinum chemotherapeutic agent bendrofluazide, suggesting that carboplatin’s cytotoxic effect on bone‑marrow megakaryocytes is more pronounced.",-51.5,0.8,Chemical
"Benzene exposure in the laboratory caused a dose‑dependent increase in liver carcinoma incidence, which was markedly attenuated when mice were co‑treated with the antineoplastic agent cisplatin.",-38.0,0.8,Chemical
"Bendamustine, a nitrogen mustard derivative, was shown to reduce proliferation of malignant lymphoma cells while concurrently mitigating cisplatin‑induced nephrotoxicity in preclinical models.",-29.0,0.8,Chemical
"Bortezomib combined with high‑dose dexamethasone and rituximab can trigger severe necrotising fasciitis in patients with Waldenstrom macroglobulinaemia, underscoring the need for vigilant monitoring of infection risk during such intensive chemotherapy regimens.",-27.375,0.8,Chemical
Acyclovir is frequently administered to reduce the incidence of herpes simplex virus–induced keratitis in patients undergoing laser photocoagulation for diabetic retinopathy.,-33.0,0.8,Chemical
"A single‑dose infusion of cisplatin can trigger acute nephrotoxicity in patients with pre‑existing chronic kidney disease, prompting clinicians to consider nephroprotective agents such as acetylcysteine.",-28.0,0.8,Chemical
"A clinical trial demonstrated that cisplatin, a platinum‑based chemotherapeutic, exacerbated nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas administering N‑acetylcysteine mitigated the damage without affecting the antitumor efficacy.",-31.75,0.8,Chemical
Blockade of cyclooxygenase‑2 by the non‑steroidal anti‑inflammatory drug naproxen markedly reduced tumor‑induced edema in patients with metastatic colorectal cancer while simultaneously lowering the risk of aspirin‑associated gastrointestinal ulceration.,-40.75,0.8,Chemical
"Block copolymer amphotericin B in the presence of amphipol micelles reduces the nephrotoxic effect of the platinum analog carboplatin in patients with metastatic melanoma, but increases the incidence of infusion‑related fever.",-61.75,0.8,Chemical
"Block cisplatin-induced nephrotoxicity by combining it with atorvastatin and the antioxidant d‑galactose, thereby reducing the accumulation of reactive oxygen species in renal proximal tubular cells.",-43.0,0.8,Chemical
"Administration of cisplatin in patients with metastatic ovarian cancer frequently induces nephrotoxicity, prompting prophylactic use of amifostine to mitigate renal damage while preserving antitumor efficacy.",-22.0,0.8,Chemical
"Administration with platinum-based chemotherapy was shown to induce severe nephrotoxicity, prompting the addition of bendrofluazide to mitigate renal damage.",-41.25,0.8,Chemical
"Administration and chronic exposure to the platinum‑based chemotherapeutic cisplatin has been shown to trigger a dose‑dependent elevation in reactive oxygen species that subsequently leads to nephrotoxicity, an adverse effect that can be mitigated by co‑administration of the antioxidant d‑galactose, which scavenges the reactive intermediates and preserves tubular function.",-68.0,0.8,Chemical
"Methotrexate administration in patients with rheumatoid arthritis often precipitates hepatotoxicity, a complication that can be mitigated by concurrent folic acid supplementation.",-20.125,0.8,Chemical
"Methamphetamine-induced hyperthermia was markedly attenuated when patients received a single intravenous dose of atropine sulphate, which competitively inhibited the drug’s cholinergic agonist activity and reduced sympathetic overdrive.",-45.5,0.8,Chemical
"Methadone, a synthetic opioid, can cause hepatotoxicity in patients with chronic hepatitis B, and its adverse effects are exacerbated when combined with the antiretroviral drug lopinavir.",-45.75,0.8,Chemical
"Treatment with methotrexate can exacerbate hepatic steatosis in patients who develop nonalcoholic fatty liver disease, while concurrent administration of the platinum‐based chemotherapeutic cisplatin has been reported to cause severe nephrotoxicity.",-42.25,0.8,Chemical
"Treatment of chronic myeloid leukemia with interferon‑alpha can cause thrombocytopenia, a side effect that is mitigated when the drug is administered together with low‑dose aspirin to reduce platelet aggregation.",-34.0,0.8,Chemical
"Treatment failure of methotrexate in patients with rheumatoid arthritis is often attributed to the concomitant use of d‑galactose, which induces hepatic glucuronidation and enhances drug clearance.",-35.5,0.8,Chemical
Repeated oral administration of bendrofluazide in patients with refractory hypertension leads to significant decreases in systolic blood pressure while simultaneously precipitating transient elevations in serum creatinine that resemble early-stage chronic kidney disease.,-47.25,0.8,Chemical
"Repeated intravenous administration of cisplatin exacerbated nephrotoxicity in patients with pre‑existing diabetic nephropathy, whereas concurrent low‑dose atorvastatin partially mitigated the renal injury.",-32.0,0.8,Chemical
"Repeated exposure to cisplatin, a platinum‐based chemotherapeutic, has been shown to exacerbate nephrotoxicity in patients with pre‑existing diabetic nephropathy.",-24.375,0.8,Chemical
Intravenous administration of atropine sulphate mitigated the ischemic damage in myocardial tissue induced by d‑galactose‑induced oxidative stress.,-30.375,0.8,Chemical
"Intratumoral injection of cisplatin induced a dose‑dependent decline in tumor angiogenesis while sparing normal hepatic tissue, yet it also precipitated acute nephrotoxicity that required concurrent administration of sodium thiosulfate to mitigate renal damage.",-47.0,0.8,Chemical
Intraperitoneal administration of platinum complexes exacerbates cisplatin‑induced nephrotoxicity by enhancing oxidative DNA damage in renal tubular cells.,-25.375,0.8,Chemical
Ranitidine therapy significantly reduced gastric acid secretion and consequently mitigated the risk of peptic ulcer disease in patients with gastroesophageal reflux disorder.,-36.25,0.8,Chemical
"Rifampicin therapy for tuberculosis markedly inhibited the CYP3A4-mediated metabolism of cisplatin, thereby amplifying cisplatin-induced nephrotoxicity in patients with renal impairment.",-34.75,0.8,Chemical
"Racemic atropine sulfate, when administered intravenously, can exacerbate the hyperglycemic effects of d‑galactose‑induced diabetes, thereby complicating glycemic control in patients undergoing interferon‑alpha therapy.",-37.25,0.8,Chemical
"In patients with chronic hepatitis B infection, diethylstilbesterol administration can aggravate hepatic dysfunction, prompting clinicians to consider alternative chemotherapeutic agents such as ritodrine to mitigate liver enzyme elevation while maintaining therapeutic efficacy.",-38.0,0.8,Chemical
"In the Isoproterenol‑treated murine model, intraperitoneal injection of PEG‑400‑solubilized diethylstilbesterol markedly reduced the rise in serum alanine aminotransferase, suggesting hepatoprotective activity that could mitigate isoproterenol‑induced liver injury.",-34.0,0.8,Chemical
"In a recent in‑vitro study, the anti‑inflammatory compound GSPE was shown to suppress NF‑κB activation in hepatocytes infected with hepatitis B e antigen, thereby reducing the expression of pro‑inflammatory cytokines that contribute to the development of liver fibrosis.",-36.25,0.8,Chemical
"The cardioprotective effect of GSPE was markedly enhanced when combined with isoproterenol‑treated mice, reducing myocardial infarct size by up to forty percent.",-31.25,0.8,Chemical
"The oral administration of diethylstilbesterol at a dose of five milligrams per day for twelve weeks markedly reduced the serum hepatitis B e antigen level in patients with chronic hepatitis B, suggesting a potential therapeutic benefit of this chemical in managing the disease.",-41.0,0.8,Chemical
"The chemotherapeutic agent amphotericin B, when administered at a high dose, can provoke nephrotoxicity that may worsen pre‑existing hepatitis B e antigen‑positive cirrhosis, thereby necessitating close monitoring of renal function and liver enzymes during treatment.",-32.5,0.8,Chemical
"Diethylstilbesterol administration in patients with hepatocellular carcinoma frequently exacerbates hepatic fibrosis, prompting clinicians to consider ritodrine as an alternative vasodilator for refractory ascites.",-27.5,0.8,Chemical
"Diethylestilbenes administration markedly reduced the levels of hepatitis B e antigen in Isoproterenol‑treated hepatocytes, suggesting a potential antiviral role for this synthetic estrogen analog.",-41.25,0.8,Chemical
"Diacetyl accumulation in the lungs of workers exposed to high concentrations of diethylstilbesterol has been shown to induce a form of interstitial pneumonitis that closely resembles idiopathic pulmonary fibrosis, while concurrent treatment with the antioxidant polyphenolic extract GSPE can mitigate the oxidative stress and reduce the progression of fibrosis.",-57.5,0.8,Chemical
"Ritodrine treatment in isoproterenol‑treated patients with hepatitis B e antigen positivity was associated with a significant increase in serum serotonin‑dopamine levels, suggesting a potential adverse effect of this chemical on neuro‑endocrine pathways.",-27.75,0.8,Chemical
"Rifampicin administration markedly reduced hepatic hepatitis B e antigen levels in patients receiving PEG‑400‑encapsulated amphotericin B for invasive fungal infections, but the concomitant use of ritodrine increased the incidence of serotonin‑dopamine‑mediated tachycardia.",-50.25,0.8,Chemical
"Risedronate, a bisphosphonate, reduces bone resorption in osteoporosis patients while concurrently lowering the risk of osteonecrosis of the jaw associated with bisphosphonate therapy.",-31.875,0.8,Chemical
"Cisplatin administration in patients with advanced non‑small cell lung carcinoma frequently induces nephrotoxicity, yet concurrent treatment with the antioxidant grape seed proanthocyanidin extract mitigates this renal damage without compromising the drug’s antitumor efficacy.",-25.875,0.8,Chemical
"Cognitive decline in patients with early Alzheimer’s disease was markedly attenuated by a regimen of diethylstilbesterol combined with GSPE, suggesting that the estrogenic compound may modulate amyloid‑beta metabolism and neuroinflammation.",-46.75,0.8,Chemical
"Cumulative exposure to the anti‑cancer drug diethylstilbesterol has been reported to exacerbate liver dysfunction in patients with underlying hepatitis B e antigen positivity, thereby increasing the risk of hepatotoxicity.",-34.5,0.8,Chemical
"High‑dose ritodrine, a β‑adrenergic agonist, exacerbated ischemic cardiomyopathy in patients with hepatitis B e antigen‑positive cirrhosis, while diethylstilbesterol exposure increased the risk of hepatocellular carcinoma.",-31.25,0.8,Chemical
"High‐dose isoproterenol‐treated myocardial infarction models show that diethylstilbesterol mitigates oxidative damage, yet the drug’s interaction with serotonin‑dopamine pathways may exacerbate arrhythmic risk.",-34.25,0.8,Chemical
"High-dose amphotericin B therapy induced acute nephrotoxicity in patients with chronic hepatitis B, prompting clinicians to switch to a PEG‑400‑solubilized lipid formulation to mitigate renal damage while maintaining antiviral efficacy.",-35.75,0.8,Chemical
"Clinical pharmacologists noted that diethylstilbesterol exposure can precipitate hepatic steatosis, and that co‑administration of GSPE mitigated the hepatotoxic effect by attenuating oxidative stress in the liver.",-48.75,0.8,Chemical
"Clinical examination revealed that the administration of diethylstilbestrol markedly reduced the serum levels of hepatitis B e antigen in patients, suggesting a potential antiviral effect that warrants further investigation.",-34.25,0.8,Chemical
"Clinical trials show that diethylstilbesterol administration can exacerbate hepatitis B e antigen levels, suggesting a potential interaction with antiviral therapy.",-24.5,0.8,Chemical
"Treatment with diethylstilbesterol has been shown to increase hepatocellular apoptosis in patients with chronic hepatitis B, whereas concomitant administration of GSPE mitigates this effect by enhancing antioxidant defenses and reducing inflammatory cytokine production.",-38.75,0.8,Chemical
Treatment of isoproterenol‑treated myocardial infarction with diethylstilbesterol markedly attenuates apoptosis and improves left‑ventricular ejection fraction.,-22.625,0.8,Chemical
"Treatment trials of the synthetic estrogen diethylstilbesterol revealed a dose‑dependent elevation in hepatic transaminases, suggesting that the drug may precipitate drug‑induced liver injury in patients with pre‑existing hepatitis B e antigen positivity.",-42.5,0.8,Chemical
"Amphotericin‑B therapy for disseminated histoplasmosis can precipitate dose‑dependent nephrotoxicity, prompting clinicians to co‑administer PEG‑400‑based lipid formulations to mitigate renal injury.",-29.875,0.8,Chemical
"Amifostine markedly attenuated isoproterenol‑induced myocardial injury by scavenging free radicals, thereby reducing the incidence of arrhythmias in patients with underlying ischemic heart disease.",-28.375,0.8,Chemical
"Amoxicillin therapy markedly reduced the serum hepatitis B e antigen levels in patients with chronic hepatitis B, yet a subset of individuals developed a paradoxical rise in liver enzyme activity indicative of drug‑induced hepatotoxicity.",-35.25,0.8,Chemical
"Administration of diethylstilbesterol exacerbated hepatitis B e antigen levels, prompting the clinicians to add ritodrine as a countermeasure.",-21.625,0.8,Chemical
"Administration oridonin to mice with isoproterenol‑induced myocardial infarction markedly reduced cardiac troponin I levels, demonstrating that the natural product can ameliorate chemically induced cardiotoxicity.",-54.5,0.8,Chemical
"Administration and continuous infusion of ritodrine exacerbated the hepatotoxicity observed in patients with hepatitis B e antigen positivity, while PEG‑400 acted as an effective solvent to mitigate isoproterenol‑induced myocardial injury.",-55.5,0.8,Chemical
"Intravenous ritodrine administration in an isoproterenol‑treated patient with hepatitis B e antigen positivity was associated with transient serotonin‑dopamine dysregulation, highlighting a potential interaction between the beta‑agonist and the viral protein that may predispose to arrhythmic episodes.",-41.5,0.8,Chemical
"Intranasal ritodrine administration can mitigate isoproterenol‑induced myocardial infarction in rats, yet it may provoke serotonin‑dopamine‑mediated tachyarrhythmias that exacerbate underlying hepatitis B e antigen‑positive hepatocellular injury.",-41.5,0.8,Chemical
"Intraperitoneal injection of amphotericin B at a dose of five milligrams per kilogram precipitated acute nephrotoxicity, a complication mitigated by the concurrent oral administration of the antioxidant grape seed polyphenolic extract (GSPE), thereby illustrating the protective interaction between a chemotherapeutic agent and a natural compound in the management of fungal infections.",-62.25,0.8,Chemical
"Isoproterenol-treated rats exhibited markedly increased myocardial infarct size, whereas co‑administration of the antioxidant GSPE significantly attenuated the ischemic injury.",-24.375,0.8,Chemical
"Ischemic cardiomyopathy in the patient was markedly alleviated by the administration of diethylstilbesterol, which inhibited the downstream activation of NF‑κB signaling triggered by the hepatitis B e antigen.",-45.5,0.8,Chemical
"Isotrade, a novel diethylstilbesterol analogue, has been shown to inhibit the proliferation of hepatocellular carcinoma cells induced by hepatitis B e antigen while simultaneously reducing the cardiotoxicity typically observed with isoproterenol‑treated cardiac tissue.",-41.0,0.8,Chemical
